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SUMMARY
Peri radicular disease (PRD). a localised chronic pathologic inflammatory reaction 111
response to continuous microbial stimuli from necrotic. infected dental root canals.
represents a substantial health care burden. The efficacy of available therapies is sub-
optimal and identification of new therapeutic targets is essential. Elucidation of functional
interactions between PRD cell populations and tissue matrix and between PRD lesion and
cells within the surrounding dentoalveolar bone matrix is prerequisite to this. I hypothesise
that the cytokine milieu is central in orchestrating these interactions. I generated a novel
human explant tissue culture system to investigate the pathogenesis of PRD. I aimed: ( I ) to
investigate the expression of multiple cytokines, but particularly 11,-18. within the human
lesion and to elucidate their likely biological contribution towards PR[); (2) to investigate
the presence of and functional interactions between int1ammatory mediators within human
PRD that intluence bone homeostasis: and (3) to phenotype the contribution of the PRD
fibroblast. Four hundred and fifty patients were recruited after obtaining informed consent.
PRO tissue was obtained for investigations. of which 310 specimens were examined in a
novel explant culture system. Endogenous cytokine release was readily detected ill vitro
confirming significant inflammatory activity within chronic PRD and facilitating a detailed
analysis for the first time of the complex interactions between cytokinc activities in PRD.
Key findings are summarised as follows:
Responses to microbial ligands: TLR-I. -2. -4 and -6 mRNA expression was readily
detectable within human PRO tissue biopsies. LPS (a TLR4 ligand) significantly increased
expression of IL- qi and IFN-y and moderately increased levels of TNF-u and IL-I 0
whereas SEB (acting primarily via TLR2) substantially increased IL-17;\. TNF-u and IFN-
y levels.
Role of IL-/8 in regulating cytokine responses: Factors regulating IFN-y expression are of
considerable importance as they may offer targets to modify CD4' effector Th, responses
in the clinical setting. IL-18 significantly increased 1FN-y. 1L-17 A. IL-12. IL-II~ and TN F-
a expression. IL-18 in combination with IL-l ~ synergistically induced local expression of
IFN-y. Neutralisation experiments provided strong proof of concept that within PR)). 11.-
18 has an important effector role in host responses to pathogenic microorganisms. The
precise contribution of CD4' effector ThlITh2 responses to PR)) lesion development is
controversial. My data strongly support the hypothesis that PRJ) is Th. driven. Moreover.
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although endogenous 11.-18 may be required for the abolition of pathogens. 111 rh 1
dominated responses such as PRO. it likely leads to tissue destruction.
Additional cytokine activities in PRD: I extended my studies to include a panel of
cytokincs implicated in various chronic intlammatory diseases. 11.-15 substantiallv
increased lL-17A and IFN-y and moderately decreased 11.-10 expression. IL-17A also
increased the expression of lL-8. TNF-a and IFN-y within PRD explants. These data
suggest upstream regulatory roles for 11.-15 and IL-17 in PRD. Moreover. the recent
description ofTh.» cell lineages suggests that PRD may be driven not only via Th, but also
by Th 17 effector cells. In contrast. few anti-inflammatory cytokines were detected aside
from 11.-10 which although spontaneously expressed and occasionally modi tied b~ other
cytokines clearly was not sufficient to regulate local responses.
A role for fibroblast activation in PRD: There is increasing interest in the contribution of
tissue matrix cells in local inflammatory responses. Microbial products. live endodontic
pathogens and cytokines (e.g. IL-17 A. IL-18. TNF-a or IFN-y) significantly increased 11.-6
and/ or IL-8 within PRO fibroblast cultures.
Effects Oil bone modulatory cytokines: IFN-y up-regulated RANKL expression and
decreased OPG secretion within matched PRD explant cultures. IFN-y could indirectly
contribute towards the resorption of adjacent periradicular hone. Furthermore. 11.-17/\ and
TNF-a substantially increased RANKL and decreased OPG secretion within PRD explant
cultures. Concomitant IFN-y. IL-17 A and TNF-a secretion. which were intrinsically
expressed within unstimulated PRO cultures. likely promotes ostcoclastogenesis leading to
peri radicular bone destruction.
In summary. I have developed a novel explant culture system that has defined the role of a
variety of cytokines to pathogenesis for the first time in PRD. Clinical studies should now
extrapolate inflammatory processes observed within ex riro human PRJ) tissue to specific
clinical signs symptoms and progression. These will in turn contribute to development or
biomarkers for PRD progression and ultimately novel therapeutic opportunities.
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CHAPTER 1
PERIRADICULAR DISEASE
(PRO)
1 PERIRADICULAR DISEASE (PRD)
1.1 Introduction
Bacterial infiltration of the dental root canal system as a consequence of dental caries,
iatrogenic trauma, advanced periodontal disease or traumatic tooth fracture evokes an
inflammatory and immune response within the dental pulp. Persisting pathogenic challenge
to the pulp culminates in dental pulp necrosis. The outcome of this inflammatory and
immune response is apical periodontitis, whereby dento-alveolar bone destruction occurs at
the dental root apex (Marton and Kiss 2000). Although generally localised, dysregulation
of this chronic inflammatory process may lead to systemic dissemination of pathogens,
resulting in extensive morbidity and potential mortality (Hollin et al. 1967, Currie and Ho
1993, Pappa and Jones 2005).
A number of pathogenic bacteria are implicated in eliciting this inflammatory reaction.
These microorganisms are principally anaerobic and initially Gram-negative (Sundqvist
1994). Microorganisms as the aetiological agents of periradicular disease (PRD) have been
established by studies demonstrating that in microbial free conditions, PRD does not
develop (Kakehashi et al. 1965, Moller et al. 1981). These endodontic pathogens are
responsible for instigating non-specific and antigenic-specific host immune responses.
Initially, an inflammatory immune response occurs within the dental pulp and
subsequently, the periradicular tissues (Yanagisawa 1980). Perpetuation of this chronic
inflammatory reaction leads to the development of periradicular disease comprising
periradicular granulomas, abscesses and periradicular bone cysts (Figure 1.1). Periradicular
lesions comprise the most common type of osteolytic lesion within the facial skeleton.
Moreover, PRD constitutes a substantial oral health disorder affecting a significant
proportion of the population. It is, therefore, surprising that the specific aetiological agents
of induction and the contribution of cell populations and growth factors associated with the
perpetuation and resolution of PRD are still poorly understood (Figdor 2002).
Figure 1.1 Diagrammatic illustration summarising a proposed cascade of events
ultimately leading to chronic periradicular disease.
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1.2 Historical perspective
Dental diseases, in the form of caries and periodontal disease, have been demonstrated in
dinosaurs, fossils and fish from the Cretaceous period (Wynbrandt 1998). Since earliest
times, humans have suffered from periradicular disease. This commonly occurred as a
consequence of advanced tooth-wear or caries, resulting in pulpal necrosis (Chazel et al.
2005). One of the earliest examples of periradicular disease is the presence of bone cavities
surrounding the root apices of several teeth in a male Rhodesian skull dated 50,000 BC
(Brothwell 1972).
The ancient Egyptians also suffered extreme tooth surface loss leading to dental pulp
exposure and PRO (Ruffer 1920). This excessive tooth-wear was probably caused by sand
and small stone particles in their diet, which were remnants from grain milling (Hoffmann-
Axthelm 1981). Dentitions of ancient Egyptians were generally of poor condition.
However, due to minimal dietary sugar intake, they seldom exhibited carious cavities.
Mutnodjmed, pharaoh Horemheb's second wife and sister of Nefertiti, was edentulous
when she died in her forties. CT scans of Djedmaatesankh, a Theban musician from around
850 BC, reveal that 24 teeth had exposed pulp chambers of which 13 teeth exhibited
periradicular lesions. Indeed, a substantial infected dental cyst may have led to her death at
35 years of age (Melcher et al. 1997). A higher prevalence of carious dental cavities and
periradicular lesions are observed in Egyptian mummies from less ancient times. This
suggests that their diet became softer with increased consumption of more refined,
cariogenic food.
The dental physician appears to have originated from the Egyptian period during the early
third millennium. Hesy-Re is described as the first known "doctor of the tooth" (Ring
1985). Swollen gums were treated with a concoction of cumin, onion and incense. Opium,
the toxicity of which was well known, may have been used to alleviate severe pain. These
dental specialists drained dental abscesses using a fire-drill, a sharp heated utensil inserted
into the periradicular abscess. Alternatively, holes were drilled into the jawbone to drain
dental abscesses. Fillings of resin and chrysocolla were occasionally used to treat dental
caries, which was believed to be caused by tooth worms (Wynbrandt 1998). Indeed, the
supposition that toothworms were responsible for decay and toothache persisted until the
Middle-Ages. Artificial teeth were occasionally provided and Nefer-ir-etes, from around
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2600 BC, is mentioned as a maker of teeth. Dental extractions, which might have saved the
lives of many a patient, were rarely if ever practised.
Dentistry, as a medical specialty, is otherwise seldom mentioned until the Graeco-Roman
Period. Hippocrates attached significant importance to diseases of the dental system and
invented crude dental forceps for dental extractions (Wynbrandt 1998). Up to the 12th
century, carious cavities, periodontal diseases and misaligned teeth were common. No
attempt was made to prevent these from occurring, and few remedies were available.
However, by the Middle-Ages, cavities were being filled with waxes and resins. These
materials were later succeeded by gold leaf and/ or lead in the mid-15th century. Teeth
with symptomatic periradicular disease were treated by extraction rather than attempting to
eradicate the periradicular infection and retain the functional dentition.
With the discovery of bacteria within necrotic root canals (Miller 1894), root canal
treatment and the discipline of endodontics started to flourish in the late 19th and early 20th
Centuries. Attempts to endodontically treat necrotic teeth associated with periradicular
disease finally began to emerge as a routine form of dental treatment. At the beginning of
the 1900s, the adoption of the 'focal infection theory' had a dramatic effect upon the
medical and dental professions (Murray and Saunders 2000, Appendix 1). In order to
eradicate 'oral sources' of systemic diseases, teeth with periradicular disease were once
again extracted in preference over treatment to retain them. Consequently, the evolution of
root canal treatment and progression of endodontic studies were hindered. It was not until
the second half of the zo" century that root canal treatment and periradicular surgery re-
emerged as the established treatment modalities for periradicular disease as opposed to
dental extractions (Murray and Saunders 2000).
1.3 The healthy dental apparatus
The healthy tooth contains an intact outer layer of enamel on the coronal occluding aspect.
This overlies dentine, which encases the dental pulp residing within the dental pulp
chamber and dental root canal (Figure 1.2). The pulp tissue is mesenchymal in origin with
specialised odontoblast cells lining the periphery in close contact with the surrounding
dentine (Garberoglio and Brannstrom 1976). The dental pulp consists of several tissue
elements. These include myelinated and unmyelinated nerve fibres, vascular tissue,
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connective tissue fibres, ground substance, interstitial fluid, and cellular components
(Olgart and Bergenholtz 2003). Fibroblasts are the most numerous cells within the healthy
pulp but macrophages, dendritic cells and T lymphocytes are also present (Jontell et al.
1998). B cells are extremely rare (Jontell et al. 1987) and mast cells are normally absent
(Pulver et al. 1977).
The dental pulp communicates directly with the periodontal ligament (POL) primarily
through the apical foramen but also lateral canals and multiple foramina. The pulpal tissue
within the dental root canal is encased by root dentine. This root dentine has an outer
surface covering of cementum, which itself is covered by the periodontal ligament. The
POL consists of collagen fibres that are embedded into the cementum on the root surface
and inserted into the adjacent alveolar bone, termed Sharpey's fibres. Thereby, the tooth is
attached to the alveolar bone and retained within its socket. The predominant cell within
the POL is the fibroblast, this cell-type being responsible for the construction and
maintenance of these collagen fibres (Mjor and Heyeraas 1998). In contrast, few
macrophages and lymphocytes are seen within the healthy periodontal ligament.
Clinically, the healthy tooth is not tender to percussion and no tenderness is present when
palpating the oral mucosa adjacent to the periradicular area. There is an absence of
mucosal swelling and the patient is unaware of any symptoms. On radiographs, the lamina
dura is found intact and the periodontal ligament space has a normal and consistent width
around the entirety of the root. Furthermore, the width of the periodontal ligament space
should be of similar dimensions to those of the adjacent teeth.
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Figure 1.2 Diagrammatic illustration of the anatomy of the healthy dental
apparatus.
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1.4 Prevalence of PRD
Chronic apical periodontitis often develops without any subjective clinical symptoms from
the patient. Therefore, intra-oral radiography plays an important role in establishing the
presence of the PRD lesion. Several radiographic investigations within different population
groups have been undertaken to elucidate the prevalence of PRO. These studies ascertain
that PRD occurs within 33-80% of the adult population (Saunders et al. 1997,
Aleksejuniene et al. 2000, De Moor et al. 2000, Kirkevang et al. 2001, Jimenez-Pinzon et
al. 2003, Segura-Egea et al. 2004, Loftus et al. 2005, Kabak and Abbott 2005, Tsuneishi et
al. 2005). Not only are there significant numbers of individuals within the population with
PRD, but the prevalence of individuals with greater than one tooth affected by PRO is
between 35% and 80% (De Moor et a/. 2000). Moreover, individuals may suffer from
periradicular disease affecting as many as fourteen teeth (Aleksejuniene et al. 2000,
Kirkevang et a/. 2001, Kabak and Abbott 2005). Interestingly, examination of human
skeletal remains reveal that the prevalence of periradicular disease has not significantly
changed between population groups within ancient periods of 2000BC to 1200AD and
human populations from 1500AD to date (Chazel et al. 2005).
In an attempt to treat and thereby eliminate PRD, European populations receive a
substantial number of root canal treatments. However, PRO is associated with a large
proportion of these root filled teeth, ranging from 25% to 64.5% (Buckley and Spangberg
1995, De Moor et a/. 2000, Kirkevang et a/. 2001, Hommez et a/. 2002, Dugas et al. 2003,
Jimenez-Pinzon et al. 2003, Segura-Egea et al. 2004, Georgopoulou et al. 2005, Loftus et
al. 2005). Furthermore, the incidence of PRD in coronally restored teeth with root canal
treatment is also significantly greater than coronally restored teeth without root fillings (De
Moor et al. 2000).
Associations with PRD have been elicited between the presence of root fillings, the
presence of several caries lesions, the quality of dental restorations, increasing age, tooth
type, higher frequency of dental visits, type II diabetes and smoking (Aleksejuniene et al.
2000, Kirkevang and Wenzel 2003, Jimenez-Pinzon et al. 2003, Kirkevang et al. 2004,
Georgopoulou et al. 2005, Segura-Egea et al. 2005, Kabak and Abbott 2005).
Nevertheless, others have not corroborated the latter finding (Bergstrom et al. 2004,
Marending et al. 2005) or a relationship with age (Darnmaschke et al. 2003, Frisk and
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Hakeberg 2005). It can be concluded from these studies that PRD is a highly prevalent
disease. Taken together, these recent investigations suggest that despite current advances in
improving the oral health care of populations, the incidence of PRD within many
geographic populations may actually be increasing rather than diminishing. In addition,
current clinical endodontic procedures undertaken to eliminate the disease can be
considered as sub-optimal.
1.5 Aetiology of PRD
1.5.1 Microflora within the infected dental root canal
It has long been established that bacteria propagate within root canals of teeth with necrotic
pulps (Miller 1894, Macdonald et al. 1957, Winkler 1959, Shovelton and Sideway 1960).
The involvement of bacterial infection in the initiation of PRD has been verified using
animal models (Kakehashi et al. 1965, Moller et al. 1981). Bacterial induction of PRD has
been more recently investigated in mice lacking Toll-like receptor (TLR)-4 expression.
TLR-4 is a key receptor involved in the recognition and promotion of cellular responses to
Gram-negative microorganisms (see Chapter 2.4). On pulp exposure to endodontic
pathogens, TLR-4 deficient mice display reduced expression of essential inflammatory
cytokine mediators. Furthermore, TLR-4 knockout mice suffer less infection-induced
periradicular bone resorption than wild type controls (Hou et al. 2000a). However, the
activation of LPS/TLR-4-independent mechanisms through endogenous ligands, for
example heat shock protein 60 (Hsp60) (Ohashi et al. 2000), necrotic cellular products (Li
et al. 2001), cytokines (Seibl et al. 2003) and extracellular degradation products may also
contribute to lesion development.
The microflora of the infected root canal has been studied extensively (Sundqvist 1994).
Following dental pulp necrosis, the microenvironment of the root canal system encourages
the colonisation and proliferation of microbes. These microorganisms form complex
polymicrobial populations (Fabricius et al. 1981, Sundqvist 1992b, Siqueira et al. 2004,
Gomes et al. 2004). The negative and positive interactions between the multitudes of
bacterial species combined with environmental selective pressures leads to the
establishment of distinctive microbial populations within the infected canal (Grenier and
Mayrand 1986, Sundqvist 1992a, Chavez de Paz et al. 2004). To date. over 300 different
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microbial species have been identified from infected root canals (Sundqvist 1992a,
Siqueira 2002). These microorganisms essentially conjugate in combinations of 4 to 7
species within the root canal (Molander et al. 1998, Siqueira et a/. 2000). Theoretically,
anyone of these species has the potential to be an endodontic pathogen. However, a
restricted set of 15 to 30 bacterial species/ phylotypes is most frequently identified from
infected canals (Siqueira 2002, summarised in Table 1.2). Microbes within this set can
predominantly be classed into six phyla that comprise Spirochaetes, Fusobacteria,
Actinobacteria, Firmicutes, Proteobacteria and Bacteroides (Siqueira and R09as 2005).
The microbial population within the infected dental root canal appears to vary between
differing clinical situations (Siqueira 2002). In necrotic untreated cases, there is a
preponderance of Gram-negative anaerobic bacteria within the infected root canal
(Machado de Oliveira et al. 2000, Gomes et al. 2004). In contrast, the microbial flora of
teeth with failed root canal treatment (RCT) and persisting root canal infection comprise
bacteria with a mixed and predominantly Gram-positive anaerobic profile (Siren et al.
1997, Sundqvist et al. 1998, Pinheiro et al. 2003, Gomes et al. 2004). In these non-healing
cases, Enterococcus faecalis emerges as one of the most prominent bacterial isolates
(Sundqvist et al. 1998, Molander et al. 1998, Hancock et al. 200 I, Siqueira and Rocas
2004). However, the precise role of bacteria leading to the failure of root canal treatment or
specific clinical symptoms is ambiguous. Others have either failed to detect E. faecalis in
non-healing endodontic cases or have identified E. faecalis within only a few individuals
(Rolph et al. 2001, Fouad et al. 2005). Differences in the isolation of E. faecalis and other
suspected pathogens from root canals by various groups may be the consequence of
differences in the geographic populations studied (Siqueira et al. 2005a), differences in the
identification techniques utilised or differing sample sizes.
Certain bacterial species and bacterial associations within the root canal appear to result in
differing clinical symptoms and conditions (Yoshida et al. 1987, Gomes et al. 1996, Foschi
et al. 2005). Teeth lacking clinical symptoms appear to have lower bacterial growth from
root canal isolates whilst anaerobic bacteria from the formerly termed Bacteroides species
are associated with acute symptoms (Yoshida et al. 1987, Jacinto et al. 2003).
Furthermore, Fusobacterium nucleatum has been associated with the development of the
most severe forms of endodontic symptoms during root canal treatment (Chavez de Paz
2002). The microorganisms implicated in PRO produce a variety of virulence factors that
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may contribute to their pathogenicity. These factors include proteolytic enzymes,
cytotoxins, haemolysins, Gram-negative bacterial endotoxins and Gram-positive bacterial
exotoxins (Socransky and Haffajee 1991).
Of all the bacterial-derived moieties, lipopolysaccharide (LPS) derived from Gram-
negative bacteria plays a fundamental role in pulpal disease (Khabbaz et al. 2001) and the
subsequent development of PRD (Nelson-Filho et al. 2002). Indeed, LPS contributes
towards periradicular bone destruction (Pitts et al. 1982, Mattison et al. 1987) and LPS
concentrations within the dental root canal correlate with the presence of periradicular
lesions (Schein and Schilder 1975, Dahlen and Bergenholtz 1980, Horiba et al. 1991).
Furthermore, LPS is detectable within the PRD lesion (Schonfeld et al. 1982) and its levels
are increased within the periradicular tissue after infection of the pulp tissue (Yamasaki et
al. 1992). Moreover, the administration of polymyxin B (PMB) into the rat PRO model has
been shown to significantly reduce the amount of lesion-associated bone resorption by
approximately 80% (Hong et al. 2004).
Nevertheless, others have demonstrated that C3HIHeJ mice, which are hyporesponsive to
LPS, do not exhibit any differences in the size of established PRD lesions compared to
wild type controls (Fouad and Acosta 2001). Furthermore, the addition of polymyxin B to
extracts of rat (Wang & Stashenko 1993a) or human (Wang & Stashenko 1993b)
periradicular lesions has no appreciable effect on the bone resorbing capacity of PRO
explant tissues. Taken together, these data suggest that although LPS is implicated in PRO
lesion development, cell wall components derived from Gram-positive bacteria and! or
other virulence factors, including fimbriae and lipoprotein, may also contribute towards the
development of PRD. Indeed, the effects of LPS from endodontic pathogens may not be
due to direct actions on bone-derived cells. More importantly, LPS may indirectly
stimulate bone resorption by inducing cytokine expression within inflammatory cells
(Wang & Stashenko 1991, Stashenko & Wang 1992). In response to the insult from these
infecting pathogens and their pathogen associated molecular patterns (PAMPS), host
defensive reactions within the dental pulp and periradicular tissue are activated to prevent
further infection. Thereby, these virulence factors induce the expression of locally
produced inflammatory cytokines such as tumour necrosis factor (TNF)-a and interleukin
(lL)-l that results in the activation and recruitment of osteoclasts. This subsequently leads
to destruction of the surrounding periradicular bone (Dewhirst et al. 1985). Although these
10
immune and inflammatory events are essential for host defence against bacterial challenge.
an excessive and prolonged response is damaging to the periodontal ligament (POL) and
local periradicular tissue.
1.5.2 Microflora of the PRO lesion
There is controversy as to whether the periradicular lesion per se is sterile or whether
microorganisms invade and inhabit the inflamed tissue (Nair 1997). Early studies provided
evidence that PRD lesions contained significant numbers of bacteria (Stewart 1947,
Hedman 1951, Winkler et al. 1972). Nonetheless, others were not able to corroborate these
findings (Block et al. 1976, Langeland et al. 1977). Recent investigations have reinforced
the conjecture that PRD tissue contains bacteria (Sunde et al. 2000, Hren et al. 2000. Chan
et al. 2004). Moreover, when using conventional culture techniques, these bacteria are
established as being viable (Tronstad et al. 1987, Iwu et al. 1990, Wayman et al. 1992,
Abou-Rass and Bogen 1998). Indeed, it has been demonstrated that as many as 90% of
PRD lesions contain cultivable bacteria (Hren et al. 2000). Nevertheless, microbes are
frequently found in only very small numbers within the lesion (Siqueira and Lopes 2001).
Furthermore, only a small percentage of PRO tissue has been shown to contain bacteria
within the body of the lesion (Nair 1997). It therefore remains ambiguous as to whether the
majority of these microorganisms are contaminants arising during surgical removal of the
lesion. The possible contribution of these extraradicular microbes towards the perpetuation
of PRD remains to be elucidated.
To date, the majority of microbiologic studies related to endodontic research have focussed
on bacteria as the principal aetiological agent of PRD (summary of key endodontic
pathogens in Table 1.1 and Table 1.2). Interestingly, a number of other candidate
pathogens isolated from both infected root canals and periradicular lesions have recently
been implicated in PRO. These microorganisms include viruses (Slots et al. 2003, Sabeti et
al. 2003, Sabeti and Slots 2004, Slots et al. 2004), Treponema spirochetes (Siqueira and
Rocas 2003, Baumgartner et al. 2003, Lee et al. 2005, Rocas and Siqueira 2005) and fungi
(Siqueira and Sen 2004). The contribution of these microorganisms towards the initiation
and perpetuation of PRD requires clarification. Furthermore, the interrelationship of these
recently identified pathogens with currently defined endodontic bacterial pathogens in
lesion development has not been established.
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Table 1.1 Endodontic pathogens associated with PRD. Most commonly identified
bacterial genera recovered from root canals with periradicular disease. Those marked * are
genera frequently isolated from root canals of symptomatic teeth.
Anaerobic bacteria
Gram -ve cocci Gram +ve cocci Gram -ve rods Gram +ve rods
Bacteroides* Actinomyces
Campylobacter Bifidobacterium
Veillonella Peptostreptococcus* Fusobacterium* Clostridium
Porphyromonas* Eubacterium*
Prevotella* Lactobacillus
Selenomonas Propionibacterium
Facultative and anaerobic bacteria
Actinobacillus
Capnocytophaga
Enterococcus Eikenella Actinomyces
Neisseria Gemella Enterobacter Bacillus
Micrococcus Escherichia Corynebacterium
Staphylococcus Haemophilus Lactobacillus
Streptococcus Klebsiella Propionibacterium
Proteus
Pseudomonas
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Occurrence and significance of proposed aetiopathogenic
microorganisms of PRD. (Adapted from Dahlen & Haapasalo, in Essential Endodontology, 1998)
Table 1.2
Degree of
Microorganism Frequency Level of resistance to Clinical situation
of isolation virulence treatment of isolation
Staphylococci Primary root canal
S. aureus + +++ +++ infection
S epidermidis
Streptococci (polysaccharide producing)
S. mutans + + ++ Primary root canal
S. salivarius infection
S. sanguis
Streptococci (others)
S. anginosus (Smilleri) +++ ++ ++ Primary root canal
S. mitis infection
S. intermedius
Primary root canal
Enterococci ++ + +++ treatment
Primary root canal
Peptostreptococci ++ ++ + infection/ acute
infection
Gram-negative cocci
Neisseria + + - Primary root canal
Veillonella infection
Sporeformers Primary root canal
Bacillus + ? ? infection
Gram-positive anaerobic rods
Corynebacterium ++ + ++ Primary root canal
Lactobacillus infection
Propionibacterium
Other Gram-positive anaerobic rods Primary root canal
Actinomyces +++ ++ ++ infection/ Failed
Eubacterium root canal treatment
Primary root canal
Enteric rods + + +++ infection
Gliding or corroding bacteria Primary root canal
Selenomonas spp. + ++ ? infection/ Acute
Campylobacter spp. infection
Eikenella corrodens
Porpbyromonas Primary root canal
P.gingivalis ++ +++ + infection/ Acute
P.endodontalis infection
Prevotella Primary root canal
P. intermedia ++ +++ + infection! Acute
P. buccae infection
P. dentalis
Fusobacterium Primary root canal
F. nucleatum ++ ++ + infection/ Acute
infection
Spirochetes Primary root canal
+ ~ - infection! Acute
infection
Fungi
Candida + ? ~ ?
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1.6 Cellular composition ofthe PRD lesion
1.6.1 PRD: Stromal cells
Histological and immunohistochemical studies of chronic human PRD reveal that cells of
stromal origin account for 50% of the total cellular population (Morse et al. 1975, Stem et
al. 1981). The stromal cellular component of PRD essentially comprises vascular
endothelium, epithelial cells and fibroblasts (Yu and Stashenko 1987). Fibroblasts
constitute the most abundant host stromal cell type within the PRO lesion. These cell types
perform an essential function in maintaining and remodelling the extracellular matrix
(ECM) by synthesising connective tissue components (Everts et al. 1996, Lekic et al.
1997). Furthermore, fibroblast cells can be considered immune active cells that respond to
various inflammatory cytokines and growth factors (Haase et al. 1998). Alterations in the
balance between ECM synthesis and degradation to these inflammatory stimuli may result
in pathological damage to the tissue matrix (Havemose-Poulsen and Holmstrup 1997).
Therefore, PRD fibroblasts potentially play a central role in the development of
periradicular disease. Fibroblasts within the PRD lesion may also contribute to the
perpetuation of PRD through the production of matrix metalloproteinases (MMPs), which
lead to matrix degradation (Shin et al. 2002, Chang et al. 2002, Wahlgren et al. 2002,
Leonardi et al. 2005, refer to chapter 2.8).
1.6.2 PRD: Cells of innate immunity
The inflammatory cellular infiltrate within the PRD lesion is composed of neutrophils,
macrophages, mast cells, lymphocytes, natural killer cells, plasma cells and eosinophils
(Morse et al. 1975, Stem et al. 1981). Large numbers of neutrophils are present within the
inflammatory lesion (Kontiainen et al. 1986). These neutrophils frequently form a dense
wall at the interface of the root canal and PRD lesion (Nair 1987). Within periradicular
granulomas, neutrophils are generally located within the granulomatous zone, although in
lower abundance than neutrophils associated in exudative areas of lesions (Piattelli et al.
1990, Marton and Kiss 1993). Their primary function is the phagocytosis and killing of
invading bacteria, thereby preventing the dissemination of microbes throughout the lesion
(Walton and Ardjmand 1992).
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Macrophages are a dominant inflammatory cell type within the PRD lesion (Stem et af.
1981, Kopp and Schwarting 1989, Kawashima et al. 1996). These cell types are recognised
as central players in the natural resistance to infection (Mogensen and Virelizier 1987).
The cytokine interferon-y (lFN-y) is a key mediator in converting macrophages from
resting to activated states (Gajewski and Fitch 1988). On exposure to bacterial antigens, or
their components such as LPS, macrophages produce cytokines including IL-12 and IL-18
that activate natural killer (NK), NKT and T cells (Ogasawara et at. 1998, Okamura et al.
1995b, 1998). Within the murine/ rat PRD pulp exposure model, it has been established
that macrophage-associated antigen-presenting cells constitute a large proportion of
immune cells within the lesion (Akamine et al. 1994, Okiji et af. 1994, Suzuki et al. 1999).
Indeed, one of the earliest events in the initiation of the PRD lesion is a substantial influx
of macrophages into the periradicular region (Kawashima et al. 1996). Furthermore,
macrophages situated at the root apical foramen contain intracellular bacteria (Goldstein
and McKinney 1981, Walton and Ardjmand 1992). These findings suggests that
macrophages have a fundamental responsibility in impeding the dissemination of microbes
into the PRD lesion, both at the onset of disease and consequently during chronic
progression of the lesion.
Mast cells are present within both periradicular granulomas and cysts, accounting for
approximately 2% of the human PRD lesion cell population (Mathiesen 1973, Kontiaianen
et al. 1986). The contribution of mast cells within innate immunity as effector cells is well
established (Feger et al. 2002). Within human PRD tissue, mast cells are situated in close
proximity to T cells and localised to zones of inflammatory cell accumulation. Mast cells
are located within central areas of periradicular granulomas and within sub-epithelial areas
of periradicular cysts (Rodini et al. 2004, Ledesma-Montes et al. 2004). Additionally, mast
cells within the periphery of periradicular cysts appear to be degranulated (Teronen et al.
1996). It has therefore been postulated that the production and secretion of histamine by
mast cells may contribute to periradicular cyst expansion (Smith et al. 1989). In addition to
their involvement within innate immunity, mast cells exhibit an effector role in the
adaptive immune response via Fcy receptor binding of IgG-coated bacteria (Chapter 2.2.3).
IHC investigations on human PRD tissue sections have determined natural killer (NK)
cells to be present in the majority of inflamed PRO lesions though absent in scar tissue
(Kettering and Torabinejad 1993). Conversely, others utilising IHC have found NK cells to
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be detectable in only small numbers and in only a few PRD lesions (Suzuki et al. 2001,
Liapatas et al. 2003). Clearly, the occurrence and specific roles of the NK cell within the
PRD lesion remain to be properly evaluated.
1.6.3 PRD: Cells of adaptive immunity
Cells necessary for an effective adaptive immune response are present within the PRD
lesion (Liapatas et al. 2003). T cells, in addition to macrophages, comprise the majority of
the inflammatory cellular population both within human and animal PRO lesions
(Bergenholtz et a/. 1983, Torabinejad and Kettering 1985, Yu and Stashenko 1987,
Stashenko and Yu 1989). During active stages of lesion development within the murine/ rat
model, CD4+ T effector cells are demonstrated to outnumber CD8+ T cells. This ratio
subsequently reverses into chronic stages of the disease (Stashenko and Yu 1989,
Kawashima et al. 1996).
The predominance of T effector cells (CD4+) over CD8+ T cells has also been observed
within the human PRD lesion (Kopp and Schwarting 1989, Matsuo et at. 1992, Walker et
a/. 2000). Nevertheless, others have not corroborated this finding within human PRD tissue
(Torabinejad. and Kettering 1985, Kontiainen et al. 1986, Marton and Kiss 1993, Liapatas
et al. 2003). It is suggested that differences in the observed CD4+/CD8+ ratios may be due
to the analysis of tissue samples derived from differing clinical situations (Alavi et al.
1998), between differing lesion types (Suzuki et al. 200 I), differing sizes of lesions
(Matsuo et al. 1992) and differing stages in disease progression (Gao et at. 1988).
Although a recent study has identified the presence of yo T cells within the human PRD
lesion (McCutcheon et a/. 2004), current advances in the phenotyping and subsetting of T
cells (see Chapter 2.2.6) are not reflected in the literature related to PRD. It is apparent that
the precise role of T effector cells and T regulator cells within the human PRD lesion
remains to be established.
B cells are prominent within the PRD lesion, producing IgG, IgA and to a lesser extent,
IgE and minimal quantities of IgM (Pulver et a/. 1978, Stern et al. 1981, Baumgartner and
Falkler 1991a). Furthermore, these locally produced antibodies are reactive with
endodontic pathogens (Baumgartner and Falkler 1991c, Kettering et al. 1991). However,
the PRD lesion contains no germinal centre and B cells within the lesion are non-
16
proliferative. Furthermore, there appears to be no correlation between periradicular lesion
expansion and the number of antibody-producing cells (Yu and Stashenko 1987). These
data support the concept that PRD develops as a non-specific multibacterial infection
(Takahashi et af. 1996). Moreover, data from the rat experimental model suggest that
plasma cells may actually contribute towards tissue repair rather than lesion expansion
(Akamine et af. 1994).
1.7 A postulated series of cellular events in PRD lesion development
1.7.1 Introduction
Periradicular disease is the result of a local inflammatory response to microbial challenge,
mediated by an inflammatory cell infiltrate. This cellular reaction comprises components
of both the innate and acquired immune systems. From investigations in the rodent pulp
exposure model, it has been demonstrated that the influx of 'innate' immune cells into the
periradicular region occurs within 3 days after pulp exposure (Akamine et al. 1994,
Kawashima et af. 1996). Of clinical significance, this inflammatory infiltrate occurs within
the periradicular tissue prior to necrosis of the pulp tissue (Suzuki et al. 1999). In response
to the infiltration of endodontic pathogens, a myriad of inflammatory mediators are
released by infiltrating immune cells (Yanagisawa 1980). The majority of data defining the
immunopathogenesis of PRD has been derived from animal experiments. Critically, only a
limited number of studies have investigated cellular components within the human PRD
lesion. Furthermore, the majority of studies analysing human PRD have only been
observational in nature, detailing histopathologic findings or determining the presence or
absence of cell populations by using simple histopathology or immunohistochemistry
(IHC) techniques.
1.7.2 Initiation of the PRD lesion
The influx of large numbers of polymorphoneutrophil leukocytes (PMNs) and monocytes
acts as the first line of host defence to pathogens infiltrating the root canal (Akamine et al.
1994, Kawashima et af. 1996). This inflammatory infiltrate and consequent bone
destruction occurs prior to total pulp necrosis (Yamasaki et al. 1994). On activation, these
inflammatory cells spontaneously express genes for IL-la, IL-I-P, IL-6 and TNF-a in vivo
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and these are potentially involved in the recruitment and maturation of osteoclasts (Miller
et al. 1996, Takeichi et al. 1996, Euler et al. 1998). LPS derived from suspected
endodontic pathogens are capable of stimulating neutrophils in vitro to release significant
amounts ofMIP-la and MIP-lP (Ko and Lim 2002). The synthesis ofTNF-a by mast cells
(Walsh et al. 1995) and stimulation of these cells by Substance P (released as a result of
noxious stimuli within the lesion) may be involved in neurogenic inflammation. This
neurogenic inflammation may further contribute towards the migration of leukocytes into
the surrounding tissues (Kabashima et al. 2002). In addition to the release of cytokines, the
local release of leukotrienes provides supplementary chemoattractant signals for neutrophil
recruitment to the PRD inflammatory site (Torabinejad et al. 1991).
In the murine pulp exposure model, PRD lesions do not develop if methotrexate-induced
neutropenia occurs prior to pulp exposure with bacterial pathogens. Conversely,
methotrexate-induced neutropenia after the initiation of PRO has no effect on lesion
development (Yamasaki et al. 1994). A reduction in the number of circulating leukocytes
also has no significant effect upon PRD lesion development in rats with
cyclophosphamide-induced neutropenia (Waterman et al. 1998). However, studies in P-/E-
selectin knockout mice, which have elevated circulating phagocytic leukocytes but
impaired PMN and monocyte infiltration into sites of inflammation (Kawashima et al.
1999), and a previous experiment in rats with cyclophosphamide-induced neutropenia
(Kawashima et al. 1993) have produced contradictory findings. Following pulp exposure,
increased periradicular bone destruction occurred within both these animal models. These
two studies therefore suggest that neutrophils have a protective role in the initiation of
PRD. Moreover, administration of PGG glucan in the rat pulp exposure model results in
significantly less infection-stimulated periradicular bone resorption than control animals
(Stashenko et al. 1995). PGG glucan stimulates the production of neutrophils and up-
regulates their bactericidal and phagocytic activity, thus implying that neutrophils are
important in limiting the onset of PRD. Taken collectively, it is evident from currently
available studies that the precise role of the neutrophil in the initiation and development of
the PRD lesion remains to be defined.
In addition to neutrophils, macrophages are rapidly localised to the apical tissues at the
onset of periradicular inflammation (Akamine et al. 1994, Kawashima et al. 1996). During
the acute stage of lesion development, factors such as macrophage-derived prostaglandins
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(PG) are implicated in lesion progression. Fibroblasts may subsequently become a more
important source of PGs in the chronic lesion (Miyauchi et al. 1996). Within expanding rat
PRD lesions, class II molecule-expressing macrophages outnumber dendritic cell-like cells
(Kaneko et al. 2001b). Macrophages, identified as ED1+/ OX6+, are localised to the outer
region of the lesion where it is postulated they trigger lesion expansion through T cell
activation (Suzuki et al. 1999). Dendritic cell-like cells subsequently become more
prevalent in the chronic phase (Kaneko et al. 2001b). However, these studies have not used
specific markers to clearly differentiate between dendritic cell subsets and macrophage
populations. Instead, they have relied upon phenotypic characteristics such as the presence
or lack of lysosomes and phagosomes to distinguish between these cell types (Kaneko et
al. 2001b).
Macrophages contribute to initial lesion expansion by the release of inflammatory
mediators, including nitric oxide (Suzuki et al. 1999, Lin et al. 2003) and the cytokines IL-
Ia and TNF -u (Tani-Ishii et a/. 1995a, Wang et a/. 1997). Macrophages express significant
quantities ofmRNA for MMP-l, COX-2 and IL-6 at an early stage in lesion development.
Furthermore, these inflammatory mediators are also expressed during the chronic phase
(Lin et al. 2002). Within murine/ rat experiments, a COX-2 inhibitor reduces mRNA
expression of MMP-I and IL-6, thereby reducing periradicular bone destruction. Taken
together, these results imply that macrophages have an important role in the release of
proinflammatory mediators that may contribute towards early lesion development. Whilst
the macrophage has been analysed in the murine/ rat model, its involvement within human
PRD lesion development and its cytokine repertoire is largely unknown. Nevertheless, one
group has demonstrated a correlation between CD 11+ monocyte/ macrophage cell numbers
and tenderness to tooth percussion within human PRD (Matsuo et a/. 1992).
1.7.3 Transition from acute to chronic PRD
Following the initial inflammatory response, a network of T cell and macrophage-derived
cytokines are implicated in regulating progress of the lesion from acute to chronic PRD
(Marton and Kiss 1993, Sol et al. 1998). On stabilisation of the lesion, dendritic-like cells
become more prevalent than macrophages and playa prominent role in the local immune
defence against perpetual antigenic challenge (Kaneko et al. 2001 a).
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Cells of innate immunity clearly have a critical responsibility in early PRD lesion
development. However, studies in RAG-2 SCID mice demonstrate that the limitation of
infection to the confines of the root canal system and the subsequent prevention of sepsis
also require the active involvement of the acquired immune response (Teles et al. 1997).
Indeed, administration of immunosuppressive agents to the murine/ rat model results in
increased bone loss and increased dissemination of infection (Yamasaki et al. 1994,
Kawashima et al. 1996). However, the precise contribution of the acquired immune
response in the development of PRD is ambiguous. Investigations of PRD experimental
lesion development in athymic BALB/c nu/nu rats have produced conflicting results. In
one study, nu/nu rats developed similar periradicular bone destruction to that seen within
immunologically intact rats (Wallstrom et al. 1993). In contrast, others ascertained that
nu/nu mice developed significantly less periradicular bone destruction than wild type
controls (Tani-Ishii et al. 1995b). In early stages of infection, PRD lesions in BALB/c
nu/nu mice are of an equivalent size as wild type controls. However, over longer time
periods the PRO lesions are generally smaller and more circumscribed than those in
controls (Tani-Ishii et al. 1995b). Furthermore, pulp exposure experiments within scid
mice result in similar PRD lesions to their BALB/cj controls (Fouad 1997). More recently,
it has been demonstrated that cyclosporin-A-induced immunosuppression, which inhibits
the activation and proliferation of T cells, results in smaller PRO lesions. Moreover, the
withdrawal of cyclosporin-A administration within these rat experiments leads to
significant increases in the size of lesions (Kawahara et al. 2004). Taken together, these
results suggest that during the acute immune response, the lack of T cells per se may not
predispose animals to the dissemination of root canal infections. Furthermore, the
involvement of T cell-independent specific immune responses may help to protect against
systemic spread of infections from the root canal. These murinel rat studies provide
important evidence that T cells are critically involved in the perpetuation of the chronic
PRD lesion. However, there is a paucity of data defining T cell-specific immune responses
within the development of human periradicular disease.
The importance of the humoral response in PRD development has been demonstrated in
monkeys immunised against pivotal infective endodontic microorganisms. These
immunised monkeys develop smaller PRO lesions than their controls (Dahlen et al. 1982).
PRD lesion development has also been compared between RAG-2 SCID, Igh-6 (B cell
deficient), Tcrd Tcrd (T cell deficient) and Hco(complement C5 deficient) mice. From this
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study, Hou et al. (2000b) provide evidence that B cells and concomitant antibody-mediated
mechanisms (possibly bacterial opsonisation) are of importance in the localisation of
anaerobic root canal infections, thereby preventing their systemic dissemination
1.7.4 The chronic PRD lesion
Following the transitional phase from acute to chronic inflammation, the periradicular
granuloma represents a reparative process of chronic localised inflammation comprised of
granulomatous tissue (Gao et al. 1988). Periradicular cysts also develop due to perpetual
low-grade chronic inflammation. These cysts, however, are lined by epithelium thought to
be derived from epithelial rests of Malassez within or adjacent to the granulomatous tissue
(Neville et al. 1995). Despite the differences in the chronic development of these two PRO
lesions, previous histopathology studies and recent immunohistochemistry experiments
ascertain that there are no significant differences in the constituents of the inflammatory
infiltrate (Stem et al. 1981, Torabinejad & Kettering 1985, Gao et al. 1988, Matsuo et al.
1992, Liapatas et al. 2003).
Histopathologic examination of chronic PRD tissue continues to be the only available
method to determine the precise nature of the chronic lesion. This allows the lesion to be
classified as: 1) a periradicular cyst, 2) an abscess or 3) a peri radicular granuloma
(Linenberg et al. 1964). The true prevalence of each type of lesion is questionable.
Periradicular cysts are reported to account for 6% (Block et al. 1976) to 55% (Priebe et al.
1954) and periradicular granulomas from 45% (Lalonde and Luebke 1968) to 95% (Block
et a/. 1976) of all PRO lesions. Differences in the sampling procedures, the population
groups being studied and the use of differing histological methods (Nair et al. 1996) and
diagnostic criteria may account for the large variability in these findings.
In summary, the murine/ rat pulp exposure model has elucidated substantial information on
the initiation and development of the PRO lesion. This model has been extremely
important in helping to characterise cellular events occurring within the acute lesion and its
subsequent progression to chronic PRO. However, it is evident from the literature that
information on the role of inflammatory cells in human PRD lesion development is limited
and the dynamics of their interactions remain poorly defined. For a summary of the
postulated cellular events in the development of the PRO lesion, see Figure 1.3.
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Figure 1.3 A postulated series of cellular events involved in the initiation and
development of the PRD lesion. Pathogenic micro-organisms stimulate resident cells of
innate immune system and stromal cells through ligation of pattern recognition receptors.
This induces rapid and spontaneous release of inflammatory mediators, including
cytokines. The subsequent activation of cells of acquired immunity results in the further
release of inflammatory mediators that act in numerous feedback loops upon recruited and
local inflammatory cells. Continued amplification of this reaction, by the release of
proinflammatory cytokines, results in the development of the chronic PRD lesion.
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1.8 Cytokine regulation in PRD
1.S.1 PRD cytokines: Introduction
Cytokines are a diverse group of secreted proteins that act as communication molecules
between virtually all host cells (refer to Chapter 2.5). They perform a fundamental function
in orchestrating and modulating the host immune and inflammatory responses to infectious
agents. Immune cells are the primary source of these inflammatory mediators including
lymphocytes (particularly T cells), monocytes, macrophages and granulocytes. However,
stromal cells, such as epithelial cells, endothelial cells and fibroblasts, are also important
sources of these mediators. Some of these cytokines have predominantly pro inflammatory
functions such as IL-lP, TNF-a, IL-6, IL-S, IL-12 and IFN-y. Conversely, others have
predominantly anti-inflammatory properties including IL-l ra, IL-4, IL-5, IL-l 0, IL-ll, IL-
13 and TGF-p (summarised in Table 1.3). The cytokine network is therefore likely to be
central to the initiation, development and perpetuation of the PRD lesion.
As with studies investigating the contribution of cell populations to PRD lesion
development, the majority of findings analysing cytokine regulation of PRD are elicited
from the murine/ rat pulp exposure model (Yu and Stashenko 1987, Wang et al. 1997,
Stashenko et al. 1998, Sasaki et al. 2000). The animal model has divulged significant
information on PRD lesion development. However, one must be cautious in extrapolating
these results per se to human disease, as it is known that distinct differences exist between
mouse and human immunology (Mestas and Hughes 2004). Furthermore, it is well
established that the use of mouse models to investigate the development of human diseases
display additional disadvantages (Shiohara et al. 2004). Disparities are found within both
innate and adaptive branches of immunology including: defensins, Toll receptors, Ig
subsets, ThllTh2 differentiation, chemokine and chemokine receptor expression and
sequence of events within disease progression, for example in multiple sclerosis. Indeed,
vaccines against infectious murine models of disease have been unsuccessful when applied
to human infections (Ruggiero et al. 2004). Although mouse models provide a valuable
experimental surrogate for the human immune system (Griffiths et al. 2005), it is important
that such essential immunologic differences are taken into account when using mice as
preclinical models of human disease (Mestas and Hughes 2004).
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Within studies investigating the pathogenesis of PRD, this is significantly demonstrated by
the fundamental difference in the principal bone resorptive cytokines. In the murine model,
IL-l a is the predominant cytokine responsible for bone resorption. In contrast, the
principal cytokine promoting bone resorption in humans is IL-l~. Whilst the animal model
will continue to offer great insight into lesion development, it is of paramount importance
that further investigations are additionally undertaken on human PRD tissue to elucidate
the contribution of the cytokine network in the development and perpetuation of the
chronic PRO lesion.
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Table 1.3 Overview of cellular and cytokine involvement within innate and
adaptive immune responses.
Cells of innate Cells of acquired Innate cytokines Innate cytokines Cytokines
immune immunity with dominant with dominant characteristic of
responses proinnammatory suppressive effects acquired
effects linking linking acquired immunity
acquired immunity immunity
Dendritic cells
Type) IFN Th) ResQonses
APC cells
GM-CSF
Eosinophils TNF-a IL-2 and IFN-y
Macrophages (IFN-y) IL-IO
Neutrophils B cells IL-) IL-13
NK cells CD4' cells IL-12 TGF-p Th2 ResQonses
NKT cells CD8+ cells IL-IS
yo T cells IL-17A lL-4 and lL-5
(epithelial cells) IL-18
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1.8.2 PRD cytokines: Animal models
In murine experiments, bacterial invasion or LPS stimulation within the dental root canal
induces up-regulated expression of the proinflammatory cytokines IL-I a, IL-I ~ and TNF-a
within the pulp tissue by 3 h (Kawashima et al. 2005). Subsequently, resident macrophages
and fibroblasts are activated within the tissue surrounding the root apex. This promotes the
infiltration of IL-l a secreting macrophages and monocytes into the lesion (Kawashima et
al. 1996, Hong et al. 2004). On experimental induction of the PRD lesion, macrophages
expressing IL-I a and IL-l ~ are located within the vicinity of extensive bone resorption
sites (Hamachi et al. 1995, Matsumoto et al. 1998). Indeed, IL-1a and TNF-a appear to
playa critical role in the initiation and development ofPRD. Expression of these cytokines
is up-regulated within PRD tissue cells at an early stage of rodent pulp infection and bone
resorption (Tani-Ishii et al. 1995a, Wang et al. 1997, Kawashima and Stashenko 1999).
However, neutralising studies in the rat indicate that TNF-a may not contribute
significantly to periradicular bone resorption (Wang and Stashenko 1993a). The majority
of inflammatory bone destruction appears to be directly related to the presence and effects
of IL-l a (Wang and Stashenko 1993a, Sasaki et al. 2000). In P-/E-selectin knockout mice,
which exhibit increased bone destruction, tissue levels of IL-2, IL-4, IL-IO, TNF-a and
IFN-y are all increased but only IL-1a is significantly up-regulated compared with controls
(Kawashima et al. 1999). Furthermore, bone resorptive activity in PRD extracts from the
murine model is substantially inhibited with neutralising antibodies to IL-l (Wang and
Stashenko 1993a). Additionally, the in vivo administration oflL-l receptor antagonist (IL-
Ira) to mice significantly inhibits expansion of the PRD lesion (Stashenko et al. 1994).
This IL-l-induced bone resorption is partly dependent on PGE2 synthesis and synergistic
effects between IL-l and PGE2 (Dewhirst et al. 1990).
The contribution of IL-l a, IL-l ~ and TNF-a in the development of the PRD lesion has
been studied extensively within animal PRD models (Tani-Ishii et al. 1995a, Wang et al.
1997, Kawashima and Stashenko 1999, Bletsa et al. 2004). Macrophages and neutrophils
are the principal sources of IL-Ia and TNF-a. Their expression within the PRD lesion
contributes towards the synthesis of downstream inflammatory mediators such as IL-6 and
IL-8. These proinflammatory molecules also act on fibroblasts, thereby stimulating the
26
production of matrix metalloproteinases. The subsequent release of MMP I and MMP3
may result in the degradation of extracellular matrix components as evidenced in other
inflammatory bone diseases, for example rheumatoid arthritis (RA) (Okada et al. 1987).
Moreover, B-1p and TNF-a promote bone resorption by increasing the maturation and the
bone resorbing activity of osteoclasts (Pfeilschifter et al. 1989).
Substantial evidence supports a destructive role for IL-I and TNF-a in PRD lesion
development. Nevertheless, it has been demonstrated that IL-I receptor (IL-I R) or TNF
receptor (TNFR) knockout mice suffer more severe periradicular bone destruction than
wild type controls (Chen et al. 1999). Furthermore, IL-1R and TNFR double knockout
mice suffer from far greater tissue damage than single knockout mice. Increased bacterial
penetration into the periradicular tissues is also observed within double knockout mice.
This suggests that IL-1 and TNF-a likely have important protective functions in host
responses to mixed anaerobic infections. Recent rat PRO experiments have defined a role
for LPS in inducing not only the early expression of IL-1a. and TNF-a., but additionally
iNOS, MMP-1 and TGF-~l from macrophages (Hong et al. 2004). Interestingly, IL-6-/-
mice develop periradicular lesions at an earlier stage than wild type controls and these
lesions progress to be much larger (Huang et al. 2001). This indicates that IL-6 may
actually have a protective role in lesion development.
1.8.3 PRD cytokines: The human lesion
Within human tissues, mRNA and! or protein expression for several proinflammatory
mediators have been identified. IL-I p has been detected within explant cultures of
periradicular cysts (Meghji et al. 1989). In a subsequent study, the same group detected IL-
l a and IL-1~ protein expression within periradicular cyst explant supernatants and mRNA
expression within all periradicular cyst tissue lesions examined (Meghji et al. 1996). An
IHe investigation of periradicular cysts also demonstrated IL-I ~ and IL-l a expression in
all examined lesions (n=12) and these cytokines were primarily localised to epithelial and
endothelial cells (Bando et al. 1993). Honma et al. (1998) analysed periradicular cysts by
in situ hybridisation and ascertained that mRNA expression for IL-l~, TNF-a, IL-6 and IL-
8 was present within all lesions analysed. Expression of these inflammatory mediators was
localised to fibroblasts, macrophages, T cells and plasma cells. Barkhordar et al. (1992)
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also found significant levels of IL-I ~ within PRD lesions but could not establish a
correlation with the degree of periradicular bone loss. High levels of IL-I P expression have
been found within the root canal (Takeichi et al. 1996). Moreover, the concentration of IL-
1P within the root canal exudate decreases during root canal treatment procedures (Matsuo
et al. 1994). Interestingly, a trend towards raised IL-l ~ levels has been shown in
symptomatic teeth (Lim et al. 1994).
As with IL-l (3,TNF-a has been detected within root canal exudates from teeth associated
with PRD lesions (Safavi and Rossomando 1991). Surprisingly, an investigation of
periradicular cysts using ELISA methodology detected IL-8 and TNF-a protein expression
within only 2 of 12 lesions examined (Bando et al. 1993). Danin et al. (2000) also
observed limited TNF-a protein expression, with TNF-a being detected within only 2 of25
PRD lesions by ELISA. From IHC experiments, others have found few cells expressing
IL-l~ and TNF-a within the periradicular granuloma lesion. This suggests that limited
bone resorption may be occurring during chronic inflammatory stages of the disease
(Artese et al. 1991).
Expression of IL-6 protein within the PRD lesion has also been measured. High levels of
spontaneously secreted IL-6 and PGE2 have been observed in periradicular cyst explant
supernatants (Formigli et al. 1995, Meghji et al. 1996). Paralleling this finding, high
concentrations of IL-6 are also detectable within root canal exudates of infected teeth
(Takeichi et al. 1996). Furthermore, IL-6 is expressed at high levels within the PRD lesion
compared to a lack of expression within healthy pulp controls (Barkhordar et al. 1999).
The expression of significant quantities of IL-6 and GM-CSF protein within human PRD
has been further confirmed in recent studies (Gervasio et al. 2002). Moreover, a trend
towards increased IL-6 in addition to GM-CSF expression has been associated with
symptomatic lesions (Radics et al. 2003). From IHC experiments, IL-6 expression is
predominantly localised to epithelial and vascular endothelial cells (Bando et al. 1993). IL-
8 has also been detected within the periradicular exudate within infected root canals.
Furthermore, its concentrations correlate significantly with the presence of clinical
symptoms (Shimauchi et al. 2001).
Using ELISA, TGF-(31 protein has been detected within the majority of PRD lesions
removed during periradicular surgery. Furthermore, a significant correlation has been
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shown to exist between the size of the lesion and the expression of TGF-~l per milligram
of tissue (Danin et al. 2000). From IHC experiments on human PRD tissues, TGF-~l
expression has been identified within lymphocytes, fibroblasts and monocytes (Tyler et at.
1999). In comparison, TGF-~l expression is localised to macrophages in active phases of
lesion development within the murine pulp exposure model. However, during chronic
stages, TGF-~l expression is primarily located to osteoblasts (Lin et al. 2000).
Taken together, these data suggest that cytokines are likely to be central in the
orchestration of events that lead to chronic PRD. A considerable problem in establishing
the clinical significance of this cytokine network within the PRD lesion is the paucity of
functional studies analysing human PRD tissue. The few studies that have investigated the
regulatory function of cytokines within PRD have been performed using the rat! murine
pulp exposure model. The limited number of investigations analysing cytokine expression
within human PRD have essentially been observational in nature. Cytokines act in a
hierarchical structure, being released in a controlled, organised manner through "upstream"
regulators that induce the expression of "downstream" cytokine mediators. Within any
disease process it is necessary to identify dysregulated expression of key upstream
inflammatory mediators. Through the identification and careful targeting of regulatory
proinflammatory mediators or their signalling pathways, attenuation of a destructive
immune response may become possible. Therefore, this thesis aims to start to address these
issues by attempting to define more clearly the nature of the cytokine network within the
human PRD lesion.
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1.9 The role of T cell derived cytokines in PRD
1.9.1 Animal studies
Within the murine/ rat model, T cells infiltrate the PRD lesion between 7 and 14 days after
pulp exposure (Kawashima et af.1996). CD4+ T effector cells are an essential component
of the immune response to infection and can be classified according to their cytokine
profile as either T helper 1 (Th 1) or T helper 2 (Th2) cells (refer to Chapter 2.2.6.3).
Proinflammatory cytokines, representative of Thl cells, and anti-inflammatory Th2 type
cytokines are induced during the course of pulpal infection. Both sets of cytokines
modulate the expression and activity of the principal bone resorptive cytokine IL-I
(Kawashima and Stashenko 1999). Of interest, extracts of the endodontic pathogen E.
faecalis has immunosuppressive effects on the release of IL-2 and IL-4 from peripheral
blood T cells. This suggests that endodontic pathogenic microorganisms may be capable of
simultaneously modulating Thl and Th2 type responses within the PRD lesion (Son et al.
2004).
Functional investigations within murine experiments implicate a Thl-driven process in the
development of periradicular disease (Kawashima and Stashenko 1999). During the
immediate four weeks following pulpal infection, Th l type cytokines IL-12 and IFN-y, in
addition to the bone resorptive cytokines TNF-a and IL-I, are up-regulated in a linear
fashion within the periradicular tissues (Kawashima and Stashenko 1999). This pattern of
cytokine expression correlates with that of a predominantly Th l-type response. In contrast,
Th2-type cytokines exhibit increased expression up until two weeks after infection and
thereafter their levels decline. Furthermore, it has been established in the murine PRD
model that in vivo elimination of the Th2 cytokines IL-IO and IL-6 markedly increases IL-
Ia production and this is correlated with increased bone resorption (Sasaki et af. 2000,
Balto et al. 2001). Indeed, infection-stimulated PRD within IL-l 0 knockout mice results in
lesions that are five times the size of those found in wild type controls. Moreover, locally
produced IL-I a is increased 10-fold over controls (Sasaki et al. 2000). In contrast with IL-
10, the Th2 cytokine IL-4 appears to have no observable effect upon PRD lesion size
within the murine model. This demonstrates the heterogeneity amongst the Th2 cytokine
group (Sasaki et al. 2000).
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1.9.2 Human studies
Studies using human PRD pathological specimens establish that T cells comprise a
significant component of the inflammatory cell infiltrate (Kontainen et al. 1986, Stashenko
and Yu 1989). However, the precise nature of the T lymphocyte response within human
PRD remains equivocal with conflicting published data. The majority of studies analysing
the role of Thl and Th2 type responses within human PRD have utilised
immunohistochemistry (IHC). A Thl dominated response has been proposed from a series
of consecutive studies performed by one group of investigators. Using IHC, this group
could not detect cellular expression of IL-4 protein within the human periradicular lesion.
However, they established that many cells expressed IFN-y protein (Kabashima et al.
1998). In contrast, the same group found that IL-4 protein was detectable in PRD
regeneration tissues whereas there was no evidence of IFN-y expression within these
regeneration lesions (Kabashima et al. 2001a). A subsequent IHC study analysed particular
subsets of chemokines and their receptors within the PRD lesion. From this, they
determined a predominance of CCR5 and CXCR3 receptor expression compared with
CCR3 expression (Kabashima et al. 2001b). Recently, the same group ascertained that
IFN-y and CXCR3 cellular expression was detectable within all inflammatory PRD lesions
examined by IHC. In contrast, IL-4 expression was not observed and cells expressing
CCR3 were only present within one lesion (Kabashima et al. 2004). Taken together, these
findings support the hypothesis that the PRD lesion is balanced towards a Th l-type
response. Furthermore, these results suggest that IL-4 and IFN-y have a significant impact
in determining the outcome of PRD towards repair or tissue destruction respectively.
However, others have determined that a Th2 process is central to the perpetuation of the
PRD lesion. Hren et al. (1999) demonstrated that PRD lesions containing a higher number
of Streptococcus sp. than anaerobic bacteria display a significant reduction in CD8+ T
cells. These results equate with previous findings wherein a relatively low index of IgG
versus IgA is observed in antistreptococcal responses (Kettering et al. 1991). Hren et al.
(1999) therefore suggest this might be representative of Th2-type immune responses in
lesions that are predominantly infected with Streptococci sp.. Furthermore, using IHe on
human PRD biopsy tissue, others have detected higher levels of IL-6 and IL-I 0 expression
in comparison to IFN-y (Walker et a/. 2000). Using IHC on fifteen tissue specimens, De
Sa et a/. (2003) established predominance for IL-4 expression over lymphotoxin-u
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expression, leading them to suggest that there was a preponderance of Th2 type cytokines
within the PRD lesion. However any real interpretation of data from this study is difficult
as such a small sample was analysed. Furthermore, the expression of only three cytokines
was studied, which does not give a fully representative picture of Thl/ Th2 type cytokine
responses within the lesion. More recently, an IHC investigation of human PRD lesions
has analysed the presence of Thl type (CCRI, CCRS and CXCR3) compared with the
expression of Th2 type (CCR2 and CCR3) chemokines and chemokine receptors (Silva et
al. 2005). Interestingly, results from this study suggest that there may not be a
predominance of either a Th 1 or Th2 type response within the PRD lesion. Indeed, both
responses appear to be occurring concomitantly.
Taken together, it is difficult to draw any real conclusions from these investigations. The
majority of studies have investigated limited numbers of lesions and have analysed only a
very small number of Th I/ Th2 type markers. The experimental techniques used have
mostly been restricted to analysis of fixed biopsy tissue by immunohistochemistry.
Moreover, the validity of some of the markers used to investigate and thereby robustly
characterise the ThllTh2 type response is questionable. However, it is of interest that the
CD4+effector Th profile may be representative of the dominant pathogenic species present
within the lesion. A Th I type response may occur when the lesion is colonised
predominantly by anaerobic microbes. Conversely, PRD infections that are dominated by
aerobic bacteria, such as Streptococci sp., may result in a Th2 driven pathway (Hren et al.
1999, Hren et at. 2000). In conclusion, it is abundantly clear that further investigations are
necessary to define the role of Thll Th2 responses within human PRD and thereby
determine the clinical significance of this response to lesion development and treatment
success.
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1.10 Treatment of periradicular disease
1.10.1 Root Canal Treatment
The objectives of root canal treatment are the biomechanical instrumentation of the root
canal to reduce the reservoir of bacteria, disinfection of the canal to eliminate remaining
bacteria followed by obturation of the root canal in combination with a coronal seal to
prevent reinfection (Bystrom et al. 1987, Sjogren et al. 1997, Trope and Bergenholtz
2002). Cleaning of the canal, through irrigation and shaping does not completely eliminate
bacteria colonising the root canal (Pitt Ford 1982, Bystrom et al. 1985a, Bystrom et al.
1985b, Matsuo et al. 2003). Therefore, the additional use of disinfectants is essential in
attempting to eradicate bacteria from within the infected canal (Haapasalo and Orstavik
1987, 0rstavik and Haapasalo 1990). Theoretically, the removal of noxious stimuli from
the root canal should allow normal reparative processes to occur within the apical tissues,
thereby leading to resolution of the PRD lesion.
However, even after careful preparation of the root canal, viable bacteria can be found in
dentinal tubules within the deeper layers of dentine in vitro (Peters et al. 2001).
Subsequent to in vivo clinical instrumentation and disinfection, viable bacteria are also
detected (Chavez de Paz et al. 2003). A recent primate study has reaffirmed that after
instrumentation and irrigation of the root canal with disinfectants, certain strains of
bacteria may remain viable. Furthermore, the presence of these bacteria leads to
persistence of the PRD lesion (Moller et al. 2004). To further reduce the bacterial burden,
it is therefore conventional clinical practice to utilise an intracanal antimicrobial
medicament between treatment visits. Currently, calcium hydroxide (Ca(OH)2) is the intra-
canal medicament of choice. Nevertheless, several studies have shown its relative
inefficiency as an antimicrobial agent in root canal treatment (Stevens and Grossman 1983,
Haapasalo and 0rstavik 1987, Reit and Dahlen 1988). There have been significant
advances in the instruments and instrumentation techniques used to clean and shape root
canals over the past decade. However, the intracanal medicament has a greater influence
on successful healing of periradicular lesions than the type of instrumentation technique
employed (De Rossi et al. 2005).
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Unquestionably, successful root canal treatment is dependent upon the technical ability of
the clinician to perform the procedure. The provision of an adequate root filling to the
correct apical length, combined with comprehensive compaction of the root filling material
are known to be significant factors in the success of this treatment (Buckley and Spangberg
1995, Kirkevang et al. 2000, Kojima et al. 2004, Orstavik et al. 2004, Segura-Egea et al.
2004). However, it is extremely difficult to instrument and disperse the antimicrobial
agents to all aspects of the root canal system (Siqueira & Lopes 1999). Therefore, it is
possible that even following careful instrumentation and obturation of the root canal,
microorganisms may continue to colonise the canal (Nair et al. 1990). Furthermore,
bacteria located within the periradicular tissue, not accessible to disinfectants or
instrumentation, may also lead to treatment failure (Bystrom et al. 1987).
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Figure 1.4 Radiograph of a PRD lesion at diagnosis.
Fi2ure 1.5
Large periradicular lesion
Radiograph of healed lesion following root canal treatment.
Healed lesion with bony infill
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1.10.2 Periradicular surgery (PRS)
In teeth with failing root canal treatment and persisting periradicular lesions, non-surgical
orthograde retreatment is generally regarded as the treatment of choice as this has a higher
success rate than surgical procedures (Allen et al. 1989). Nevertheless, in certain clinical
situations, re-root canal treatment may not be possible. Teeth restored with large post core
crowns may suffer root fracture on post removal and some teeth may have inaccessible
canals. Periradicular surgery (PRS) may therefore be the preferred treatment option in
these cases (Royal College of Surgeons England 2001).
The surgical procedure aims to remove the necrotic and infected dental root apex, curettage
and remove the periradicular lesion and seal off the apical aspect of the root canal. The
apical seal of the root canal with a retrograde root filling has been shown to be a significant
factor towards the successful outcome of PRS (Harty et al. 1970, Friedman 1991). There
have been several significant advances in endodontic surgical procedures over the past
decade. These include the use of improved root end filling materials such as mineral
trioxide aggregate (Torabinejad et al. 1995, Bates et al. 1996), the use of magnification
(Carr 1992) and the use of ultrasonics in root end preparation (Wuchenich et al. 1994,
Taschieri et al. 2005).
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Figure 1.6 Radiograph of a PRD lesion prior to periradicular surgery (PRS).
Large periradicular lesion
Figure 1.7 Clinical photograph of periradicular surgery.
Large surgical defect
Radiograph of the healing lesion after PRS.
Healing lesion with bony infill
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1.11 Success rates in treatment of PRD
Bacteria and other microorganisms play a central role in the initiation, progression and
persistence of PRD. Endodontic treatment, therefore, aims to eliminate bacteria from the
infected root canal and prevent reinfection by the clinical procedure of root canal
treatment. Many studies report high success rates for RCT of greater than 90% (Lazarski et
al. 2001, Alley et al. 2004). Conversely, other studies report the success of RCT to be as
low as 45% (Meeuwissen and Eschen 1983). Epidemiologic studies consistently report
significantly lower rates of RCT success than endodontic treatment undertaken within
controlled clinical settings (Siqueira et al. 2005b). Indeed, the majority of investigations
reporting high success rates in the treatment of PRO are limited to experiments undertaken
on selected cases treated by endodontic specialists or supervised trainees (Boucher et al.
2002). Nevertheless, Cheung (2002) ascertained that success rates of RCT in patients
receiving treatment within training institutions can be as low as 50%.
Studies analysing cross sections of the general population identify that the technical quality
of root canal treatment is performed to a satisfactory standard in only 30-42% of cases
(Buckley and Spangberg 1995). Others establish that root filled teeth are 5-12 times more
likely to have radiographic evidence of PRD than teeth without root fillings (Petersson et
al. 1986, Odesjo, et al. 1990, Buckley and Spangberg 1995). Furthermore, teeth with
inadequate root fillings demonstrate a significant correlation with the presence of PRD
(Lupi-Pegurier et al. 2002, Hommez et a/. 2002, Chugal et al. 2003). Part of the reason for
treatment failure with root canal fillings may be attributed to the lack of effective
intracanal medicaments that eliminate a broad spectrum of bacteria during cleansing of the
root canal. A recent meta-analysis of published root canal treatment literature calculated
the success rate for root canal treatment to be 82.8% for vital teeth and 78.9% for non-vital
teeth. This provides a cumulative success rate of 82% for teeth without a PRO lesion and
71.5% for teeth with a lesion (Kojima et al. 2004).
A significant problem in endodontic research is the lack of high quality controlled clinical
studies that provide sound evidence on which clinicians can inform patients as to treatment
outcomes. No studies investigating the outcome of re-root canal treatments have been
published that provide scientific level of evidence (LOE) one. Only three LOE 2 and two
LOE 3 studies have been published and the remainder of studies are in the low evidence
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groups (Paik et al. 2004). Nevertheless, associations have been made between failed root
canal treatment and missing adjacent teeth, greater plaque accumulation, the degree of
marginal bone support, a history of trauma to the treated tooth, the lack of postoperative
coronal restoration and older patients (Caplan and Weintraub 1997, Kirkevang et al. 2004,
Orstavik et al. 2004). Most importantly, current research clearly identifies that the most
significant factor influencing the success of root canal treatment is the presence and
magnitude of a PRD lesion prior to commencing treatment (Friedman 1998, Chugal et al.
2001, Chugal et al. 2003, Dammaschke et al. 2003, Kojima et al. 2004, Orstavik et al.
2004, Wang et al. 2004a, Marending et al. 2005, Negishi et al. 2005).
In addition to localised tissue destruction, it is suggested that chronic persistence of
periradicular disease may have an effect upon the host's systemic inflammatory mediators
(Marton and Kiss 1992). Indeed, a reduction in peripheral blood levels of acute-phase
proteins compared to levels in controls has been demonstrated after completion of
endodontic treatment (Marton et al. 1988). However, within the endodontic literature it is
only gradually being acknowledged and accepted that the host's immune response is an
important factor in the outcome of endodontic treatment, this having previously been
largely ignored (Marending et al. 2005).
The success of periradicular surgery has been reported to vary between 25% and 99%
(Gutmann and Harrison 1994). A recent systematic review of periradicular surgery
determined that the weighted average of success was 64%, whilst the outcome from 25.7%
of cases remained uncertain and 15.7% of surgical cases were unsuccessful (Peterson and
Gutmann 2001). Periradicular resurgery has been demonstrated to have a significantly
greater failure rate than a first surgical procedure (Gagliani et al. 2005). Repeat surgery is
reported to be associated with a weighted average healing rate of 35.7% and a failure of
38%. Furthermore, the success rate of non-surgical retreatment of failed periradicular
resurgery cases is lower than non-surgical retreatment of failed endodontically managed
cases (Caliskan 2005). Clinical success or failure appears to be associated with the operator
and the types of materials used within the surgical procedure (Peterson and Gutmann 2001,
Wang et al. 2004b). It remains to be established if the use of modem materials,
magnification, improved surgical techniques and better postgraduate training will result in
improved surgical success rates over the longer-term.
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Recently, a Swedish group established that within a low caries risk population group,
which may be expected to undergo less root canal treatment over time than the general
population, the number of endodontic procedures carried out between 1997 and 2003 had
actually increased annually by 20% (Bjerndal and Reit 2004). However, the current
success rates of RCT procedures are unsatisfactory. The population trend is towards an
ageing population whom are retaining more teeth and will potentially require more root
canal treatment procedures to retain their teeth. Taking these considerations together, the
future cost burden to healthcare services to provide effective treatment of PRO will be
substantial.
In summary, these studies clearly demonstrate that the current treatment strategy of root
canal treatment, undertaken to prevent and resolve PRO, is at the very least sub-optimal.
Furthermore, most of the data defining the immune component of PRO and the role of the
host response in the initiation and progression of the disease has been derived from animal
models. The distinct lack of functional investigations upon the human PRO lesion is a
significant problem in being able to accurately understand and thereby treat this prevalent
disease. There is unquestionable evidence that the presence of a PRO lesion prior to the
start of treatment is the single most significant factor influencing the successful outcome of
RCT. It is therefore surprising that there is such a lack in knowledge of the
immunopathogenesis of the human PRO lesion.
Improved understanding as to the development of the PRO lesion may significantly help
towards developing better treatment strategies that may increase treatment outcome.
Thereby, the current morbidity to the patient may be significantly reduced. Furthermore,
the substantial cost to the health service in financing re-treatment procedures for re-root
canal treatment, periradicular surgery, re-surgery, dental extraction and/ or prosthetic
rehabilitation may be significantly reduced. This thesis therefore aims to improve the
current knowledge of the immunopathologic processes that contribute towards the
development of the human PRO lesion.
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2 INFLAMMATORY CELLS ANDCYTOKINES CONTRIBUTING
TO INFLAMMATORY BONE DESTRUCTION
2.1 Introduction to immunity
The ability to combat pathogenic microbes that potentially would destroy the host is
termed 'immunity'. Host immunity encompasses two functionally different but interrelated
immune systems comprising non-specific, 'innate immunity' and the specific, adaptive or
'acquired system'. These two systems have evolved to provide protection from the
invasion of pathogenic bacteria, fungi, and protozoa and altered self, as in viral infection.
Innate and acquired immunity comprise cellular and humoral components interacting in a
complex manner with the collective aim of eradicating pathogenic agents from the host
(Janeway 1992). Innate immunity combines internal and external mechanisms to afford an
instantaneous first line of defence against pathogenic challenge (Beutler 2004). The innate
immune response is relatively efficient at preventing systemic infection and limiting
pathogenic burden whilst sparing damage to host tissue (self tolerance). The rapid control
over invading pathogens is achieved by the immediate activation of phagocytic antigen
presenting cells (APCs). The concomitant release of down-regulatory mediators, for
example the cytokine IL-IO, tempers the potential for host tissue destruction arising from
an exaggerated rapid inflammatory response. However, complete control of infection by
the host is normally only achieved with the simultaneous induction of the adaptive immune
response. Due to the requirement of T and B cell population expansion, an effective
acquired immune response is only instigated a week after induction of innate immunity.
Activation of the inflammatory/ innate response is not directly pathogen specific, but is
dependent upon ligand binding to germline encoded receptors (pattern-recognition
receptors, PRRs). These PRRs, which include Toll-like receptors (TLRs), recognise
pathogen associated microbial patterns (PAMPS) that are conserved between, and shared
by classes of microbial pathogens not found in higher eukaryotes (refer to chapter 2.4).
These receptors allow the recognition, uptake and phagocytosis of microbes by antigen-
presenting cells. However, the innate system not only uses PRRs to recognise pathogens,
but also utilises the complement system, specialised receptors on NK cells and certain
intracellular receptors (Hoebe et al. 2004).
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Innate and subsequent adaptive immune responses are not isolated sequential host events to
infection but through cellular contacts and the secretion of soluble mediators, they interact
with and impact upon one another. In particular, the cytokine milieu established during
innate inflammatory responses to pathogens initiates the migration of antigen-specific T
cells to lymph nodes where they meet antigen-presenting cells (APCs). The
commencement of acquired immunity is dependant upon the innate system providing
effective antigen presentation through class I and class II MHC antigens. These are
predominantly located on macrophage and dendritic cells. In contrast to MHC-II binding
of internalised exogenous antigenic molecules, MHC-I principally binds endogenous
peptides from the cytosol (Harding et al. 2003). The concomitant engagement of T cell
receptors with co-stimulatory molecules, including C080, C086 and C040, is necessary to
initiate an efficient acquired immune response (Borriello et al. 1997). In addition to the
recognition of peptides, T cells also recognise microbial-derived and self-derived lipids
bound to CD1molecules (Harding et al. 2003).
Cells of innate immunity comprise mononuclear phagocytes and polymorphonuclear
phagocytes. Pathogens are usually taken up by APCs and transported to secondary
lymphoid organs. Antigen recognition within acquired immunity occurs through T cell
antigen receptors (TCRs) and immunoglobulin (IgG) B cell receptors. A significant
repertoire of these antigen receptors is present within the host, being expressed clonally on
the surfaces of lymphocytes (van den Berg et al. 2004). The innate immune system
developed long before acquired immunity and therefore defects in cells of innate immunity
produce a more profound immunodeficiency state than lymphoid aplasia (Beutler 2004).
Of critical importance in the crosstalk between cells of the innate and acquired immune
responses is the release of soluble inflammatory mediators, including cytokines.
2.2 Contribution of immune cells to the cytokine network
2.2.1 Neutrophils
Polymorphonuclear leukocytes (PMN) are the first line of defence against microorganisms
and act as critical effector cells within both innate and adaptive immune responses.
Neutrophils are the most abundant leukocyte population, accounting for about 60% of all
circulating leukocytes. In the average adult human, approximately 10 million PMN are
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produced and released into the bloodstream every minute. However, due to their short
lifespan before undergoing apoptotic cell death, their circulatory nwnbers remain constant.
Neutrophil homeostasis is tightly regulated by dendritic cells and macrophages.
Phagocytosis of apoptotic PMN leads to suppressed phagocyte secretion of IL-23, which in
turn down-regulates IL-17 expression and thereby granulocyte-colony stimulating factor
(G-CSF) production from yo and a~ neutrophil-regulatory T cells (Stark et al. 2005).
The essential role of neutrophils as professional phagocytes has been extensively
investigated. This has rather overshadowed research into their ability to orchestrate the
immune response by the generation of their own inflammatory mediators including
cytokines and chemokines (Kunkel et al. 1995, McDonald 2004). As individual cells,
neutrophils produce lower cytokine quantities than macrophages or dendritic cells.
However, in consideration of their vast numbers at inflammatory sites in comparison with
other immune cells, they are an important source of cytokines. Through the release of these
inflammatory mediators, PMN greatly influence the outcome of infectious diseases
(Cassatella 1995). Neutrophils express TLR-4 and CD 14 (Sabroe et af. 2002) and, in
response to pathogenic challenge and concomitant cytokine stimulation, produce TNF-n,
IL-1~, IL-8, IL-12 and IFN-y (Cassatella et al. 1995b, Cassatella 1999, Witko-Sarsat et al.
2000, Ellis and Beaman 2002, Ethuin et al. 2004). Indeed, several agents have been
identified that induce neutrophil expression of these proinflammatory cytokines. These
include the cytokines IFN-y, TNF-n, IL-1~, IL-4, IL-10, IL-13 and TGF-~, bacterial
PAMPS, fungi, viruses, protozoa and matrix proteins (Meda et al. 1994). Through the
release of these cytokines, neutrophils are essentially capable of linking innate and
adaptive immunity.
In addition to the production of Th1 type cytokines described above, neutrophils also
secrete the Th2 type cytokines IL-I0 and IL-4. Furthermore, they have been implicated in
driving Th2 type responses (Romani et al. 1997, Brandt et al. 2000). In a similar manner to
dendritic cell sub-populations, it is suggested that PMNs may be divided into subsets
capable of promoting either Thl or Th2 driven host responses (Denkers et al. 2003). PMNs
not only regulate T cell functions, but LPS-stimulated neutrophils are also responsible for
inducing the production of IL-12 and TNF-n from dendritic cells (Bennouna and Denkers
2005). Taken together, it is evident that neutrophils perform a central role in controlling the
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immediate innate immune response. Moreover, through their release of cytokines and
chemokines, they subsequently influence the development of the adaptive response.
2.2.2 Antigen presenting cells: macrophages and dendritic cells
Macrophages and immature dendritic cells (DCs) are phagocytic antigen presenting cells
that not only internalise and degrade bacteria but also present bacterial peptides on MHC-I
and MHC-II molecules for T cell recognition. These phagocytic antigen-presenting cells
are essential components within the interface between innate and adaptive immunity. They
originate from bone marrow and circulating precursors and are ideally located within the
peripheral tissues to swiftly respond to harmful pathogenic challenge. Dendritic cells can
be distinguished in at least two subsets: myeloid derived DCs and dendritic cells derived
from non-myeloid precursors, of which plasmacytoid DC (pDC) and Langerhans cells
predominate (Banchereau et al. 2003).
Whilst DCs are the most important APCs for T cell priming, macrophages are important in
presenting microbial antigens to effector T cells. Thereby, macrophages are essential in
eliciting appropriate cytokine responses (Harding et al. 2003). Macrophages also interact
with T lymphocytes by the release of reactive oxygen intermediates (ROI) and reactive
nitrogen intermediates (RNI). Both ROI and RNI suppress lymphocyte function and this is
further enhanced by the effect of low concentrations of IL-10 upon macrophages.
Conversely, higher concentrations of IL-lO profoundly reduce macrophage derived ROI
secretion. Furthermore, IL-10-induced suppression of TNF-a expression may also be
capable of down-regulating the release of RNI (Bogdan et al. 1991). Importantly, the
microbicidal activity of macrophages to pathogens is inhibited by IL-I0 in a dose-
dependant manner by a reduction in nitrogen oxide metabolites (Gazzinelli et al. 1992).
Through their virulence factors, pathogens induce DC maturation that consequently
influences antigen presentation and T cell stimulation (Pierre et al. 1997, Rescigno et al.
1998). Pathogen recognition by dendritic cells occurs through cellular expression of Toll-
like receptors (TLRs) and these are responsible for modulating co-stimulatory molecule
expression. Gram-negative bacteria and LPS, particularly in the presence of IFN-y, also
increase macrophage expression of MHC-I, MHC-II, CD40 and CD86 (Yrlid et al. 2000,
Svensson et al. 2001). However, long-term stimulation of macrophages with PAMPS leads
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to down-regulated expression of MHC-II, thereby reducing their antigen processmg
capabilities (Chu et al. 1999). Dendritic cells are the most potent type of APC and are
central to initiating both innate and acquired immunity (Banchereau and Steinman 1995).
On encountering pathogens within peripheral tissues, DCs increase their antigen
presentation properties, express co-stimulatory molecules and migrate to lymphoid organs
to establish an immune response. Dendritic cells not only produce a core response to any
pathogen but also exhibit stimulus-specific maturation and activation (Huang et al. 2001).
Dendritic cells and macrophages have complimentary roles in anti-bacterial immunity.
Dendritic cells appear to be critical for the priming of naive CDS+ T cells. Macrophages
however, are important in presenting bacterial antigens to effector T cells at infected tissue
sites, producing and inducing cytokine expression and preventing bacterial replication
(Harding et al. 2003). The first phase of the innate response to pathogenic challenge
involves the rapid expression of monocyte-derived TNF-u, which in tum induces the
release of pro-inflammatory cytokines such as IL-l and IL-6. The second phase response
involves the production of IL-IO, which is detectable within S h of exposure to LPS.
Furthermore, cytokines released by cells of innate immunity, including macrophages, are
responsible for regulating the differentiation and activity of DCs. Indeed, macrophages are
a significant source of type 1 cytokines and on encountering mycobacterial pathogens,
release significant quantities of IL-12, TNF-u and IFN-y (Wang et al. 1999). The local
release of inflammatory cytokines, particularly IL-12 and IL-lS, can further induce
macrophage-derived cytokine secretion, including IFN-y (Schindler et al. 2001).
2.2.3 Mast Cells
Mast cells are multifunctional, long-lived tissue dwelling cells distributed throughout
connective and mucosal tissues. They originate from myeloid precursors and circulate as
CD34+committed progenitor cells. Their differentiation into mature mast cells occurs only
after tissue entry (Kirshenbaum et al. 1991). Human mast cells consist of two subsets that
show functional, biochemical and morphological heterogeneity. Mast cells found in
mucosal tissues contain only tryptase as a protease. In contrast, those located in connective
tissue sites contain both tryptase and chymase.
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Within tissue sites, mast cells interface with the external environment at epithelial surfaces
and around blood vessels (Church and Levi-Scaffer 1997, Feger et al 2002). The
preferential location of mast cells at the portals of entry to many infectious agents ensures
their early contact with invading pathogens. On activation, mast cells spontaneously
extrude granule-associated substances, such as histamine. Furthermore, they express lipid-
derived mediators including leukotrienes minutes after exposure to pathogens (Brody and
Metcalfe 1998). Within hours of activation, mast cells synthesise an array of cytokines
including GM-CSF, IFN-y, TNF-a, IL-l, IL-2, IL-4, IL-5, IL-6, IL-8, IL-lO, IL-13 and IL-
18, and several chemokines (Kobayashi et al. 2000). Mast cells are important players
within several chronic inflammatory disease processes including rheumatoid arthritis (RA),
Crohn's disease, interstitial cystitis and scleroderma (Krishnaswamy et al. 2001).
Mast cells are a major source of TNF-u and IL-4, which are decisive in initiating
appropriate host immune and inflammatory responses to pathogenic bacteria (Li and Krlis
1999). Indeed, mast cell-derived TNF-u plays a crucial function in innate immunity by
enhancing the recruitment of neutrophils to sites of pathogenic bacteria (Maurer et al.
1998). Bacterial recognition and killing is further aided by receptors for complement and
Fey receptors that bind IgG coated bacteria to the mast cell membrane (Talkington and
Nickell200l). Of importance, mast cell-derived leukotriene B4 recruits memory CD4+ and
effector CD8+ T cells to sites of inflammation. Subsequently, mast cells are capable of
processing and presenting bacterial antigens to these locally recruited T cells (Ott et al.
2003, Nigrovic and Lee 2005). By secreting biologically active products in response to
pathogenic components and other stimuli generated during innate immune responses, mast
cells modulate DC, T cell and B cell functions. This occurs in such a way that the ensuing
acquired immune response may be enhanced and modified. Therefore, mast cells are not
mere effector cells within innate immune responses but are critical immune cells linking
and influencing both innate and acquired immunity (Galli et al. 2005).
2.2.4 Natural Killer (NK) Cells
Natural killer (NK) cells are an important component of innate immunity in the resistance
to intracellular pathogens and tumours. Through their release of chemokines and cytokines,
NK cells mediate inflammatory responses to induce haematopoiesis and regulate the
developing acquired immune response (Moretta et al. 2005). NK cells comprise 10-15% of
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peripheral blood lymphocytes and are defined by a lack of expression of CD3 and their
expression of CDS6. NK cells carry out their effector functions by balancing endogenous
MHC-I class-specific inhibitory derived responses with multiple activating receptor
responses (Moretta 2005).
In response to pathogenic challenge, one of the principle immunomodulatory properties of
NK cells is their ability to secrete IFN-y. They are also capable of secreting TNF, GM-
CSF, CCL3, CCL4 and CCL5, thereby contributing towards the recruitment of other
inflammatory cells to the site of inflammation (Ferlazzo 2005). Various stimuli enhance
NK cell activity that is accompanied by increased expression ofFas ligand (FasL), CDlla,
CD II b, CD28 and CD44 and decreased levels of CD62L. NK cells do not have specific
antigen receptors and lack the capacity to specifically recognise foreign antigens. As a
consequence, the events that lead to NK cell activation are very different from those of
other lymphocytes. For example, cytokines (IL-2, IL-12, IL-IS, IL-18 and IL-21) and other
ligands (Ly49, CD28, ICAM) can directly activate NK cell effector functions without the
requirement for antigen-specific recognition. These act through their extensive range of
cell surface receptors, including members of the C-type lectin or Ig superfamily, natural
cytotoxic receptors (NCRs), cytokine receptors and a range of costimulatory molecules
(Moretta 2005).
2.2.5 B lymphocytes
Similar to APCs, B cells recognise PAMPS such as LPS (Poltorak et af. 1998, Hoshino et
al. 1999a). Indeed, PAMPs are capable of directly stimulating B cells and at high
concentrations lead to polyclonal B cell activation (Moller 1975). Furthermore, CpG-
containing DNAs and LPS modulate B cell effector function, promote B cell proliferation,
induce plasmacytoid differentiation and class switching as well as regulating autoimmunity
and Th I-related inflammation (Peng 2005). Many PAMP-related effects upon B cells
occur through TLR ligation and signalling. Indeed, B cells express significant mRNA
encoding TLR-I, and TLR-6-10 (Peng 2005). In contrast to T cells, B cells are efficient at
recognising the geometry of pathogens. Pathogenic microorganisms are therefore able to
directly crosslink B cell receptors (BCRs) thus activating B cells without the requirement
of Th- cell-dependant isotype switching and memory B cell generation (Ruedl et al. 2000).
Subsequently, BCR or CD40 ligation results in significant up-regulation of TLR
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expression within the B cell. Of importance, B cells are 100 to 1000 times more potent
than other antigen presenting cells, such as dendritic cells and macrophages, at inducing T
cell activation to a specific antigen (Lanzavecchia 1990).
B cells are now recognised as being fundamental in the effector mechanism of tissue
damage within chronic inflammatory bone diseases such as RA (Kotzin 2005). They
release the key proinflammatory cytokine regulators TNF-a, IL-l, lymphotoxin, IL-6 and
IL-lO (Duddy et al. 2004). The release of the latter two cytokines further stimulates B cell
function via a feedback loop and in doing so, perpetuates chronic inflammation (Kotzin
2005). B cells also have central responsibilities within the inflammatory cascade through
their effects on dendritic cells, their influence on germinal centre formation and the
effective presentation of antigen to CD4+ T cells, thereby mediating CD4+ T cell
activation. Interestingly, T cell infiltration into inflammatory sites and the ability of tissues
to produce IL-l and IFN-y are inhibited in B cell-depleted mice (Kotzin 2005). This
suggests that, at least in part, Th1 type inflammatory responses are governed by the
presence of B cells.
2.2.6 T lymphocytes and adaptive responses
2.2.6.1 Introduction
Antigen recognition is the first stage in the activation and clonal expansion of antigen-
specific T cells. Peptide antigens are recognised via the T cell receptor (TCR), which is
situated alongside CD4 and CD8 coreceptor molecules. In addition, T cell activation
requires costimulatory signalling through molecules such as C028 and CD40 ligand. C08+
cytotoxic lymphocytes mediate resistance to infectious agents and tumours. Classically,
they recognise antigens that are localised in the cytoplasm of target cells. These are
subsequently processed and presented as peptide complexes with MHC-I molecules. CD4+
T cells critically determine the outcome of any given infection. After leaving the thymus,
naive CD4+T cells are predominantly located in the lymph nodes and have the potential to
differentiate into two functionally distinct T helper effector cell subsets, Th 1 or Th2.
Several factors influence the differentiation process toward Th I or Th2 lineage including
the type of APC, the concentration of antigen, the ligation of select costimulatory
molecules and the local cytokine milieu (Szabo et al. 2003).
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2.2.6.2 T Regulatory Cells
In an attempt to diversify and refine its ability to regulate adaptive immune responses, the
immune system has evolved numerous mechanisms. Of these, naturally arising CD4+ T
regulatory (Treg) cells afford one of the critical mechanisms for the maintenance and the
modulation of self-tolerance. They are responsible for suppressing the activation and
expansion of self-reactive lymphocytes, which are implicated in autoimmune diseases. The
majority of Treg populations have been defined on their phenotype and their ability to
produce suppressor cytokines including IL-4, IL-IO and TGF-~. Treg cells frequently arise
after antigen exposure and include regulatory Th2 cells, regulatory Th 1 cells, IL-I0
producing Trl cells, TGF-~-secreting Th3 cells, CD8+ T cells, NK cells and y8 T cells
(Piccirillo and Shevach 2004). However, the precise phenotype and exact mode of function
of these cells remains poorly defined.
Regulatory CD4+ T cells were originally recognised by their expression of the IL-2Ra
chain (CD2S). These CD4+CD2S+regulatory T cells constitute S-IS% of the peripheral
CD4+ T cell population and may be classified as naturally occurring (nTreg) or induced
(iTreg) (Mittriicker and Kaufmann 2004, Piccirillo and Shevach 2004). In response to a
number of different polyclonal stimuli, CD4+CD2S+ regulatory T cells suppress both the
proliferation and cytokine production of CD4+CD2S- responder (T-resp) T cells. This
occurs in a cell contact-dependent manner, independent of IL-I0 (Beacher-Allan et al.
200S). CD4+CD2S+regulatory T cells are also adept at modulating the responses of CD8+
T cells, NK cells and the antigen specific responses of CD4 T cells to specific antigens
(Beacher-Allan et al. 200S). These data suggest CD4+CD25+ cells may significantly
contribute towards the regulation of immune responses. Interestingly, CD4+CD2S+
regulatory T cells isolated from RA synovial joints exhibit increased suppressive effects
compared with peripheral CD4+CD2S+ T cells. Furthermore, activated synovial fluid T
cells have a reduced susceptibility to suppression by these CD4+CD25+ regulatory T cells.
This implies that in chronic inflammatory disease processes, such as RA, the degree of
immune regulation is influenced by the balance between activated regulatory CD4+CD2S+
T cells and local inflammatory cells (van Amelsfort et al. 2004). However, the potential
contribution of T regulatory cells towards PRO pathologic processes has not been
investigated.
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2.2.6.3 CDF effector Th 1/ Th2 paradigm
During adaptive immune responses, lymphocytes differentiate to produce an appropriate
immune response tailored specifically to the invading pathogens. Importantly, the early
cytokine environment at the initial stage of T cell priming influences the type of immune
response elicited against different pathogens. CD4+ effector T lymphocytes can be divided
into subclasses based upon their cytokine configuration and thereby, their potential
functional activity (Mosmann et al. 1986). The avidity of the T-cell receptor (TCR) to the
antigenlMHC complex, the nature of costimulatory molecules and the local cytokine
milieu all influence the fate of the naive CD4+ ThO precursor cell (Table 2.1). As such,
effector Th 1 development is induced by the presence of IL-12. Therefore, mice deficient in
IL-12 or signal transducer and activator of transcription (Stat)4 exhibit impaired Th 1
responses. Likewise, mice with targeted disruptions of IL-4 or its downstream signalling
molecule Stat6 are unable to mount appropriate Th2 responses (Murphy et al. 2000).
Despite intensive research, the mechanisms regulating the initiation and down-regulation
ofThlITh2 responses are still incompletely understood (Szabo et al. 2003).
The Thl response is a critical element of host defence, responding to IL-12 derived from
macrophages and dendritic cells in the presence of pathogens that require internalisation.
Characteristic features of Thl type responses include the secretion of IFN-y, TNF-a, IL-2,
IL-12 and TNF-P (LT) and isotype switching to immunoglobulin G2a (lgG2a). This
essentially leads to the development of a dominant cell-mediated response. Thereby,
macrophages, NK cells and cytotoxic T cells are activated, resulting in a prolonged
inflammatory reaction (Mosmann and Coffman 1989). In addition to specific secreted
components, Th 1 cells preferentially express the IL-12RP2 chain, IL-18R, P-selectin
glycoprotein ligand-l and the chemokine receptors CXCR3 and CXCR5 (Ho and Glimcher
2002).
By binding to its IL-12RP2 receptor unit and signalling through Stat4, IL-12 is a key
mediator directing the development of Th 1 type responses. Furthermore, optimal Th 1
development requires sustained IL-12 signalling (Athie-Morales et al. 2004). Nevertheless,
provided IL-23 is present, IL-12 is not prerequisite for the generation of Th 1 responses
(Cooper et al. 2002). IFN-y is critically involved in orchestrating protective functions
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necessary for the elimination of most pathogenic microbes and is central to Th I
development. lFN-y promotes phagocytosis and up-regulates microbial killing by inducing
the availability of NO. hydrogen peroxide and superoxide in phagocytic cells. When
combined with LPS. IFN-y up-regulates IL-l and TNF-a expression in macrophages
(Collart et al. 1986. Sieling et a/. 1994). IFN-y is principally produced by
macrophage/monocytes, which upon stimulation with IL-18 in combination with IL-12
secrete high levels of IFN-y protein (Munder et al. 1998). IFN-y signals through Stat l ,
thereby activating the T-box transcription factor T-bet, which is the principal inducer of
IFN-y and subsequent Th I differentiation (Bettelli and Kuhcroo 2005, Kitamura et al.
2005). Indeed, the effects of T-bet are so potent that the expression of this transcription
factor in previously differentiated Th2 cells reverses their phenotype and results in IFN-y
expression. Of importance, there appears to be a strong genetic influence that controls T-
bet expression and therefore Thl polarisation (Hohler et al. 2005). Thl development is
also suggested to result from IFN-y-maintaincd expression of IL-12R~2, thus allowing
cellular responsiveness to IL-12. Subsequent signalling by IL-I2 activates the Stat4
pathway, thereby inducing expression of IL-18R and stabilising IFN-y production.
Consequently, the expression of IL-18R enables cellular responsiveness to IL-I8. This
ultimately leads to a Th I cell capable of antigen driven IFN-y production and antigen-
independent cytokine production of IFN-y by ligation of its IL-12 and IL-18 receptors
(Berenson et al. 2004).
In contrast. the Th2 pathway is typically generated in the presence of large extracellular
parasites e.g. helminths. Th2 type responses are largely characterised by the development
of the humoral pathway and the production of Th2 type cytokines that promote B cell
growth. The release of Th2 cytokines, including IL-4, IL-5. IL-IO and IL-I3, govern what
is considered to be a protective humoral type response, typified by the production of IgG I.
IgA and IgE. Effector cells that use these antibody isotypes, including eosinophils via IL-5
and mast cells via IL-4, are thereby stimulated. IL-4 induces Stat6 activation, which
promotes the expression of GATA-3. This is an essential transcription factor for both IL-4
and the development of Th2 cells (Bettelli and Kuchroo 2005). In addition to specific
patterns of cytokine expression. Th2 cells preferentially express the chemokine receptors
CeR3, eCR4 and CCR8 and inducible costimulatory molecule (IeOS) (Ho and Glimcher
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2002). In contrast to Th I cytokines, Th2 type cytokines down-regulate the production of
IL-I and TNF-a by macrophages treated with LPS (Zissel et al. 1996).
The fine balance of effects between Th I and Th2 type subsets generally determine whether
there is a successful outcome to an infectious disease or a perpetual chronic inflammatory
reaction (Abbas et al. 1996). Although extensively investigated, many discrepancies are
evident in attempting to define the exact nature of the Th IITh2 response and the specific
role of cytokine mediators. For example. the role of IL-I is controversial with different
groups. using differing in vivo murine models. suggesting that IL-I establishes a type-2
response (Huber et al. 1998. Helmby and Grencis 2004). Conversely. others implicate IL-I
in driving Th I type responses (Shibuya et al. 1998). IL-IO, a general inhibitor of
proliferative and cytokine responses in T cells. is produced by mononuclear phagocytes
(Fiorentino et al. 1991. de Waal Malefyt et al. 1991, Hsu et al. 1992) and by both Th I and
Th2 lymphocytes (Del Prete et a/. 1993). Furthermore. the roles of IL-18 and more
recently IL-17 have been debated as to their preferential involvement in driving either Th I
or Th2 mediated responses. Indeed, it has recently been suggested that a third subset of
CD4+ T cells exist, termed Th17, which are induced by the presence of IL-23 (Bettelli and
Kuhcroo 2005).
A further confounding problem in defining Th I or Th2 responses in disease processes is
the identification of reliable markers that specifically identify CD4+ T effector Th I or Th2
cells. The elucidation of such stable markers would enable studies of diseased tissues to
accurately determine a predilection towards a Th I or Th2 pathway that results in chronic
pathogenicity. Recently, the identification of another IL-l R family member. the TlIST2
cell receptor, has been proposed as a suitable marker. Whilst IL-18 and IL-18R augment
Thl responses, TI/ST2 appears to be selectively expressed on Th2 cells (Mitcham et al.
1996. Xu et al. 1998a. Carter et al. 200 I). Furthermore. T IIST2 expression strongly
correlates with IL-4 production. thus implicating T1/ST2 as a stable marker for Th2 cells
in vivo (Lohning et al. 1998). However. others have demonstrated that ST2 expression is
induced in activated human Th2 cells. but it is absent in resting cells implying that ST2
may not be a stable marker (Lecart et al. 2002). More recently. Dardalhon et al. (2005)
have identified that the costimulatory molecule CD226 is expressed on the surface of Th I
cells and this regulates their expansion and effector functions.
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In conclusion. it is evident from studies to date that the precise nature of Th 1/ Th2 type
responses and the role of cytokine regulation in the development of appropriate C04+
effector T cell responses still remain to be defined. Moreover. the endodontic literature is
comparatively devoid of investigations accurately detailing the functional role of the C04 +
effector T cell response within the human PRO lesion. Furthermore, the involvement of
regulatory T cells within the initiation and perpetuation of the PRO lesion has not been
reported.
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Table 2.1 Characterisation of CD4+ Th subsets.
Characteristic Th 1 cells Th2 cells
Cytokine production IFN-y, IL-2. TNF, IL-4. IL-5. IL-13, (lL-I 0 in
lymphotoxin a mice)
Transcription factors Stat I , Stat4, T-bet, NF-KB Stat6, GAT A3, NF AT
Inducing stimuli IL-I2, IFN-y. IL-I8, IL-27. IL-4
PRR signalling
Chemokine receptor CXCR3. CCR5. CCRI CCR3. CCR4. CCR8
expression
Antibody isotypes IgG 1. Ig03, Ig02 IgG4.IgE
Cell-mediated immunity
Effector response Macrophage activation Eosinophil activation
Antibody-mediated cellular Allergy
cytotoxicity
---- --
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2.3 Innate immunity and PAMPs
Lipopolysaccharides, whose biological effects were first reported over 100 years ago
(Pfeiffer 1892), are an essential component of the outer membrane of Gram-negative
bacteria. They are heat stable, non-proteinaceous molecules composed of a predominantly
lipophilic region, lipid A. and a covalently linked hydrophilic poly- or oligosaccharide
portion (Holst et al. 1996). The lipid A domain represents a highly specific and conserved
pathogen associated molecular pattern (PAMP) for infection by Gram-negative bacteria.
Indeed, Lipid A is the bioactive component of LPS and is responsible for its toxicity
(Dixon and Darveau 2005). In humans, the primary target cells of LPS virulence are the
professional phagocytes of innate immunity i.e. peripheral monocytes, tissue macrophages,
dendritic cells and neutrophils. These cells constitutively express the membrane bound
form of the CD 14 glycoprotein and Toll-like receptor (TLR)-4 (Haziot et al. 1988, Muzio
et al. 2000). LPS is an important virulence determinant that exhibits several important
properties including immunogenicity, induction of pro-inflammatory cytokines, and
protection against phagocytosis and complement killing (Devine 2003).
LPS is a potent stimulator of cytokines from inflammatory cells. One of its most important
properties is the induction of steady-state levels of IFN-y mRNA and cell-associated
immunoreactive IFN-y (Fultz et al. 1993). IFN-y further enhances the sensitivity,
magnitude and maintenance of inflammatory monocyte responses to LPS in vitro (Hayes et
al. 1995). Moreover, IFN-y induces increased TLR4 mRNA expression in human
monocytes and neutrophils in vitro (Muzio et al. 2000). In addition to IFN-y. LPS
activation of mononuclear cells leads to the secretion ofTNF-a, IL-lP, IL-6. IL-8, IL-I2.
IL-IS, IL-18 and M-CSF. LPS may significantly contribute towards infection associated
tissue damage by inducing TNF-a production, thereby stimulating expression of pro-
apoptotic genes and promoting the cytoplasmic apoptotic pathway (Alikhani et al. 2004).
LPS derived from invading endodontic pathogens. which induce resident monocytes and
ncutrophils to secrete IL-l, IL-6, IL-8 and TNF-a, may therefore promote the degradation
of hard tissue surrounding the dental root apex. However, in addition to stimulating the
release of these pro inflammatory mediators by neutrophils, LPS prepares these cells to
rapidly respond to IL-IO. Thereby. the extent of the inflammatory response. which may
lead to adverse destructive pathways. is carefully regulated (Cassatella et al. 2005).
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Gram-positive endodontic microorganisms such as Streptococci and Staphylococci are also
capable of causing substantial tissue damage. Although not possessing LPS, these
microbes possess a variety of virulent exotoxins including lipopeptides, peptidoglycans,
lipoteichoic acid, double stranded (ds)RNA and unmethylated DNA fragments such as
CpG-containing motifs. Although their biological properties are weaker than endotoxin,
these virulence factors, in addition to Gram-positive pore forming toxins and
superantigens, contribute to the overall toxic potential of bacterial challenge of the host
(Beutler and Rietschel 2003). Bacterial and viral derived superantigens bind to the outer
surface of both MHC-II molecules and the VII region of the T cell receptor. Each
superantigen can bind a variety of the different V~ gene products. Thereby, superantigens
are capable of potently stimulating 2-20% of all T cells (Torres and Johnson 1998,
Yamazaki and Nakajima 2004). Cell contact with mononuclear phagocytes and a
combination of cytokines are usually required for the induction of IFN-y (Billiau 1996).
However, the Staphylococcal enterotoxin B (SEB) superantigen is capable of
independently inducing IFN-y production in human NK cells (D'Orazio et at. 1995).
Indeed, SEB augments antigen-specific T cell responses by up-regulating IL-12 production
in macrophages. The increased expression of IL-12 is then responsible for augmenting
antigen-induced proliferation of Th 1 type cells (Bright et at. 1999).
There are common elements in cellular responses to both Gram-negative and Gram-
positive pathogens including the release of chemokines and cytokines. for example IL-6
and TNF -u. However. the pattern of gene expression induced by these two distinct PAMPs
in leukocyte cell cultures ex vivo does not correlate well with in vivo protein expression of
cytokine mediators in patients suffering with Gram-negative or Gram-positive sepsis
(Feezor et al. 2003). Studies within humans have identified high levels of LPS within the
PRD lesion and dental root canal exudates. However, within human PRO, the precise role
of PAMPS upon immune cell activation and specifics of the subsequent induction of
cytokine expression is largely unknown.
2.4 Toll-like receptors (TLRs)
Cellular recognition of invading pathogens by APCs IS accomplished by pattern
recognition receptors (PRR) binding invariant pathogen associated molecular patterns
(PAMPS) (Bachmann and Kopf 2002). Members of the Toll-like family of receptors
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(TLRs) perform a central role in initiating appropriate host innate responses to invading
pathogenic microorganisms. To date, the expression of 11 human TLR paralogues have
been found within humans. The cytoplasmic portion of TLRs is similar to that of the IL-l
receptor family and is termed the TollllL-l receptor (TIR) domain. However the
extracellular units of both types of receptors are structurally unrelated with TLRs bearing
leucine-rich repeats (Takeda and Akira 2005).
Specific microbial virulence factors and invariant microbial structures can be distinguished
by the differing Toll receptors. Lipoproteins, viral derived double stranded RNA (dsRNA),
LPS, bacterial flagella and bacterial DNA containing unmethylated CpG motifs are
recognised by TLR2, TLR3. TLR4, TLR5 and TLR9 respectively. In addition, TLR2
appears to recognise LPS derived from pathogens such as Porphyromonas gingivalis,
which has a differing number of acetyl chains within the lipid A component from that of
Gram-negative LPS (Takeda and Akira 2005). TLR recognition of pathogens induces TLR
dimerisation, thereby activating their signalling pathways. As such, TLR2 is capable of
forming heterophilic dimers with TLRI or TLR6 but generally homodimers are formed.
Furthermore, gene expression changes induced by pathogens upon first contact are
primarily driven by TLRs (O'Neill 2004). However. PAMPS are not the only ligand
activators of TLR-induced signalling. Interestingly, TLRs also recognise and are activated
by endogenous host proteins such as extra cellular matrix proteins (ECM), heparin
sulphate, p-defensins and heat shock proteins (Miyake 2004). Nonetheless, the crucial role
of TLRs in the host defence against infection is emphasised by pathogens that are able to
manipulate or inhibit TLRs. such as the Vaccina virus that inhibits TLR signalling (O'Neill
2004).
Individual TLR signalling pathways are divergent. Therefore. the activation of each TLR
leads to slightly different patterns of gene expression profiles. Nevertheless. MyD88 is
common to all TLR signalling pathways and culminates in the activation of NF-KB.
Signalling of TLRs through MyD88 is essential for the induction of int1ammatory
cytokines such as TNF-a, IL-6. IL-12 and IL-18. However. signalling through MyD88-
independent pathways, as can occur with TLR4 ligation, may also lead to late NF-KB
activation. Excessive production of these inflammatory mediators would result in serious
systemic disorders and mortality. TLR-mediated responses are therefore carefully
modulated. This can occur through reduced expression of TLR4 and MD-2 that results in
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LPS tolerance, reduced expression of IRAK-l, induction of the inhibitor IRAK-M,
expression of SOCS 1 or ubiquitination-mediated degradation of TLRs (Takeda and Akira
2005). In addition to microorganisms, TLR expression is regulated by many cytokines and
chemokines such as colony stimulating factor (CSF-I), macrophage migration inhibitory
factor (MIF), IL-2, IL-15, IL-l p, IFN-y and TNF-a (Takeda et al. 2003) and inflammatory
mediators such as histamine (Talreja et al. 2004).
Each TLR exhibits distinct tissue activity and their absolute levels within differing cell
types is highly dynamic (Hopkins and Sriskandan 2005). Thereby, bronchial and
gastrointestinal epithelial cells express distinct TLR patterns compared to the blood-brain
barrier and endothelium. For example, TLR3 has a central role in protecting the
penetration of the blood-brain barrier by West Nile virus whereas TLR2 and TLR4 on lung
endothelial cells are sensitive to specific bacterial ligands and direct the migration of
rolling neutrophils into inflamed tissues (Hopkins and Sriskandan 2005). In addition to the
ligation of TLRs, co-expression of other molecules is often required for cellular
responsiveness. This is classically demonstrated by the critical requirement for association
ofTLR-4 with CDl4 and the MD-2 molecule for successful cell signalling to LPS (Miyake
2004).
Although TLR recognition is central to innate immunity, it is now recognised that these
receptors are important in linking innate and acquired immune responses. TLR expression
appears to be an essential component in the successful recognition and phagocytosis of
bacteria, leading to expression of inflammatory cytokine and co-stimulatory molecule
genes. In addition to phagocytosis-mediated antigen presentation, TLR-mediated cytokine
gene expression instructs the development of antigen specific acquired immunity (Takeda
and Akira 2005). Indeed, TLR family members represent critical PRRs, whose signals lead
to the generation of effector responses including Thl and CTL responses. Following TLR
ligation, cytokines secreted from DCs, in combination with T cell C028 engagement, are
fundamental in allowing C04+ effector cell activation by overcoming the suppressive
effects of T regulatory cells. The secretion of IL-6 and other cytokines makes CD4" cells
refractory to suppression whilst not altering the activity of T regulatory cells (Pasare and
Medzhitov 2004).
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2.5 Cytokines: regulators of immune responses
2.5.1 Introduction
Cytokines are small, secreted proteins that govern host responses against pathogenic
challenge. They regulate communication between APCs, lymphocytes and other cells
involved within inflammatory and immune responses (Belardelli and Ferrantini 2002).
Indeed, these inflammatory mediators orchestrate the initiation, progression and
termination of all immunological processes. In addition to instructing host responses within
inflammation and immunity, cytokines control cellular differentiation, maturation and
activation and thereby, tissue repair and fibrosis. They frequently act simultaneously and
may mutually modulate actions upon their cellular targets through synergistic
enhancement/suppression or neutralisation effects.
Cytokines, such as IL-2, are traditionally considered to be characteristic of the acquired
immune response. However, 'innate' cytokines derived from cells of innate immunity,
including TNF-a, GM-CSF, IL-12, IL-15 and IL-18, are also involved in the generation of
adaptive immune responses (summarised in Figure 2.1). Although cytokine expression is
essential for host protection to intlammatory stimuli, they are also responsible for the
pathogenesis of several chronic inflammatory disorders including rheumatoid arthritis
(RA), Crohn's disease. ulcerative colitis, psoriasis, and atherosclerosis. Thereby, cytokines
are capable of driving chronic inflammatory processes that exhibit concomitant tissue
destruction (Andreakos et al. 2004).
Cytokines can be broadly classed according to generally accepted functional effects of
CD4 + effector Th I and Th2 cells. Type I cytokines, promoting Th I immune responses
include IL-2, IL-12, IL-15, IL-18, IFN-y, IFN-a and IFN-P and these generally drive cell-
mediated immunity. By contrast, IL-4, IL-5, IL-lO and IL- 13 are principally involved in
Th2 type immune responses that primarily promote humoral responses. However, it is
becoming increasingly evident that depending on the local cytokine milieu, these cytokines
are capable of evoking either type of immune response. In tum, they determine whether the
inflammatory response is directed towards tolerance or immunity (Banchereau and
Steinman 1998).
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In norrnal physiological circumstances. inducing stimuli result in transient cytokine
production. Consequently, cytokine gene expression is rapidly down-regulated and
cytokine proteins are degraded. However, in chronic inflammatory disorders such as PRO,
these cytokines are up-regulated for extended periods of time. Importantly, dysregulated
cytokine expression does not occur in a random and haphazard fashion. Conversely, they
are expressed in an ordered hierarchical cascade of events.
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Figure 2.1 Schematic illustration representing cellular components of PRD and
their contribution towards the cytokine network within the host response to infection.
Macrophages activated by endodontic pathogens and! or microbial-derived products or
acute phase reactants release a variety of pro-inflammatory cytokines and chemokines.
Excessive levels of these mediators are carefully regulated by the concomitant secretion of
antagonist molecules. The inflammatory reaction is further propagated by T cell activation
upon cell contact with macrophages, inducing further secretion of proinflammatory
cytokines. Activation and release of cytokines by stromal and other inflammatory cells
results in a complex inflammatory cytokine network. Dysregulation of this inflammatory
response leads to chronic inflammation and associated pathology.
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2.5.2 Interleukin (lL)-l P
The IL-I cytokine family is classically composed of ll.«l u, IL-IP and IL-Ira. These three
family members are structurally related to each other and bind to IL-I receptors (IL-I R) on
cell membranes (Dinarello 1994, 1996). Gene sequences encoding six new members of the
IL-I family have recently been elucidated and named from IL-I F5 to IL-I FlO (Barton et
£II. 2000, Busfield et al. 2000, Smith et al. 2000, Debets et £II. 200 I). IL-I a shares 22%
sequence similarity with mature IL-I P and 18% with IL-I ra. IL-I a and IL-I ~ are potent
agonists and recognise the same type 1 IL-I receptor (lL-1 R). IL-I receptor antagonist (IL-
Ira) acts as an antagonist to this receptor, thereby blocking the biological response of IL-
Ia and IL-I p. The IL-I signalling system is critical for appropriate innate immune
responses to infectious agents and is conserved in plants, insect and mammals.
Signal transduction of IL-l into target cells involves ligation of its cognate receptors, IL-
l RI. IL-l RH and IL-l RAcP. The IL-I type I receptor (IL-I RI) is the primary signal
transducing receptor. The IL-I type II receptor (lL-I RH) lacks a signal transducing
cytostolic domain and thus acts as a decoy receptor. The signalling receptor complex
consists of the IL-I-R 1 and the IL-I Receptor accessory protein (IL-l RAcP). IL-l binds to
the IL-I receptor complex with high affinity (Dinarello 1996). The cytoplasmic domains of
IL-I Rand IL-I RAcP share signiticant homology with Toll, the Drosophila melanogaster
receptor, which has a central role in primitive immune responses (Gay and Keith 1991).
IL-la and IL-l p are both released as 31 kDa precursor molecules that require processing to
produce the mature 17 kDa form. IL-I B is predominantly a proinflammatory cytokinc that
mediates a variety of inflammatory responses in the majority of organ systems throughout
the body (Fitzgerald and O'Neill 2000). However, little is known of the distinction
between the roles of IL-la and IL-IP during these processes. IL-Ia remains primarily cell
associated and is detected in the cytosol and on the plasma membranes of cells. Therefore.
IL-l a is not usually detectable within plasma. Nearly all the cell types that produce IL-l a
and IL-I ~ also produce the antagonist. IL-I ra. IL-I regulates gene expression of many
mediators essential to the initiation and development of the intlammatory state, including
the cytokines TNF. IL-2. IL-3. IL-6, IL-12 and IFN-y, chemokines such as lL-8, cytokine
receptors. growth factors. adhesion molecules. matrix metalloprotcinases and clotting
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factors (Oinarello 1996). Through these multiple effects, IL-I IS fundamental In
maintaining the health of the organism.
Accumulating evidence suggests that IL-l P levels are increased at sites of active bone
resorption in a variety of chronic inflammatory bone and joint diseases (Tatakis 1993,
Taubman and Kawai 2001). It is also well established that viruses, bacteria, yeasts and
soluble microbial products up-regulate IL-l p expression (Oinarello 1996). Furthermore,
high levels of IL-l P have been detected within dental root canal exudates from teeth
associated with periradicular lesions (Matsuo et al. 1994) and within the lesion itself
(Barkhordar et af. 1992). However, factors governing IL-l p expression within the human
PRO lesion are unknown.
2.5.3 Interleukin-4
IL-4 is a 15 kDa globular glycoprotein originally described as a B cell growth factor (Paul
and Ohara 1987). It signals through type 1 and type II receptor complexes that share a
common gamma chain (ye) with IL-7 and IL-9 (Reinecker and Podolsky 1995). In addition
to the yc chain, the type I receptor contains an IL-4Ra subunit whereas the type II receptor
contains the IL-13Ra. The secreted extracellular domain of IL-4Ra, termed sIL-4Ra, binds
IL-4 and antagonises its activity. Ligation of the IL-4R by IL-4 leads to Jak I and Jak3
activation and subsequent nuclear translocation of Stat6 to induce its target genes. In
addition, the lL-4Ra chain also recruits insulin receptor unit substrate-2 that results in the
activation of the Akt signalling pathway (Mowen and Glimcher 2004).
IL-4 is a pleiotropic cytokine that regulates diverse T and B cell responses including cell
proliferation, survival and gene expression. Produced by mast cells, basophils, NKT cells,
T cells and bone marrow stromal cells, IL-4 is the hallmark cytokine regulating the
differentiation of naive CD4+ T cells into effector Th2 type cells. IL-4 is responsible for
up-regulating MHC-II on antigen presenting B cells, promoting antibody isotype switching
to IgE and IgG 1 and serving as a mitogen for B cells (Nelms et af. 1999). Through its
ability to inhibit macrophage expression of IL- L TNF-a and IL-6, it is considered as a
predominantly anti-inflammatory cytokine (Hart et al. 1991).
63
2.5.4 Interleukin-6
IL-6, leukaemia inhibitory factor (LIF). oncostatin (OSM), IL-ll and cardiotrophin-I (CT-
1) are classed as gp 130-signalling cytokines. These cytokines have common features that
include functional redundancy. structural similarity and a signal-transducing component
(gp 130) in their receptors (Hirano 1998). Human IL-6 is synthesised as a precursor protein
of 212 amino acids (Kerr et al. 2001). The IL-6 receptor consists of two polypeptide
chains. The a chain (CD126) is an 80 kDa transmembrane glycoprotein that binds IL-6
with low affinity and its cytoplasmic domain is not necessary for signal transduction. A
soluble form of the IL-6Ra has also been described which acts in an agonistic rather than
an antagonistic manner (Hirano 1998). IL-6 activates gp130 through this soluble form.
even on mast cells that lack the IL-6Ra on their membranes (Kishimoto et al. 1995). The p
chain is a 130 kDa transmembrane glycoprotein that interacts with the IL-6/IL-6Ra
complex to form a trimer. The trimer as such is not capable of signalling and the 01
domain of the gp 130 is required for forming the higher order activation complex. The
sequential assembly of the IL-6 signalling complex results in the activation of the Jak
kinases followed by the phosphorylation and nuclear translocation of Stat3 and to a lesser
extent Stat6 (Diehl and Rincon 2002).
IL-6 is an important multifunctional cytokine centrally involved in immune responses,
inflammation. haematopoiesis as well as the regulation of the endocrine and nervous
systems (Kerr et al. 2001). Several cell types produce IL-6 including leukocytes,
monocytes, macrophages, T and B-lymphocytes, polymorphonuclear cells and mast cells.
Furthermore. many nonimmune cells secrete IL-6 including endothelial and epithelial cells.
keratinocytes, fibroblasts. adipocytes, osteoblasts, bone marrow stromal cells.
synoviocytes, chondrocytes and trophoblasts. IL-l, IL-4, TNF-a and IFN-y are all capable
of modulating cellular IL-6 expression. A wide variety of biological activities in various
cell populations are elicited by IL-6 and it plays a major role in cellular activation. IL-6
acts as a B cell differentiation factor responsible for the final maturation of B cells into
plasma cells, which results in increased IgM, IgG and IgA production. IL-6 also stimulates
the proliferation of thymocytes and peripheral T cells and promotes the activation.
proliferation and differentiation of NK cells. Of importance, IL-6 may have a positive.
negative or neutral effect on cell proliferation depending on the target cell type, its state of
differentiation and cross-talk with locally expressed cytokines (Xing et al. 1998. Heinrich
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et al. 1998. Jones et al. 2001). Thereby. IL-6 may exert pro- or anti-intlammatory effects
within differing inflammatory conditions.
2.5.5 Interleukin-8
Acute inflammation is characterised by plasma and leukocyte extravasation from the blood
compartments towards the injured tissue. PMNs are the first leukocyte population to
migrate to areas of inflammation. and CXC chemokines are critical in the recruitment of
PMNs to these inflammatory sites. IL-8. classed as the chemokine CXCL8. is a
proinflammatory CXC type chemokine that signals through the CXCRI and CXCR2
receptors. The predominant form of IL-8 is an 8.4 kDa protein containing 72 amino acid
residues.
IL-8 is a potent chemoattractant and activator of neutrophils and is of pivotal importance
for the generation of acute inflammatory responses (Witko-Sarsat et al. 2000). Several
cells express IL-8 including T lymphocytes. epithelial cells, keratinocytes, fibroblasts,
endothelial cells and neutrophils. IL-8 expression can be induced by bacterial PAMPS,
fungi and related products. mitogens such as PHA, cytokines such as IL-l P and aggregated
immune complexes (DeForge et af. 1992). Indeed, IL-8 expression can be induced by
TNF-a and/or IL-l within cultures of dermal and gingival fibroblasts (Larsen et al. 1989.
Mielke et at. 1990. Kristensen et al. 1991. Takashiba et al. 1992), keratinocytes (Larsen et
al. 1989. Kristensen et al. 1991) or endothelial cells (Kristensen et al. 1991). Of
importance. IL-8 is a key modulator in the release of PMNs from the bone marrow
(Terashirna et al. 1998).
IFN-y inhibits the expression of IL-8 in human monocytes stimulated with lL-2 (Gusella et
al. 1993). IL-IO or LPS (Schnyder-Candrian et al. 1995). IFN-y also interferes with LPS
and TNF-a-induced IL-8 production in human PMNs by down-regulating gene
transcription within these cells (Cassatella et al. 1993. Cassatella et al. 1995a). Moreover.
IL-8 release is impaired by IFN-y in cultures of human synovial or dermal fibroblasts
(Rathanaswami et al. 1993. Maruyama et al. 1995). arthritic osteoblasts (Lisigonoli et al.
2002) and endothelial cells (Borgmann et al. 2002). Reduced 11,-8 expression has been
associated with impaired TNF-a-induced NF-KB and activator protein I activity
(Borgmann et al. 2002). IL-8 expression has been reported within human PRD tissue.
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However, factors that govern the expression of IL-8 within the PRO lesion have not been
identified.
2.5.6 lnterleukin-l O
IL-IO, an 18.5 kOa non-N-glycosylated polypeptide, was first described as "cytokine
synthesis-inhibitory factor" and represents one of the most important immunoregulatory
cytokines (Fiorentino et al. 1989). IL-IO signalling occurs through its receptor, a member
of the class II cytokine receptor family. This consists of two subunits, the ligand specific
IL-I OR1 subunit and accessory IL-IOR2 chain. These subunits are constitutively expressed
on a variety of cells (Moore et al. 200 I). IL-to signalling predominantly activates the
JaklStat3 pathway in myeloid cells and StatS in non-myeloid cells. Within myeloid cells,
Stat3 is required for many of the anti-inflammatory effects induced by IL-to. However,
several other IL-to signalling pathways have been suggested (Moore et al. 2001).
IL-IO is produced as part of the homeostatic response to infection and inflammation and
plays a critical role in limiting the duration and intensity of immune and inflammatory
reactions (Moore et al. 2001). IL-IO production is carefully regulated as excessive
production leads to an inability to control infectious pathogens. Conversely, insufficient
IL-to leads to pathology secondary to tissue injury. This is classically demonstrated in IL-
10 gene-deficient mice, which develop chronic inflammatory disorders as a consequence of
unregulated inflammatory cytokine production (Lang et al. 2002). Both Th 1 and Th2 type
CD4+ T cell lines are capable of IL-to production and human C08+ T cells also produce
this cytokine (Yssel et al. 1992). In addition to peripheral T cells, activated human
monocytes. macrophages. B cells and keratinocytes are important cellular sources of IL-l 0
(Powrie et al. 1997). Kinetic studies reveal that following the activation of T cells.
monocytes and macrophages, IL-IO production occurs at a relatively late stage.
Furthermore, maximal IL-to mRNA expression in CD4+ T cells and purified peripheral
blood T cells is obtained after 24 hand IL-I0 protein synthesis peaks between 24 hand 48
h after cellular activation (Y ssel et al. 1(92).
IL-tO inhibits the synthesis and gene expression of several prointlammatory cytokines
including TNF-a, IL-l. IL-6, Il.-8, IL-12. Il.-18 and GM-CSF within monocytes. T and B
lymphocytes. neutrophils and mast cells (Del Prete et al. 1993. Chernoff et al. 19(5).
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Furthermore, IL-I0 modulates inflammatory reactions, regulates B cell functions
(Fiorentino et al. 1989) and is a potent simulator of NK cells (Gerard et al. 1996. Zheng et
al. 1996, Ignatius et al. 2000). Indeed. IL-I0 is a dominant immunosuppressive and anti-
inflammatory cytokine that deactivates macrophages and dendritic cells and suppresses
antigen presentation cells (Moore et al. 2001). The inhibitory effects of IL-IO on T cells
and NK cells occur indirectly through its effects upon macrophages and monocytes (Ding
and Shevach 1992). Indeed, its major function appears to be the suppression of
macrophage released cytokines, oxygen radicals, nitric oxide and chemokines (Bogdan et
al. 1991. Gazzinelli et al. 1992, Roilides et al. 1997) by inhibiting NF-KB signalling
(Wang, et al. 1995, McInnes et al. 2001, Denys et al. 2002). Furthermore. the inhibitory
effect of PGE2 on TNF-a and IL-6 expression from LPS stimulated macrophages is IL-lO
dependent (Strassmann et al. 1994).
The effects of IL-I 0 in combination with LPS upon human monocyte-derived DCs reveal
the activation of distinct functional pathways when compared with the actions of IL-I 0
alone. These effects can be categorised as: the inhibition of inflammation and immunity
and the regulation of tissue remodelling; the tuning of cytokine/growth factor receptors: the
stimulation of B cell function and lymphoid tissue neogenesis (Perrier et al. 2(04).
Although IL-IO generally suppresses the production of DC-derived chernokines, it is also
capable of stimulating CCLl3. CCLl6 and CCLl8 expression (Perrier et al. 2004). Taken
together. it is evident that IL-l 0 is more than a mere deactivator of macrophage and DC
function.
IL-I0 possesses an important position within chronic intlammatory diseases. It is
detectable at relatively high levels within inflamed joints and the addition of IL-IO
neutralising antibodies to dispersed RA membrane cultures increases IL-I Band TNF-a
expression. In contrast, the addition of exogenous IL-IO suppresses IL-1f3 and TNF-a
production and reduces IL-8 secretion after 5 days. Taken together. these data indicate a
relative deficiency of anti-inflammatory cytokines in diseased. chronically inflamed joints
(Katsikis et al. 1994). Stimulation of antigen presenting cells with LPS induces 11.-10
release that is further increased by the presence of damaged cells (Byrne et at. 2002.
Huang et al. 2001). Furthermore. the expression of TNF-a and IL-I B by LPS-stimulated
APCs in the presence of damaged cells is reduced (Byrne et at. 2002).
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However, several inconsistencies exist in defining a pro- or anti-intlammatory role for IL-
10. Priming of primary human macrophages with the type I interferon IFN-a diminishes
the ability of IL-lO to suppress TNF -a production. Indeed, this actually contributes
towards a proinflammatory gain in IL-IO activity (Sharif et al. 2004). Intravenous
administration of IL-I0 to healthy volunteers has proinflammatory effects through the
release of IFN-y, IP-I0 and granzyme levels (Lauw et al. 2000). However, these
proinflammatory effects may be counteracted by the inhibition of TNF-a, IL-l~, IL-6 and
IL-8 expression (Chernoff et al. 1995, Pajkrt et al. 1997) and the down-regulation of T cell
function (Chernoff et al. 1995). Nevertheless, it appears that the overall effect of IL-l 0 in
mice and humans is to promote local effector mechanisms such as NK cell activation and
the enhancement of expression of cytotoxic molecules.
More recently, homologues of IL-I0 have been described that also exhibit potential
immune regulatory roles (Conti et al. 2003). Of these, IL-19 and IL-20 are preferentially
expressed in monocytes, IL-22 (summarised in chapter 2.5.10) and IL-26 have been
exclusively detected within T cells and IL-24 expression has been located within both
monocytes and T cells (Wolk et al. 2002).
2.5.7 Interleukin-12
IL-12 is a critical cytokine that bridges the division of cellular and humoral branches of
host immunity. Bioactive IL-12p70 is a major Thl driving cytokine produced by DCs
interacting with CD4' T effector cells. The IL-12p70 molecule is a 75 kDa heterodimer
comprising two disulphide-linked p35 (light chain) and p40 (heavy chain) subunits
encoded by separate genes (Gubler et al. 1991. Wolf et al. 1991). Most cell types
constitutively express IL-12 p35. Conversely, p40 is inducible and restricted to a subset of
haemopoietic cells namely B cells. macrophages, granulocytes and Des (Trinchieri et al.
1998). Optimal production of the bioactive IL-12p70 heterodimer by DCs both in vivo and
in vitro requires two signals. These are provided by initial microbial stimuli. which
predominantly up-regulate the expression of CD40 on Des, and a T cell derived stimulus
produced by eD40 ligand expression from interacting activated T cells (Cella et al. 1996,
Snijders et al. 1998).
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The IL-12 receptor is composed of IL-12RP 1 and IL-12RP2 and is expressed mainly on
activated T- and NK cells (Presky et al. 1996). Ligand binding to the IL-12R activates the
Janus kinase (JAK)-Stat pathway of signal transduction. The specific cellular effects of IL-
12 are principally due to activation of Stat4 (Thierfelder et al. 1996). Up-regulation of the
IL-12R chains is enhanced by IFN-y, TNF, IL-12 itself and co-stimulation with CD28. The
IL-12RP2 is confined to Th 1 cells and its expression correlates with responsiveness to IL-
12 (Rogge et al. 1997. Szabo et al. 1997). Furthermore. expression of this subunit is
increased on resting T cells by IL-18 (Chang et al. 2000).
Several cytokines such as IFN-y are able to act on a variety of cells, thereby increasing
their ability to secrete IL-12 (Hayes et al. 1998). Surprisingly. the Th2 type cytokines IL-4
and IL-13 can also induce IL-12 secretion (D'Andrea et al. 1995, Ma et al. 1996). A
number of inhibitory factors of IL-12p70 production by DC cells have been elucidated.
Most of these observations have been made using cultures of the human monocyte-derived
DC. Among these inhibitors. IL-I0 is the most potent mediator acting on several cell types
of human and murine dendritic cells (De Smedt et al. 1997. Buelens et. al. 1997. Allavena
et al. 1998, Corinti et al. 2001). TGF-p and surprisingly TNF are also capable of down-
regulating IL-12 expression (Du and Sriram 1998. Ma and Trinchieri 2001).
IL-12 enhances the proliferation and cytolytic activity of activated NK cells and T cells
and potently stimulates their production of IFN-y (Trinchieri 1994). Furthermore. IL-12-
induced secretion of IFN-y requires the presence of low levels of both TNF-a and IL-l p
(D' Andrea et al. 1993. Hunter et al. 1995). Most importantly. IL-12 induces the
development of Th 1 cells in vitro (Manetti et al. 1993) and in vivo (Afonso et al. 1994). In
addition. IL-12 is a potent cofactor in the stimulation of growth, lFN-y synthesis and cell
adhesion of differentiated Th 1 cells (Germann el al. 1993). IL-12 also has effects on B
cells and, in synergy with IL-I8, inhibits Ig production through up-regulated production of
IFN-y from these cells (Lauwerys et al. 1998). In response to infection. IL-12 expression
occurs rapidly in Des and this is independent of IFN-y or responses from T cells
(Gazzinelli et al. 1994, Scharton-Kersten et al. 1996). More recently. IL-12 has been
demonstrated to induce the synthesis and secretion of biologically active IFN-y from
human neutrophils (Ethuin et al. 2004). Thus. in host responses to pathogenic challenge.
IL-12 is a key cytokine regulating responses between innate and acquired immunity
(Gately et at. 1998).
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2.5.8 Interleukin-l S
IL-IS is a member of the four-a-helix bundle cytokine family with closest homology to IL-
2 and IL-21 (Bamford et al. 1994, Burton et al. 1994, Parrish-Novak et al. 2000). IL-15
was originally described as a T cell growth and activation factor with a molecular weight
of 14-15 kDa (Grabstein et al. 1994). IL-IS uses the heterotrimeric IL-IS receptor (IL-
ISR) complex comprising the yc-chain. IL-2Rp-chain (CDI22) and a unique IL-ISRa
subunit (Giri et al. 1995). The Ye and IL-2R~ subunits are responsible for intracellular
signal transduction and the a subunit mediates specific high-affinity binding of IL-IS
(Grabstein et al. 1994). Ligation of the IL-ISRapy complex results in signalling through
Jaki/3 and Stat3/S pathways (Giri et al. 1995, Waldmann 2002).
The importance of cytokines using the IL-2! ISRp-chain for signalling is demonstrated in
IL-21 ISRp-knockout mice that are deficient in NK cells, TCRyo cells and natural killer T
(NK- T) cells (Suzuki et al. 1997). Interestingly these cells, which are severely affected by
the deficiency of IL-2RP or IL-iSRa, are implicated in innate immunity. Therefore IL-IS,
and possibly some yet unidentified cytokine(s) that also use IL-2IlSRP and IL-ISRa, is an
essential mediator in the development of cytotoxic cells responsible for innate immunity.
Macrophages and monocytes express a complex of biologically active IL-15 and IL-15 Ra
on their surface that can be further up-regulated by IFN-y (Dubois et al. 2002). On
macrophage! monocyte activation, this complex is internalised and IL-I5 is recycled in the
endosomes and re-expressed on the cell surface (Dubois et al. 2002). IL-I5 signalling
through IL-I5R is crucial for the functional maturation of APCs (both macrophages and
Des) and can stimulate IL-12 production. This activity is impaired in IL-15 deficient mice
(Ohteki et (II. 2001).
IL-IS is expressed in several cell types including macrophages, fibroblasts. dendritic cells.
osteoclasts and endothelial cells (Grabstein et al. 1994. Doherty et al. 1996. Melnnes and
Liew 1998. Thurkow et al. 1997. Oppenheimer-Marks et al. 1998, Kurowska et al. 2(02).
Many of the biological properties attributed to IL-2 are also exhibited by 11.-15. Under
physiological conditions. IL-15 promotes the differentiation and proliferation of NK cells,
NKT cells and CD8' T cells (Lodolce et al. 1998, Kennedy et al. 2000. Fehninger and
Caligiuri 200 I). Furthermore, in pathological processes, IL-IS stimulates the activation.
recruitment. proliferation. survival. and effector function of several immune cells (Carson
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et af. 1994, Kanegane and Tosato 1996, Alleva et al. 1997, Fehninger and Caligiuri 2001).
Although initially thought to have limited effects on naive COg+ or C04 + T cells, IL-15
induces the proliferation and maintenance of both memory and naive COg+ and C04 + T
cells (Marks-Konczalik et al. 2000, Nishimura et al. 2000, Niedbala et al. 2002). IL-15
alone is not capable of driving Th I or Th2 type conditions. However, priming with IL-12
or IL-4 enables IL-I5 to promote the differentiation of COS+ and C04 + Type I (lFN-y) or
Type 2 (IL-5) T cells respectively (Niedbala et al. 2002).
IL-15 is ovcrexpressed in patients with active RA and acts as a chemoattractant and
proliferation-inducing factor for synovial T cells (McInnes et al. 1996). IL-15 also
increases synovial macrophage TNF-a production via processes that require direct contact
between T cells and macrophages (Wilkinson and Liew 1995, Me Innes et al. 1997).
Furthermore, constitutive expression of IL-I5 within synovial fibroblasts is capable of
stimulating freshly isolated T cells (Miranda-Carus et al. 2004). A positive feedback loop
is thereby generated with IL-15 inducing and maintaining T cell synthesis of TNF-a, IFN-y
and IL-17 which may further activate synovial fibroblast production of IL-6, IL-S and IL-
15 (Miranda-Canis et al. 2004). However, IL-15 activities are not strictly limited to T cells
and macrophages but also extend to synoviocytes and neutrophils (McDonald et al. 1998a).
Indeed, IL-15 induces IL-17 production from T cells (Ziolkowska et af. 2000). which in
turn induces inflammatory cytokine expression by synoviocytes (Fossiez et al. 1996) and
macrophages (Jovanovic et al. 1998). Furthermore, IL-15 also induces the proliferation and
survival of hyperproliferating primary human fibroblast-like-synoviocytes (Kurowska et
af. 2002).
Recent evidence has emphasised the protective effects of IL-IS during bacterial and fungal
infection (Nishimura et af. 1996, Musso et af. 1995, Hirose et al. 1999, Tran et al. 2003).
PBMCs mount a strong IL-15 response to infection with C. albicans, E. coli and S. aureus,
which remarkably enhances their cytocidal (NK) activities (Tran et al. 2003). Furthermore,
this response occurs early, peaking at 12 h post infection or later at 36 h. depending on the
implicated pathogen. Taken together, these data provide important evidence of the
essential role that IL-15 plays in the host" s innate immune response against pathogenic
microorganisms.
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2.5.9 Interleukin-17 A
2.5. 9.i introduction
Interleukin 17A is a proinflammatory, 17 kDa dimeric cytokine implicated in cartilage
destruction and bone loss (Yao et al. 1995. Fossiez et al. 1996). Additional molecules with
the characteristic IL-l 7A conserved cysteine residues, though heterogeneity of function,
have also been discovered and termed lL-17B-F (Aggarwal and Gurney 2002). CD4 + T
cells are the principal source of IL-l 7A however, it can also be found in eosinophils (Molet
et al. 2001), CD8+ T cells and neutrophils (Ferretti et al. 2003). IL-17A exhibits similar
biological effects to. though less potent than, IL-l ~ and TNF-a. In addition. IL-I7 A
enhances the effects of these two cytokines. Importantly. IL-17 A demonstrates potent
chemoattractant properties for neutrophils (Laan et al. 1999. Umemura et al. 2004).
Thereby, T cell derived IL-I7 A may enhance and concentrate the actions of non-specific
phagocytic effector cells at inflammatory sites (Stamp et al. 2004).
IL-17 A secretion appears to predominantly be limited to activated CD4+ CD45Rn" T cells.
Expression of IL-17 A is induced by stimulation of these cells or PBMC cultures with
Iipopeptides, PMA. PHA, concanavalin A, anti-CD3 and/ or anti-CD28 (Infante-Duarte et
al. 2000, Lenarczyk et al. 2000. Kim et al. 2005). In addition, several cytokines are
capable of inducing IL-I 7A expression within PBMC cultures including IL-6. IL-15 and
MCP-I (Ziolkowska et al. 2000. Ferretti et al. 2003, Happel et at. 2003. Kim et al. 2005).
Of importance. IL-23 appears to be a key cytokine regulating the expression of IL-17 A
(Aggarwal et al. 2003. Murphy et al. 2003). Interestingly, other prointlammatory cytokines
including IL-Ij3, TNF-a, IL-18 and TGF-j3 are not capable of inducing IL-17 A expression
within PBMC cultures (Kim et al. 2005). It is accepted that IL-17-secreting CD4+ effector
T cells are central participants in autoimmune disorders (Wynn et al. 2005). However, it
has only more recently been elucidated that CD4+ effector cells that secrete IL-17 are
developmentally distinct from Th 1 or Th2 CD4+ effector cells (Harrington et al. 2005.
Park et al. 2(05). IL-17 A expression occurs through signal transduction dependent upon
PI3K1Akt and NF-KB pathways (Kim et al. 2(05).
In contrast to the limited cellular expression of IL-17 A. the 130 kDa transmembrane IL-
17A receptor is ubiquitously expressed and does not belong to other cytokine receptor
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families (Yao et al. 1997). Indeed, IL-17R has been found on fibroblast-like synoviocytes
(Kehlen et al. 2002), fibroblasts (Maertzdorf et al. 2002), airway epithelial cells (Kao et al.
2004) and intestinal epithelial cells (Awane et al. 1999). Ligation of IL-17R generally
results in activation of NF-KB (Awane et al. 1999, Hata et al. 2002, Kehlen et al. 2002,
Kao et al. 2004, Sebkova et af. 2004). However, IL-17 A signalling can also act through
AP-l (Granet and Miossec 2004, Sebkova et al. 2004), MAPK (Hata et al. 2002, Hsieh et
al. 2002, Kehlen et al. 2002) and JAK cellular pathways (Kao et al. 2004). Interestingly,
IL-17 A in combination with IL-1 and/or TNF -a has a synergistic effect upon transcription
and nuclear translocation of AP-I members, Ebr-I and NF-KB in osteoblast cells (Granet
and Miossec 2004) and in rheumatoid synoviocytes (Granet et al. 2004).
2.5.9.2 Biological effects ofIL-17A
To date, the principal stimulatory effects elucidated for IL-17 A is its capability to up-
regulate IL-6 and/or IL-8 expression within fibroblast populations (Fossiez et al. 1996),
fibroblast-like synoviocytes (Kehlen et al. 2002), keratinocytes (Teunissen et al. 1998),
airway epithelial cells (Jones and Chan 2002), renal epithelial cells (Hsieh et al. 2002) and
gastric epithelial cells (Sebkova et af. 2004). Indeed, IL-17 A-induced secretion of IL-6, IL-
8 and MCP-l occurs rapidly after stimulation of human colonic myofibroblasts cultures
(Hata et at. 2002). In addition to its individual effects upon the expression of cytokines and
chemokines, IL-17 A exhibits synergistic properties with several prointlammatory
mediators. IL-17 A exerts a strong synergistic effect with TNF -a in up-regulating IL-6
and/or IL-8 production from fibroblasts (Andoh et al. 2002, Hata et al. 2002, Maertzdorf et
al. 2002). Furthermore, IL-6 and IL-8 expression is enhanced by IL-17 A in combination
with IL-l ~ (Hata et al. 2002). IFN-y also synergises with IL-17 A to significantly increase
the secretion of IL-8 and MCP-l from intestinal epithelial cells (Andoh et al. 200 I) and
ICAM expression on bronchial epithelial cells (Kawaguchi et al. 2001). Not only does IL-
17A enhance the actions of cytokines, but it also supplements bFGF-. HGF- and VEGF-
induced growth of vascular endothelial cells (Takahashi et al. 200Sa).
In addition to its effects upon stromal cell-derived IL-6 and IL-8, IL-17 A also induces IL-
1~ and TNF-a secretion from human PBMC-derived rnacrophages (Jovanovic et al. 1998).
Individually, IL-17 A and IL-17F are not capable of inducing G-CSF or GM-CSF
expression from lung microvascular endothelial cells cultures. However, IL-17 A and IL-
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I7F have differential regulatory roles in the production of G-CSF or GM-CSF in
endothelial cells concomitantly stimulated with IL-l p and/or TNF-a (Numasaki et al.
2004a,b,c). Furthermore, IL-I7 A synergistically enhances the production of IL-8 and G-
CSF from TNF-(l stimulated human bronchial epithelial cells (Jones and Chan 2002).
These studies establish that IL-I 7A synergises with prototypical Th 1 cytokines to increase
the expression of several pro-inflammatory mediators. However, it has also been
ascertained that IL-I7 A synergises with Th2 cytokines. For example, IL-I7 A in
combination with IL-4 or IL-13 synergistically increases IL-8 production from bronchial
epithelial cells (Kawaguchi et al. 2001).
Taken together, these studies establish that the major role of IL-17 A, and its related family
members, is the co-ordination of local tissue inflammation. This primarily takes effect
through the induction of pro inflammatory and, in particular, neutrophil-attracting
chemokines and cytokines from its target cells. As such, IL-17 A has been implicated in a
variety of inflammatory disorders including malignancy, allergy, human lung disease, RA
and inflammatory bowel disease (Lubberts et at. 2001, Kolls and Linden 2004).
2.5.9.3 IL-17 A in inflammatory bone diseases
Elevated levels of IL-17 A are detected within synovial fluid from patients with RA. IHC
studies on synovial tissues demonstrate IL-17 A protein to be localised to T cell rich areas
(Chabaud et al. 1999, Kotake et al. 1999). In experimental models, IL-I7 A stimulates
osteoclast differentiation and induces bone resorption through the induction of RANKL on
the surface of osteoblasts. Conversely, OPG inhibits IL-17 A-induced osteoclast
differentiation (Kotake et al. 2001). Within the collagen induced arthritis (CIA) model, IL-
17A is significantly involved in both early and late stages of disease progression. This
occurs through up-regulated IL-6, IL-I and RANKL expression (Lubberts et al. 2003).
Furthermore, neutralisation of IL-17 A within this CIA model significantly reduces the
severity of CIA, which is demonstrated by suppressed levels of joint damage (I .ubberts et
a/. 2004). Similarly, neutralisation of IL-17 and/ or IL-17R in mice infected with Borrelia
burgdorferi alleviates severe destructive arthritis through the concomitant increase in CD4+
CD2S+ T cells (Burchill et al. 2003, Nardelli et al. 2004).
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In IL-17 A knockout mice, collagen-induced arthritis is significantly diminished, though
not completely when compared with controls. This strongly implicates IL-17 A as being
central to the pathogenesis of CIA (Nakae et at. 2003a). Indeed, in IL-l ra deficient mice,
inactivation of IL-l 7A completely attenuates the spontaneous development of destructive
arthritis (Nakae et al. 2003b). Furthermore, in the antigen-induced arthritis murine model,
neutralisation of IL-17 A attenuates joint inflammation and bone erosion (Koenders et at.
200Sa). Reduction in joint erosion correlates with decreased levels of RANKL and
interleukin-l. The significant contribution of IL-17 A towards inflammatory arthritis has
been further established by investigations of streptococcal cell wall (SCW)-induced
arthritis in IL-l knockout mice. In this model, IL-17 A increases the extent of cartilage
damage and up-regulates MMP expression (Koenders et al. 200Sb). SCW-induced arthritis
is attenuated in IL-17R knockout mice, thereby preventing bone erosion (Lubberts et al.
200Sa). Of interest, IL-J mRNA levels are significantly decreased in this model suggesting
that in progressive chronic joint inflammation, IL-17 A signalling takes place upstream of
IL-I (Lubberts et al. 200Sb). In the sew model, IL-17R deficiency results in the reduced
accumulation of neutrophils to inflamed joints. This emphasises the importance of IL-17 A
in neutrophil chemoattraction and indicates that PMNs contribute towards inflammatory
bone destruction. It has been demonstrated that IL-17 A induces MMP production from
chondrocytes. Moreover, MMP expression is synergistically increased when IL-17 A is
added in combination with IL-l, IL-6, TNF -u and/or oncostatin M (Koshy et al. 2002, van
Bezooijen et al. 2002). Indeed, the induction of sew arthritis in IL-17R-deficient mice
results in reduced synovial expression of IL-l, IL-6, MMP-3, MMP-9 and MMP-13, which
corresponds with an absence of cartilage erosion (Koenders et al. 200Sc). Nevertheless, IL-
17A is also capable of promoting cartilage matrix degradation independently of MMPs
(Cai et al. 2001). The significant contribution of IL-17A towards intlammatory joint
damage is now clearly established. Of importance, IL-23 appears crucial in promoting the
development of IL-17 A producing cells (Murphy et al. 2003).
2.5.9.4 lL-/ 7A in response to pathogenic challenge
The majority of studies investigating the role of IL-17 A in the host response to hacterial
challenge have been undertaken within murine models. LPS exposure in mouse airways
results in the release of IL-17 A from T cells and neutrophils. The up-regulation of IL-17 A
expression leads to the mobilisation ofneutrophils to sites of bacterial challenge (Ferretti et
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a/. 2003). Subsequently, endogenously produced IL-17 A induces the local release of
neutrophil-mobilising cytokines including IL-6 and MIP-2. These mediators further
contribute towards the recruitment of neutrophils to the inf1ammatory site (Miyamoto et al.
2003a). The importance of IL-17 A-regulated early migration of PMNs to infected tissues
has been demonstrated in IL-17R-I- mice. These mice develop a normal adaptive immune
response to infection with Toxoplasma gondii. However, as a consequence of impaired IL-
17 signalling, they suffer a defective neutrophil response at the outset of infection resulting
in increased rates of mortality (Kelly et al. 2005). Furthermore, leukocyte function-
associated antigen 1 (LF A-I) knockout mice are more resistant to systemic Listeria
monocytogenes infection than controls. This is essentially due to their development of a
neutrophilia, which corresponds with an increase in serum IL-17 A levels (Miyamoto et al.
2003b).
The importance of IL-l 7A in the initial recruitment of neutrophils to locations of
pathogenic challenge has also been established in murine models of Klebsiella pneumoniae
infection. Mice lacking the IL-17R show greater bacterial burden and increased mortality
that correlates with impaired neutrophil recruitment (Ye et al. 2001a). Indeed,
administration of IL-17 A in this model leads to enhanced chemokine production,
neutrophil recruitment and survival (Ye et al. 2001 b). More recently, it has been elucidated
from this infection model that TLR-4 signalling is the principal mechanism behind
endogenous IL-17 A production. Furthermore, CD8+ T cells are a significant source of IL-
17A, this occurring through an IL-23-dependent mechanism (Happel et al. 2005). The
central involvement of IL-23 in the induction of IL-17 A expression has been further
demonstrated within activated naive CD4+ and CD8+ T cells (Eijnden et al. 20(5). The
requirement of IL-17 A in successful host responses to invading pathogens has also been
investigated within other infectious models. Endogenous IL-17 A, derived from CD4 t T
cells, mediates the in vivo development of experimentally induced intra-abdominal abscess
formation in mice challenged with Bacteroidesfragilis (Chung et al. 20(3). Moreover, pre-
treatment of the host with a specific IL-17 A neutralising antibody attenuates abscess
formation.
Recent evidence from animal experiments intimate that IL-17 A expression may be
essential for host survival against cecal ligation and puncture (CLP) induced sepsis.
Through the actions of IL-17A, bacterial infection of the peritoneal cavity is contained
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(Rice et al. 2005). Furthermore, from an analysis of a panel of 21 cytokines that induce the
expression of innate response mediators, IL-I7 A is the most potent stimulatory cytokine
for human p-defensin 2 and macrophage inflammatory protein 3 (MIP-3) (Kao et al. 2004).
Through the induction of these inflammatory mediators, IL-17 A would appear to be an
important mediator in the interplay between innate and acquired immunity. However, the
precise role of IL-I7 A in host defence against microbial infection remains to be defined.
Nevertheless, studies to date emphatically support a central immunoregulatory position for
IL-I 7A within host mechanisms against pathogenic challenge. It is therefore surprising that
IL-I7 A has not been described within the PRO lesion.
2.5.10 Interleukin-22
Originally termed IL- TIF, two groups concomitantly identified interleukin 22 (lL-22)
(Dumoutier et al. 2000a, Xie et at. 2000). IL-22 is a member of the IL-I 0 Class II cytokine
family that includes IL-19, IL-20, IL-24 IL-26, IL-28A1B and IL-29. Although structurally
related to IL-lO, it shares only 22% homology and its biological activities are dissimilar.
The gene for human IL-22 is localised on chromosome l2q 15 in close proximity to IL-26,
another IL-lO related factor (Oumoutier et al. 2000b). Comprising a six alpha helical
bundle, the IL-22 structure closely resembles that of IL-l O. In comparison to IL-l 0, which
functions as a dimer. IL-22 is predicted to function as a monomer (Gurney et al. 2004). IL-
22 readily binds to the second component of the IL-I 0 receptor (termed CRF2-4, IL-IOR2
or IL-l ORP). In combination with the IL-I OR2 chain, IL-22 weakly binds its specific IL-22
receptor (termed IL-22R1IL-22RlICRF2-9) thereby forming a unique signalling complex
(Kotenko et al. 200 Ia). There appears to be no interaction between IL-IO and IL-22 upon
biological events. Both require independent ligation with their respective R I chains to
create a binding site with the IL-lO R2 subunit (Wolk et al. 2005). Interestingly, IL-22R 1
appears to be predominantly expressed on epithelial cells or stromal cell fibroblasts derived
from various tissues (Boniface et al. 2005, Nagalakshmi et al. 2004a, Whittington et al.
2004).
IL-22 is expressed by T cells stimulated with cytokines such as IL-9 or via TeR
stimulation (Xie et al. 2000, Dumoutier et al. 2000a) and NK cells (Wolk et al. 2002). In
contrast to the high levels of IL-22 expression within T cells, other immune and stromal
cells exhibit low IL-22 expression (Nagalakshmi et al. 2004a). Expression of IL-22
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appears to be confined to memory CD4+ T cells and is markedly enhanced within Thl
polarised populations rather than Th2 cell types. IL-22 mRNA expression within these
CD4+ cells is up-regulated by IL-12, anti-CD3+anti-CD28, or anti-CD3+ICAM. In
agreement for a role within Thl type responses, IL-22 mRNA expression is further
enhanced by the action of IL-18 (Gurney et af. 2004). Of importance, IL-22 expression is
closely regulated by a soluble decoy receptor termed IL-22BP/IL-22RA IICRF2-1 0
(Dumoutier et al. 2001, Kotenko et al. 2001 b, Xu et af. 2001).
Several cell lines are responsive to IL-22 including a murine acinar cell line (266-6),
human kidney cell line (TK-IO), rat and human hepatic cell lines (H4IIE and HepG2),
human colon adenocarcinoma (SW480) and colonic epithelial cell line (Col0205) (Xie et
af. 2000, Dumoutier et al. 2000c, Aggarwal et af. 200 I, Nagalakshmi et af. 2004b). Within
these cells, the expression of IL-22R I appears to be the limiting factor for a cellular
response to IL-22. Ligation of the IL-22R primarily results in activation of Stat I and Stat3
signalling pathways (Nagalakshmi et al. 2004b). IL-22 can generally be considered as a
proinflammatory molecule. It induces large increases in acute phase-mediators such as
PAPI/Reg2, osteopontin (Aggarwal et al. 2001), serum amyloid A. alpha-
lantichymotrypson and haptoglobin (Dumoutier et al. 2000c) and ~-defensins and MMP3
from keratinocytes (Boniface et al. 2005, Wolk et al. 2004). Recently, IL-22 has been
identified within synovial fibroblasts and macrophages. Furthermore, it increases the
growth of synovial fibroblasts and induces the release of MCP-I (lkeuchi et al. 2005). It is
of interest that despite its defined pro inflammatory roles (Andoh et al. 2005), IL-22
induces IL-IO expression within the colonic epithelial cell line Col0205 (Nagalakshmi et
af. 2004b).
2.5.11 TNF-a
TNF-a is a type II, 26 kDa transmembrane glycoprotein containing a C terminus that is
external to the cell and a cytoplasmic domain. TNF is released from the cellular membrane
by a protease of the metalloproteinasel disintegrini cysteine-rich family called TNF-alpha
converting enzyme (TACE) (Gearing et al. 1994). This results in a soluble homotrimcr of
17 kDa subunits, which was originally described as a product of activated macrophages
and monocytes with tumouricidal activity (Beutler et al. 1985). TNF-a is a highly
pleiotropic cytokine belonging to a superfamily that incorporates 19 members (Fcng 20(5).
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These family members compnse membrane-anchored and soluble cytokines that are
predominantly involved in T cell-mediated immunity. TNF-a has a wide array of target
cells including monocytes, macrophages, lymphocytes, eosinophils and neutrophils and is
capable of enhancing proliferation of certain normal cells. TNF-a has potent
proinflammatory effects and is a central mediator of septic shock, cachexia, autoimmunity
and inflammatory diseases. The pleiotropic biological properties of TNF-a include
leukocyte recruitment and activation, macrophage and fibroblast cellular proliferation,
increased prostaglandin and matrix degrading MMP activity and bone destruction (Romas
et af. 2002). Although TNF-a is predominantly pro-inflammatory in nature, it is also
capable of exerting anti-inflammatory effects for example inhibiting IL-12 and IL-23 in
macrophages pretreated with LPS and IFN-y (Zakharova and Ziegler 2005).
TNF-a is a cytokine produced by a wide spectrum of cells types but primarily by
monocyte-macrophages (Sunderkotter et al. 1994). The effects of TNF-a are mediated
through its two functionally distinct membrane receptors. These comprise the 55 kDa type
1 receptor, TNF-Rl (p55), and the 75 kDa type II receptor, TNF-RII (p75). Most cell types
express both receptors, including macrophages, lymphocytes, neutrophils and fibroblasts
(Aderka 1996). Through the proteolytic cleavage of the extracellular domain of these
receptors, TNF-a activity is antagonised by the release of sTNF-Rl and sTNF-R2
(Engelmann et al. 1989, Engelmann et al. 1990). Ligation of the TNF receptors leads to the
activation of ReIINF-KB and MAP kinase signal transduction pathways (Campbell et al.
2003). Importantly, TNF-a signalling is closely related to bone resorption (Gravallese et al.
2001). Indeed, TNF-a is one of the most potent osteoclastogenic cytokines produced in
inflammation and is central to the pathogenesis of destructive inflammatory bone disorders
including RA (Romas et al. 2002). Furthermore. TNF-a modulates osteoclast formation
and function through its effects upon the expression of RANKL (Feng 2005). TNF-a has
been described within PRD tissues. However, factors that are capable of regulating TNF-a
expression within the human PRD lesion remain to be elucidated.
2.5.12 IFN-y
Interferon- y (IFN-y) is a pleiotropic cytokine belonging to the Type II interferon family. It
is a potent mediator of both innate and adaptive immunity. contributing significantly to
host defence against various microbes. The principal cellular sources of IFN-y are
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activated natural killer cells (NK cells). CD4+ Thl cells and CD8+ T cells (Rady et al.
1995, Young and Hardy 1995, Munder et al. 1998). However, expression of IFN-y mRNA
is readily detected in other cell types including B cells, dendritic cells and macro phages
(Pang et al. 1992, Fenton et a/. 1997, Yoshimoto et al. 1997, Gessani and Belardelli 1998).
IFN-y binds to the IFN-yRI and IFN-yR2 receptor chains, thereby activating Jak l , Jak2
and Statl and occasionally Stat3 and Stat5 pathways (Ramana et al. 2002, Pestka et al.
2004). Under certain conditions, IFN-y may also enhance activation of NF-KB (Cheshire et
al. 1997). The expression and secretion of IFN-y by NK cells, T cells and macrophages can
be induced by the pro-inflammatory cytokines IL-12, IL-18 and IL-2 (Hardy and Sawada
1989, Trinchieiri et al. 1995, Puddu et al. 1997). Indeed, IL-18 is a principal inducer of
IFN-y (Gracie et a/. 2003). Conversely, expression of the IL-18 antagonist, IL-18 binding
protein (IL-18BP), is induced by IFN-y in a variety of cellular systems including PBMCs
(Corbaz et al. 2002), monocytes (Veenstra et al. 2002), fibroblast synoviocytes (Moller et
al. 2003) and immortalised and primary keratinocytes (Miihl et al. 2000, Paulukat et al.
2001). This regulatory pathway has been shown to operate both in vitro and in vivo.
Although exceptions exist, it appears that IFN-y is the prime regulator of IL-18BP gene
induction. Thereby, IFN-y-induced IL-18BP may serve to control IL-18 and subsequent
IFN-y bioactivity in a classical negative loop.
Among the many biological activities of IFN-y, activation of monocytes/ macro phages and
the promotion of T cell differentiation towards a Th-l type immune response are of central
importance (Nathan et al. 1984, Gajewski and Fitch 1988). IFN-y is primarily pro-
inflammatory in nature. up-regulating several inflammatory mediators such as IL-12
(Fantuzzi et al. 1996, Ma et al. 1996), IL-15 (Doherty et af. 1996), TNF-a (Collart et al.
1986, Hayes et a/. 1995) and inducible nitric oxide synthase (iNOS) (Xie et al. 1993). On
exposure to bacterial antigens or their components such as LPS. macrophages produce IL-
12 and IL-18, thereby activating NK, NKT and T cells (Okamura et al. I995a. Ogasawara
et al. 1998. Okamura et al. 1998). These cells in turn produce IFN-y that further activates
local macrophages in a positive feedback loop. IFN-y therefore plays a critical role in the
first line of host defence by augmenting the Thl type response (Qiu et al. 20(1). In mice
spleens challenged with LPS, the predominant IFN-y producing cells are NK cells and
NKT cells whereas rnacrophages, T cells and dendritic cells contribute less (Varma et al.
2002).
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Nevertheless, not all the properties displayed by IFN-y are prointlammatory in nature
(Muhl and Pfeilschifter 2003). IL-l ~ production can be inhibited by IFN-y due to a
reduction of mRNA steady-state levels without affecting mRNA stability, thereby
suggesting a transcriptional mechanism of regulation (Schindler et al. 1990). IFN-y has
also been shown to suppress spontaneous intracellular production of proinflammatory IL-
l ~ in synovial fluid macrophages derived from RA patients (Ruschen et al. 1989). Indeed,
IFN-y promotes the secretion of IL-I Ra from PBMCs and THP-I cells, thereby modulating
the effects of IL-l ~ (Kline et al. 1995). Furthermore, IFN-y also enhances the release of
IL-IRa from synoviocytes (Seitz et al. 1994), keratinocytes (Gueniche et al. 1994) and
neutrophils (McDonald et al. 1998b). In addition to the modulation of IL-l Ra expression,
IFN-y may also disturb IL-l bioactivity by inducing the release of type II IL-I receptors
(Groves et al. 1995). By inhibiting production of pro-inflammatory IL-J and IL-8, up-
regulating the production of cytokine antagonists such as IL-I Ra and IL-I8BP and by
inducing expression of members of the SOCS family, IFN-y has the potential to modulate
inflammatory responses in either pro- or anti-intlammatory directions.
Indeed, these anti-inflammatory properties of the principally pro-intlammatory cytokine
IFN-y may be essential to controlling the extent of inflammatory conditions. thereby
avoiding concomitant tissue destruction. Although IFN-y has been described within the
PRO lesion, the dynamics of IFN-y expression and factors regulating this are currently
poorly defined.
2.6 Interleukin-18
2.6.1 Introduction
2.6.1.1 Structure of1L-18
The novel pleiotropic cytokine IL-18 was originally isolated through toxic shock generated
by the injection of mouse livers with heat-killed Propionibacterium acnes and challenged
with LPS (Okamura et al. 1995b). Subsequently, the full-length IL-I8 eDNA clone
sequence was identified as a precursor polypeptide of 192 amino acids. possessing an
atypical leader sequence of 35 amino acids (Okamura et al. 1995b, Ushio et al. 1996). This
was mapped in the human gene to chromosome 1Iq22.2-q22.3 (Nolan et al. 1998).
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Human IL-18 is a cytoplasmic protein synthesised as a 24 kDa biologically inactive. prolL-
18 precursor molecule. The IL-18 precursor is devoid of a signal peptide and. like its
family member IL-l, requires cleavage by interleukin-l converting enzyme (ICE/ caspase-
1) to generate a mature active polypeptide (Gu et al. 1997, Ghayur et al. 1997, Fantuzzi et
al. 1999). IL-18 serum levels appear to be critical to the outcome of innate immune
responses to LPS and this is primarily regulated by caspase-l (Joshi et al. 2002). However,
caspase-l independent processing pathways, including neutrophil proteinase-3 (Sugawara
et al. 2001), are also capable of generating the biologically active 18.3 kDa IL-18 molecule
(Fantuzzi et al. 1998. Tsutsui et al. 1999). To date, IL-18 does not possess sequence
similarities to other proteins but its molecular structure (Bazan et al. 1996), receptor
family, signal transduction pathways and processing enzyme (Gu et al. 1997) relate it to
the IL-l superfamily (Ushio et al. 1996). Human prolL-18 shares 65% homology with its
mouse counterpart and contains five structural cysteines. Mature IL-18 contains four
cysteines, of which Cysl12 and Cys 163 are highly conserved across species and are essential
for IL-I8 function (Pei et al. 2005).
2.6.1.2 Cellular sources of lL-18
IL-18 was originally defined as being preferentially produced by phagocytic immune cells
associated with acute inflammatory immune responses (Okamura et al. 1995a, Ushio et al.
1996, Seki et al. 2001). However. IL-I8 mRNA and pro-IL-18 protein are ubiquitously
expressed in many cell types including Kupffer cells (Okamura et al. 1995b, Matsui et al.
1997), T- and B-cells (Klein et al. 1999), dendritic cells (Stoll et al 1998, Gardella et al.
1999, Mee et al. 2000), osteoblasts (Udagawa et al. 1997), keratinocytes (Stoll et al. 1997,
Sampanthanarak et al. 2005), intestinal epithelial cells (Takeuchi et al. 1997, Pizarro et al.
1999), Langerhans cells (Matsui et al. 1997), corneal epithelial cells (Burbach et al. 2001),
oral epithelial cells (Sugawara et al. 2001), airway epithelial cells (Cameron et al. 1999),
glucocorticoid-secreting adrenal cortex cells (Conti et al. 1997), astrocytes and microglia
(Conti et al. 1999), pancreatic islet cells (Frigerio et al. 2002), chondrocytes (Olee et al.
1999), squamous carcinoma cells (Martone et al. 2004) and adipocytes (Skurk et (II 2005).
Under normal physiological conditions, IL-18mRNA is considerably stable. In contrast to
prolL-l B, many of these cells store substantial quantities of proIL-18. Thereby, these cell
populations may respond swiftly to inf1ammatory/ immune stimuli by enabling the rapid
release of constitutively expressed IL-18. Through this, IL-18 likely plays a central role in
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regulating early innate immune responses. In a similar fashion to IL-1 p, cellular secretion
ofIL-1S operates via the purinergic receptor P2X-7 (Mehta et af. 2001).
Whilst most of the aforementioned cells produce both pro, 24 kDa, and biologically active
18.3 kDa IL-18, monocytes and macrophages produce a wide variety of IL-18 forms
(Kikkawa et al. 200 I). Some of these are inactive dimers whilst other IL-IS forms have
weak IFN-y-inducing activity such as IL-18 type 2. This variant has been found at high
levels in the plasma of approximately 30 percent of normal subjects, bound to plasma IgM
(Shida et al. 200 Ia). It is suggested that this IL-18 derivative may have some responsibility
in the development of Th2 type responses involving IgE production in association with
atopic lesions (Shida et af. 2001 b).
2.6.1.3 Cellular activation by lL-18
IL-18 signalling through its receptor unit (refer to chapter 2.6.2) initiates the cascade of
kinases MyD88, IRAK (Robinson et af. 1997, Adachi et al. 1998) and TRAF-6 (Kojima et
al. 1998). Consequently, IL-IS induces the activation of transcription factors AP-I
(Barbulescu et al. 1998, Greene et al. 2000) and NF-KB (Matsumoto et al. 1997, Kojima et
al. 1999, Takayama et af. 1999, Morel et al. 2001, Chandrasekar et al. 2003, Weinstock et
al. 2003). Furthermore, the synergistic effects of IL-12 with IL-18 are probably due to
Stat4-up-regulated AP-I-mediated IFN -y promoter activation (Schindler et al. 200 L
Nakahira et al. 2002). The importance of lRAK in IL-18 signalling and function has been
demonstrated in lRAK deficient mice challenged by LPS or IL-18. These mice exhibit
dramatically reduced IFN-y production from Th I and NK cells. Furthermore, IL-IS-
induced NK cell cytotoxicity is also severely impaired (Kanakaraj et af. 1999).
Nevertheless, IL-18 is also capable of operating through IRAK independent pathways
(Thomas et af. 1999, Wald et al. 200 I). IL-18-induced IFN-y expression is primarily
mediated by the mitogen activated protein kinase p38 (MAPK p38) and p42/44 also known
as ERK I12 (Fukao et al. 2000). Moreover, IL-18 stimulation of synovial fibroblasts, which
leads to up-regulated VCAM expression, activates three separate signal transduction
pathways: the Ras/Raf-I/ERKlAP-I, PI3-kinase/Akt, or IRAKINF-KB pathways (Morel et
al. 2002). In contrast IL-18 signal transduction in epithelial cells is primarily through the
MAPK p38 pathway rather than NF-KB (Lee et al. 2004a).
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2.6.2 IL-I8 Receptor
2.6.2. 1 /L-18 receptor structure
IL-I8 acts by binding to the heterodimeric IL-I8 receptor complex comprising the IL-
I8Ra and IL-I8RP chains (Torigoe et af. 1997, Debets et al. 2000). Although IL-I8 does
not bind to the IL-I receptor type 1, the ligand binding IL-I8Ra chain is a member of the
IL-l receptor family identified as IL-l R-related protein 1 (lL-1 Rrp/IL-l RS) (Pamet et af.
1996, Torigoe et al. 1997, Thomassen et af. 1998, Hoshino et al. 1999b). IL-18Ra
represents the extracellular ligand-binding site for IL-IS. However, co-expression of IL-
ISRP is essential for the high affinity binding of IL-I8 and consequential signal
transduction (Hoshino et al. 1999, Oebets et al. 2000, Wu et al. 2003, Cheung et al. 2005).
IL-18RP is structurally related to and was originally identified as IL-l R accessory protein
like molecule (IL-IRAcPLIIL-IR7) (Greenfeder et al. 1995, Born et al. 1998, Kim et al.
2001). Importantly, IL-I8 binding to the extracellular IL-I8Ra chain is essential for
recruitment of the IL-I8RP subunit. This functional complex of IL-18, IL-18Ra and IL-
18RP has a mass of approximately 160 kDa (Azam et af. 2003).
Cellular expression of IL-18R is central to the development of an appropriate immune
response. Furthermore, clinical studies demonstrate that dysregulated expression of the IL-
I8R may contribute towards disease processes (Kobashi et al. 200 L McQuaid et al. 2003,
Itoi et al. 2004). Interestingly, both IL-18R components harbour extracellular lg-folds and
an intracellular domain homologous to the cytostolic part of the Drosophila Toll protein,
which is characteristic of IL-l Rand IL-l R-like molecules (Oebets et af. 2000). Indeed, IL-
18R signalling operates through similar downstream effector pathways to those resulting
from TLR ligation. The binding of IL-18 to this IL-18R complex induces formation of an
IL-l R-associated kinase (lRAK)/TNF receptor associated factor-6 (TRAF6) complex that
predominantly results in NF-KB activation in Thl cells (Pamet et al. 1996, Matsumoto et
af. 1997, Torigoe et al. 1997, Thomassen et al. 1998).
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2.6.2.2 Biological role of1L-18 receptor
IL-18R is widely expressed on several cell types, including T cells, B cells, NK cells,
macrophages, neutrophils, endothelial cells, epithelial cells, smooth muscle cells and mast
cells (Olee et al. 1999, Kunikata et al. 1998, Yoshimoto et al. 1995, Okamura et al. 1998,
Lauwerys et at. 1999, Gerdes et al. 2002, Gutzmer et al. 2003, Dahl et al. 2004, Lorey et
al. 2004). Moreover, 24 of 39 analysed cell lines demonstrate constitutive expression of
IL-18R, which occurs independently of cellular maturation in a non-lineage-specific
manner (Nakamura et al. 2000). IL-18Ra expression was originally thought to occur on
Th 1 cell surfaces after T cell activation but not Th2 cells, thus explaining the predominate
biological Th 1 type immune responses afforded by IL-18 (Tomura et al. 1998, Xu et al.
1998, Yoshimoto et al. 1998, Debets et al. 2000). However, through the use of more
specific antibodies, IL-18Ra subunit expression but not that of IL-18RP has been detected
on almost all CD4+ and CDS+ T cells. Furthermore, T cell activation appears not to be a
prerequisite for inducing expression of the IL-lSRa subunit (Smeltz et al. 200 I). Th 1 cells
have therefore been phenotypically characterised by preferential surface expression of both
IL-12RP2 and IL-ISRa (Rogge et al. 1997, Szabo et at. 1997, Xu et al. 1995b). However,
FACS analysis reveals a poor correlation between the Th 1 differentiation status of CD4+ T
cells with levels of IL-ISRa and IL-12RP2 expression. Clearly, the status of Th 1
differentiation can therefore not be defined by the expression of these receptors alone
(Smeltz et al. 2002).
Myeloid and monocytic cell lines, which constitutively express IL-1SR, secrete IL-IS that
may contribute towards autocrine proliferation of these cells (Nakamura et at. 2000).
Moreover, up-regulation of the IL-18 receptor complex on these cells in vivo increases
their responsiveness to IL-18, which may increase TNF-a production from these cells
(Puren et at. 1998). Inflammatory cytokines such as IL-ll3, IFN-a and TNF-a enhance IL-
18R expression on NK cells, T-lyrnphocytes, monocyte dendritic cells and chondrocytes
(Dai et al. 2005). Increased expression of both receptor subunits leads to specific in vitro
responses that may reflect patterns occurring within disease processes in vivo (Nakamura et
al. 2000, Sareneva et al. 2000, Gutzmer et al. 2003). IL-113 and TNF -a commonly coexist
at chronic inflammatory sites and are not required for physiological T-Iymphocyte or NK
cell activation. It is therefore interesting that IFN-y alone is unable to promote IL-18R but.
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when combined with IL-I ~ and TNF-a, IL-18R expression is induced. This may indicate
important pathways that distinguish physiological processes from pathological responses.
Furthermore, IL-18R ligation induces the expression of cytokines such as IL-l~, IL-6 and
TNF-a, which are up-regulated in many int1ammatory diseases of an infectious aetiology
(Puren et af. 1998, Ross 1999).
IL-12, IL-15 and IL-21 up-regulate IL-18Ra expression on NK cells and T cells (Fehniger
et af. 1999, Tominaga et al. 2000, Strengell et af. 2002). However, the ability of IL-12 to
increase IL-I8Ra expression is severely impaired in IFN-y-I- mice. Furthermore, the
addition of IFN-y has no effect upon IL-18Ra expression but, when combined with IL-I2,
IL-18Ra expression is enhanced (Smeltz et af. 200 I, Nakahira et af. 200 I). Studies on T
cells derived from 5CC7 TCR transgenic mice demonstrate that in the absence of IL-4, IL-
12 alone is sufficient and IFN-y is dispensable for IL-12R~2 and IL-18Ra expression and
Th I differentiation (Smeltz et al. 2002). However, in the presence of IL-4, IL-12-induced
Th 1 differentiation additionally requires IFN-y. This effect occurs through IFN-y limiting
the suppressive effects of IL-4 on both IL-18Ra and IL-I2R~2 receptor expression whilst
simultaneously neutralising IL-4. In addition, IFN-y enhances IL-18Ra expression to
greater levels than those induced by IL-12 alone and almost completely restores IL-12R~2
expression (Smeltz et al. 2002). Furthermore, IL-I2-induced expression of steady state
mRNA for IL-18R~ chain is not increased in Stat4 deficient cells. This implies that Stat4 is
essential for IL-12 induction of the functional IL-18R complex (Yoshimoto et al. 2000).
In response to infections and foreign antigens, endogenous IL-18 activity int1uences the
development of Th I as well as Th2 type immune responses. T cells cultured with IL-18,
but without T cell receptor stimulation, produce the Th2 cytokines IL-4 and It-13 and
evolve into Th2 T cells in a Stat6-dependent manner (Yoshimoto et al. 20(0).
Furthermore, basophils expressing IL-18Ra produce large amounts of IL-4 and IL-13 in
response to stimulation with IL-3 and IL-I8 (Yoshimoto et al. 1999). From experiments on
IL-4-1- mice and Stat6-1- T cells, it has been ascertained that IL-4 plays a central role in
down-regulating IL-18Ra expression. However, TCR stimulation is required for this effect
(Smeltz et al. 200 I). Subsequent to IL-18 stimulation of CD4 + T cells, IFN-y secretion
correlates with the level of cellular IL-18Ra expression. Importantly, this is tightly
regulated by IL-4, which decreases IL-18Ra expression and thereby reduces the production
of IFN-y (Tominaga et al. 2000, Smeltz et al. 2001).
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2.6.3 IL-18 Binding Protein
2.6.3.1 Introduction to cytokine inhibitors
Binding proteins, including soluble receptors that constitute the ligand binding
extracellular domain of the cell surface receptor, are key regulators of cytokine activities.
Thereby, they are critical in regulating appropriate host responses to pathogens
(Fernandez-Botran et al. 1996). These soluble receptors are derived from receptor mRNA
splice variants or by proteolytic cleavage of cytokine cell surface receptors. However, the
affinity for their ligand is generally lower than that of the corresponding cell surface
receptor. Binding proteins may either agonise or antagonise the activity of the cytokine
they bind. For example, soluble IL-6R binds IL-6 to form a complex that confers
responsiveness to IL-6 onto a variety of cells that do not express transmembrane IL-6R but
do express gp 130 such as endothelial cells (Romano et al. 1997). Conversely, soluble TNF
receptors act as antagonists to TNF activity (Engelmann et at. 1989, Engelmann et at.
1990).
However, the IL-18 binding protein (lL-18BP) is not the counterpart of the cell surface
receptor IL-18Ra chain. Nevertheless, its affinity to IL-18 is comparable with the cell
surface IL-18 receptor (Okamura et al. 1995). Several viruses produce molecules that are
homologous to binding proteins. Through the release of such molecules, they are able to
escape challenges from host immunity (Alcami and Smith 1995). In addition to soluble
receptors for IL-I p, interferons and certain chernokines, poxviruses secrete active viral
proteins homologous to IL-18BP, thereby implicating its significance as an
immunoregulator (Xiang and Moss 1999, Born et at. 2000, Smith et al. 2000).
2.6.3.2 Introduction to /L-18BP
In contrast to IL-I p, IL-18 is constitutively expressed in humans and rodents at both gene
and protein levels (Puren et al. 1999). Therefore, IL-18 activity requires careful regulation.
This close control takes place through the binding of IL-18 with the naturally occurring
and constitutively expressed IL-18BP (Novick el al. 1999). IL-18BP, a 38 kDa circulating
decoy receptor, possesses high-affinity binding to IL-18 (dissociation constant of 400 pAl)
and potent anti-intlammatory properties (Aizawa el al. 1999, Novick et al. 1999, Xiang
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and Moss 1999, Kim et af. 2000, Faggioni et af. 2001, Yatsiv et af. 2002, Banda et al.
2003). Importantly, the high affinity of IL-18BP to its ligand and the low dissociation rate
of this complex suggest that IL-18BP is not merely a carrier protein (Novick et af. 2001).
Located in chromosome 11q 13 at the inverted position of the nuclear mitotic apparatus
protein 1, the human IL-I8BP gene encodes for four isoforms each derived from a single
mRNA by splice variants (Novick et al. 1999, Kim et af. 2000). Approximately 60% of the
mature human IL-18BP resembles the extracellular domain of Ig-like receptors, which
includes a highly conserved pair of cystienes and tryptophan residue (Aizawa et al. 1999,
Novick et al. 1999). The isoforms share homology in their carboxyl termini whereas at the
N terminal, one-third to two-thirds of the amino acids are different. Only isoforms IL-
18BPa and IL-18BPc retain the intact immunoglobulin and are therefore biologically
functional. Indeed, IL-18BPa is the most abundant and most potent inhibitor of IL-I8
(Novick et al. 1999, Kim et al. 2000). Although present within humans, IL-I8BPb and IL-
18BPd are unable to neutralise IL-18 biological activity (Kim et af. 2000). With a single
immunoglobulin domain, IL-18BP resembles the extracellular segment of a cytokine
receptor with immunoglobulin like structures. Nevertheless, it is a novel protein distinct
from members of the IL-I and IL-18 receptor family (Kim et af. 2002a).
2.6.3.3 Effectors of IL-18BP expression
IL-18BP is constitutively expressed in normal tissues at the mRNA level. However, the
spleen and lungs and to a lesser extent the colon, small intestine and prostate express
significant quantities of IL-I8BP (Novick et al. 1999). Healthy individuals have readily
detectable levels of IL-18BP at concentrations of 2.15 ng/ml within the serum (Novick et
af. 2001). Thereby, IL-18BP may serve as a natural buffer to IL-18, which is also
constitutively expressed within the human blood compartment (Puren et af. 1999). IFN-y
up-regulates IL-18BPa expression in several cell lines including keratinocytes, colon
carcinoma/epithelial cells and renal mesangial cells. Furthermore, IL-12 promotes IFN-y-
up-regulated IL-18BP expression within monocytes (Veesntra et al. 2002). This suggests
that by regulating IL-18 concentrations. IL-18BP may act as a negative feedback inhibitor
of the Th l immune response (Milhl et al. 2000. Paulukat et al. 2001).
88
IFN-a is also capable of inducing IL-18BPa in the sera of chronic hepatitis C patients. This
occurs independently of IFN-y and results in decreased circulatory levels of IL-I8. These
effects have been further confirmed in isolated macrophages (Kaser et al. 2002). IL-12 also
regulates cellular expression of IL-18BP through decreasing its expression in resting
PBMCs from healthy donors. Conversely, IL-12 increases IL-18BP expression in RA
synovial tissue cells and activated PBMCs (Kawashima et al. 2004). Given the high
affinity of IL-18BP for IL-18, IL-18BP may be an effective therapeutic neutralising
inhibitor within immune and inflammatory diseases associated with up-regulated
expression of IL-18.
2.6.3.4 Biological significance ofIL- J 8BP
The major function of IL-18BP is to regulate the inflammatory activity of IL-18 by
specifically neutralising the biological activity of the mature form of IL-18 (Novick et at.
1999, Kim et al. 2000, Novick et al. 200 I). Indeed, IL-18BP effectively neutralises IFN-y
production from IL-18 stimulated KG-I cells (Aizawa et al. 1999). Moreover, in a similar
manner to IL-18 neutralising antibodies (Fantuzzi et al. 1998), IL-18BP prevents LPS-
induced expression of IFN-y (Novick et al. 1999). Furthermore, IL-18BPa transgenic mice,
with concanavalin A induced hepatotoxicity are significantly protected by reduced IFN-y
expression after mitogenic challenge (Fantuzzi et al. 2003). IL-18BPa increases
spontaneous and IL-I p-induced prostaglandin production by the inhibition of IFN-y
(Reznikov et al. 2000). However, in contrast to antibodies to IL-18, the IL-18BP does not
exhibit species specificity. Human IL-18BP therefore neutralises both human and murine
IL-18 (Novick et al. 1999). In vitro. IL-18BP can effectively diminish IL-18-induced NF-
KB activation, thereby decreasing IFN-y and IL-8 expression.
IL-18BP likely has a significant role in regulating appropriate host immune responses to
pathogenic challenge. Administration of IL-18BPa to mice challenged with LPS
diminishes circulating levels of IFN-y. This demonstrates that IL-18BP functions as an
inhibitor of the early Thl response in vivo (Novick et al. 1999). Furthermore, IL-18BP
reduces Staphylococcus epidermidis-induced IFN-y expression in human whole blood
cultures by up to 77% (Stuyt et al. 2003a). Up-regulated expression of IL-18BP may also
be responsible for reducing IFN-y in ex vivo whole blood cultures obtained from patients
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with septic shock (Oberholzer et at. 2000). Taken together, these findings establish that IL-
18BP is an important immunoregulator (Grobmyer et al. 2000, Novick et at. 2001).
Within the murine model, IL-18BP has been used in vivo to determine its effects upon
several diseases in which IL-18 has been implicated as an important participant of the
pathological process. Indeed, the administration of IL-18BP protects against CIA in mice
(Plater-Zyberk et al. 200 I), reduces levels of metastasis of murine melanoma cells
(Carrascal et al. 2003) and improves myocardial dysfunction (Dinarello 2001).
Furthermore, IL-18BP prevents endogenous IL-18-induced murine diabetes by reducing
IFN-y expression (Nicoletti et at. 2003). In the NOD mouse model, the development of
cyclophosphamide-induced diabetes IS significantly reduced by prophylactic
administration of IL-18BP:FcIg (Zaccone et at. 2005). Interestingly, inhibition of in vivo
IL-18 activity by IL-18BP in mice leads to the stimulation of tissue neovascularisation in
response to ischaemic injury (Mallat et al. 2002). IL-18BP promotion of post ischaemic
neovascularisation results in increased expression of VEGF, increased phosphorylation of
Akt and increased numbers of culture differentiated BM-EPCs. Furthermore, the
proangiogenic properties of IL-18BP are also associated with its known anti-inflammatory
and antiatherosclerotic effects (Gracie et at. 1999, Mallat et al. 2001, Plater-Zyberk et at.
2001, Ten Hove et al. 2001). Findings from these studies suggest that IL-18BP and/ or
other IL-18 inhibitors may be suitable candidates for the treatment of ischaemic disease.
Whereas a combination of the ligand binding and the non-ligand binding extracellular
domains of IL-18R are required to neutralise IL-18 activity, IL-18BP effectively
neutralises IL-18 at equimolar concentrations (Reznikov et al. 2002). It has therefore been
suggested that isoform IL-18BPa, which posses the highest affinity for IL-18, may
represent a suitable candidate with which to inhibit IL-18-induced pathology in human
diseases (Dinarello 2000). In vivo experiments on mice receiving a lethal dose of LPS have
shown that pre-administration of IL-18BP:Fc reduces LPS-induced IFN-y expression,
resulting in significant reductions in host mortality (Faggioni et al. 2001). Blocking IL-18
function in vivo with IL-18BP:Fc effectively attenuates DSS induced intestinal
inflammation. This effect occurs through attenuating the expression of MMP-3, -7, -9, -10
and -13, thereby indicating a role for IL-18 in the initiation of lBD associated intestinal
damage (Sivakumar et al. 2002).
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In human diseases, correlations between serum levels of IL-18 and IL-18BP have been
demonstrated. Furthermore, correlations between disease status and IL-18 and IL-18BP
serum concentrations are also suggested (Kawashima et al. 2001, Ludwiczek et a/. 2002).
However, as with many cytokines and their inhibitors, others have demonstrated that the
correlation between circulatory IL-18 and IL-18BP concentrations may not be
representative of the disease status. Furthermore, the circulatory IL-18/ IL-18BP ratio may
not reflect the host response to treatment of chronic diseases at localised sites (Bresnihan et
al. 2002). Indeed, IL-18BP is significantly up-regulated in human Crohn's disease and this
correlates with an increase in IL-18 expression. However, despite increased expression of
IL-18BP, free biologically active IL-18 is readily detectable within the tissues (Corbaz et
al. 2002). It is therefore apparent from studies to date that the complex biology between
IL-18 and IL-18BP remains to be defined.
2.6.4 Functional properties of IL-18
IL-18 is predominantly proinflammatory in nature, sharing similar biological properties to
IL-12 and is associated with numerous pathological processes. However, IL-18 and IL-12
are not structurally related. IL-18 promotes the expression of several key inflammatory
mediators. These include inducing IFN-y production (Okamura et al. 1995a, Ushio et al.
1996, Kohno et al. 1997, Kojima et al. 1999), enhancing IL-2 expression (Kohno et at.
1997) and up-regulating GM-CSF from human PBMC or enriched T cells (Micallef et al.
1996, Ushio et al. 1996). In addition to promoting inflammatory mediators, IL-18 also
down-regulates the expression of IL-l 0 in Con A-stimulated PBMC but has no apparent
effect upon IL-4 expression (Ushio et al. 1996). Conversely, within the IL-lO-I- murine
model, IL-I0 fails to inhibit the production of IL-18 in response to int1ammatory stimuli
(Zediak and Hunter 2003).
The most potent biological function of IL-18 is its IFN-y inducing activity from T cells,
NK cells and NK T cells in combination with IL-12 (Micallef et al. 1996, Fehniger et al.
1999, Leite-de-Moraes et al. 1999, Otani et al. 1999, Walker and Rotondo 2004). Indeed,
the synergy between IL-12 and IL-18 results in the rapid secretion of IFN-y from NK cells.
This effect appears to be dependent upon MAPK p38, which stabilises IFN-y mRNA by
the MAPK p38 signalling pathway (Mavropoulos et al. 2005). However, antagonists such
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as PGE2 carefully regulate the degree of IL-18-induced IFN-y expression (Walker and
Rotondo 2004). In addition to IL-I2. IL-2. IL-J 0 and IL-2I also have the ability to
augment IL-18-induced IFN-y expression by NK cells (Son et al. 2001, Cai et al. 1999,
Strengell et al. 2003). Although NK cells are an important source of IFN-y, IL-I8 also
induces IFN-y expression in macrophages and vascular cells (Tenger et al. 2005). IL-I8 in
combination with IL-12 not only enhances IFN-y expression, but additionally induces the
production of IL-3, IL-6 and TNF-a from NK cells (Lauwerys et al. 1999). Furthermore.
IL-I8 alone induces IL-12 and TNF-a expression within PBMC cultures (Yoshida et al.
2001). The production of TNF-a and IL-l ~ by monocytes through direct contact with
lymphocytes is also augmented by IL-I8 (Dai et al. 2004a).
Like IL-I2, IL-I8 enhances allospecific CTL activity in vitro and augments NK cell
cytotoxic activity and proliferation (Okamura et al. 1995a,b, Ushio et al. 1996, Bazan et af.
1996, Lauwerys et af. 1999). These actions are mediated in a Fas ligand-dependent
(Tsutsui et al. 1996) and perforin-dependent manner (Hyodo et al. 1999) that IS
independent of TNF-a (Dao et al. 1998). The complex regulatory circuit involved III
apoptotic cell death is in part mediated by IL-I8-induced IFN-y production, thereby up-
regulating expression of the receptor for Fas Ligand, Fas antigen (Watanabe-Fukunaga et
al. 1992). Although IL-I8 is not required for early NK cell development, in combination
with IL-I2 it plays an important role in the functional maturation of NK cells (Takeda et
al. 1998).
In addition to its important effects upon NK cells, IL-18 acts on other immune cells and
stromal cell populations participating in inflammatory responses. IFN-y secretion, induced
from activated B cells by IL-12 and IL-I8, inhibits IgE production (Yoshimoto et al.
1997). Additionally. IL-I8 is synergistically capable of up-regulating IFN-y from
epidermal cells (Sugaya et al. 1999). IL-I8 and IL-12 share the capacity to induce IFN-y
secretion by activated Th I cells. However. their induction pathways appear to be
independent, since neutralising antibodies to IL-12 do not block IFN-y production induced
by IL-I8 and vice versa. Furthermore, IL-18 is more potent than IL-I2 in inducing IFN-y
expression from T-cells (Okamura et al. 1995, Micallef et al. 1996) and natural killer cells
(Tsutsui et al. 1996, Okamura et al. 1995, Ushio et al. 1996. Gu et al. 1997). Moreover.
even in the presence of saturated amounts of IL-12. IL-18 is able to up-regulate the
expression of IFN-y. Many of these lL-18-mediated effects upon cytokine expression,
including the induction of IFN-y (Kojima et al. 1999, Tsuji-Takayama 1999, Strengell et
al. 2003) and IL-2 gene expression (Matsumoto et al. 1997), are regulated via NF-KB
activation.
lL-18 induces the proliferation of murine T cells, Th I clones and human enriched T cells
stimulated with mitogen, anti-CD3 or antigen (Kohno et a/. 1997, Jacobsen et al. 1995).
IL-I8-mediated T-cell proliferation takes place through an IL-2 dependent pathway
(Micallef et al. 1996). IL-I8 induces the release of Th 1 type cytokines by T cells and
macrophages and also stimulates the production of mediators such as CXC-chemokine IL-
8, MGSA (CXCL 1) and ENA-78 in rheumatoid arthritis synovial fibroblasts. Macrophage-
derived chemokines and nitric oxide is also enhanced by IL-18 (McInnes et a/. 200 I,
Morel et a/. 200 I). IL-18 promotes the release of IL-8 and lL-J P from mononuclear cells
by inducing TNF-a secretion from C03+/C04+ cells (Puren et al. 1998). Furthermore, IL-
18-induced release of monocyte-derived TNF -a and IL-I P is dependant upon cell-cell
contact with T cells (Dai et a/. 2004a). Not only does IL-I8 induce cytokine release from
dendritic cells and macrophages but it is also involved in the maturation of myeloid
dendritic cells. However, it is not responsible for the differentiation of monocytes into
dendritic cells (Li et a/. 2004).
Many of these described effects impart a key role for IL-I8 in orchestrating acquired
immune responses. Nevertheless, through several actions, IL-18 may be involved in early
stages of the initial inflammatory immune response. Indeed, IL-18 activates human
neutrophils and induces their expression and secretion of IL-J P and IL-6 (Jablonska and
Jablonski 2001, Jablonska et a/. 2002). Furthermore, the initial recruitment of cells of
innate immunity to inflammatory sites is fundamentally influenced by lL-18 (Umemura et
a/. 2004, Taube et al. 2004). IL-18 promotes neutrophil accumulation in vivo, whereas IL-
18 neutralisation suppresses the severity of footpad inflammation following carrageenan
injection (Leung et al. 2001). IL-18 induces the production of MMPs from chondrocytes
(Dai et a/. 2005), NK cells, U937 monocytes (Abraham et al. 2003) and PBMC (Nold et
al. 2003). Some of these effects occur in a TNF-a dependent manner and are down-
regulated by IL-4 and/or IL-I O. Consequently, these IL-18-induced proteases are
responsible for the degradation of the surrounding extracellular matrix and basal lamina
(Ishida et (II. 2004). Thereby, T cells (Komai-Koma et al. 2(03) and neutrophils are
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recruited into the inflammatory site (Cannetti et al. 2003). Moreover, lL-I8-induced
expression of IL-8, further contributes to the intlux of these inflammatory cells (Wang et
al. 200Ia). In addition to its effects upon cytokines, IL-I8 up-regulates ICAM-I expression
in human monocytes (Yoshida et al. 2001, Stuyt et af. 2003 b) and KG-I cells (Kohka et al.
1998). However, these predominantly proinflammatory IL-I8 properties are carefully
counterbalanced by the local release of down-regulatory mediators such as histamine
(Takahashi et al. 2001, Itoh et al. 2002) and heat shock proteins (Wang and Chang 2005).
These data clearly demonstrate that IL-I8-mediated effects are predominantly
pro inflammatory in nature. Nevertheless, IL-I8 also possesses anti-inflammatory
properties. IL-18 induces Th2 type cytokine expression including IL-4, IL-S, IL-I 0 and IL-
13 from murine naive spleen cells (Xu et af. 2000) and IL-4 from basophils (Yoshimoto et
al. 1999). Furthermore, in the absence of IL-12, IL-I8 stimulates CD4 + T cells and
macrophages to secrete IL-5, GM-CSF, IL-6, and G-CSF. In tum, these mediators induce
haematopoietic cell proliferation leading to neutrophilia and eosinophilia in mice (Ogura et
al. 2001). Intraperitoneal administration of IL-I8 into mice has also been shown to reduce
circulating leukocyte numbers by inducing IFN-y release from NK cells (Hosohara et al.
2002). Not only does IL-I8 stimulate pro inflammatory cytokine secretion from NK cells
but, when combined with lL-2, it is a potent co-inducer of IL-I3 from NK and T cells. This
effect appears to be lFN-y-dependent (Hoshino et al. I999c).
IL-I8 is an angiogenic mediator, inducing microvascular endothelial cell migration and
endothelial cell tube formation in a matrigel matrix in vitro and in vivo (Park et al. 2001).
Functional IL-I8 and IL-18 receptor are expressed by human atheroma-associated
endothelial cells, smooth muscle cells, and mononuclear phagoeytes. In combination with
its ability to induce IFN-y expression in smooth muscle cells, this suggests that IL-IS may
have a paracrine pro-inflammatory role in atherogenesis (Gerdes et al. 2002). Conversely,
Mallet et 01. (2002) have demonstrated that the neutralisation of IL-18 by IL-ISBP leads to
neovascularisation after ischemia-induced pathology. This therefore implies that
endogenous IL-I8 may not always be proangiogenic. Indeed, 11.-18 has been demonstrated
to suppress tumour growth by its inhibitory effects upon angiogenesis (Coughlin et al.
1998, Cao et al. 1999). Clearly, the precise relationship of IL-18 with angiogenesis
requires further clarification.
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2.6.5 IL-18 and the Th 11Th2 paradigm
After its discovery, IL-18 was found to exert a powerful synergy with IL-12 upon the
induction of IFN -y (Micallef et al. 1996). Furthermore, the costimulatory effects of IL-I8-
induced IFN-y expression were selectively targeted towards Th I type cells but not Th2
cells (Kohno et al. 1997). However, Th 1 cell development is not directly induced by IL-I8.
It is established that IL-I2-induced Th I polarisation is required prior to IL-I8-induced
expression of IFN-y from differentiated Thl cells (Robinson et at. 1997, Stoll et at. 1998).
Therefore, the predominant effect of IL-I8 on Th 1 development was suggested to be its
role in the up-regulation of IL-12RP2 expression. Up-regulation of the IL-I2 receptor
enhances the capability of IL-I2-mediated signalling. This would be of critical importance
if IL-I2 levels within the microenvironment were below threshold levels required for
successful Th 1 development (Chang et al. 2000). Furthermore, IL-18 in combination with
anti-CD3 induces IFN-y, IL-13, GM-CSF and IL-8 expression from Thl cells but not from
Th2 cells (Hata et al. 2004).
In consideration of its potent proinflammatory properties within the Th I pathway, IL-I8
was surprisingly demonstrated to be capable of inducing T cells to differentiate into Th2
cells independently of IL-4 (Xu et at. 2000). Additionally, IL-I8 in combination with IL-2
is a potent co-inducer in the production of the Th2 type cytokine IL-I3 in both murine NK
and T cells (Hoshino et al. 1999). Moreover, IL-18 can direct Th2 responses by inducing
IL-4 expression from NKT cells, irrespective of the presence of IL-12. Subsequently, this
NKT cell-derived IL-4 contributes towards the adaptive Th2 immune response by up-
regulating expression of the early activation marker CD69 on B cells (Leite-de-Moraes et
al. 2001). Furthermore, IL-I8 has been demonstrated to increase IL-4 expression in
allergen stimulated T cells (Tarkowski et al. 2002).
The first in vivo investigation demonstrating the capability of IL-I8 to induce a Th2
phenotype determined that it was a contributory factor towards allergic asthma (Wild et al.
2000). The broader role of IL-I8 on Th I ITh2 orientation has been further investigated in
IL-I8 transgenic mice. These mice have higher serum levels of IgE, IgG 1, IL-4 and IFN-y
and their splenic T cells produce higher levels of IFN-y, IL-4, IL-5 and IL-I3 than wild
type controls (Hoshino et al. 2001). Indeed, IL-18 can induce IL-4 and IL-13 expression
independently of TCR engagement through CD40 ligand expression on CD4+ effector cells
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(Yoshimoto et al. 2000. Konishi. et al. 2002). Additionally. it has been established that IL-
18 can directly regulate Th2 cytokine expression in response to gastrointestinal nematode
infections (Helmby et al. 2001). Of importance, it has recently been elucidated within the
murine model that the determining factor as to whether IL-IS mediates a Th 1 or Th2 type
response to intracellular pathogens is dependent upon the genetic background of the host
(Wei et al. 2004).
2.6.6 IL-IS and host responses to pathogens
2.6.6. i introduction
IL-IS induces a myriad of potent immunomodulatory functions. many of which are central
to the containment of microbial infection. IL-IS is a critical mediator in host defence
mechanisms against intracellular bacteria, including Listeria, Shigella, Salmonella and
Mycobacterium tuberculosis (Dybing et al. 1999, Sugawara et at. 1999. Biet et at. 2002).
The expulsion of invading pathogens for host survival requires a robust Th 1 response and
IL-IS is fundamental to this (Kobayashi et al. 1995, Takeda et at. 1995, Sugawara et a/.
1999). The single most important factor in generating an efficient response against
pathogenic insult is the appropriate induction of IFN-y expression (Mastroeni et at. 1999).
Through its up-regulatory effects upon IFN-y expression, IL-IS significantly contributes
towards efficient eradication of these microorganisms from the host (Kawakami et at.
1997). Furthermore, IFN-y expression is also indirectly up-regulated by IL-IS through the
induction of TNF-a (Kawakami et al. 1999). Host antimicrobial activity is further
enhanced by the synergistic expression of NK cell and cost derived IFN-y. which is
synergistically induced by IL-12 in combination with IL-18 (Zhang et al. 1997. Berg et al.
2002). The importance of IL-18 within host resistance to pathogenic insult is emphasised
by several pathogens. Pathogens including viruses and enteric protozoa. are capable of
neutralising or cleaving IL-18 to render it inactive. Through these mechanisms.
microorganisms may subvert immunity thereby prolonging their survival within the host
(Xiang and Moss 1999, Born et a/. 2000, Smith et al. 2000, Que et al. 2(03).
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2.6.6.2 Injection of in vitro cell cultures
IL-18 mediates resistance against a wide variety of infectious pathogens. This primarily
occurs through increased cellular expression of IFN-y. This important property was
initially recognised in experiments using whole blood cell cultures stimulated with the
Gram-negative derived PAMP. LPS (Puren et af. 1998, Manigold et af. 2000). Following
early studies which established that IL-18 expression was induced by LPS, numerous in
vitro cell culture experiments have been performed. These have explored the capability of
several live and killed microbial pathogens and their mitogenic components to induce IL-
18 expression.
IL-18 mRNA expression was subsequently demonstrated to be directly increased in PBMC
cultures stimulated with LPS, LTA or Staphylococcus aureus Cowan strain I (SAC)
(Marshall et al. 1999). Indeed, SAC up-regulates protein production of IL-I 0, IL-12, IL-18
and IFN-y within PBMC cultures and this occurs independently of CD 14 (Boeker et al.
2001). Interestingly, lipoteichoic acid (LTA), a structural component of SAC, is not
capable of inducing lL-18 expression, although it induces IL-IO in a dose dependent
manner. The Gram-positive mitogen SAC is also capable of increasing IL-18 production
within whole blood cultures (Oberholzer et al. 2001). The secretion of IL-18 from cells
challenged with microorganisms or their associated microbial products is mediated through
TLR interactions (Seki et af. 2001, Adachi et af. 2001). Therefore following stimulation
with LPS, TLR-deficient macrophages do not secrete IL-18 (Seki et al. 2001). Importantly,
IL-18 expression induced within LPS-stimulated PBMC or monocyte cultures can be
inhibited by histamine or prostaglandin El respectively. Following pathogenic infection,
the potential for tissue damage resulting from increased IL-18 expression may therefore be
countered by down-regulation of IL-18 expression arising from the local release of
histamine or prostaglandins (Takahashi et af. 2004, Takahashi et af. 2005a).
Staphylococcus epidermidis infection of whole blood cultures induces increased IFN-y
production through endogenously expressed IL-18, lL-12 and TNF-a and independently of
IL-l (Stuyt et al. 2003a). The staphylococcal superantigen, SEA also induces IFN-y
expression within PBMC cultures. NK cells, but in particular NK-type T cells, are the main
source of this SEA-induced IFN-y and its expression appears to be independent of IL-18
(Ami et al. 2002). Non-pathogenic lactobacillus strains and a pathogenic Streptococcus
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pyogenes strain induce mRNA and protein production within PBMC cultures for IL-1 p. IL-
6, TNF-u, IFN-y and IL-18. Conversely, these microbes only weakly up-regulate IL-I0
expression and have no appreciable effect upon IL-4 (Miettinen et al. 1998). Infection of
PBMC cultures with live Helicobacter pylori dose dependently induces expression of IFN-
y, IL-IO and IL-18 (Stassi et al. 2002). Helicobacter pylori infection of gastric epithelial
cells also induces increased IL-18 expression and this enhances increased IL-8 production
within these cell cultures (Day et al. 2004). Interestingly, the pre-treatment of PBMC
cultures with killed H. pylori prior to infection with the live microorganism significantly
down-regulates IFN-y and IL-18 expression (Stassi et al. 2002).
Bacteria are not the only microorganisms that have effects upon cellular expression of IL-
18 as fungi (Netea et al. 2002) and viruses (Manigold et al. 2003) also modulate IL-18
production. Indeed, IFN-y production in whole blood cultures infected by Candida
albicans is regulated in an IL-18, IL-12 and IL-1 p dependent manner (Netea et at. 2002).
In addition to PBMC and whole blood cell cultures, infection of other cell types by
microorganisms and their virulence factors elicit IL-18 expression. Indeed, Candida
albicans and LPS stimulate IFN-y production from oral epithelial cells by inducing the
secretion of mature IL-18 (Rouabhia et al. 2002). Infection of dendritic cells by Listeria
monocytogenes induces the expression of IL-I8 (Kolb-Maurer et a/. 2003). Furthermore,
Chlamydia trachomatis infection of epithelial cells and dendritic cells results in IL-18 and
IL-12 production, which drives IFN-y expression from NK cells thereby, resolving the
infection (Lu et al. 2000a. Hook et al. 2005).An involvement for IL-I8 in linking innate
and acquired immune responses is further emphasised by human p-defensin-2-induced
secretion of IL-18 by keratinocytes (Sampanthanarak et al. 2005).
In contrast. some pathogens have been demonstrated to decrease the expression of IL-I8 in
cell cultures. For example, mouse macrophages infected with Salmonella exhibit decreased
IL-18 expression. This has been further confirmed in vivo with Salmonella inoculated
mucosal sites, which also exhibit reduced IL-18 expression. This suggests that some
intracellular microorganisms may be capable of limiting the protective host response
through their actions upon IL-18 (Elhofy and Bost 1999). This is in agreement with other
pathogens including viruses that neutralise IL-I8 bioactivity. thereby circumnavigating
host immunity and prolonging their survival within the host (Xiang and Moss 1999. Born
et al. 2000. Smith et a/. 2000, Que et al. 2003).
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2.6.6.3 Animal models of infection
IFN-y and IL-18 are diminished in the sera of ICE-deficient mice exposed to P. acnes and
LPS. Furthermore, ICE-deficient mice and mice lacking IFN-y or its receptor are resistant
to septic shock induced by endotoxin. This suggests that IL-18 has a central responsibility
in inducing this type of septic shock (Li et al. 1995). Supporting this view is the
observation that liver damage arising by infection with Propionibacterium acnes and septic
shock induced by LPS challenge are alleviated in IFN-y-deficient mice (Tsuji et al. 1999)
and prevented by neutralising IL-18 activity (Okamura et al. 1995b). Part of the destructive
element of IL-18 in lethal E. coli and Salmonella typhimurium infection has been
demonstrated by a significant reduction in neutrophil-mediated tissue damage after IL-18
neutralisation (Natea et al. 2000). Conversely, P. acnes-primed IL-18 knockout mice
exposed to LPS are highly susceptible to septic shock, although they have reduced
endotoxin-induced liver damage (Sakao et al. 1999).
Several investigations have analysed the effects upon the exogenous administration or
neutralisation of IL-18 in mice inoculated with a variety of pathogens. IL-18, particularly
in combination with IL-12, has a beneficial synergistic action in the protection of mice
challenged by Cryptococcus neoformans infection. This appears to be regulated through
the early production of IFN-y by NK and yo T cells concomitant with suppressed IL-4
expression (Qureshi et al. 1999). This IL-18/IL- 12 cytokine combination has also been
demonstrated to afford protection against Brucella infection in mice. In contrast, either
cytokine alone has only a limited effect against this infection. The protective synergistic
effects of IL-12 and IL-18 appear to be through inducing increased IFN-y expression
(Pasquali et al. 2002). Interestingly, Brucella abortus infection selectively limits IL-18
expression from mouse splenocytes without affecting endogenous IFN-y production
(Fernandez-Lago et al. 2005). The combined effect of IL-18 and IL-12 upon IFN-y
expression is also crucial in protecting mice infected with Trypanosoma cruzi. Within this
infection, increased host expression of IFN-y is related to a potent and early Th I type
response that is subsequently modulated by IL-13 expression (Antunez and Cardoni 200 I).
Although IFN-y up-regulation is critical to a successful outcome from pathogenic insult.
host up-regulation of IL-18 is also important. Indeed, IL-18 has been shown to be more
potent than either IFN-y or IL-12 in protecting both primary and secondary host immune
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responses to Listeria monocytogenes infection (Neighbors et al. 2001). This has been
further demonstrated by the administration of exogenous GM-CSF, which leads to
increased clearance of Pneumocystis carinii infection within neonatal mice (Qureshi et al.
2005). Neonatal mice infected with group B streptococci (GBS) have significantly elevated
IL-18 plasma levels and neutralisation of IL-18 increases mortality and bacterial burden.
Furthermore, the administration of exogenous IL-18 markedly improves their survival,
thereby implying an important role for IL-18 in protecting the host against neonatal GBS
infection (Cusumano et al. 2004). Conversely, neutralisation of endogenous IL-18 in adult
COl mice inoculated with GBS results in decreased mortality, although their incidence of
arthritis is decreased (Tissi et al. 2004). Furthermore, administration of exogenous IL-18
within these CD Imouse experiments actually increases mortality rates.
The transgenic IL-18 knockout mouse has allowed the detailed investigation of the role IL-
18 plays within a number of infectious diseases. IL-18-1- mice are susceptible to
Leishmania major infection and in comparison to wild type controls, express significantly
lower IFN-y levels and greater quantities of IL-4 (Wei et al. 1999). Experiments from
Streptococcal pneumonia infected IL-18 knockout mice suggest that IL-18, and not IL-12,
is required for an efficient early antibacterial host reaction to this pathogen (Lauw et at.
2002). The requirement for IL-18 in the early response to pathogenic challenge is further
reinforced within IL-18 knockout mice infected with E. coli. IL-18-1- mice exhibit
increased numbers of neutrophils. However, these are less active thereby rendering E. coli
infected mice to disseminating infection (Weijer et at. 2003). The importance of IL-18 has
been further demonstrated within IL-18 knockout mice with Yersinia (Hein et al. 2001) or
Cryptococcus neotormans (Kawakami et al. 2000) infections. Disseminated Candida
albicans infections in IFN-y-I- and IL-18-1- mice have established that in addition to
increased IFN-y expression, successful host resistance to this pathogen requires monocyte
recruitment, which is dependent upon IL-18 (Stuyt et al. 2003c, Netea et al. 2003).
However, induced infections in IL-18 knockout mice also reveal that IL-18 may adversely
influence the outcome to certain infections, including Pseudomonas aeruginosa (Schultz et
al. 2003) and Streptococcus pneumoniae (Zwijnenburg et al. 2(03) or be dispensable
(Graefe et al. 2003). Furthermore, Staphylococcus aureus infections in these mice are less
severe than controls but they develop significantly more severe septic arthritis than
controls, This is accompanied by a reduction in the levels of antigen-induced splenic T-cell
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proliferation, decreased lFN-y and TNF-a synthesis, but increased IL-4 expression (Wei et
al. 1999).
In addition to bacteria, IL-I8 is also important against viral infection. IL-I8 reduces
morbidity within BALB/c mice infected with herpes simplex virus (Fujioka et af. 1999).
Murine experiments also establish that IL-12 and IL-18 act in synergy to clear vaccinia
virus infection from the host (Gherardi et af. 2003). However, similar to bacterial
infections, experimental viral infections In the IL-I8 knockout murine model have
produced conflicting results. In contrast to previous studies, it has recently been
demonstrated that endogenous IL-18 impairs viral clearance during influenza infection
(Van Oer Sluijs et al. 2005). IL-12RP I-deficient mice, which suffer from significantly
reduced coxsackie virus-induced myocarditis, also have decreased levels of IL-l p and IL-
18 (Fairweather et al. 2003). Furthermore, although IL-I8 has a role in modulating
respiratory syncytial virus-induced airway inflammation, this is distinct from being
responsible for viral clearance (Wang et af. 2004). It is apparent from these studies that the
role for IL-I8 in host immunity to viral challenge remains to be clarified. Nonetheless, the
expression of vIL-18BPs by distinct poxvirus genera, which cause local infection or
general viral dissemination. emphasise the importance of IL-I8 in response to viral
infections (Smith et al. 2000).
It is evident that several discrepancies exist between studies investigating the effects of IL-
18 within host responses to invading pathogens in both wild type and IL-18 knockout
mouse models. Recent investigations have started to elucidate some of the possible
mechanisms behind this. Streptococcus pnuemoniae infections within IL-I8 knockout mice
establish that the differing effects of IL-I8 to host infection appear to be dependent upon
the individual microorganism strain used, the infection type and the host genetic
background (Paterson et al. 2005). Furthermore. the levels of inflammatory cytokines,
including IL-18, prior to infection impact upon the varying effects within and mortality
rates of the host (Culshaw et al. 2005). In addition, the route or site of administration of
pathogenic challenge influences host outcome to infections within these murine models
(Baldwin et al. 2003).
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2.6.6.-4 Human infectious diseases
In pathogenic challenge to the host, the Th I/ Th2 balance is central to defining disease
outcome. However. current data on the contribution of IL-IS towards pathogenic clearance
in many human infectious diseases is conflicting. Such contradictory findings for the role
of IL-IS are classically demonstrated in human leprosy. In resistant tuberculoid leprosy
(TL), protective IFN-y production is associated with increased IL-ISmRNA expression
within lesions. In addition. monocytes and TL patients show increased IL-18 mRNA
expression following in vitro challenge with bacterial antigen (Garcia et al. 1999).
Furthermore, in vitro challenge of T and NK cells of TL patients by exogenous IL-18
results in increased IFN-y production compared to cells from patients with susceptible
lepromatous leprosy (LL). Surprisingly. serum IL-18 levels in the LL cohort are found to
be much higher than patients with TL (Yoshimoto et al. 1999). This raises the possibility
that IL-IS may contribute towards the development of Th2 responses, characteristic of LL.
Human patients with active M. tuberculosis infection have raised plasma IL-I8 levels
(Morosini et at. 2003) and in vitro stimulation of PBMC cultures leads to increased IL-IS
(Yamada et at. 2000. Inomata et at. 2005). However, they exhibit a decreased ability to
produce IL-IS and IFN-y in response to antigen compared to healthy responsive controls
(Vankayalapati et at. 2000. Morosini et al. 2003, Vankayalapati et al. 2003). This
demonstrates that the precise contribution of IL-IS towards protective Th I type responses
in such disease processes requires clarification.
Septic patients have increased plasma IL-IS concentrations compared with severely injured
patient controls. Moreover. this is particularly evident within patients suffering from
Gram-positive sepsis (Oberholzer et al. 2001). IL-18 serum levels in patients with fatal
necrotising fasciitis are also raised compared with those of survivors (Lungstras-Butler et
al. 2004). In severe myeloidosis, caused by the Gram-negative bacillus Burkholderia,
patients have elevated IFN-y levels. Increased endogenous 11.-18 expression is a
contributing factor towards this (Lauw et al. 1999). IL-18 serum levels are also increased
within patients with HIV infection (Ahmed et at. 2002. Stylianou et at. 2003) and renal
allograft dysfunction (Hu et al. 2003). Conversely, IL-IS serum levels are decreased in
patients with hepatitis C virus hepatitis. Interestingly. plasma IL-IS levels within these
patients are related to hepatic histological activity (Schvoerer et (II. 2(03). Nevertheless. in
vitro studies have demonstrated that IL-18 plays an important role in the protective
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response to a number of bacterial infections including Salmonella yersinia. Chlamydia and
Shigella (Mastroeni, et al. 1999, Bohn et al. 1998, Lu et al. 2000, Sansonetti et al. 2000).
The data derived from these studies clearly demonstrate that the role of IL-18 in host
responses to human infectious diseases is extremely complex. The exact contribution of
IL-18 towards host protection and pathogenic clearance or inflammatory dysregulation and
morbidity within many of these infectious diseases remains to be elucidated.
2.6.7 Contribution of IL-18 to general systemic diseases
IL-18 is reported as being involved in the initiation or development of a multitude of
inflammatory processes. Indeed, serum IL-18 levels have been measured in human patients
suffering from a variety of general inflammatory diseases. Increased serum levels of IL-18
have been recorded in patients with Graves' ophthalmology (Mysliwiec et al. 2003),
Behcet's disease (Hamazaoui et al. 2002, Oztas et al. 2005), allergic asthma (Wong et al.
2001), fatal cardiovascular disease (Blankenberg et el. 2002), psychiatric disorders (Kokai
et al. 2002), type I diabetes (Nicoletti et al. 2001), acute kidney allograft rejection (Striz et
al. 2005), adult-onset Still's disease (Kawaguchi et al. 200 L Saiki et al. 2004), fulminant
hepatic failure (Yumoto et al. 2002), systemic lupus erythematosus (Robak et al. 2002,
Amerio et al. 2002, Wong et al. 2002, Wong et al. 2000, Park et al. 2004), ANA-positive
subacute cutaneous lupus erythematosus (Maczynska et al. 2006), Crohn's disease (Furuya
et al. 2002, Ludwiczek et al. 2005), coeliac disease (Merendino et al. 2003, Lettesjo et al.
2005), ulcerative colitis (Wiercinska-Drapalo et al. 2005), idiopathic pulmonary fibrosis
(Kitasato et al. 2004), heart failure (Mallat et al. 2004), systemic sepsis and in patients
with liver disease such as autoimmune hepatitis and primary biliary cirrhosis (Grobmyer et
al. 2000, McGuinness et al. 2000, Yamano et al. 2000).
However, the mere fact that IL-18 expression is up-regulated within the peripheral blood
compartment of these patients compared with their control cohort needs to be interpreted
with some caution. In several chronic inflammatory diseases, IL-18 serum levels are found
to correlate with disease severity, including primary biliary cirrhosis (Yamano et al. 2000)
acute pancreatitis (Endo et al. 2001, Grobmyer et al. 2000, McGuinness et al. 2000), SLE
(Wong et al. 2000, Amerio et al. 2002), coronary heart disease (Blankenberg et al. 2003),
atopic dermatitis (Tanaka et al. 2001 b, Hon et al. 2004) and pulmonary tuberculosis
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(Akgun et af. 2005). Conversely, others suggest that IL-18 serum levels do not specifically
correlate with disease severity such as in SLE (Robak et al. 2002) and ulcerative colitis
(Furuya et af. 2002). Whether raised IL-18 serum concentration is a contributing factor to
the disease process or a mere by-product of the chronic inflammatory reaction requires
further clarification.
Nonetheless, increased IL-18 mRNA and protein expression IS demonstrated within
intestinal epithelial cells and lamina propria mononuclear cells in Crohn's disease (Pizarro
et al. 1999) and in samples from involved mucosal areas (Monteleone et al. 1999).
Furthermore, expression of mature IL-18 and both IL-18 receptors are up-regulated in
coeliac disease (Salvati et af. 2002). IL-18 expression is also increased in autoimmune
non-obese diabetic (NOD) mice (Rothe et af. 1997) and BDC2.S TCR transgenic mice
with diabetes (Andre-Schmutz et af. 1999). However, its role in the development of
diabetes remains to be defined, with the administration of exogenous IL-18 being shown to
alternatively inhibit (Rothe et af. 1999) and promote (Oikawa et af. 2003) diabetes
development. IL-18 expression is increased in PBMC cultures from patients with multiple
sclerosis (Huang et af. 2004a). Furthermore, IL-18 is mitigated as a major contributing
factor in atopic diseases including allergic asthma (Wild et al. 2000), bronchial asthma,
allergic rhinitis (Verhaeghe et af. 2002) and atopic dermatitis (El-Mezzein et al. 2001).
Indeed, following gut ischaemia! reperfusion, IL-18 levels are significantly elevated and
contribute towards lung inflammation (Yang et af. 2005). These findings suggest that IL-
18 may be a central mediator of inflammatory pathology within humans (Dayer 1999,
McInnes et af. 2000). It has therefore been postulated that an IL-18 inhibitor may offer
desirable therapeutic benefits (Dinarello 2000). However, in other disease processes,
neutralisation of IL-18 may have adverse consequences. In vivo murine experiments have
demonstrated that IL-18 exerts a protective effect against the development of chronic graft-
versus-host disease (Okamoto et al. 2000). Furthermore, 11.-18 inhibition accelerates
mortality within acute graft-versus-host disease as a consequence of increased FAS antigen
mediated donor T-cell apoptosis (Reddy et al. 2001).
11.-18 exhibits strong antitumoural activities, protecting experimental animals against
repeated challenges with tumour cells through NK cell activation (Micallef et al. 1997).
Decreased tumour growth and inhibition of metastasis occurs with the administration of
11.-18. both alone (Akamatsu et al. 2002) and in combination with IL-2 (Arai et al. 2000.
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Coughlin et af. 2000). Furthermore, IL-18 gene transfer into murine tumours exerts potent
antitumour effects that appear to be mediated by local IL-18 expression (Osaki et aJ. 1999,
Liu et al. 2002, Hikosaka et af. 2004, Zhang et af. 2004). Moreover, the simultaneous
expression of IL-18 and IL-12 by engineered melanoma cells confers significant
antitumour properties in mice (Kishida et al. 2001). Indeed, vaccination with IL-18 gene-
modified, superantigen-coated tumour cells elicits potent antitumour immune responses
(Wang et al. 200Ib). However, in contrast to these antitumour effects, IL-I8 together with
other cytokines may be responsible for the development of hepatic metastases of
melanoma in vivo through up-regulating the expression of vascular cell adhesion molecule-
1 and melanoma cell adherence (Vidal- Vanaclocha et af. 2000). Of significance, the initial
published results of phase I trials of IL-18 therapy in cancer patients are not encouraging
(Golab and Stoklosa 2005). Further trials and investigations into the involvement of IL-I8
in the initiation, progress and metastasis of malignant tumours are therefore required to
provide evidence of safety and efficacy of proposed IL-18 therapy.
More recently, studies have analysed relationships between IL-18 polymorphisms and
disease processes. These investigations have identified a possible link of IL-18
polymorphisms with the pathogenesis of atopy (Kruse et al. 2003), insulin dependant
diabetes mellitus (Kretowski et al. 2002), atopic eczema (Novak et af. 2005) and the
development of post-injury sepsis (Stassen et al. 2003). Conversely, others have
determined no association between IL-18 polymorphisms with periodontal disease
(Folwaczny et af. 2005), autoimmune thyroid disease (Ide et al. 2003) or Type 1 diabetes
(Ide et al. 2004, Novota et al. 2004, Martin et al. 2005). Furthermore, studies are divided
over the relationship between IL-18 polymorphisms and certain diseases processes. For
example. IL-18 gene polymorphisms are suggested as a contributing factor in rheumatoid
arthritis (Gracie et aJ. 2005) and asthma (Higa et al. 2003). Conversely, others have
determined that IL-I8-promoter polymorphisms are not associated with RA (Rueda et af.
2005) or confer susceptibility to sarcoidosis (Zhou et al. 2005) and that the genetic effect
of IL-I8 polymorphisms is not associated with asthma (Shin et al. 2005). It is evident that
in order to obtain any true meaning in the relationship between gene polymorphisms and
disease processes, larger population samples will have to be analysed.
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2.6.8 Contribution of IL-18 to bone metabolism
Bone remodelling involves the carefully coordinated partnership between bone deposition
and bone resorption. Osteoblasts are responsible for the synthesis and deposition of the
extracellular bone matrix (Ducy et al. 2000). Conversely, osteoclasts are central to bone
resorption (Teitelbaum 2000). Osteoclast and osteoblast functions are intimately related
and closely balanced between one another. Bone is continuously being resorbed or
destroyed by osteoclasts whilst concomitantly being replaced by osteoblasts. Systemic
hormones and local mediators closely regulate the dynamic process of bone deposition and
resorption (refer to chapter 2.7).
Osteoblastic stromal cells are known to express IL-18 mRNA (Atkins et al. 2000). In
mouse osteoblast! bone marrow-spleen cell co-cultures, osteoblastic stromal cell-derived
IL-18 inhibits osteoclastogenesis through GM-CSF but not IFN-y production (Udagawa et
al. 1997). The inhibitory effect of IL-I8-induced T cell-derived GM-CSF on osteoclast
formation was further confirmed in cell co-cultures derived from GM-CSF-/- mice
(Horwood et al. 1998). Subsequent studies have demonstrated that IL-18 mRNA is
expressed in a mouse stromal cell line ST2, a mouse osteoblast cell line MC3T3-E I and
mouse calvarial osteoblasts. Furthermore, it is suggested that IL-18 inhibits
osteoclastogenesis by up-regulating osteoprotegerin (OPG) in vitro (Makiishi-
Shimobayashi et al. 2001).
When combined with IL-12, IL-18 synergistically inhibits in vitro osteoclast formation
(Horwood et at. 2001) and osteoclast bone resorbing activity (Yamada et al. 2002). In
addition to up-regulated IFN-y expression, these effects take place through unknown
molecules. Furthermore, the mitogenic action of IL-18 on primary osteoblasts occurs
independently of both GM-CSF and IFN-y. This datum suggests that IL-IS may act
directly on osteoblasts through its receptors (Cornish et al. 2003). IL-IS transgenic mice
have deformed cortical bone plates and a reduced trabecular lumbar bone turnover rate
compared with wild-type controls. These biological effects occur as a result of increased
IL-IS expression and thereby significantly increased IFN-y and reduced IL-4 expression
within bone marrow cells (Kawase et at. 2003). IL-18 appears to have little int1uence upon
the activity of mature osteoclasts. Its central attribute within the bone compartment may
therefore be to limit osteoclast formation (Cornish et al. 2003). However. the majority of
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findings from these studies are limited to animal in vitro experiments. It therefore remains
unclear as to whether IL-I8 influences bone mass or bone remodelling in vivo within
humans.
Osteoblasts are an important source of a number of key proinflammatory mediators.
Exposure of osteoblasts to either Gram-positive S. aureus or the Gram-negative pathogen
Salmonella elicits marked induction of mRNA levels encoding IL-l p and IL-I8. Indeed,
murine osteoblasts infected with S. aureus or Salmonella express IL-I p and IL-18 mRNA
as early as 6 h post infection, which peaks at 12 h post infection (Marriott et al. 2002).
However, elevated mRNA levels within these cells 24 h post-infection does not translate
into intracellular accumulation or secretion of mature IL-l p or IL-18 protein, even in the
presence of caspase-l activity. This demonstrates that bacterial pathogenic stimuli are not
sufficient to promote translation of IL-l p and IL-18 in these cells (Marriott et at. 2002). It
has also been established that bacterial infection of osteoblasts induces the production of
IL-6, IL-12 (Bost et al. 1999), MCP-I (Bost et at. 2001) and GM-CSF (Bost et at. 2000).
IL-18 is known to be an angiogenic inhibitory factor (Coughlin et al. 1998) and through
down-regulating angiogenesis may lead to aberrant bone formation (Gerber and Ferrara
2000).
Despite the demonstration of direct anti-bone destructive effects in vivo, IL-18 is highly
expressed within the synovial joints of human RA patients (Gracie et al. 1999, Yamamura
et al. 2001, Tanaka et al. 2001). Moreover, up-regulated expression of IL-18 within RA
joints appears to be related to and responsible for locally increased production of TNF-a
and IL-I P (Joosten et al. 2(03). It has also been established within the murine model that
IL-I8 promotes collagen-induced arthritis (Leung et al. 2000). Furthermore, this effect is
abrogated in mice lacking IL-18 (Wei et al. 200 I). A prointlammatory role for IL-18 in
destructive processes within CIA has further been elucidated in BB rats. In this model, the
neutralisation of endogenous IL-18 with anti-l l.vl B antibodies attenuates CIA (Ye et al.
2004). Increased interleukin-18 levels are also found at diseased sites associated with
increased periodontal destruction (Johnson and Serio 2005) and may be associated with
incipient periodontal attachment loss in patients with juvenile idiopathic arthritis (Miranda
et al. 2005).
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The direct effects of IL-I8 on osteoblasts and osteoclasts appear to be the suppression of
bone resorption. In the murine model, however, IL-18 induces joint inflammation
independently of IL-I. although cartilage destruction occurs through IL-18-induced
expression of IL-I P (Joosten et at. 2004). In the murine streptococcal cell wall arthritis
model. IL-I8 also induces joint destruction that appears to be independent of IFN-y
(Joosten et al. 2000). Furthermore. IL-I8 induces RANKL production by T cells in RA
synovitis and conversely has no effect upon OPG expression (Dai et al. 2004b). Thereby,
IL-I8 is capable of indirectly stimulating osteoclast formation through the up-regulation of
RANKL. Indeed. IL-18-induced osteoclast formation is as effective as IL-I P but less
potent than TNF-a (Dai et al. 2004b).
Taken together, these data suggest that the direct actions of IL-I8 on bone cells in vitro
may be anti-destructive in nature. Nevertheless, the overall effect of IL-18 within the
cytokine milieu may be to induce the secretion of downstream inflammatory mediators that
result in and perpetuate bone destruction. Indeed, there is accumulating evidence that IL-I8
may directly contribute towards inflammatory bone destruction. IL-18 expression has not
been characterised within the PRO lesion. It is therefore of importance to investigate its
expression and potential involvement within the inflammatory reaction occurring within
PRO.
2.7 Regulation of inflammatory bone resorption
2.7.1 Introduction
Alveolar bone is a specialised dynamic connective tissue comprising a mineralized matrix
that endows it with elasticity and strength. The synthesis of organic matrix by osteoblasts
and bone resorption by osteoclasts enables bone remodelling to take place in accordance
with surrounding mechanical influences. Osteoblasts differentiate from mesenchymal stem
cells through a series of progenitor stages to form mature matrix-secreting osteohlasts that
are progressively transformed into osteocytes. The two major functions of osteoblasts arc
to synthesise the components of bone matrix and to control the hone resorbing activities of
osteoclasts. However. osteoblasts have a third and equally important function in
inflammatory bone diseases. the ability to secrete cytokincs (Bast et al. 1999) and
chemokines (Bost et al. 1999. Gasper et al. 2002). Following bacterial exposure. cytokinc
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and chemokine production by osteoblasts likely serves to recruit macrophages, neutrophils
and activated T lymphocytes to the infected periradicular tissue. Thereby, osteoblasts are
capable of sustaining an inflammatory response by maintaining the activated status of
recruited inflammatory cells.
Osteoclasts are large multinucleated cells that are infrequently seen in normal adult bone
but present at bone resorption sites within Howship's lacunae (Martin et al. 1998).
Osteoclasts are the main protagonists of bone destruction and are haematopoietic in origin.
They are formed through the fusion of mononuclear osteoclast precursor cells of the
monocyte-macrophage lineage (Baron et al. 1986, Roodman 1999). Osteoclasts regulate
bone resorption by attaching to the surface and secreting protons into the extracellular
compartment formed beneath their ruffled border. Monocytes, macrophages, lymphocytes
and endothelial cells are also implicated in bone remodelling by direct contact with bone
cells. Subsequent to the initiation of periradicular disease, dento-alveolar bone destruction
is therefore controlled by the numerous cell protagonists within the lesion that interface
with bone tissue, the immune system and vascular component of the PRO tissue.
Fundamental to the bone remodelling process are the interactions between osteoblasts and
osteoclasts (Epker and Frost 1965). Physical factors such as mechanical stimulation and
polypeptides, including cytokines and hormones, are responsible for controlling the
equilibrium between osteoblast and osteoclast activities. Through direct cell contact,
osteoblasts regulate both osteoclast differentiation and osteoclast bone resorption activities
(Jimi et af. 1996, Udagawa et af. 1999). This finding led to the discovery of cytokines
within the TNF family that are central to the control of bone remodelling (Simonet et af.
1997, Tsuda et a/. 1997, Lacey et al. 1998. Yasuda et al. 1998a.b).
Among the array of mediators that can directly act upon osteoblast and osteoclast
precursors. receptor activator of nuclear factor-xls ligand (RANKL) has been identified as
the principal regulatory protein. Up-regulation of this cytokine by factors acting on bone
lining cells or other stromal cells provides a novel system that modulates
osteoclastogenesis. Osteoprotegerin (OPG) is a naturally occurring antagonist of RANKL
and a gene product that is distinct from the RANKL receptor. RANK (Bucay et al. 1998,
Emery et al. 1998). Several recent studies have elucidated that activated T cells can
support osteoclast formation from mononuclear precursor cells. These data directly
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implicate lymphocytes in the pathogenesis of enhanced bone loss that is associated with
immune mediated inflammatory disorders such as RA (Horwood et al. 1999, Kotake et af.
200 I, Weitzmann et al. 200 I).
2.7.2 Osteoprotegerin (OPG)
Osteoprotegerin (OPG), originally termed osteoclastogenesis-inhibitory factor (OCIF), was
discovered as a soluble protein capable of suppressing osteoclast survival. OPG is a
secreted TNFR-related protein that acts as a decoy receptor for RANKL. Furthermore, it
interferes with stromal cell-osteoclast interactions and contributes towards a marked
osteoporosis phenotype (Simonet et al. 1997, Tsuda et af. 1997. Akatsu et af. 1998, Yasuda
et af. 1998b). Thereby, it is functionally responsible for regulating bone density and bone
mass in animals (Simonet et af. 1997, Yasuda et af. 1998b). OPG is expressed ubiquitously
and abundantly by a wide variety of cell types including bone marrow stromal cells,
dendritic cells, lymphoid cells, endothelial cells, fibroblasts and monocytes (Simonet et af.
1997, Tan et al. 1997, Tsuda et af. 1997, Akatsu et af. 1998, Kwon et af. 1998, Yasuda et
af. 1998a).
Primarily, the in vitro biological effects of OPG oppose those of RANKL. These include
the inhibition of differentiation, survival and fusion of osteoclastic precursor cells,
suppression of osteoclastic activation and promotion of osteoclast apoptosis (Akatsu et al.
1998, Fulier et al. 1998, Hakeda et af. 1998, Lacey et al. 1998, Miyamoto et al. 1998,
Yasuda et al. 1998b, Burgess et af. 1999, Jimi et al. 1999, Lacey et al. 2000, O'Brien et al.
2000, Udagawa et af. 2000). Interestingly, the stimulation of human RA-derived synovial
fibroblast cultures with TNF-a promotes OPG mRNA and protein expression (Kubota et
al. 2004).
2.7.3 Receptor activator ofNF-KB Ligand (RANKL)
Subsequent to the discovery of OPG, RANKL was identified as the ligand for OPO (Lacey
et al. 1998, Yasuda et al. 1998a) and was termed OPG Ligand. TRANCE and osteoclast
differentiation factor. Structurally. RANKL is smaller than OPG and is expressed in three
distinct forms. These include a cell bound peptide of 317 amino acids (Lacey et al. 1998.
Yasuda et af. 1998a), a truncated ectodomain created from the cell bound form by the
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enzymatic cleavage by TNF-a converting enzyme protease (Lum et al. 1999) and a
primary secreted molecule (Kong et al. 1999a, Nagai et al. 2000). The cell bound form is
the most common and is expressed by many cell types (Lacey et at. 1998, Yasuda et at.
1998a). In contrast, the primary secreted form is limited to activated T cells (Kong et al.
1999b ) and a squamous cell carcinoma cell line (Nagai et al. 2000). Various skeletal and
extraskeletal cell types are capable of expressing RANKL including stromal cells,
osteoblasts, osteoclasts. mesenchymal periosteal cells, chondrocytes and endothelial cells
(Wong et al. 1997, Anderson et al. 1997, Lacey et at. 1998, Yasuda et al. 1998a). On
osteoblastic cells, RANKL naturally exists as a surface transmembrane protein. However,
cleavage of this membrane protein by MMPs results in a secreted form (Lum et at. 1999).
In direct contrast to OPG, RANKL is a potent positive regulator for osteoclastogenesis
with downstream signalling events mediated by its transmembrane signalling receptor
RANK (Yasuda et al. 1998a, Boyle et al. 2003). A combination of RANKL and colony
stimulating factor-I (CSF -I) are necessary to induce gene expression that typifies the
osteoclast lineage, resulting in the development of mature osteoclasts (Lacey et al. 1998).
Indeed, RANKL in the presence of M-CSF is sufficient to promote osteoclast
differentiation (Matsuzuki et al. 1998, Quinn et al. 1998) and stimulate osteoclast
activation (Fuller et al. 1998, Burgess et al. 1999, Jimi et al. 1999) survival (Lacey et al.
2000) and adherence to bone surfaces (O'Brien et al. 2000).
RANKL signals through the integral type I transmembrane receptor protein RANK, which
is preferentially located on osteoclasts and dendritic cells. On signalling through its
receptor, RANKL induces a strong activation of the NF-KB transcription factor. NF-KB
activity appears to be critical for osteoclast differentiation as mice deficient in NF-KB
proteins pSO and pS2 have deficient osteoclastogenesis (Iotsova et al. 1997). However,
signalling through RANK can also occur through Erk, Akt, JNK and MAPK pathways
(Phan et al. 2004, Feng et al. 2005).
2.7.4 The OPGI RANKLI RANK regulatory axis
RANKL and OPG expression is carefully regulated to balance bone density and resorption
positively and negatively by controlling the activation state of RANK on osteoclasts
(Simonet et al. 1997, Akatsu et at. 1998, Kong et at. 1999, Boyle cl al. 20(3). Both the
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promoter region of RANKL (Gao et al. 1998) and that of OPG (Thirunavakkarasu et a/.
2000) contain binding sites for the osteoblastic transcription factor cbfa-l (Ducy et al.
2000). Cbfa-l is essential for osteoblast differentiation and function and therefore, the
generation of normal bone. Indeed, cbfa-l deficient mice not only lack mature osteoblasts
but also lack osteoclasts (Ducy et al. 2000). This suggests that cbfa-l and RANKL are
essential factors for the osteoblast and osteoclast lineages respectively. Furthermore, they
may represent a molecular link for the osteoblastic regulation of osteoclast biology and
bone resorption.
The regulation of RANKL and OPG gene expression, in addition to OPG secretion, by
human and rodent osteoblastic lineage cells has been extensively studied. Many known
osteotropic cytokines and hormones regulate either RANKL or OPG or the expression of
both and in either comparable or opposite directions. Dysregulation of the delicate balance
between RANKL and OPG expression is implicated in the pathogenesis of postmenopausal
osteoporosis, rheumatoid arthritis, Paget's disease, periodontal disease, benign and
malignant bone tumours, bone metastases, and hypercalcaemia of malignancy (Hofbauer
and Heufelder 2001). Furthermore, administration of OPG in animal models has been
demonstrated to prevent or mitigate these disorders (Hofbauer and Heufelder 2001).
Although the dominant effects of RANKLIRANKJOPG are related to bone biology, this
molecular triad is also associated with pathological events underlying cardiovascular
diseases and malignancy (Theoleyre et al. 2004).
2.7.5 Cytokine contribution towards inflammatory bone destruction
A multitude of factors is involved in the maintenance of bone homeostasis (Rodan 1998).
For decades, multiple cytokine systems have been proposed as central regulators of
osteoclast function (Suda et al. 1997). Growth factors such as those of the TGF-~
superfamily that includes bone morphogenic proteins (Pfeilschifter and Mundy 1987).
hormones and cytokines have all been implicated in regulating the equilibrium between
bone resorption and deposition (Jilka et al. 1998, Manolagas 1995). However, cytokines
are not obligatory for osteoclastogenesis but are simply involved in modulating this
process (Phan et al. 2004).
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Bone erosion is inhibited by IL-4 interacting directly with osteoclasts and indirectly by
inhibiting the production of pro inflammatory cytokines (Mirosavljevic et al. 2003). Indeed,
RANKL-induced bone resorption is dose dependently inhibited by the direct effects of IL-
4 upon both osteoclast precursors and mature osteoclasts (Wei et al. 2002, Mangashetti et
al. 2005). OsteocIastogenesis is also indirectly suppressed by IL-4 down-regulating the
transcription factors NF ATc I and c-Fos (Kamel Mohamed et al. 2005). Furthermore, IL-4
suppresses the expression of RANKL mRNA and protein and increases the secretion of
OPG by fibroblast-like synoviocytes (Lee et al. 2004b). Lee et al. (2004b) suggest that IL-
4 inhibits osteoclast formation by suppressing RANKL expression rather than altering
RANK expression whilst IL-IO has no appreciable effect upon RANKL. Conversely,
others have demonstrated IL-I0 to have an inhibitory effect upon osteoclastogenesis (Hong
et al. 2000). Furthermore, IL-J 0 knockout mice display greater bone loss in pathogen-free
conditions (Al-Rasheed et al. 2004) and to bacterial and antigenic challenge (Al-Rasheed
et al. 2003, Finnegan et al. 2003, Gjertsson et al. 2003, Sasaki et a/. 2004a). Through their
inhibition of cellular proliferation, IL-4 and IL-I3 are generally anti-inflammatory in
nature. Nevertheless, they are also capable of up-regulating IL-6 expression from
osteoblasts. IL-6 is a potent stimulator of osteoclast recruitment. Therefore, increased
concentrations of IL-I3 and IL-4 may inadvertently lead to bone resorption through
inducing increased IL-6 expression (Frost et al. 200 I).
The proinflammatory cytokines IL-I and TNF -a are implicated in both the formation and
functional activity of osteoclasts. TNF -a-induced osteoclastogenesis occurs as the result of
direct stimulation of macrophages that are exposed to a stromal environment expressing
permissive levels ofRANKL (Lam et al. 2000, Kudo et al. 2002). IL-J and TNF-a are also
capable of regulating OPG and RANKL gene expression in osteoblastic cells (Hofbauer et
al. 1999). Indeed, TNF-a enhances the expression of RANKL by ostcoblasts and stromal
cells (Hofbauer et al. 1999). Furthermore, TNF-a induces the expression of RANK on
osteoclasts, leading to a higher activation status of these cells by locally expressed RANKL
(Kobayashi et al. 2000). IL-l mediates the osteoclastogenic effects of TNF -o: by enhancing
stromal cell expression of RANKL and directly stimulates the differentiation of osteoclast
precursors (Wei et al. 2005). Furthermore, cytokines such as TNF-a are also capable of
inducing osteoclast differentiation independently of the RANKL-RANK- TRAF6 axis (Kim
et al. 2005). Through these effects, cytokines can thereby shift the balance of bone
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remodelling towards bone resorption and are therefore implicated in the pathogenesis of
several inflammatory bone diseases including rheumatoid arthritis (Chu et al. 1991) and
osteomyelitis (Meghji et a/. 1998). IL-6 promotes osteoclast formation through cellular
interactions between osteoblastic cells and progenitor cells. This property is related to
further stimulation of IL-l ~ release (Kurihara et al. 1990, Rozen et al. 2000, Ishmi et a/.
1990). Although IL-6 has little direct effect in regulating the RANKLIRANKIOPG system,
interactions between IL-6 and the PGE2 signalling system result in increased
osteoclastogenesis (Liu et al. 2005). IL-8 is also a potent stimulator of bone destruction
and has a direct stimulatory effect upon osteoclastogenesis and bone destruction (Bendre et
a/. 2003).
The presence of M-CSF is essential for human osteoclast formation from circulating
mononuclear precursors. This induces both the proliferation and differentiation stages of
human monocyte-osteoclast formation (Fujikawa et a/. 2001). IL-17 is also capable of
stimulating osteoclast differentiation and thereby inducing bone resorption. Indeed, IL-17
enhances the effect of TNF-a-induced osteoclast resorption in vitro (van Bezooijen et al.
1999). The effects of IL-17-mediated bone destruction occur in a prostaglandin dependant
manner. Furthermore, they appear to be mediated through the induction of RANKL on the
surface of osteoblasts as OPG inhibits IL-17A-induced osteoclast differentiation (Kotake et
al. 200 I). The local release of IL-17A in chronic inflammatory bone disorders may result
in up-regulated expression of RANKL from local stromal cells, thereby contributing
towards osteoclastogenesis (Page and Miossec 2005). Moreover, IL-17-mediated increase
in RANKL expression is potently enhanced by the concomitant addition of IL-I ~ or TNF-
u.
lL-12 inhibits osteoclast formation in co-cultures of mouse adult spleen cells and
osteoblastic cells treated with M-CSF and RANKL (Horwood et al. 2001) and additionally,
in bone marrow cell cultures (Nagata et al. 2003). IL-12 potently induces the production
of IFN-y from T and NK cells (Yoshimoto et al. 1998). Interestingly, IFN-y is capable of
inhibiting osteoclast formation in cell co-culture systems by interfering with the RANKL-
RANK signalling pathway (Takayanagi et al. 2000). Furthermore, IFN-y prevents
osteoclast formation by directing the differentiation of osteoclast progenitors towards an
alternative cytocidal lineage to that of the osteoclast (Fox and Chambers 20(0). After T
114
cell activation, IFN-y may therefore have a key responsibility in protecting against the
destruction of calcified tissue. Nevertheless, in vivo studies using the pulp exposure model
in murine knockout mice have failed to support an individual role for IL-12, IL-18 or IFN-
y in either protecting against or contributing towards infection stimulated bone destruction
(Sasaki et al. 2004b).
Although many of the aforementioned effects of cytokines upon bone remodelling are
related to the modulation of RANKL expression, osteoclasts can additionally be formed
and activated independently of RANKL and RANK. Indeed, this may occur through the
proinflammatory cytokines TNF -a (Azuma et al. 2000, Kobayashi et al. 2000) and IL-l
(Jimi et al. 1999, Fox et al. 2000). TNF-a appears to activate the generation of mature
osteoclasts, whereas IL-I stimulates the resorbing activity of osteoclasts (Jimi et al. 1999,
Kobayashi et al. 1999, Azuma et al. 2000, Fox et al. 2000). This provides evidence that
these inflammatory cytokines are partially capable of circumventing the RANKL-RANK
pathway, especially in inflammatory diseases. However, RANK-deficient mice are
resistant against the hypercalcaemic and bone resorptive effects of IL-l and TNF-a (Li et
al. 2000). Furthermore, OPG can prevent bone loss in a model of adjuvant arthritis that is
characterised by local overproduction of IL-I and TNF-a (Kong et al. 1999). These
observations suggest that the direct contribution of IL-I and TNF -a to bone resorption is
minimal. Therefore, it is likely that the majority of bone destructive properties related to
TNF-a and IL-I are mediated through their potent induction of RANKL (Brandstrom et al.
1998, Vidal et al. 1998, Hofbauer et al. 1999).
2.7.6 RANKLI OPG within PRD
OPG mRNA expression was initially identified within human POL, human pulp cells and
human gingival fibroblasts (Sakata et al. 1999). Furthermore, expression of OPG mRNA is
increased in POL cultures stimulated with IL-l p and TNF-a but not by TGF-~3 or IL-6.
Despite the production of RANKL by POL cells, endogenously expressed OPG is capable
of preventing osteoclastogenesis within bone marrow cell co-cultures. This may provide a
mechanism by which root resorption is prevented (Hasegawa et al. 2002a). Conversely, the
pattern of OPG and RANKL mRNA expression within human POL cell cultures derived
from deciduous teeth is capable of inducing osteoclastogenesis. This may be a significant
factor contributing towards root resorption and exfoliation of the deciduous dentition
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(Hasegawa et a/. 2002b). Using IHC methodology, OPG protein has been detected within
inflamed dental pulp tissue and its cellular expression is primarily localised to fibroblasts,
endothelial cells and chronic int1ammatory cells (Kuntz et al. 200 I).
RANKL production is increased by C04+ T lymphocytes stimulated with the periodontall
endodontic pathogen Actinobacillus actinomytemcomitans. Within the murine model of
periodontitis, infection with this microorganism enhances alveolar osteoclastic bone
resorption. Of importance, these effects are abolished by the administration of OPG (Teng
et al. 2000). A. actinomytemcomitans has also been shown to increase RANKL mRNA
expression in both POL and gingival fibroblast cultures. However, this pathogen has no
effect upon OPG mRNA expression within these cell types (Belibasakis et al. 200Sb).
Recently, RANKL mRNA expression has been demonstrated to be present within the
human PRO lesion and absent in healthy periodontal ligament controls (Sabeti et al. 2004).
From experiments using lHC within the rat PRO model, RANKL protein expression within
the periradicular tissues increases after pulp exposure and reaches maximal expression at
day 14 (Zhang and Peng 2005). However, the presence of RANKL protein and mediators
that are capable of modulating RANKL and OPG expression within the human PRO lesion
remain to be determined.
2.8 Fibroblasts
2.8.1 Fibroblast origins
Fibroblasts are relatively long-lived flat, oval nucleated, elongated spindle-shaped cells
derived from mesenchyme (Postlethwaite et al. 2004). They are distinguished from other
cells by their characteristic morphology, their ability to adhere to plastic culture vessels
and the absence of markers defining other cell lineages. Originally, fibroblasts were
thought to be a homogeneous cell population. However, investigations have determined
that cellular proliferation, size, shape, collagen synthesis and responsiveness to
inflammatory mediators vary between fibroblasts originating from different hosts and
differing host sites (Castor et al. 1962, Elias et al. 1987, Raghu et al. 1988, Chen et al.
2005). Thereby, fibroblasts comprise a diverse group of distinct functionally differentiated
cell types that can be categorised on their gene expression profiles (Fries 1'/ al. 1994a,
Chang et al. 2002c). Furthermore, even within a specific disease process, fibroblasts form
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a heterogeneous population and the differing characteristic phenotypes of these
subpopulations are stable (Kasperkovitz et al. 2005). Indeed, these distinct phenotypes are
maintained in vitro after prolonged cell culture (Brouty-Boye et al. 2000, Marinova-
Mutafchieva et al. 2000).
Developmentally, fibroblasts are classically derived from the primary mesenchyme.
However, within the head and neck region fibroblasts are ectodermal in origin, being
derived from neural crest tissue (Komuro 1990). Subsequent to trauma or inflammation,
fibroblasts may also differentiate from local epithelial structures (lwano et al. 2002).
Furthermore, in renal fibrosis the tubular epithelium contributes towards more than a third
of the fibroblast population by a process termed epithelial-mesenchymal transition (Kalluri
and Neilson 2003). Fibroblasts are also generated from circulating fibrocytes that are
primarily derived from CDI4+ PBMCs (Abe et al. 2001) and a population of CD34°
mononuclear cells (Zvaifler et al. 2000).
2.8.2 Physiological roles of fibroblasts
The predominant function of fibroblasts is to maintain the structural integrity of connective
tissue. They synthesise extracellular matrix (ECM) products that afford mechanical
strength and tissue architecture to organs and tissues of the body (Buckley et al. 200 I). Of
importance, the ECM also serves as a scaffold for cell adhesion of extravasated leukocytes
(Shimizu and Shaw 1991). Matrix deposition can be increased by fibroblast stimulation
with TGF-~, IL-l and mast cell tryptase. Conversely, fibroblasts stimulated with IL-4
and/or interferon exhibit decreased collagen synthesis (Konttinen et al. 2000). Fibroblasts
are also a central cell line regulating wound healing, they have an essential supporting role
in haematopoiesis and help define the bone marrow stromal niche (Dexter 1982).
Furthermore, thymic function and the generation of secondary lymphoid tissue are in part
controlled by chemokines and cytokines released by resident fibroblasts (Parsonage et al.
2005). In addition to these physiological regulatory functions, fibroblasts are capable of
differentiating into a number of connective tissue cells including cartilage, bone,
adipocytes and smooth muscle cells (Harris 1994). Importantly, inflammatory cytokines
are critical factors that influence fibroblast differentiation (Yamasaki et al. 2004).
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2.8.3 Contribution of fibroblasts to inflammation and immunity
In addition to providing the supporting framework for other cell types, there is substantial
evidence that fibroblasts perform a central active role within inflammatory processes
(Buckley et al. 2004, Chen et al. 2005). The secretion of IL-8 and other molecules such as
IL-16 (Franz et al. 1998), MCP-l and MIP-l a by fibroblasts aid in the attraction of
macrophages and CD4+ T cells to inflammatory sites (Ritchlin 2000). Thereby, fibroblasts
are frequently the first cell line that comes into contact with extravasated leukocytes such
as T cells and macrophages. Moreover, the selective accumulation, survival, differentiation
and retention of leukocytes at sites of inflammation are mediated by the stromal address
code that fibroblasts contribute towards defining (Parsonage et al. 2005). Through
fibroblast and immunocyte expression of transmembrane IL-I R type 1 and cell surface
associated IL-I, interactions of cell-surface bound ligand and membrane-receptor likely
occurs between fibroblasts and inflammatory cell lines.
Infiltration of haematopoietic cells at damaged tissue sites is regulated by fibroblasts
through CD40-CD40 ligand (L) interactions (Zhang et al. 1998). Fibroblasts also appear to
exercise an important regulatory function in initiating immune responses by inhibiting the
production of IL-12 by dendritic cells, thereby precluding the development of Th I type
responses (Berthier et al. 2003). Fibroblasts possess Toll-like receptors and upon
stimulation with PAMPS express a variety of MMPs and prointlammatory cytokines
(Kyburz et al. 2003, Zeisel et al. 2005). Synovial-like fibroblasts exposed to Salmonella
enterica are capable of enhancing the maturation of osteoclast precursors into active
multinucleated osteoclast-like cells (Zhang et al. 2004). Furthermore, fibroblast-like
synoviocytes (FLS) not only augment bone resorption but may also directly contribute to
bone resorption (Pap et al. 2003). Taken together, this clearly demonstrates that, upon
encountering microbial products, fibroblasts are capable of eliciting an innate immune
response. Following activation by these microbes and their associated PAMPS, fibroblasts
act as central players in adjusting the equilibrium between repair and destruction of the
surrounding tissue matrix.
Dermal fibroblasts were originally recognised as primary targets of proinflammatory
cytokines such as IL-I and TNF-a (Dayer et al. 1977, Butler et al. 1994). Upon stimulation
with these cytokines, fibroblasts express chemokines such as IL-8 and MCP-I, matrix
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metalloproteinases (MMPs) and prostaglandins (Dayer et al. 1986, Larsen et al. 1989).
Differing fibroblast populations secrete distinct patterns of chernokines, cytokines and
matrix proteins. The production of these inflammatory mediators epitomises their
influential role as effector cells in inflammatory reactions. Moreover, secretion of such
inflammatory products suggests that fibroblasts are not mere bystanders within
inflammatory events (Buckley et al. 2004). Fibroblasts themselves express IL-I and thus
contribute to paracrine and autocrine activation of neighbouring cells (Sporri et al. 1996,
Rezzonico et al. 1998). Up-regulation of fibroblast-derived cytokines, including IL-6 and
chemokines such as CXCLI2 and CXCLl3 (Hjelstrom 2001), may contribute towards the
perpetuation of chronic int1ammatory diseases including RA (Buckley et al. 2000),
Sjogren's syndrome (Amft et al. 2001) and liver cirrhosis (Grant et al. 2002).
Fibroblasts may be classified according to their expression of Thy-I, a 25 kDa
glycoprotein (Phipps et al. 1989). Upon challenge with cytokines, the differential
expression of Thy-I leads to specific patterns of response from fibroblasts. Whereas Thy-T
fibroblast subsets stimulated with TNF-a produce IL-Ia, fibroblasts expressing Thy-I do
not secrete IL-I a (Phipps et al. 1990). Furthermore, only the Thy-T subset responds to
IFN-y stimulation, which results in up-regulated expression of class II MHC antigens
(Phipps et al. 1989). However, both Thy-T and Thy-I + subsets produce IL-6, which acts as
an autocrine growth factor (Fries et al. I994b ). More recently, the response of fibroblasts
to exogenous IFN-y has been further scrutinised. These investigations establish that
stimulation of peripheral tissue-derived fibroblasts with either Th I (lFN-y) or Th-2 (IL-4)
type cytokines induces gene expression more akin to lymphoid tissue (Parsonage et al.
2003).
Fibroblast activity is int1uenced by cell contact with T cells. It is known that cytokine
activated fibroblast-like synoviocytes (FLS) bind T cells through an ICAM-I dependent
pathway (Bombara et al. 1993, Shingu et al. I994). Furthermore, direct contact between
fibroblasts and mitogen-activated T cells leads to down-regulation in the synthesis of
fibroblast-derived collagen types I and III (Rezzonico et al. 1998). Additionally, contact
with blood-derived activated T cells or synovial CD4+ and CD8+ T cell clones up-regulates
FLS production of MMPs and prostaglandin (Burger et al. 1998). This effect appears to be
dependent upon membrane bound cytokines, including TNF -a and IL-l a. Cytokines
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produced by IL-I~ and TNF-a- activated fibroblasts, such as IL-7 and IL-15, may also
provide positive feedback loops for T cell activation (McInnes et al. 2000).
Through the inappropriate production of stromal derived factor (SOF -I) and IFN-~,
fibroblasts may contribute to the perpetuation of chronic inflammation (Buckley et al.
2001). In addition to propagating chronic inflammatory disorders, LPS-stimulated
fibroblasts may directly influence inflammatory bone destruction by releasing RANKL and
OPG (Wada et al. 2004). Indeed, murine synovial fibroblasts promote osteoclast formation
from macrophages through RANKL expression (Wu et al. 2005). Fibroblast-like
synoviocytes have been shown to express IL-18R chains, although the majority of cultured
FLS express only one chain, thereby rendering them unresponsive to IL-18 (Moller et al.
2002, Kawashima and Miossec 2003). Importantly, FLS have been shown to secrete large
amounts of IL-6 and IL-8 and limited TNF-a, IL-l, IL-15 and IL-18 (Georganas et al.
2000, Hirth et al. 2002). These data implicate fibroblasts as immune active cells that are
potentially responsible for regulating inflammatory processes, from acute through to
chronic stages (Buckley 2003).
2.8.4 PRO fibroblasts
Periodontal ligament (POL) fibroblasts are defined by their tissue localisation within the
periodontal ligament surrounding the dental root. They are responsible for maintaining the
rapid and extensive remodelling of the collagen attachment fibres that support the tooth in
the alveolar bone socket (Bardin et al. 1984). Gingival fibroblasts, which coordinate the
construction of the gingival soft tissue, are additionally situated within the region of the
dental attachment to alveolar bone. These two fibroblast populations manifest distinct
morphological characteristics and they may be further divided into heterogeneous sub-
populations (Rose et al. 1987, Piche et al. 1989, McCulloch and Bordin 1991).
Furthermore, as a result of their neural crest origin, POL and gingival fibroblasts exhibit
greater similarity in their gene profiling with osteoblasts than fibroblasts derived from
dermal tissues (Lallier et al. 2005).
Periradicular disease lesions contain approximately equal numbers of inflammatory cells
and fibroblastic cells (Stem el al. 1981). There are a substantial number of studies
analysing the effects of intlammatory mediators upon PDL (Belibasakis cl al. 2005b),
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gingival (Imatani et al. 2001, Chu et al. 2004, Tardif et al. 2004, Belibasakis et al. 2005a,
b) and pulp fibroblasts (Hosoya and Matsushima 1997, Chu et al. 2004, Coil et al. 2004,
Huang et al. 2004, Chan et al. 2005, Tancharoen et al. 2005). In contrast, few studies have
investigated the phenotype of fibroblasts derived from chronically inflamed PRO tissue
lesions. Maeda et al. (2004) established that fibroblasts obtained from 3 human PRO
lesions have the potential to differentiate into osteoblastic or cementoblastic cells. From
this study, they suggest that PRO-derived fibroblast cells have the ability to contribute to
osseous healing after root canal treatment. Conversely, through the production of cytokines
and/or metalloproteinases that indirectly or directly promote matrix degradation,
fibroblasts may actively contribute to the pathogenesis of PRO.
Only one study has analysed the cytokine profile of cultured fibroblasts from PRO lesions.
Furthermore, these fibroblasts were isolated from only periradicular cysts. These cyst-
derived fibroblasts secrete significantly greater quantities of IL-6 compared with
fibroblasts derived from healthy pulp or gingival tissues (Kusumi et al. 2004).
Interestingly, secreted levels of IL-l p, IL-8, TNF -a and IFN-y from the PRO cyst-derived
fibroblast cultures are not significantly different from pulp and gingival fibroblasts.
Thereby, IL-6 may be a significant contributing factor towards PRO cystic expansion.
Given the important role that fibroblasts perform in the regulating matrix structure both in
health and in inflammation, the paucity of research defining the PRO fibroblast is
somewhat surprising.
2.9 Aims of Study
Over two thirds of the Scottish adult population is affected by periradicular disease. In an
attempt to treat this common ailment, root canal procedures and dental extractions cost the
National Health Service within Scotland greater than £ 1.5m per annum. Furthermore, this
figure does not incorporate the additional costs of providing the definitive coronal
restoration required to seal the root canal access cavity, the subsequent provision of cuspal
coverage coronal restorations, re-root canal treatments, re-surgery and/or the replacement
of lost teeth with dental prosthesis (and their long-term replacement). Moreover, the
indirect costs incurred by businesses resulting from lost working time as a consequence of
patients undergoing such time consuming treatment procedures is substantial.
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In contrast to many other chronic inflammatory diseases, PRO is a readily accessible,
intact inflammatory tissue lesion in which immunoregulatory events may be explored.
Given the high prevalence within and the substantial cost and morbidly to populations
worldwide, it is remarkable that significant deficiencies exist in the understanding of
processes integral to the immunopathogenesis of the human PRO lesion. This IS
particularly evident in the lack of knowledge as to the expression of novel inflammatory
cytokines and their involvement in the initiation, development and perpetuation of the
disease process. It is also surprising that functional investigations, which analyse the
dynamics of immune and inflammatory mediators, have not been undertaken upon the
human PRO lesion. This is astonishing when one considers the quantity of diseased tissue
available from routine dental extractions and peri radicular surgery that could be analysed.
It is now established that fibroblasts have a central active role within chronic inflammatory
disease processes. Furthermore, it has been recognised since early studies that fibroblasts
constitute a significant proportion of the cellular population within the PRO lesion.
However, PRO-derived fibroblasts have not been isolated, analysed and phenotyped and
their potential involvement in PRO progression remains to be elucidated.
As scientific understanding of pathologic processes that lead to chronic PRO is inadequate,
I hypothesised that PRO explant tissue cultures would permit detailed investigation of
inflammatory events within human PRO. The specific aims of this thesis were:
1. To develop a novel human PRO explant culture model in which to investigate the
functional role of likely inflammatory mediators involved in the initiation and
perpetuation of the human PRO lesion.
2. Upon establishing a PRO explant tissue system, to investigate the expression of IL-
18 within the human lesion and to elucidate its likely biological contribution
towards inflammatory responses occurring within PRO.
3. To investigate the presence of and functional interactions between inflammatory
mediators within the human PRO lesion that influence bone homeostasis.
4. To undertake investigations that would begin to phenotype the PRD fibroblast.
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CHAPTER3
GENERAL
MATERIALS AND METHODS
3 GENERAL MATERIALS AND METHODS
3.1 General Materials
3.1.1 General reagents
OM EM was supplemented with 100 U/ml penicillin, lOO pg streptomycin, 2 mM L-
glutamine. 1.25 mg/ml amphoterecin and 10% foetal calf serum (FCS) obtained from
Sigma (Poole, UK). A murine monoclonal antibody (mAb) raised against recombinant
human IL-18 (clone 1.51 E3El), gifted by A Jackson (Imperial Cancer Research Fund.
Leeds, UK). was used for immunohistochemistry experiments. Vectastaini)<) ELITE kit.
3.3·-diaminobenzidine (DAB) tetrahydrochloride, Vector® SG, V ectorl<: NovaRED and
secondary biotinylated antibodies were from Vector Laboratories Ltd (Peterborough, UK).
IL-18Ra and 13 and IL-18BP RT-PCR primers (Table 1), TRIzOL,R; Reagent and
SuperScript™ II reverse transcriptase and Taq polymerase were from Invitrogen (Paisley,
Scotland). PVDF membrane, ECL Plus™ and horseradish peroxidase (HRP) conjugated
anti-mouse Ig secondary Ab for Western blotting were obtained from Amersham
Biosciences (Buckingharnshire, UK).
3.1.2 Sample collection
80 dental periradicular tissue biopsies (60 periradicular granulomas and 20 radicular cysts)
were immunohistologically examined. Specimens were obtained from patients (36 male
and 44 female) undergoing periradicular surgery under local anaesthesia within the
Restorative or Oral Surgery Departments. University of Glasgow or University of Dundee
Dental Schools. Patients were in good health and not taking long-term medication for
chronic conditions. The mean age of patients was 43 years (range 17-82 years). Local
dental ethical committee approval was obtained for the project protocol. The diameter of
PRO lesions was recorded from radiographs. The tissues were immediately fixed in 10%
neutral buffered formalin at room temperature for processing for immunohistochemistry. A
routine pathological diagnosis was concomitantly obtained. Control tissue for (HC
experiments consisted of healthy periodontal ligament (POL) tissue obtained from non-
carious. unrestored third molar teeth extracted under local anaesthetic from systemically
healthy patients. POL tissues were carefully dissected off the mid-third of the root with a
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sterile Swan-Morton)' scalpel (Swann Morton, Sheffield, UK). Care was taken to avoid
contamination from attached periodontal tissue or apical tissue. POL tissue was
immediately fixed in 10% neutral buffered formalin at room temperature for processing for
immunohistochemistry. Further control experiments were also carried out on healthy pulp
of sectioned teeth extracted for orthodontic purposes.
For RT-PCR experiments, PRD tissues were obtained from 90 patients, 41 male and 49
female, undergoing peri radicular surgery under local anaesthesia within the Restorative
and Oral Surgery Departments, University of Glasgow and University of Dundee Dental
Schools. The mean age of patients was 45 years (range 18-84 years). Tissue was collected
in RNALater® (Ambion) or TRIzOLID Reagent (Invitrogen Life Technologies, Scotland)
and stored at minus 20°C until further analysis. Control tissue for RT-PCR consisted of
healthy pulpal tissue obtained from non-carious, unrestored third molar teeth extracted
under local anaesthetic from systemically healthy patients. Crowns and the coronal third
of the roots were cleaned with PBS and any adherent soft tissue removed. The teeth were
sectioned horizontally below the amelocemental junction with a sterile high-speed
diamond bur and sterile water coolant. The pulpal tissue was removed aseptically with a
sterile barbed endodontic broach and immediately stored in RNA Later at -20°C until
analysis.
PRO tissues obtained from 25 patients (14 male/II female) undergoing routine dental
extractions within the Oral Surgery Department, University of Glasgow Dental School
were obtained for Western blot experiments. The mean age of patients was 35 years (range
19-71 years). Periradicular tissues were carefully dissected off the dental root apex with a
sterile Swan-Morton I<; scalpel (Swann Morton, Sheffield, UK), avoiding contamination
with adjacent periodontal ligament cells or attached periodontal tissue. PRD tissues were
snap-frozen in liquid nitrogen and stored in liquid nitrogen until further analysis. Control
tissue for Western blotting comprised 10 healthy pulp tissues obtained from non-carious,
unrestored third molar teeth extracted under local anaesthetic from systemically healthy
patients. Crowns and coronal third of the roots were cleaned and adherent soft tissue
removed. Teeth were washed with PBS and horizontally sectioned below the AC J with a
sterile high-speed bur and sterile water coolant. The pulpal tissue was removed aseptically
with sterile barbed broaches, snap-frozen in liquid nitrogen and stored in liquid nitrogen
until analysis. A summary of the patient study population is given in Table 3.1.
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Table 3.1 Characterisation of study population. Specific numbers of patients with
periradicular disease and healthy donors (dental pulp controls) for individual laboratory
procedures. Age (years) is shown as the mean and range.
IHC RT-PCR Tissue Western TaqMan Healthy
Culture Blot peR Pulp
Control
Number of 80 90 310 25 23 20
specimens
Age (years) 17-82 18-84 9-76 19-71 18-55 16-43
mean 43 45 36 35 31 24
Male/F emale 36/44 41/49 181/129 14111 13/10 8112
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3.2 General Methods
3.2.1 PCR
3.2.1.1 RNA extraction
Samples stored at -':WoC were thawed at RT, homogenised using a Polytron PT 2100
electric homogeniser (Kinernatica, Switzerland) and 0.2 ml of chloroform (Prolabo,
France) added per I ml of TRIzOL ® Reagent to each sample. Samples were shaken
vigorously for 15 seconds and left at RT for 3 minutes. Samples were freeze/ thawed three
times and subsequently centrifuged at 1200 g at 4°C for 15 minutes. The upper aqueous
layer was transferred to a sterile polypropylene tube and an equal volume of isopropyl
alcohol (BDH Laboratory supplies, England) added to precipitate the RNA. Following 10
min incubation at RT. the sample was centrifuged at 1200 g to pellet the RNA. Subsequent
to removal of the supernatant and washing in 75% ethanol (Hayman, Essex, UK), the pellet
was air dried for 5 minutes and then resuspended in 22 ,lll of sterile water and incubated at
55°C for 10 minutes. RNA concentration was calculated by measuring the OD using a
Bioquest spectrophotometer (Cecil Instruments, Cambridge, England). The purity of the
sample was assessed from the ratio of the OD at 260 nm to the OD at 280 nm.
3.2.1.2 rc« amplification
5 ,llg of the total RNA obtained from samples was used for reverse transcription. Prior to
reverse transcription. samples were treated with RNA free DNAase~ (Arnbion,
Huntingdon. UK) for 15 minutes at 37°C then denatured at 70"C for 10 min. The RNA was
reverse-transcribed into cDNA using the SuperScript™ II reverse transcriptase system
according to the manufacturer's recommendations. RT reaction products (I ,lll) were mixed
with either IL-18Ra, IL-I8RP, IL-I8 or IL-18BP (a, c or b and d) sense or anti-sense
primer pair (1 ,lll) each in a 10 ,lll total reaction mix (025 mM MgCh, 2 ,llM dNTPs, Taq
polymerase and I ,lll lOx buffer). 10,ll1 of the reaction products were run on 2% w/v
agarose gels with a 100 bp DNA Ladder (Promega, Southampton. UK). The PCR reaction
was performed on the Genius PCR machine (Techne). Mock RT reaction products,
obtained in the absence of reverse transcription or H20 served as templates for negative
control studies. The housekeeping gene. p-actin served as an mRNA integrity control.
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whereas cDNA derived from LPS/ IFN-y stimulated THP-l cells and/or collagenase
digested rheumatoid arthritis synovial tissue served as positive controls. Details of primer
sequences are provided in Table 3.2.
3.2.1.3 AKarose gel electrophoresis
A 2% agarose gel (Bioline) containing 0.001% ethidium bromide (Sigma Chemicals,
Dorset, UK) was set in a gel tank (Life Technologies, UK) containing a 20-toothed comb.
Once set, the gel was overlaid with Ix TBE Buffer. Along with samples, a 1 kB DNA
Ladder (Advanced Biotechnologies, Surrey, UK) was loaded onto the gel to allow sizing
and appropriate quantification of the products within the sample. 10,u1 of sample with 5 ,ul
of orange G solution containing 50% glycerol and 50% TBE were added to individual
wells. Electrophoresis of samples was undertaken at 100 volts for 60 minutes to allow
migration of the cDNA within the gel from cathode to anode. The gel block was removed
at the end of the run and visualised using UVI-photo software programme.
3.2.1.-1 Quantitative rc«
24 ,ul of reaction mixture (12.5 ,ul Master mix, 1 ,ul probe, 0.75 ,ul of forward and reverse
primers and 9 ,ul H20) was added into each well in a 96 well plate (Thermo fast ABgene,
Epsom, UK). Taqman" probes (Table 3.3) were obtained from Biosource, UK and
Taqrnan" master mix from Eurogentech, Southampton, UK. Hypoxanthine Ribosyl
Transferase (HPRT) or GAPDH served as control genes (12.5 ,ul master mix, 1.25,u1 probe
and 10.25 ,ul H20). Thereafter 1 ,ul of eDNA, standards or water as a negative control was
added into triplicate wells. Following thermocycling, eDNA levels were quantified using
an ABI prism 7700 sequence detector (Applied Biosysterns, Foster City, CA). Products
were expressed as a percentage of HPRT or GAPDH. Details of probe sequences arc in
Table 3.3. For analysis of TLR-l,- 2, -4 and -6 expression, IO,ug of each total RNA was
subjected to first strand cDNA synthesis with a High-Capacity cDNA Archive kit (Applied
Biosystems, UK). Real-time PCR on 1/30 of the cDNA pool was performed in duplicate on
an ABI 7500 system (Applied Biosystems). Universal PCR Master Mix. TaqMan" probes,
sense and anti-sense primers were obtained as Assays-on-Demand" kits (Applied
Biosysterns, UK) and used according to the manufacturer's protocol.
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Table 3.2 Primer sequences for RT - peR.
Target Sequence 5'-3' Product
Size
(bp)
p-actin
Sense 5'GTGGGGCGCCCCAGGCACCA3' 548
Antisense S'CTCCTTAATGTCAC GCACG ATTTC3'
IL-18BPa
779
Sense S'T ATATCT AGAGCCACCA TGAGACACAACTGGACACCA3"
Antisense 5"ATATCTAGA TTAATGA TGATGA TGA TGA TGA-
CCCTGCTGCTGTGGACTGC3 '
IL-18BPb+d
568
Sense 5'T ATATCT AGAGCCACCA TGAGACACAACTGGACACCA3'
Antisense 5' ATATCT AGA TTAATGA TGA TGA TGA TGA TGCA-
GGCTGCTCTGGCAGAGC3 '
IL-18BPc
805
Sense 5'T ATATCT AGAGCCACCA TGAGACACAACTGGACACC A3'
Antisense 5'ATATCTAGATTAATGATGATGATGATGATGAGGT-
TGTGCTGCTGCTGGCC3 '
IL-18
Sense S'ATCAGGA TCCTTTGGCAAGCTTGAATCTAAATTT ATC3' 487
Antisense S' ATAGGTCGACTTCGTTTTGAACAGTGAACATT ATAG3'
IL-18Ra
Sense 5' ACT TGT CAT TAG GTT GGC GG 305
Antisense S'ACT CAG TCA CCC ACT GGT CC
------- I---~--
IL-18RfJ
Sense CCG CAT CAC ATA AGC AAG AC 606
Antisense ACC ACT CCT CTC TTT TCT TTC A
----~--- ------_._----
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Table 3.3 TaqMan primer sequences and probes used for quantitative peR
analysis of IL-I8 expression.
Description Sequence 5 '-3 '
IL-I8
Forward
Primer
11-18
Reverse
Primer
IL-I8
Probe
CGCCTCTATTTGAAGATATGACTGATT
CCTCTAGGCTGGCTATCTTTATACATACT
TGACTGTAGAGATAATGCACCCCGGACC
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3.2.2 Immunohistochemistry
3.2.2.1 Tissue processing
Formalin fixed tissues were embedded in paraffin wax and 5 J.iITl serial sections were
collected on silane coated glass or Superfrost Plus slides (BOH Laboratory Supplies, UK).
Prior to immunohistochemistry, two sections in each sample were used for morphological
examination that was based upon haematoxylin and eosin staining. Dried sections (60°C
for 35 minutes) were dewaxed in xylene and rehydrated in graded alcohol solutions to
PBS. Endogenous peroxidase was inhibited with 0.3% H202 (Sigma) in methanol for 30
min. Antigens for IL-18, CD3, CD68, IL-17, C057, C025 and Ki-67 were unmasked by
heating in 1L 0.01 M pre-hated citrate buffer, pH 6.0, under pressure within a microwave
(650 W) for 8 minutes. Antigen retrieval for OPO was undertaken by heating 1L preheated
EDT A, pH 8.0, under pressure within a microwave for 8 minutes. Antigen retrieval for
mast cell tryptase was performed using 0.1% trypsin solution (Sigma) in Tris butler (pH
7.6) containing 0.1% calcium chloride. Slides were incubated within this solution for 15
minutes at 3rC. After washing with PBS, a wax ring was drawn around each specimen
and slides were incubated with blocking solution at RT for 1 h using 20% serum of the
species in which the secondary antibody was raised in PBS. The blocking solution was
tapped off and sections were then incubated overnight at 4°C with primary Ab in a
humidified chamber. Subsequent to further washing in PBS at RT, slides were incubated
with secondary Ab (Vector, Peterborough, UK). Primary antibodies used for lHC are
detailed in Table 3.4.
3.2.2.2 Visualisation ofproducts
Following a 30-minute incubation with secondary antibodies at RT, a standard avidin
biotin protocol was followed (Vectastain" ELITE. Vector Laboratories). The product was
viewed with DAB or Vector<l<)NovaRED (Vector Laboratories) and sections counterstained
with Harris's haematoxylin (BDH Ltd, Merck Ltd, Lutterworth, Leicester, UK). For double
staining, sections were first stained with anti-IL-18 Ab and developed with DAB. After
quenching of residual HRP activity, sections were incubated with anti-CD68 (Dako,
Cambridgeshire, UK) or anti-CD3 (Novocastra Laboratories, Newcastle upon Tyne, UK)
130
and stained with Vector" SG or Vector® NovaRED (Vector Laboratories. England),
Finally. sections were dehydrated in ethanol. cleared in xylene (BOH Laboratories,
England) then mounted in DPX mountant (BDH Ltd- Merck Ltd), Control tissues
comprised human tonsil sections, periodontal ligament cells and sections of asymptomatic
teeth. Specificity of staining for IL-I8 and IL-I7 was confirmed by the addition of the
corresponding recombinant proteins to establish blocking of antibody activity prior to
immunostaining. Negative controls included the omission of one or both pnmary
antibodies or the addition of isotype-matched control antibodies of irrelevant specificity.
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Table 3.4 Primary antibodies used for IHC experiments.
Antibody Manufacturer Source Concentration/ Dilution
Novacastra
Anti-CD3 NCL-CD3-PS 1 Mouse monoclonal 1: lOO
DakoCytomation
Anti-CD20 Clone L26 Mouse monoclonal 1:200
Anti-CD2S Novocastra Mouse monoclonal 1:100
Serotec
Anti-CDS7 MCA1305 Mouse monoclonal 10.ug/ml
DakoCytomation
Anti-CD68 Clone PG-MI Mouse monoclonal 1:100
R&D
Anti-IL-I7 BAF 317 Goat Polyclonal 0.5.ug/ml
Clone E3EL
Anti-IL-IS Andrew Jackson Mouse monoclonal OA.ug/ml
Anti- Novocastra
Mast Cell NCL-MCTRYP-428 Mouse 1:200
Tryptase
Anti-Human Novocastra
neutrophil NCL-DEFENSIN Mouse 1:500
defensin
DakoCytomation
Anti-Ki-67 Clone MIB-I Mouse I: 100
----- --------~-- ----
R&D
Anti-OPG AF805 Mouse 15pg/ml
-----~-- __ L.______ __ .___ ._.. __ ._. ______
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3.2.3 Western Blotting
3.2.3. J Protein preparation
Western blot analysis was performed, following a standard protocol. Briefly, snap frozen
specimens were ground under liquid nitrogen. Pulverised tissues were denatured in RIP A
Buffer containing 50 mM Tris-HCL pH 8.0, 150 mM NaCl, 1mM EOT A, 1% NP40,
0.05% SOS, 1 mM OTT, 1 mM phenylmethanesulfonyl fluoride, 1 "g/ml Aprotinin, 1
,ug/ml Pepstatin and 1 zzg/ml Leupeptin. Samples were stored on ice for 15 minutes then
subjected to three rapid freeze-thaw cycles. Soluble protein was harvested after
centrifugation at 12,000 g for 15 minutes, the supernatant collected and stored at -20De
until analysis.
3.2.3.2 Gel electrophoresis
10 ,ul of protein sample was heated with 2 ,ul of sample buffer at 95°C for five minutes and
then spun down for 2 minutes. Subsequently, protein lysates were loaded into a 12% SOS-
PAGE electrophoresis gel. Protein samples were fractitionated on 12% SDS-
polyacrylamide gels at 200V for 45 minutes in a BioRad mini-PROTEAN III
electrophoresis chamber.
3. 2.3. 3 Transfer 0.(protein
Following electrophoresis, Hybond-P PVDF membrane (Amersham Life Science) was
prewetted with methanol. The Western blot sandwich was created with the gel, PVDF
membrane and Whatman 3MM filter paper and wetted with transfer buffer. Proteins were
transferred to PVDF membranes by means of a semi dry transfer apparatus (BioRad
Laboratories, Hemel Hempstead, UK) at 15V for 25 minutes. Following protein transfer,
non-specific protein binding was blocked for 1 h at RT with 5% fat free milk in TBS/
0.05% Tween20, pH 7.6 and membranes probed overnight at 4"C with relevant primary
antibodies (summary of primary antibodies in Table 3.5).
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3.2.3." Visualisation ofproteins
Following three 5 minute washes with TBST, bound antibody was detected by incubation
with the relevant secondary antibody for 60 min at RT on a shaker. Membranes were
washed and developed by enhanced chemiluminescence, using Eel Plus™ (Amersham
Biosciences, UK) for 5 minutes then exposed to X-ray films (KODAK scientific imaging
film, X-OMAT AR) in a dark room for 2 minutes and 10 minutes. Molecular weights of
products were compared with Precision Plus molecular weight markers (Bio-Rad, UK) and
recombinant human cytokine controls.
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Table 3.5 Primary antibodies used in Western blotting experiments.
Antibody Manufacturer Source Concentration
R&D
Anti-IL-17 BAF 317 Goat Polyclonal 0.5.ug/ml
R&D
Anti-IL-18 MAB318 Mouse monoclonal l zzg/ml
R&D
Anti-IL-18Ra MAB 840 Mouse monoclonal 0.5.ug/ml
R&D
Anti-IL-18BPa AF 119 Goat monoclonal 0.2.ug/ml
R&D
Anti-RANKL MAB626 Mouse monoclonal 1 .ug/ml
R&D
Anti-OPG AF805 Goat 0.I.ug/ml
Delta Biolabs
Anti-NFKB p65 DB033 Rabbit 0.2.ug/ml
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Table 3.6 Secondary antibodies and controls used for IHC and Western blotting.
Secondary Working
Antibody Manufacturer Source Dilution
Biotinylated Vector Laboratories
anti-Goat BA-5000 Rabbit 1:200
Biotinylated Vector Laboratories
anti-Mouse BA-2000 Horse 1:200
Biotinylated Vector Laboratories
anti-Rabbit BA-IOOO Goat 1:200
Biotinylated Vector Laboratories
anti-Rat BA-4000 Horse 1:200
DakoCytomation
IgGI X0931 Mouse monoclonal 1:6
Anti-Mouse
HRP Amersham Biosciences Sheep 1:5000
Anti-Goat
HRP Amersham Biosciences Donkey I: 10000
Anti-Rabbit
HRP Amersham Biosciences Donkey 1:5000
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3.2.4 PRO tissue explant culture
3.2.4.1 Patient recruitmentfor explant culture
Specimens were obtained from consecutive patients undergoing periradicular surgery with
local anaesthesia by the author within the Department of Restorative Dentistry or routine
dental extractions within the Oral Surgery Department, University of Glasgow Dental
School and Hospital. Patients were in good health and not taking long-term medication for
chronic conditions. A total of 310 specimens were collected for tissue explant culture.
Tissue biopsies were collected from 181 male patients (age range 9 to 76, mean 35) and
129 female patients (age range 11 to 70, mean 39). Specimens were collected in DMEM on
ice and used in explant culture experiments within three hours. Periradicular tissues
obtained upon dental extraction were carefully dissected off the dental root apex with a
sterile Swan-Morton1\' scalpel (Swann Morton, Sheffield, UK). Care was taken to avoid
contamination from adjacent periodontal ligament cells or attached periodontal tissue
(Figures 3.1 and 3.2). PRO tissues were stored in DMEM on ice until explant culture
experiments.
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Figure 3.1 Figure of periradicular lesion attached to root apex of extracted tooth.
Figure 3.2 Figure of dissected PRD lesion detached from root apex.
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3.2.4.2 Preparation ofexplant specimens
Freshly collected PRD tissue was weighed, minced with a sterile scalpel in a Class II
Safety cabinet (Microflow, Bioquell UK Limited) and divided into separate pieces. The
tissue architecture of the PRO lesion is not well structured. In contrast, it consists of
discrete localised areas of acute inflammation that are dispersed throughout the lesion.
Therefore. to ensure an even distribution of inflammatory cell components between
individual explant plates, PRO lesions were minced for explant experiments with a sterile
Swan-Morton" scalpel. Subsequently, explant tissues were cultured in 290,u1 DMEM in 24
well flat-bottomed Cellstar:)i) plates (Greiner Labortechnik, UK). Explant tissues were
stimulated with LPS, SEB, IgO (Sigma, UK), IL-IO, IL-12, IL-15, IL-17, TNF-a, IFN-y
(PeproTech EC). TOF~I' MCSF, IL-18, IL-22 and/or anti-IL-18 and/or antiST2 (R&O
Systems) at concentrations detailed in Table 3.7. One well with unstimulated. matched
explant tissue served as a control in each experiment. The addition of IgO to an initial
series of explant cultures served as further control. Having established that control IgO had
no impact upon explant tissue cytokine expression. the addition of IgO was not used in
subsequent experiments due to the small volume of tissue available for explant culture. In
addition to unstimulated and IgO controls, immunostaining was also performed on 5
tissues to assess the cellular composition after culture. After 18 to 72 h incubation at 37°C
in a humidified atmosphere of 5% C02/ 95% air, the explant culture was centrifuged, the
cell-free supernatant collected and stored at -20°C until analysis by ELISA. The numbers
of explant cultures used for each cytokine analysed after mitogenic or cytokine challenge is
detailed in Table 3.8 and Table 3.9.
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Table 3.7 Mitogens, recombinant human proteins and antibodies used within
PRD explant, PDMC and fibroblast cultures.
MOIETY SOURCE CONCENTRA TION ORIGIN kDa
LPS Sigma l,ug/mt E-Coti -
L4391
SED Sigma 10 ng/rnl - -
S0812
SAC Sigma 1 mg/rnl Staphylococcus -
aureus Cowan
strain
PHA Sigma 5,ug/mt - -
IL-IO Pepro Tech EC 20 ng/ml - 18.6
200-10
IL-12 R&D 10 ng/ml - 75
219-IL
IL-15 Pepro Tech EC 50 ng/rnl - 12.9
200-15
IL-17A PeproTech EC 50 ng/ml - 15.5
200-17
11-18 R&D 100 ng/rnl - 18
IL-22 R&D 10 ng/rnl - 16.5
782-IL
IFN-y R&D 5 ng/rnl - 17
MAB28S
TNF-a PeproTech EC 0.1 ng/ml - 17.5
200-10
MCSF R&D 1.5 ng/ml - 18.5
216-MC
TGF-pl R&D 2 ng/ml - 25
240-B
Anti IL-18 R&D 1,ug/ml mouse -
MAB 318
Anti IL- R&D l zzg/ml mouse -
12RPI MAB839
OPG PeproTech EC 100 ng/ml - 19.9
450-14
RANKL PeproTech EC 100 ng/rnl - 20.0
310-01
IgG Sigma 1 rng/ml mouse -
5381
Anti ST2 R&D 1 ,ug/ml mouse -
MAB523
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3.2.4.3 Peripheral blood cell separation
In addition to unstimulated internal control cultures in fibroblast and tissue explant culture
experiments, peripheral blood monocytes (PBMC) were collected from 20 healthy
volunteers (8 male, 12 female) as a further control. Wash media was prepared from RPMl
containing amphotericin, streptomycin, L-glutamine and penicillin (all Sigma). 25 ml of
peripheral blood was collected by venepuncture from the anticubital fossa of volunteers in
sodium heparinised Vacutainer® tubes (Becton Dickson, UK). Blood, diluted with an equal
volume of RPM!, was carefully layered onto 10 ml Histopaque'"-1077 (Sigma, Poole,
Dorset, UK) and centrifuged at 350 g for 25 minutes to allow separation of blood into its
component layers. Following centrifugation, the interface containing peripheral blood
mononuclear cells (PBMC) was carefully removed using a sterile Pasteur pipette and
placed in a separate universal container. This PBMC suspension was further washed three
times with fresh RPMI to obtain a pure pellet of PBMC and cells were suspended in RPMII
10% (v/v) heat-inactivated FCS.
Cell numbers were calculated from a 1 in 10 dilution of the cell suspension in cell counting
fluid by placing 10 ,lil of this fluid on a haemocytometer (Weber, England) under a
coverslip. Using a light microscope, the number of live cells was counted over 16 squares
and averaged over four quadrants. The number was multiplied by the dilution factor of 10
and then multiplied by the volume of the suspension to give the total number of cells. The
suspension was then adjusted to 1x 106 viable cells/ml and cells were cultured in flat-
bottomed 24 well Cellstar® plates (Greiner Bio-One GmbH, Germany) with RPMI and
10% FCS. Cells were stimulated with cytokines and mitogens (for concentrations see
Table 3.7) for 18 h at 37°C in a humidified incubator with 5%C02/95%02. After 24 h, cell-
free supernatants were harvested and stored at -70°C until analysis by ELISA.
3.2.4.4 Whole blood cultures
As a further control to culture experiments, whole blood was collected from 20 healthy
human volunteers (8 male, 12 female) by venepuncture from the anticubital fossa in
heparinised Vacutainer® tubes. Whole blood was diluted by one third with RPMI,
containing amphotericin, streptomycin, L-glutamine and penicillin (all Sigma) and without
FCS.
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Whole blood cell samples were cultured in tlat-bottomed 24 well Cellstar" plates (Greiner
Bio-One Grnbl-I, Germany) in RPM!. Cultures were stimulated with equivalent cytokine
concentrations as PMBC culture controls (for concentrations sec Table 3.7) for 18 h at
37"C in a humidified incubator in 5%C02/95%02. After 18 h, whole blood supernatants
were spun down at 12, OOOgfor 10 minutes, the cell-free supernatant harvested and stored
at -70"C until analysis by ELISA.
3.2.5 Fibroblast cultures
3. 2. 5.1 Cell culture
PRO tissue was carefully dissected from the root apex with a sterile Swan-Morton" scalpel
as previously described for tissue explant cultures to avoid contamination with POL
fibroblasts. PRO tissue was subsequently minced and placed in OM EM supplemented with
10% FCS, penicillin! streptomycin! amphotericin in T25 Cellstar" flasks (Greiner Bio-One
GmbH. Germany) and placed in a humidified 5% CO2 incubator at 37"C. Fibroblasts were
allowed to outgrow from the PRO tissue fragments over a three-week period and the
culture medium changed every 3-4 days. At sub-confluence, fibroblasts were washed twice
with PBS then detached with 0.025% trypsin and 0.05% EDTA (Sigma, Poole. UK) at
37"C for 5 min and seeded into a T75 Cellstar" flask (Greiner Bio-One GmbH. Germany).
Once PRO fibroblasts had reached 80% confluence, this procedure was repeated and all
fibroblasts cultures were then used for experiments at passage 3-4. Prior to experiments.
contluent fibroblast cultures were grown in reduced serum for 24 hours and experiments
were performed in serum free media. For all cell culture experiments, cell counts and cell
viability were assessed by trypan blue dye exclusions. Cell numbers were calculated from a
1 in 10 dilution of the cell suspension in Trypan blue (Sigma) cell counting fluid and
placing IO.u1 of this on a haemocytometer as previously described.
3.2.5.2 Analysis ofcytokinesfrom resting PRDfihrohlas/s
Culture supernatant was collected at a variety of time points from unstimulated fibroblast
cultures and spun down to remove non-adherent cellular debris. Supernatant was
immediately frozen and stored at -20"C until analysis. Supernatants were analysed for
cytokine levels by ELISA. For Western Blots. protein lysates were obtained from the cell
pellet as described in 3.2.3.1.
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32.5.3 Mitogenic stimulation of Plcirfibroblast cultures
Confluent fibroblast cultures in T75 flasks were stimulated by mitogens or cytokincs at
concentrations described in Table 3.7. Following mitogenic stimulation. culture
supernatant was collected at a variety of time points and spun down to remove non-
adherent cellular debris. Supernatant was immediately frozen and stored at -20°C until
analysis. Supernatants were analysed for cytokine levels by ELISA.
3. 2. 5 . ./ Microhial infection of PRD/ihrohlast cultures
The bacterial strains tested came from culture collections of Fusobacterium nucleatum
(ATCC 25586). the gram negative rod Prevotella intermedia (ATCC 25611) and
Peptostreptococcus micros (NCTC 11808). Bacterial strains were maintained in brain-
heart infusion agar plates. prereduced anaerobically, sterilised and supplemented with
hemin (5 mg/l) for anaerobes. Plates were incubated in anaerobic conditions (80%
nitrogen, 10% carbon dioxide and 10% hydrogen) in a Don Whitley MK 3 anearobic
chamber at 37°C (Don Whitley Scientific Services. Shipley, UK). After five days growth.
bacteria were removed from the agar plates with sterile cotton tipped applicator stick and
placed in PBS. Bacterial suspensions were obtained by centrifugation at 3000 g for 15
minutes. washing three times in PBS and finally resuspended in PBS. The density of the
live F. nucleatum. P. intermedia and P. micros prepared inoculum was measured
spectrophotometrically (Dynex Technologies MRXII) and subsequently adjusted to a
turbidity of 2 McFarland standard (6 x 108 CFU/ml). Live cells were washed a further
twice in PBS solution and then added at this concentration to fibroblast cultures in T-75
tlasks. Fibroblasts were used at passage 3-4 in serum free media without the addition of
antibiotics or antifungals. After culture at the specified time intervals, the supernatant was
collected, centrifuged and stored at -70"C until analysis by ELISA.
3.2.6 Enzyme Linked Imrnonosorbent Assays (ELISA)
Explant culture and fibroblast culture supernatants were analysed by ELISA for IL-Ilt IL-
4, IL-6, It-S. IL-IO, It-12, TNF-u, IFN-y (Cytosets, Biosource International), IL-18
(Bender MedSystems l.td.). IL-17 A, RANKL (Pcpro Tech Fe) and OPG (R&D, Duoset).
96 well Immulon-4 HBX rnicrotiter plates (Dynex. Basingstoke, UK) were incubated
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overnight with 100,u1 capture Ab at 3"C. Following four washes with PBS/ 0_()5%Twcen-
20, non-specific protein sites within wells were blocked with 300 ,ul PBS/ O.5%BSA or as
otherwise directed by the manufacturer overnight at 3"C. After four further washes with
PBS/ 0.05% Tween-20. 50 ,ul of standards or supernatant samples were incubated with
relevant biotinylated, capture Ab or as directed by the manufacturer at RT on a shaker for 2
h. Streptavidin-HRP was added after thorough washing with PBST and incubated for 45
min at RT. Colour was developed with tetramethyl benzidine (TMB) and the reaction
stopped with 0.2M H2S04. Absorbency was determined at 450 nm (reference filter 600
nm) on a microplate plate reader (Dynex Technologies MRXlI). Cytokine concentrations
(pg/ml) were calculated with reference to a standard curve, established by serial 1:2
dilutions of standard concentration as detailed in Table 3.10.
3.2.7 Statistical analysis
Supernatant cytokine concentrations were compared usmg Student's Hest for each
stimulated culture against corresponding paired non-stimulated control (significant results
of p:<s0.05are marked *, results of p:<sO.Olare indicated **). In addition to comparison of
paired specimens, Mann-Whitney U test was used to compare stimulated culture
supernatant cytokine concentrations with whole population controls tor each cytokine
assayed (significant results are marked +). Analysis was undertaken using Minitab
Software (Minitab Inc, USA). P values of <0.05 were considered significant, otherwise not
significant (NS). Results are represented as means ± SEM. Additive cytokine effects are
desribed in the context of the combination of cytokines inducing the sum of their
individual effects, Synergistic effects are described when the combined effect(s) is
significantly greater than the sum effect of individual cytokines.
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Table 3.10 Details of ELISA used in culture experiments.
Analyte Measured Source Detection Range Sensitivity
Biosource, 31.25-2000 pg/rnl >2 pg/ml
IL-l~ CytoSets
Biosource, 31.25-2000 pg/ml >5 pg/ml
IL-4 CytoSets
Biosource, 31.25-2000 pg/ml >2 pg/rnl
IL-6 CytoSets
Biosource, 31.25-2000 pg/ml >7pg/m!
IL-8 CytoSets
Biosource, 31.25-2000 pg/ml >10 pg/ml
IL-I0 CytoSets
Biosource, 31.25-2000 pg/rnl >2 pg/rnl
IL-12p40 CytoSets
Pepro Tech EC 31.25-2000 pg/rnl >10 pg/ml
IL-17A
Bender 78.1-5000 pg/ml >55pg/ml
IL-18 MedSystems
Biosource. 31.25-2000 pg/ml >4 pg/ml
IFN-y CytoSets
Biosource, 31.25-2000 pg/ml >3 pg/ml
TNF-a CytoSets
PeproTech EC 31.25-2000 pg/ml >IOpg/ml
RANKL ~-- ----
R&D Systems. 78.1-5000 pg/ml >70pg/ml
OPO Duoset
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3.3 General solutions and chemicals
Phosphate Buffered Saline 2.51, lOX, pH, 7.5
NaCl 200g
Na2HP042H20 3S.Sg
KCL Sg
Sg
to 2.SL
Trypsin solution 0.1%, 11,pH 7.35
Trypsin lg
Glucose Ig
1% phenol red solution l.Sml
dH20 to IL
Ethylenediamine tertraacetate, EDTA (Versene), pH 7.35
EDT A tetrasodium salt
PBS
IOOmg
SOOml
Electrophoresis Transfer buffer, pH 8.0
Methanol 800ml
Tris Base 20mM 12.1g
Glycine S7.6g
dH20 to 4L
Tris Buffered Saline/ Tween, pH 8.0
Tris HCL 10mM pH 8.0
NaCl1S0mM
Tween 20. O.OS%
dfbO
40 ml of 1M
120mlofSM
2ml
to 4L
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Electrophoresis Buffer, 5X
Tris Base
Glycine
SOS
dH20
15.1g
72g
5g
to 1L
Sample Buffer
dH20 4ml
TrisCI 0.5M pH6.0 l ml
Glycerol 0.8ml
10% SOS 1.6ml
2 Mertcaptoethanol OAml
Bromophenol Blue 0.1% 0.2ml
RIP A Buffer stock solution, pH 7.4
Tris base 790g
dH20 75ml
NaCI 900g
10% NP-40 10ml
10% Na-deoxycholate 2.5ml
EOTA 100mM Iml
RIPA Buffer working solution
RIPA Buffer stock solution l ml
OTT ImM 1111
PM SF 200mM 5111
Aprotinin lOug/rnl 1111
Pepstatin lug/ml 1111
Leupeptin I ug/rnl 1111
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A NOVEL EX-VIVO
HUMAN PRD EXPLANT CULTURE MODEL
TO INVESTIGATE
CYTOKINE REGULATION
IN-VITRO
4 A NOVEL EX-VIVO HUMAN PRO EXPLANT CULTURE MODEL
TO INVESTIGATE CYTOKINE REGULATION IN VITRO
4.1 Introduction
The host immune response to microbial challenge of the dental pulp and the subsequent
infiltration of pathogens and their associated PAMPS into the periradicular tissue is central
to the pathogenesis of human periradicular disease (Marton and Kiss 2000). Infiltration of
bacteria into the dental root canal leads to the stimulation of macrophages and fibroblasts
resident within the surrounding periradicular bone. Activation of these local cell
populations leads to the concomitant recruitment of macrophages and monocytes into the
periradicular site (Kawashima et al. 1996). Considerable data support the hypothesis that
cytokines orchestrate the complex processes underlying this prevalent human
inflammatory disease. Several studies have identified the expression of significant
quantities of cytokines and chemokines within the PRD lesion. including TNF-a, IL-1-~.
IL-6 and IL-8 (Meghji et al. 1989, Artese et al. 1991, Safavi and Rossomando 1991,
Barkhordar et a/. 1992. Formigli et al. 1995, Meghji et al. 1996, Takeichi et al. 1996.
Honma et al. 1998).
To date. the rat! murine pulp exposure model has imparted the majority of findings on the
involvement of the cytokine network within PRO. These animal experiments clearly
demonstrate the relevance of the host immune response in the initiation and progression of
PRD (Stashenko et al. 1998). In contrast, few studies have investigated the role of the host
immune response and its relationship to root canal treatment success within humans. This
is surprising given that the patient's non-specific immune response may represent the most
significant predictor for root canal treatment outcome (Marending et al. 2005). Indeed, a
variety of patient-dependent factors influence the successful outcome of root canal
treatment. These include patient gender, pulp diagnosis, periapical diagnosis. the size and
the presence of an existing periradicular lesion and/ or a sinus tract (Chugal et al. 2(01). Of
all these factors, the presence and size of the PRO lesion is the strongest predictor of
treatment outcome (Chugal et al. 2001). It therefore seems remarkable that only a small
number of published studies have analysed functional immunological components of the
human PRO lesion in vitro. ex vivo.
Human explant tissue cultures provide useful models in which to study human tissue in
vitro, ex vivo. This methodology enables functional experiments to be undertaken on tissue
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that preserves its inflammatory constituents. Explant cultures have been used extensively
within immunologic research to investigate the effects of mitogenic and cytokine
stimulation upon the release of inflammatory mediators (Monteleone et al. 1999, Dionne et
al. 2003, Zhao et al. 2004 and Maerten et al. 2004). By using such experimental
techniques, the inflammatory and immune responses of diseased tissue to specific
aetiological pathogens and inflammatory agents can be elucidated in vitro, ex vivo. In
contrast to cell culture experiments, explant cultures allow the complex interaction
between the many cellular components of the disease process to be studied. Development
of human explant culture models thereby reduces the absolute reliance upon animal
experimentation.
The concentrations of a limited number of secreted inflammatory mediators have been
analysed from human explant PRO tissue (Danin et al. 2003). The capacity for
unstimulated PRO explant tissues to produce immunoglobulins has previously been
examined (Baumgartner and Falkler 1991a, Baumgartner and Falkler 1991 b). Furthermore,
the specificity of these secreted antibodies to specific endodontic pathogenic bacteria has
been investigated (Baumgartner and Falkler 1991c, Kettering et al. 1991). However, no
studies have investigated the functional effects of stimuli upon PRO explant tissue cultures
and the capacity of inflammatory mediators to modulate the expression of endogenous
mediators.
Within PRO tissues, endotoxin concentrations are reported to correlate with inflammatory
levels (Schonfield et al. 1982). Although LPS levels are significantly raised within the
PRO lesion, it is suggested that LPS has minimal direct bone resorbing capacity. Instead,
LPS appears to exert its bone destructive effects through the induction of proinflammatory
cytokines (Wang & Stashenko 1993). It is therefore surprising that the effects of Gram-
negative endotoxins or Gram-positive exotoxins upon inflammatory mediator expression
within human PRO have not been explored. An appropriate combination of cytokines and
immunocompetent cells is essential for the host to mount a successful immune response.
Therefore, the identification of novel inflammatory mediators within the PRO lesion and
the nature of their involvement in the inflammatory reaction is of considerable importance.
I therefore investigated if PRD tissue would serve as a useful human tissue explant model
with which to explore the cytokine network. Furthermore, I investigated the effects of
PAMPS upon cytokine responses within PRD tissue ex-vivo, which likely reflects
processes involved in perpetuation of the PRO lesion in vivo.
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4.2 Endogenous cytokine expression within unstimulated human PRD tissue
explant cultures
In order to gain a better understanding of cellular-derived events occurring within chronic
PRO, I first established a novel human PRD tissue explant culture system. Fresh PRD
tissue was obtained from patients sequentially undergoing peri radicular surgery or routine
dental extractions (described in section 3.2.4.1). Harvested tissue and/ or its culture
supernatant were analysed either at the time of collection or at one of several time points
during tissue culture as indicated (Figure 4.1). PRO explant tissue was initially assessed to
determine its potential as an in vitro, ex-vivo human tissue explant model in which to
investigate the cytokine network within chronic inflammatory disease. I therefore cultured
human PRD tissue explants for 18 and 72 h to analyse the spontaneous expression of a
panel of cytokines that are central to inflammatory responses.
Cytokine concentrations within culture supernatants from unstimulated human PRD
explant tissue were measured by ELISA (described in chapter 3.2.6). After 18 h culture,
'resting' PRD explant tissues consistently expressed high levels of proinflammatory
cytokines. Conversely, concentrations of prototypical anti-inflammatory cytokines such as
IL-4 were low or not detectable (Figure 4.2A). Furthermore, substantial proinflammatory
cytokine release from resting PRD explant tissue was observed within supernatants after 72
h culture (Figure 4.2B). The inherent production of inflammatory cytokines without any
stimulation suggested that the PRD tissues were highly immunologically active. This was
further confirmed by analysing NF-KB expression, which was readily detectable within the
lesions using Western blots (Figure 4.2C)
Importantly, IL-4 was barely detectable within unstimulated explant culture supernatants at
either 18 h or 72 h (n=30). Indeed, IL-4 protein expression was not inducible by either
mitogenic or cytokine stimulation of explant tissue in subsequent experiments. The
expression of IL-4 was therefore not included in any further analysis of PRD tissues.
152
Figure 4.1 Development of a novel PRD explant culture system. Diagrammatic
representation of the source of human PRD tissue and the laboratory experiments
performed on the collected tissue and! or culture supernatant. Tissue culture supernatant
was harvested after 18 h or 72 h of culture for explant experiments.
WESTERN
BLOT
18 h
QPCR
1 ELISA
IHC
TIME
POINT
RT-PCR Oh
MULTIPLEX 72 h
153
Figure 4.2 Development of a novel human PRD explant culture system. 'Resting'
levels of spontaneously released cytokines within PRO tissue explant culture supernatants
were assessed. Unstimulated PRO explant tissue culture supernatant was harvested (A) at
18 h and (B) at 72 h. The expression of a panel of cytokines was analysed by ELISA. Bars
represent the mean concentration for each cytokine and the standard error of the mean. The
number of unstimulated PRO tissues from individual donors used in experiments for the
measurement of each individual cytokine is given in parenthesis. (C) Western blot for
detection ofNF-KB expression within PRO tissues. Four PRO specimens representative of
12 specimens analysed.
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4.3 In vitro effects of Gram-negative mitogens upon endogenous cytokine
expression within human PRD tissue explant cultures
Using ELISA, the previous experiments established that unstimulated ex-vivo PRO tissue
spontaneously expressed detectable levels of cytokines for up to 72 h culture. I therefore
undertook a further series of experiments to determine if this novel explant culture
methodology could be utilised to investigate functional tissue responses in vitro. The
effects of pro- and anti-inflammatory stimuli upon endogenous cytokine expression were
therefore studied within the PRO explant system. Each PRD tissue biopsy was weighed,
minced and divided into separate tissue culture wells for culture (described in 3.2.4.2).
Human explant tissues were stimulated with a panel of mitogens (for concentrations see
Table 3.7). Culture supernatants were harvested at 18 h and/ or 72 h as indicated in
subsequent figures and analysed by ELISA. In each explant experiment, one well with
unstimulated matched explant tissue served as control. An initial series of experiments
established that the addition of IgG, serving as control, had no modulating effect on the
cytokine expression being analysed. Due to the small volume of tissue available for each
individual explant culture experiment, IgG was not used in subsequent experiments.
To reflect the likely bacterial aetiology of PRO, explant tissues were stimulated with
Gram-positive or Gram-negative derived moieties (for concentrations see table 3.7).
Initially, I undertook experiments to determine if bacterial derived mitogens had any
modulatory effects upon cytokine expression within 18 h explant tissue cultures. As LPS
has been observed at high levels within the PRO lesion, I firstly investigated its effects
upon a panel of key cytokine inflammatory mediators at 18 h tissue culture. In addition to
the unstimulated explant tissue controls, the addition of LPS to PBMC and whole blood
cell cultures served as further controls.
At 18 h culture, the addition of LPS to human PRD tissue explant cultures resulted in
substantially increased levels of the proinflammatory cytokines IL-I p (p=O.046) and IFN-y
(p=O.032) (Figure 4.3A and B). Furthermore, LPS promoted a moderate increase in the
expression of TNF-a (p=O.02) and IL- IO (p=O.046) that were at levels of statistical
significance. The addition of LPS to PRO explants had no observable effect upon the
expression of IL-6, IL-8 or IL-17 A at 18 h culture compared with paired unstimulated
control tissues. The order from greatest to least increase for LPS-induced cytokine
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expression was IL-l~. IFN-y. IL-IO. TNF-a. and a minimal. non-significant increase in IL-
17A.
Having determined that functional responses of a significant nature were detectable within
PRO tissue explant cultures at 18 h. I next undertook a series of experiments to determine
if these effects were sustained over longer-term culture. Explant tissue cultures were
therefore maintained for 72 h with LPS and the supernatant harvested and subsequently
analysed by ELISA for the quantitative expression of endogenous secreted cytokines. After
72 h culture. the expression of IFN-y (p=0.004) was substantially increased by the addition
of LPS to PRO tissue explants (Figure 4.5A and B). LPS also induced a moderate increase
in TNF-a (p=0.013) expression. which was at levels of significance. LPS-induced
expression of IL-l ~ (p=O.O17) at 72 h culture was minor. although at a level of statistical
significance. The increase in IL-l p expression was markedly lower than that observed at
18 h culture. The addition of LPS to 72 h cultures produced only a minor increase in IL-I 0
(p=O.OI) expression, although this was at a level of statistical significance. In contrast. 72 h
tissue explant culture with LPS resulted in a modest reduction of IL-8 (p=0.0176)
expression. that reached levels of statistical significance. Compared with corresponding
matched unstimulated control tissues LPS had no observable effect upon IL-6 or IL-17 A
expression at 72 h culture.
It can clearly be seen from Figure 4.5C that LPS substantially up-regulated IFN-y
expression. Furthermore the effect of LPS-induced IFN-y expression occurred in a steady
manner throughout the period of culture to 72 h. LPS also induced moderate levels of
TNF-a throughout the culture period to 72 h. although this was not as marked as the effect
upon IFN-y. Interestingly, LPS induced a substantial increase in the expression of lL-l ~ at
18 h, which was as great as that of IFN-y. Nevertheless. increased lL-Ij3 levels were not
sustained over longer-term culture. This may be the result of endogenous enzymatic
cleavage of lL-1 p over longer culture conditions. In 18 h PBMC control cultures, LPS
induced significant increases in the pro inflammatory cytokines IL-Ip. IL-6. IL-8. IL-12
and TNF-a and the anti-inflammatory cytokine IL-IO (Figure 4.4A and B). The pattern of
increased cytokine expression in PBMC controls and absence of an effect upon IFN-y at 18
h is in accordance with others (lwadou et af. 2002).
The cellular composition of the PRO lesion was examined by IHC experiments to identify
potential cellular sources of these inflammatory cytokines (Figure 4.9).
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Figure 4.3 In vitro effects of 18 h Gram-negative-derived mitogenic stimulation upon
cytokine expression within PRD tissue explants. PRD explant tissues were stimulated
with LPS for 18 h and supernatant collected and analysed by ELISA for a panel of
cytokines. (A) The mean concentration of each cytokine after LPS stimulation of explants
compared with their corresponding unstimulated controls. (B) The percentage change in
culture supernatant cytokine concentration between LPS stimulated and unstimulated
paired control tissues. The number of PRD tissues used in experiments for the
measurement of each individual cytokine is given in parenthesis. Bars represent the mean
concentration for each cytokine and the standard error of the mean.
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Figure 4.4 In vitro effects of 18 h LPS stimulation upon cytokine expression within
PBMC and whole blood cell cultures. CA) The mean concentration of cytokines after LPS
stimulation compared with unstimulated control in 18 h PBMC cultures. (B) The mean
concentration of cytokines after LPS stimulation compared with unstimulated control in 18
h whole blood cell cultures. The total number of separate patient derived cultures
stimulated with LPS is given in parenthesis. Bars represent the mean cytokine
concentration with the standard error of the mean.
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Figure 4.5 Effects of 72 h Gram-negative mitogenic stimulation upon PRD tissue
explant cytokine expression. PRD explant tissues were stimulated with LPS for 72 h and
supernatant collected and analysed by ELISA for a panel of cytokines. CA) The mean
concentration of each cytokine after LPS stimulation of explants compared with their
matched unstimulated controls. (B) The percentage change in culture supernatant cytokine
concentration between LPS stimulated and unstimulated paired control tissues. (C) Time-
line chart representing percentage changes of each analysed cytokine compared with
unstimulated control over full period of culture with LPS stimulation. The number of PRD
tissues used in experiments for the measurement of each individual cytokine is given in
parenthesis. Bars represent the mean concentration for each cytokine and the standard error
of the mean.
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4.4 In vitro effects of Gram-positive-derived moieties upon endogenous cytokine
expression within human PRD tissue explant cultures
The previous experiments clearly established that in response to Gram-negative mitogenic
stimulation, functional cellular responses could be elucidated from the PRO tissue explants
cultured to 72 h. In addition to Gram-negative micro-organisms, Gram-positive bacteria
are implicated in the perpetuation of chronic PRO. Indeed, they are frequently isolated in
greater numbers than Gram-negative bacteria from the root canals of teeth associated with
PRO lesions or failed root canal treatment. Therefore, I next investigated Gram-positive
dependent responses within this novel explant culture system. PRO explant tissue cultures
were initially stimulated with SEB for a culture period of 18 h (tor concentration see Table
3.7). The addition of SEB to PRO explants resulted in a substantial increase in the
supernatant concentration of IFN-y (p=O.OOI) at 18 h culture (Figure 4.6A and B). The
addition of SEB to PRO explants at 18 h culture also markedly increased the expression of
IL-17A (p=O.023) and TNF-u (p=O.Ol). These results presumably reflect a predominant T
cell-mediated response as SEB is a superantigen acting via TCR Vll8 MHC class-Il cross
linking. There was no observed effect of SEB upon IL-6 or IL-8 expression at 18 h culture
and only modest (non-significant) increases in IL-l p (p=O.117) and IL-I O. Possible cellular
sources of cytokines within PRO are shown in Figure 4.9.
SEB increased the endogenous expression of several critical proinflammatory cytokines
during 18 h explant culture. Therefore, I further explored the effect of SEB addition to
tissue explants over 72 h tissue culture. At 72 h culture, the addition of SEB to PRO tissue
explants resulted in substantial increases of IL-IP (p=O.OII) and IFN-y (p=O.004) at
statistically significant levels (Figure 4.7 A, B). Furthermore, SEB stimulation over 72 h
culture resulted in significantly increased expression of IL-17 A (p=O.027) and TNF-u
(p=O.O1). 72 h explant culture with SEB induced only a modest increase in IL-IO
(p=O.096) expression. No observable biological effect upon IL-6 or IL-8 (p=O.138)
secretion was detected after 72 h explant culture with SEB. These experiments established
that SEB was capable of markedly increasing prointlammatory mediators within the novel
explant culture system. Therefore. Iadditionally investigated the effects of an intact Gram-
positive agent, namely S. aureus (Cowan Strain, SAC) within this tissue culture model. In
a similar manner to SEB, the addition of SAC to 18 h explant cultures resulted In
substantially increased levels of IFN-y expression and significantly increased secretion of
TNF-a (p=O.005) (Figure 4.8A, B). The addition of SAC to the tissue explants had no
observable effect upon IL-6 secretion.
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Figure 4.6 In vitro effects of the addition of Gram-positive-derived moieties upon
cytokine expression within 18 h PRD tissue explant cultures. PRD explant tissues were
stimulated with SEB for 18 h and supernatant collected and analysed by ELISA for a panel
of cytokines. (A) The mean concentration of each cytokine after SEB stimulation of
explants compared with their corresponding unstimulated controls. (B) The percentage
change in culture supernatant cytokine concentration between SEB stimulated and
unstimulated paired control tissues. The number of PRD tissues used in experiments for the
measurement of each individual cytokine is given in parenthesis. Bars represent the mean
concentration for each cytokine and the standard error of the mean.
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Figure 4.7 In vitro effects of the addition of Gram-positive-derived moieties upon
cytokine expression within 72 h PRD tissue explant cultures. PRD explant tissues were
stimulated with SEB for 72 h and supernatant collected and analysed by ELISA for a panel
of cytokines. (A) The mean concentration of each cytokine after SEB stimulation of
explants compared with their corresponding unstimulated controls. (B) The percentage
change in culture supernatant cytokine concentration between SEB stimulated and
unstimulated paired control tissues. (C) Time-line chart representing percentage changes
for each analysed cytokine compared with unstimulated control over full period of culture
with SEB stimulation. The number of PRD tissues used in experiments for the
measurement of each cytokine is given in parenthesis. Bars represent the mean
concentration for each cytokine and the standard error of the mean.
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Figure 4.8 In vitro effects of the addition of the Gram-positive-derived mitogen SAC
upon cytokine expression within 18 h PRD tissue explant cultures. PRD explant tissues
were stimulated with SAC for 18 h and supernatant collected and analysed by ELISA. (A)
The mean concentration of each analyte after SAC stimulation compared with
unstimulated control. (B) The percentage change in culture supernatant cytokine
concentration between SAC stimulated and unstimulated control tissues. The number of
PRD tissues used in experiments for the measurement of each cytokine is given in
parenthesis. Bars represent the mean concentration for each cytokine with the standard
error of the mean.
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Figure 4.9 Potential ceUular sources of secreted cytokines within PRD. Representative
pictures of immunohistochemistry experiments undertaken upon 25 PRD biopsy
specimens, tissues counterstained with H&E. (A) CD20+B cells. (B) Neutrophils identified
by anti-human neutrophil defensins. (C) Mast cells identified by anti-mast cell tryptase.
(D) NK T cells identified by anti-CD57. (E) Cellular staining positive for CD25. (F)
CD68+ macrophages. (G) PRD fibroblasts. (H) CD3+ T celis, no counterstain. Arrows
identify examples of positively stained cells.
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4.5 Regulation of cellular responses to pathogenic moieties
Having observed that the PRO tissue explants were responsive to Gram-negative and
Gram-positive moieties, I next investigated if gene expression for Toll-like receptors was
present within the tissue explants. Explant cultures were stimulated with either SEB or LPS
for 18 h and tissue collected and analysed by real-time Pf.R for mRNA expression of TLR-
1, -2, -4 and --6. Expression for all four TLR mRNA was detectable within both
unstimulated control tissue and mitogen stimulated explants (Figure 4.10). However, the
use of only two PRO tissue specimens does not allow for any detailed analysis.
Nevertheless, these data establish that TLR expression is present within PRO and that the
tissue is responsive to mitogenic stimuli. However, further studies are necessary to
elucidate through which TLR pathways endodontic-derived PAMPs exert their
inflammatory effects within the PRO lesion.
LPS activates macrophages VIa TLR, inducing the production of proinflammatory
cytokines including IL-I ~ and TNF-a, thereby activating fibroblasts and other cell types to
produce Tl/ST2. Subsequently, ST2 binds to macrophages and selectively represses the
expression of several proinflammatory cytokines including IL-6, IL-I2, IFN-y and TNF-a
(Sweet et af. 2001). Tl IST2 may therefore provide an effective endogenous mechanism to
regulate the inflammatory response through its interaction with macrophages (Sweet et al.
2001). Therefore, I examined the effects of the addition of an ST2 neutralising antibody
upon cytokine expression within the PRO explant cultures. However, neutralisation of ST2
in the PRO tissue cultures had no effect upon the expression of IL-6, IL-IO, IL-I7 A, IFN-y
or TNF-a (Figure 4.11). The addition of anti-ST2 concomitant with LPS to PRO explants
also had no effect upon the expression of these cytokines. Further studies are necessary to
elucidate the expression of ST2 within the PRO lesion and define its relevance to the
inflammatory disease process.
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Figure 4.10 In vitro effects of mitogenic stimulation upon mRNA TLR expression
within 18 h PRD tissue explant cultures. PRD tissue explants were stimulated with LPS
or SEB for 18 h. Stimulated and unstimulated matched control tissues were subsequently
analysed by real-time peR for TLR mRNA expression. Bars represent relative mRNA
expression between all analysed samples after normalisation to GAPDH. Experiments are
representative of two PRD explant culture experiments.
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Figure 4.11 In vitro effects of the addition of neutralising antibody to ST2 upon
cytokine expression within PRD tissue explant cultures. Anti-ST2 antibody was added
to PRD explant tissues and supernatant collected and analysed by ELISA. (A) The mean
concentration of each cytokine after neutralisation of ST2 compared with matched control
for 18 h culture. (B) The mean concentration of each cytokine after neutralisation of ST2
compared with matched control for 72 h culture. The number of different patient-derived
PRD tissues used in experiments for the measurement of each cytokine is given in
parenthesis. Bars represent the mean concentration for each cytokine with the standard
error of the mean.
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4.6 Discussion
PRD tissues for explant culture were obtained sequentially from 310 patients undergoing
periradicular surgery by the author or routine dental extractions. Previous studies
demonstrate that of lesions derived from extracted teeth, 35-63% are peri radicular
abscesses, 5-50% are granulomas and 15-24% are periradicular cysts (Nair et al 1996, Vier
and Figueiredo 2002). These lesions develop from the same infective origin and progress
by similar processes. Furthermore, no significant differences have been found between the
types or proportions of immunocompetent cells contributing towards these differing lesion
types (Stern et al. 1981, Torabinejad and Kettering 1985, Gao et al. 1988, Matsuo et al.
1992, Liapatas et at. 2003). Given the limited volume of tissue available after dental
extraction and the similar cellular composition of these lesions, the whole tissue lesion was
used for each explant culture experiment without a pathological diagnosis.
Tissue explant cultures retain all their cellular components including their structural
elements. Thereby, investigation of these integrated cell models can provide experimental
advantages over isolated cell-culture systems. Tissue explant models have been widely
used to investigate cytokine pathways in a variety of human diseases (Lordan et al. 2001).
Surprisingly, no published studies have analysed functional responses within PRD tissue
explant cultures. Recent evidence suggests that the cytokine network is central in
orchestrating the cellular events that lead to the development of the periradicular lesion.
Therefore, in initial experiments I sought to characterise the spontaneous release of
endogenous cytokines by human PRD explant tissues cultured for 18 h and 72 h after
surgical retrieval.
Significant release of monokines including TNF -u, IL-113 and IL-6 was evident within 18
h cultures. Although these cytokines were detectable at 72 h, culture beyond the 18 h point
did not yield significant further accumulation suggesting that this was the optimal time
point at which to observe functional activities. The high levels of constitutive expression
of IL-6 and other cytokines within the PRD explant model likely indicates a high intrinsic
activation status of the cells. This was also reflected by the detection of substantial NF -KB
protein expression within the lesions. Furthermore, continued production of these
inflammatory mediators to 72 h suggests the retention of the in vivo features present within
the PRD lesion before removal from the bony crypt. Substantial release of IL-12 and IFN-
y, but little or no IL-4 or IL-5, strongly suggest that the PRD lesions examined in these
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experiments were predominantly of a Th I phenotype. This IS in contrast to the
observations from immunohistochemical experiments by others whom have reported a
predominating Th2 phenotype (Walker et al. 2000, De Sa et al. 2003).
On encountering bacteria and their associated PAMPS from infected root canals, local host
cells release inflammatory mediators to attract immune cells to the periradicular tissues.
This establishes a localised inflammatory reaction within the tissue surrounding the dental
root apex. Unless root canal treatment is undertaken to eradicate these pathogens or in
cases where root canal treatment has failed, continual bacterial challenge from the root
canal perpetuates this inflammatory process. This subsequently leads to the development
and propagation of the chronic PRO lesion, resulting in periradicular granulomas or cysts.
Substantial levels of LPS have been detected within the root canals of teeth associated with
PRD lesions (Schein and Schilder 1975, Dahlen and Bergenholtz 1980, Horiba et al.
1991). Furthermore, high concentrations of LPS have been observed within the PRO tissue
itself (Schonfeld et al. 1982). Nevertheless, it has been suggested that LPS alone may not
be directly responsible for lesion development. More importantly, it has been purported
that the induction of inflammatory cytokines by LPS may be more significant in the
initiation and perpetuation of PRD than direct effects of LPS (Wang and Stashenko 1993a,
Wang and Stashenko 1993b). Moreover, in cases of persisting PRO arising after failed
RCT, the root canal flora is primarily composed of Gram-positive microorganisms (Siren
et al. 1997, Sundqvist et al. 1998, Pinheiro et al. 2003, Gomes et al. 2004). The release of
exotoxins by these Gram-positive pathogens may therefore be as, if not more influential
than bacterial-derived LPS in contributing towards lesion development and chronicity. It is
therefore of central importance to establish the contribution of PAMPS in eliciting
endogenous cytokine responses, which may directly contribute towards the inflammatory
reaction occurring within the PRO lesion. I therefore investigated the functional effects of
Gram-positive and Gram-negative moieties upon endogenous cytokine expression within
the PRD lesion by developing the novel human PRO tissue explant culture system.
The Gram-negative derived mitogen, LPS promoted a strong inflammatory response within
PRO tissue explant cultures. Addition of LPS to explant cultures resulted in significant
increases in proinflammatory cytokines IL-l~, TNF-a and IFN-y and had no effect upon
IL-6, IL-8 and IL-l 7A. This powerful proinflammatory reaction to LPS challenge is likely
regulated by concomitant IL-I0 release by cellular components of the PRD lesion.
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Interestingly, LPS exerted this potent proinflammatory effect upon cytokine expression
over long-term cultures at 72 h. The T cell superantigen SEB, a component of some Gram-
positive bacteria, also induced a strong proinflammatory effect that resulted in increased
secretion of the inflammatory mediators IL-l~, IL-17A, TNF-a and IFN-y. Moreover, the
addition of SEB to explant cultures substantially increased secreted levels of TNF-a and
IFN-yat both 18 h and in long-term culture to 72 h. Rapid production of these cytokines
likely propagates the release of downstream inflammatory mediators including chemokines
and matrix metalloproteinases. Thereby, further contact with bacterial products from the
dental root canal results in chronic inflammation within the PRO lesion and concomitant
destruction of the local dento-alveolar bone matrix.
It is most probable that the observed effects of these PAMPs upon endogenous cytokine
expression within the PRD explants were regulated via TLR signalling pathways. Indeed,
the experiments established that Toll-like receptors were expressed within the lesion.
However, further work is required to study a larger number of tissues in order to elucidate
the relevance of their expression within PRO and thereby, their contribution to destructive
inflammatory pathways. Surprisingly, IL-4 was neither constitutively expressed within
PRD tissue explants nor was it inducible by explant stimulation with microbial-derived
moieties. In contrast, the stimulation of explants with microbial moieties resulted in
substantially increased quantities of IFN-y. These data further support the hypothesis that
the human PRD lesion is dominated by a Th 1 phenotype. A summary of the data from
these experiments is presented in Figure 4.12.
175
Figure 4.12 Diagrammatic illustration summarising cytokine and potential cellular
events occurring within the chronic inflammatory PRD lesion in response to PAMPs.
NK- Natural Killer cell; M0- macrophage/ dendritic cell; PMN- neutrophil. Microbial
challenge of cells within the periradicular lesion and surrounding periradicular tissue
induces a marked pro-inflammatory response with release of cytokines that exhibit potent
inflammatory properties. Their continued release results in chronic inflammation. The
concomitant secretion of IL-10 likely counters and down-regulates the extent of this
inflammatory cascade, preventing exaggerated tissue destruction (broken red arrow).
~ iiiIFN-y
----?!
~
\
\
\
\
\
\
\
\
\
\
\ ?I
\ .'"
\ ..,
\ ,.. '
\ "
\ ,
\ I
\ I
I
\ I
C
H
R
o
N
~~
iitTNF-a
it IL-1~
i IL-6
iIL-10
PATHOGENS!
MICROBIAL
PRODUCTS
/
iiiIFN-y
iiIL-17A
TLR@
PMN •.:. iIL-6?tIL-8
I
N
F
L
A
M
M
A
T
I
o
N
176
CHAPTERS
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AND
PERI RADICULAR DISEASE
5 INTERLEUKIN-18 AND PERI RADICULAR DISEASE
5.1 Introduction
Recent evidence from animal studies implies a prominent role of pathways of innate and
acquired immunity in the pathogenesis of PRO. Cytokines have garnered considerable
interest as potential mediators of these inflammatory pathways. Several studies have
identified the expression of IL-I. IL-6, IL-8 and TNF-a at the initiation of PRO and
subsequently during chronic stages of the disease (Tani-Ishii et al. 1995, Wang et al. 1997,
Kawashima and Stashenko 1999). It is established that the expression of these
prointlammatory cytokines and the presence of LPS are capable of inducing IL-18 gene
expression thereby directing the synthesis of an inactive 24 kOa precursor product
(Nakanishi et al. 2001). IL-18 augments the production of several critical inflammatory
mediators implicated in chronic inflammatory diseases and inflammatory bone disease.
These include the up-regulation of the proinflammatory cytokines IL-I p, IL-6 or TNF -a,
the chemokines IL-8, MCP-I and MIP-I a, the intracellular adhesion molecule ICAM-l
and inflammatory mediators GM-CSF, iNOS and iCox-2. Through these proinflammatory
actions, IL-18 mediated processes are implicated in contributing towards chronic
inflammatory diseases such as RA (reviewed in Gracie et al. 1999. McInnes et al. 2000).
IL-18 is capable of regulating cytokine production during the early phase of bacterial
infections by influencing IL-12 production. Thereby, IL-18 provides a protective effect to
the host in contributing towards the eradication of microbial pathogens within innate
immune responses. Recent evidence further implicates a role for IL-18 within early innate
immunity through its properties of neutrophil recruitment and activation. Nevertheless. the
range of IL-18 activities so far reported suggest that this novel cytokine plays an essential
regulatory role within cell-mediated immunity against foreign pathogens.
Elevated levels of both IL-18 mRNA and protein have been detected in several chronic
inflammatory diseases embracing infection and bone destruction (Gracie et al. 19(9). This
suggests that although IL-18 is an essential component of host immune responses, the
inappropriate production of lL-18 may contribute to the pathogenesis of chronic
inflammatory diseases. However. the expression of IL-18 and its receptor has previously
not been reported within PRO. I therefore investigated the expression of both IL-18 and its
corresponding signalling receptor within the PRJ) lesion. Furthermore. using the PRD
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explant culture model that I had established from the previous set of experiments, I
investigated the functional effects of rhIL-18 addition to human PRD tissue cultures upon
endogenous cytokine expression. Thereby, I intended to elucidate the mechanisms by
which IL-18 may regulate inflammatory events occurring within the human PRD lesion.
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5.2 IL-18 is expressed within inflamed human periradicular tissues
Given the importance of IL-18 in the host response within infectious diseases, I undertook
initial experiments to determine if IL-18 mRNA expression was detectable within the PRO
lesion. Using RT-PCR, IL-18 mRNA was detected in 70 of90 PRO tissues (Figure S.IA).
However, in non-inflamed pulp tissue samples IL-18 mRNA was not expressed (n=ll
tissues). In addition to ~-actin, THP cells stimulated with LPS and IFN-y and/or RA
synovium served as positive controls. Negative controls comprised H20 without the
addition of eDNA. Having established that IL-18 mRNA was expressed within inflamed
PRO lesions, I also determined its relative expression by using quantitative-PCR within a
set of 23 PRO lesions (Figure 5.1 B)
Using immunohistochemistry, I next sought to determine the cellular expression of IL-18.
Widespread IL-18 expression was observed throughout the PRO lesion, within leukocyte
aggregates and in diffuse interstitial tissue areas (Figure 5.1C). Double IHC staining
revealed that the majority of IL-18 expressing cells were C068+, indicative of macrophage
origin. In contrast, C03+ T cells were consistently IL-18 negative (Figure S.IO-F). Tonsil
tissue was additionally stained as a positive control. Periodontal ligament, a further control,
exhibited no IL-18 expression commensurate with the absence of inflammatory infiltrate.
Staining was neutralised by the addition of rhIL-18 to the anti-IL-18 antibody prior to
section incubation. The specificity of the antibody to detect IL-18 was additionally
confirmed by a lack of neutralisation when the IL-18 antibody was preincubated with the
structurally related rhIL-I ~ protein.
Since currently available anti-IL-18 antibodies cannot distinguish mature and pro forms of
IL-18 using IHC, I performed Western blot analysis to confirm the presence of mature IL-
18. The majority ofPRD samples (n=14) exhibited IL-18 present in both pro (23 kOa) and
mature (18 kOa) forms, whereas in non-inflamed pulp tissues (n=12), only pro-IL-18 was
detected (Figure 5.1G). This suggested that IL-18 was present in healthy mucosal tissue
but cleaved to the mature biologically form only in the context of inflammation.
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Figure 5.1 Identification of IL-18 expression within periradicular disease. (A)
IL-18 mRNA detected within inflamed PRD tissues by RI-peR. (B) Relative
expression of IL-18 within PRD tissues to GAPDH by Q-peR in 23 PRD lesions. (e) IHe
single stain for IL-18 within PRD, arrows represent IL-18 positive cells. (D) Double stain
IHe for IL-18 within PRD; blue arrow-Cl.B" cells, orange arrow- IL-18 positive cells. (E)
Double stain IHe for IL-18 within PRD; blue arrow-Cfrox" cells, orange arrow- IL-18
positive cells (F) Western Blot of PRD tissues for IL-18, establishing mature IL-18 to be
present within inflamed PRD tissues.
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5.3 IL-18 receptors and IL-18BP are expressed in inflamed human PRD tissues
For IL-18 to be biologically functional within inflammatory responses in the PRO lesion,
there is a requirement for the IL-18 signalling apparatus to be present. Therefore, I next
examined if components of the IL-18 receptor were present within inflamed PRO tissues.
IL-18Ra and IL-18RI3 chains were detected at mRNA level in inflamed PRO tissues
(Figure S.2A,B), whereas in non-inflamed pulp, IL-18Ra mRNA but no IL-18RI3 mRNA
was detectable. These data were confirmed using Western blotting that revealed IL-18Ra
protein was present within all PRO tissue (n= 14/14) and half of pulp tissue (n = 3/6)
(Figure 5.2C). Currently available antibodies to IL-18Ra and IL-18RI3 were not functional
in immunochemical assays comprising fresh cytopreps, frozen sections or FFPE sections.
Nevertheless, these data indicated that IL-18 and IL-18Ra mRNA and protein and IL-
18R13 mRNA were present in inflamed PRD lesions, providing rationale for further
functional characterisation in vitro.
IL-18 expression is tightly regulated by the concomitant production of IL-18BP. I therefore
also investigated the expression of IL-18BP within the PRO lesion (Figure 5.3A,B).
mRNA expression for IL-18BPa subunit was detectable within only 5/11 PRD tissue
lesions and IL-18BPc mRNA was observed in 3/11 lesions. Gene expression for IL-18BPb
and d subunits was not detectable within any of the PRO tissues examined. Using Western
blotting, IL-18BPa was present within the majority of PRD protein lysates (n= 18/20,
Figure 5.3C)
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Figure 5.2 Identification of IL-18 receptor within periradicular disease tissues. (A)
IL-18Ra mRNA detected by RT-PCR within inflamed PRD tissues. Results are
representative of three independent experiments with similar results. Stimulated PBMC
were used as positive controls for cDNA quantification. (B) IL-18RP mRNA expression
detected within inflamed PRD tissues. Cc) IL-18Ra protein expression detected within
PRD tissue protein lysates.
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Figure 5.3 Identification of IL-18BP within PRD. (A) peR detection of IL-BPa gene
expression within PRD tissues, positive specimens identified by arrow. (B) mRNA for IL-
18BPc chain detectable within only 3/11 PRD specimens by RT-PCR (C) Western blot
detection of IL-18BPa within 18/20 PRD protein specimens.
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5.4 In vitro effects of Gram-negative and Gram-positive mitogens upon IL-18
expression within human PRD explant cultures
The previous series of experiments ascertained that IL-18 was present within inflamed
PRO tissue lesions and that its receptor subunits were also expressed within these tissues.
Therefore. I next examined if secreted IL-18 was detectable within the explant culture
model that I had previously established. Indeed. high levels of spontaneous IL-18 release
were observed in the majority of PRO tissue explant culture supernatants examined at 18 h.
Furthermore. moderate levels of secreted IL-18 were also detectable at 72 h explant culture
(Figure S.4A).
Experiments undertaken within the previous chapter demonstrated that Gram-positive and
Gram-negative microbial products were capable of inducing marked changes in the
expression of endogenous cytokines within the PRD explant culture system. Moreover,
these effects were predominantly related to the induction of significantly increased
secretion of key proinflammatory cytokines. I therefore investigated if the addition of these
mitogens to 18 h PRO explant cultures were able to modulate IL-18 expression.
Interestingly, the addition of LPS or SEB to PRD explant tissue cultures at 18 h had no
observable effect upon the expression of secreted IL-18 (Figure S.4B).
I therefore further investigated the effects of mitogenic challenge upon IL-18 expression
over longer-term culture to 72 h. After 72 h explant culture. LPS induced a minimal but not
significant increase in IL-18 expression. SEB slightly reduced IL-18 expression but this
was also below levels of significance (Figure S.4C). These experiments provided
interesting data establishing that the expression of IL-18, although spontaneously released
by 'resting' tissue explants, was not further inducible by the effects of Gram-positive or
Gram-negative microbial products.
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Figure 5.4 In vitro effects of mitogenic stimulation upon IL-18 expression within PRD
explant cultures. 'Resting' levels of spontaneously released IL-18 within PRD tissue
explant culture supernatants were initially assessed. (A) Unstimulated PRD explant tissue
culture supernatant was harvested at 18 h and at 72 h and IL-18 concentrations determined
by ELISA. PRD explant tissues were subsequently stimulated with LPS or SEB and
supernatant collected and analysed by ELISA. (B) The mean concentration of IL-18
supernatant after 18 h mitogen stimulation compared with unstimulated control. (C) The
mean concentration of IL-18 supernatant after 72 h mitogen stimulation compared with
unstimulated matched control. The total number of PRD explant tissues analysed in each
experiment is given in parenthesis. Bars represent the mean IL-18 concentration with the
standard error of the mean.
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5.5 In vitro effects of cytokine addition to human PRD explant cultures upon
endogenous IL-18 expression
Previous experiments established that the addition of mitogens to the PRO explant culture
model significantly up-regulated endogenous inflammatory cytokine expression. Having
established that neither Gram-positive nor Gram-negative mitogenic challenge of PRD
explant cultures had any inducible effect upon endogenous IL-I8 expression, I therefore
explored the effects of cytokine manipulation of the explant tissues. I investigated the
effects of several critical cytokincs that are expressed within inflammatory immune
responses to infectious pathogens and that are also intimately related to inflammatory bone
resorption. IL-I8 expression within this explant culture model was therefore analysed after
the addition of several inflammatory cytokine mediators by ELISA. Initially, I investigated
the effects of these cytokines upon IL-I8 expression within short-term culture.
At 18 h, the addition of the majority of cytokines to PRO explant cultures failed to
consistently modulate IL-I8 release. However, the addition of IL-IO to PRO explants
induced a significant reduction in IL-I8 expression (p<O.O10). The addition of IFN-y
(p=O.143) and TNF-a (p=O.058) resulted in minor reductions of IL-I8 expression that were
both below levels of statistical and biological significance (Figure S.SA,B). Having
established that these cytokines had little effect upon IL-I8 expression in short-term
culture. I next analysed whether they could modulate IL-I8 expression within explants
over 72 h culture. As previously observed at 18 h, IL-IO (p=O.OIOl) significantly reduced
endogenous IL-I8 expression at 72 h culture (Figure S.6A,8). Interestingly, MCSF
(p=0.032) induced a moderate though statistically significant increase in IL-18 expression
after 72 h culture. However, no other cytokines were capable of regulating endogenous IL-
18 expression within the PRO explant culture system.
These experiments established that IL-I8. which was spontaneously released in substantial
amounts in unstimulated PRO tissue, is at maximal production and not further inducible by
exogenous stimuli. whether bacterial-derived mitogens or pro-inflammatory cytokines,
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Figure 5.5 In vitro effects of 18 h cytokine stimulation upon IL-18 expression within
PRD explant cultures. PRD explant tissues were stimulated with a panel of cytokines for
18 h and supernatant collected and analysed by ELISA. CA)The mean concentration of IL-
18 after cytokine stimulation compared with unstimulated control. (B) The percentage
change in culture supernatant IL-18 concentration between stimulated and unstimulated
matched control tissues. The total number of PRD explant tissues stimulated with each
cytokine is given in parenthesis. Bars represent the mean IL-18 concentration with the
standard error of the mean.
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Figure 5.6 In vitro effects of 72 h cytokine stimulation upon IL-18 expression within
PRD explant cultures. PRD explant tissues were stimulated with a panel of cytokines for
72 h and supernatant collected and analysed by ELISA. (A) The mean concentration of IL-
18 after cytokine stimulation compared with unstimulated control. (B) The percentage
change in culture supernatant IL-18 concentration between stimulated and unstimulated
matched control tissues. The total number of PRD explant tissues stimulated with each
cytokine is given in parenthesis. Bars represent the mean IL-18 concentration with the
standard error of the mean.
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5.6 In vitro effects of exogenous IL-18 addition to PRD explant cultures
From the Western blot experiments, IL-18 was detectable in its 18 kOa biologically active
form within PRD lesions. It was therefore of interest to explore the potential contribution
of IL-18 to inflammatory pathways within the PRD lesion. I therefore investigated the
effect of adding additional bioactive rIL-18 to the 18 h PRD explant culture. IL-18 was
used at concentrations defined as optimal through previous experiments within our
laboratory and subsequently by others (Gracie et al. 1999, Monteleone et al. 1999, Dai et
al.2004)
Addition of rIL-18 induced a modest but significant increase in the release of monocyte-
derived cytokines IL-113 (p=O.OO1), IL-6 (p=O.OOO1), IL-8 (p=O.OOO1), IL-12 (p=O.OOI) and
TNF-a (p=O.OOOI) (Figure 5.7A). The expression of T cell derived cytokines IL-17A
(p=O.0042) and IFN-y (p=O.007) were also significantly enhanced (Figure 5.7B). After 18
h culture, IL-18 had no consistent effect upon IL-lO expression, which was minimally
down-regulated though not at significant levels (Figure 5.7C). No effect upon IL-4
expression was observed. Addition of IL-18 to 18 h PBMC and whole blood cell cultures
served as a further control to tissue explant experiments (Figure 5.8A,B).
Having established that IL-18 had a stimulatory effect upon the expression of several
inflammatory cytokines over 18 h culture, I next sought to examine the effect of the
addition of exogenous rIL-18 to longer-term explant cultures. I therefore investigated the
effects of IL-18 upon the expression of several key cytokines within the PRD explant
culture model at 72 h. After 72 h culture, IL-18 induced a substantial increase in the
expression of the T cell derived cytokines IFN-y (p=0.009) and IL-17 A (p=0.0008) (Figure
5.9B,C). Furthermore, IL-18 modestly up-regulated the expression of monocyte derived
IL-113 (p=0.064), and TNF-a (p=O.009) and minimally increased IL-6 (p=O.OOOI) and IL-8
expression to levels of statistical significance (Figure 5.9A,C). IL-12 (p=O.076) expression
was minimally increased by IL-18, though below levels of significance (Figure 5.9A,C).
IL-18 resulted in a minor, non-significant decrease of IL-l 0 (p=0.177) after 72 h explant
culture. These experiments therefore established that the addition of biologically active
rIL-18 to explant cultures induced proinflammatory pathways within the PRD lesion. In
particular, the effect of exogenous biologically active IL-18 upon the expression of the T
cell derived cytokines IFN-y and IL-17 A over the whole term of culture was quite marked
(Figure 5.90).
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Figure 5.7 In vitro effects of IL-18 manipulation in 18 h PRD explant cultures. PRD
explant tissues were stimulated with rhIL-18 for 18 h and culture supernatant collected and
analysed by ELISA. (A) The mean concentration of a panel of monokines after explant
tissue stimulation with rhIL-18 compared with unstimulated control. (B) The mean
concentration of a panel of T cell-derived cytokines after explant tissue stimulation with
IL-18 compared with unstimulated control. (C) The percentage change in culture
supernatant cytokine concentration between stimulated and unstimulated matched control
tissues. The total number of PRD explant tissues stimulated with IL-18 for each individual
cytokine is given in parenthesis. Bars represent the mean cytokine concentration with the
standard error of the mean.
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Figure S.8 In vitro effects of 18 h IL-18 stimulation upon cytokine expression within
PBMC and whole blood cell cultures. (A) The mean concentration of cytokines after IL-
18 stimulation compared with unstimulated control in 18 h PBMC cultures. (B) The mean
concentration of cytokine after IL-18 stimulation compared with unstimulated matched
control in 18 h whole blood cell cultures. The total number of separate patient derived
cultures stimulated with each cytokine is given in parenthesis. Bars represent the mean
cytokine concentration with the standard error of the mean.
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Figure 5.9 In vitro effects of IL-18 manipulation in 72 h PRD explant cultures. PRD
explant tissues were stimulated with IL-18 for 72 h and supernatant collected and analysed
by ELISA. (A) The mean concentration of a panel of monokines after explant tissue
stimulation with IL-18 compared with unstimulated control. (B) The mean concentration of
a panel of T cell-derived cytokines after explant tissue stimulation with IL-18 compared
with unstimulated control. (C) The percentage change in culture supernatant cytokine
concentration between stimulated and unstimulated matched control tissues. (D)
Percentage change of cytokine expression within PRD explants after IL-18 stimulation
over whole time of culture to 72 h. The numbers of PRD explant tissues stimulated with
. IL-18 for each individual cytokine is given in parenthesis. Bars represent the mean
cytokine concentration with the standard error of the mean.
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5.7 The specificity of in vitro effects of IL-18 manipulation in PRD explant
cultures
The previous experiments established that the addition of rhIL-18 to PRD tissue explant
cultures resulted in up-regulated pro-inflammatory endogenous cytokine expression.
Thereby, these experiments defined a potential pro inflammatory role for IL-I8 in the
perpetuation of inflammation that occurs within the chronic PRO lesion. I therefore next
investigated the specificity of these findings. Each individual culture experiment was
undertaken within matched tissue explants stimulated with IL-18 or IL-I8+anti-IL-18 and
the corresponding unstimulated control from the same individual donor for 18 h culture.
The total number of patients analysed for the effects of IL-I8 neutralisation is given for
each cytokine.
Finally, I investigated whether the addition of anti-lL-18 alone to the cultures had any
inducible or suppressive effects upon the expression of the panel of cytokines previously
analysed at 18 h explant culture and compared this with IL-I8 addition to matched
explants. Each individual culture experiment analysing these effects was undertaken within
matched tissue explants stimulated with IL-I8 or anti-IL-I8 and unstimulated control from
the same individual donor for 18 h culture.
At 18 h culture, the addition of neutralising IL-I8 antibody to the explants concomitantly
with rhIL-I8 abrogated the effect of IL-I8 induced cytokine expression (Figure s.lOA, B).
Furthermore, the effect of the addition of anti-IL-I8 alone in comparison with explants
stimulated with rIL-I8 with their matched unstimulated controls is shown in Figure 5.1 OC
and D. These results clearly confirmed that following the addition of rhIL-I8 to PRO
explant cultures, the previously observed proinflammatory changes in cytokine expression
were specific to the actions of IL-18. Interestingly, the addition of anti-IL-18 by itself had
no significant modulating effect upon cytokine expression within 18 h explant cultures
(Figure 5.1OC).
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Figure 5.10 Specificity of IL-18 effects within PRD explant cultures. PRO explant
tissues were stimulated with IL-18 and neutralising anti-IL-18 for 18 h and supernatant
collected and analysed by ELISA. (A, B) The mean concentration of a panel of cytokines
after explant tissue stimulation with IL-18 or anti- IL-18+ IL-18 compared with
unstimulated control from matched donors (C,D) The effects of anti-IL-18 alone upon
cytokine expression after 18 h culture in comparison to rhIL-18. (E) Total effects of the
addition of anti-IL-18 neutralising antibody to PRO explants upon endogenous cytokine
expression. The numbers of PRD explant tissues stimulated with IL-18 and/ or anti-IL-18
for each individual cytokine is given in parenthesis. Bars represent the mean cytokine
concentration with the standard error of the mean.
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5.8 Effects of IL-18 in combination with other cytokines upon endogenous
cytokine expression within PRD explant cultures
5.8.1 Effects ofIL-18 in combination with IL-12
Having determined that the addition of exogenous IL-I8 induced significantly increased
expression of several endogenous cytokines within the PRD explant culture model, I
undertook further investigations to determine if these IL-18 mediated effects could be
modified when given in combination with other cytokines. I had previously established
that the individual addition of IL-18 to PRO explants induced increased IFN-y and IL-12
expression. Therefore I initially explored the effect of IL-12 in combination with IL-I8
upon IFN-y expression on short-term cultures.
At 18 h culture, the synthesis of IFN-y was synergistically enhanced by the combined
addition of IL-12 and IL-18 compared to the administration of IL-18 (p=O.OO1) or IL-12
(p=0.012) alone (Figure 5.11A). Given this marked synergism upon IFN-y expression, I
further explored the effects of this combination upon other immunoregulatory cytokines
within the explant system (Figure 5.11A). IL-18 in combination with IL-12 had an additive
effect upon increased IL-8 production and conversely upon the reduction of IL-IO
(p=0.12). However, both of these changes were below levels of significance.
I next sought to examine these combinational effects over a longer period of culture. After
72 h culture, IL-18 in combination with IL-12 synergistically up-regulated IFN-y secretion
(p=O.OOI)compared to either individual cytokine (Figure 5.12A). IL-18 in combination
with IL-12 had an additive effect upon the reduction of IL-IO expression compared to
either cytokine alone but below levels of significance (p=0.16). Furthermore, IL-I8 with
IL-12 had an additive effect upon IL-8 levels. These were increased compared to either
cytokine alone but below levels of significance. Although TNF -u was up-regulated by this
cytokine combination, no synergistic effects were observed.
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Figure 5.11 In vitro effects of IL-18 in combination with IL-12 upon cytokine
expression within 18 h PRD explant cultures. PRD explant tissues were stimulated with
IL-18 and IL-12 for 18 h and supernatant collected and analysed by ELISA. (A) The mean
concentration of a panel of cytokines after explant tissue stimulation with IL-18 and/ or IL-
12 compared with unstimulated control. (B) The percentage change in culture supernatant
cytokine concentration between stimulated and unstimulated control tissues. The numbers
of PRD explant tissues stimulated with IL-18 for each individual cytokine is given in
parenthesis. Bars represent the mean cytokine concentration with the standard error of the
mean.
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Figure 5.12 In vitro effects of IL-18 in combination with IL-12 upon cytokine
expression within 72 h PRD explant cultures. PRD explant tissues were stimulated with
IL-18 and IL-12 for 72 h and supernatant collected and analysed by ELISA. (A) The mean
concentration of cytokines after explant tissue stimulation with IL-18 and IL-12 compared
with unstimulated control. (B) The percentage change in culture supernatant cytokine
concentration between stimulated and unstimulated control tissues. The numbers of PRD
explant tissues stimulated with IL-18 for each individual cytokine is given in parenthesis.
Bars represent the mean cytokine concentration with the standard error of the mean.
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5.8.2 Effects of IL-I8 in combination with IL-I 0
IL-IO is generally classed as a cytokine with predominantly anti-inflammatory properties.
The previous investigations had established that exogenous IL-I8 was capable of driving a
proinflammatory cytokine response within the explant culture system and that this was
synergistically enhanced by the concomitant addition of IL-I2. I therefore next
investigated the addition of IL-I 0 in combination with IL-I8 to PRD explant cultures to
determine whether IL-IO was capable of down-regulating the previously observed IL-I8-
induced proinflammatory response upon several inflammatory cytokines implicated in
lesion development.
At 18 h culture, IL-IO in combination with IL-I8 had no observable effect upon IL-6
expression (Figure 5.13A, B). Therefore, IL-IO reduced the effect that IL-I8 alone had in
up-regulating IL-6 expression. IL-IO had a moderate inhibitory effect on IL-I8-induced IL-
8 expression. IL-I8-induced up-regulation of IL-8 decreased form a significance value of
p=O.OOOI,when added alone, to p=O.066 when added in combination with IL-to to PRD
explant cultures. The addition of IL-I 0 with IL-I8 also reduced the significant effect of IL-
18-induced secretion of both IFN-y and TNF-a to levels below significance at 18 h culture.
Having established that IL-IO was able to down-regulate the pro-inflammatory effects of
IL-I8 over 18 h culture, I next investigated this over longer-term culture. IL-IO in
combination with IL-18 had no direct effect upon IL-6 secretion after 72 h culture (Figure
S.l4A,B). Thereby, the addition ofIL-lO significantly reduced the individual effect of up-
regulated IL-6 secretion by IL-I8 when added alone (p=O.027). This combination of IL-I 0
with IL-I8 significantly increased IL-8 expression within the explant culture compared
with unstimulated control. This effect was additive compared to IL-IO or IL-I8 alone but
below levels of significance. IL-IO when added in combination with IL-18 reduced the
previously observed significant effect of IL-I8-induced up-regulated TNF -c secretion to
non-significant levels at 72 h culture.
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Figure 5.13 In vitro effects of IL-18 in combination with IL-IO upon cytokine
expression within 18 h PRD explant culture. PRD explant tissues were stimulated with
IL-18 and Il-- lOfor 18 h and supernatant collected and analysed by ELISA. (A) The mean
concentration of a panel of cytokines after explant tissue stimulation with lL-18 and lL-l 0
compared with unstimulated control. (B) The percentage change in culture supernatant
cytokine concentration between stimulated and unstimulated control tissues. The numbers
of PRD explant tissues stimulated with lL-18/ 1L-12 for each individual cytokine is given
in parenthesis. Bars represent the mean cytokine concentration with the standard error of
the mean.
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Figure 5.14 In vitro effects of IL-18 in combination with IL-IO upon cytokine
expression within 72 h PRD explant culture. PRD explant tissues were stimulated with
IL-18 and IL-l 0 for 72 h and supernatant collected and analysed by ELISA. (A) The mean
concentration of a panel of cytokines after explant tissue stimulation with IL-18 and IL-IO
compared with unstimulated control. (B) The percentage change in culture supernatant
cytokine concentration between stimulated and unstimulated control tissues. The numbers
of PRD explant tissues stimulated with IL-18/ IL-12 for each individual cytokine is given
in parenthesis. Bars represent the mean cytokine concentration with the standard error of
the mean.
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S.8.3 Effects of IL-I8 in combination with IL-1S
IL-IS is a cytokine with many proinflammatory properties. I therefore investigated whether
IL-IS in combination with IL-I8 exhibited any synergistic effects upon the expression of
cytokine inflammatory mediators within the PRD explant system. After 18 h culture, IL-IS
in combination with IL-I8 had no direct effects upon IL-8 secretion (Figure S.ISA,B).
Interestingly, the addition of IL-IS resulted in a significant reduction of IL-8 secretion
when compared with IL-I8 alone (p=O.OS).No effects were observed upon IL-6, IL-8, IL-
10 or TNF-a expression by the combination of IL-15 and IL-I8 compared with the
individual actions of IL-IS or IL-I8. However, IL-IS in combination with IL-I8 markedly
induced IFN-y (p=0.002) secretion at 18 h culture although this effect was not significant
over either IL-I8 (p=O.IS) or IL-I5 alone.
I further investigated the combined effects of IL-IS and IL-I8 over long-term culture. At
72 h culture, no effects were observed upon IL-6, IL-8 or IL-IO expression by IL-IS in
combination with IL-I8 compared with the individual actions of IL-IS or IL-I8. The
addition of both IL-IS and IL-I8 into the explant culture reduced TNF-a expression, but
this was below levels of significance (Figure 5.16A,B). IL-I8 with IL-I5 markedly
increased IFN-y (p=O.Ol) although this increase was not statistically significant compared
to the individual effects of either cytokine.
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Figure 5.15 In vitro effects of IL-18 in combination with IL-1S upon cytokine
expression within 18 h PRD explant culture. PRD explant tissues were stimulated with
IL-18 and IL-15 for 18 h and supernatant collected and analysed by ELISA. CA)The mean
concentration of a panel of cytokines after explant tissue stimulation with IL-18 and IL-15
compared with unstimulated control. CB) The percentage change in culture supernatant
cytokine concentration between stimulated and unstimulated control tissues. The numbers
of PRD explant tissues stimulated with IL-18/ IL-15 for each individual cytokine is given
in parenthesis. Bars represent the mean cytokine concentration with the standard error of
the mean.
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Figure 5.16 In vitro effects of IL-18 in combination with IL-15 upon cytokine
expression within 72 h PRD explant culture. PRD explant tissues were stimulated with
IL-18 and IL-15 for 72 h and supernatant collected and analysed by ELISA. (A) The mean
concentration of a panel of cytokines after explant tissue stimulation with IL-18 and IL-15
compared with unstimulated control. (B) The percentage change in culture supernatant
cytokine concentration between stimulated and unstimulated control tissues. The numbers
of PRD explant tissues stimulated with IL-18/ IL-15 for each individual cytokine is given
in parenthesis. Bars represent the mean cytokine concentration with the standard error of
the mean.
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5.8.4 Effects ofIL-18 in combination with IL-17A
The concomitant addition of IL-17A and IL-18 to explant cultures resulted in a significant
increase in IL-8 expression compared with unstimulated control (p=O.030). However, this
was only marginally greater than IL-18-induced up-regulation of IL-8 alone (Figure
5.17A,B). Although IL-18 in combination with IL-17A increased IFN-y expression, this
combination had no additional effect upon IL-6, IL-lO or IFN-y explant concentrations
compared with the administration of either individual cytokine. IL-17A in combination
with IL-18 markedly increased TNF-a secretion at 18 h (p=O.003). This increased TNF-a
secretion was statistically significant compared with individual stimulation by IL-17A
(p=O.046) but below significance when compared with IL-18 (p=O.09) alone. This may be
the result of only four tissues being analysed.
The addition of IL-17A combined with IL-18 to 72 h PRD cultures, had a marked effect
upon decreasing IL-lO secretion (Figure 5.18A,B). However this did not reach
significance, likely as the result of only three explant cultures being analysed for this
effect. At 72 h, IL-18 in combination with IL-17A had an additive effect upon TNF-a
secretion compared with either cytokine alone. Although this increase appeared quite
marked, only three cultures were examined so the effect was below levels of significance.
IL-17A with IL-18 had no observable effects upon IL-6 or IFN-y expression though they
induced a significant increase in IL-8 expression compared with unstimulated control
(p=O.030, n=II). Furthermore, this increase in IL-8 expression was greater than
upregulatory effects of either cytokine administered individually but below levels of
significance.
As the majority of significant effects of IL-18 in combination with other cytokines was
upon IFN-y expression, further control experiments were undertaken upon 18 h PBMC and
whole blood cell cultures (Figure 5.19A and B).
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Figure 5.17 In vitro effects of IL-18 in combination with IL-17 A upon cytokine
expression within 18 h PRD explant culture. PRD explant tissues were stimulated with
IL-18 and IL-17A for 18 h and supernatant collected and analysed by ELISA. CA)The
mean concentration of a panel of cytokines after explant tissue stimulation with IL-18 and
IL-17A compared with unstimulated control. CB) The percentage change in culture
supernatant cytokine concentration between stimulated and unstimulated control tissues.
The numbers of PRD explant tissues stimulated with IL-18/ IL-17A for each individual
cytokine is given in parenthesis. Bars represent the mean cytokine concentration with the
standard error of the mean.
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Figure 5.18 In vitro effects of IL-18 in combination with IL-17A upon cytokine
expression within 72 h PRD explant culture. PRD explant tissues were stimulated with
IL-18 and IL-1?A for 72 h and supernatant collected and analysed by ELISA. (A) The
mean concentration of a panel of cytokines after explant tissue stimulation with IL-18 and
IL-17A compared with unstimulated control. (B) The percentage change in culture
supernatant cytokine concentration between stimulated and unstimulated control tissues.
The numbers of PRD explant tissues stimulated with IL-18/ IL-I? A for each individual
cytokine is given in parenthesis. Bars represent the mean cytokine concentration with the
standard error of the mean.
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Figure 5.19 In vitro effects of 18 h IL-18 stimulation in combination with other
cytokines upon IFN-y expression within PBMC and whole blood cell cultures. (A) The
mean concentration ofIFN -y after IL-18 stimulation compared with IL-18 in combination
with other cytokines in 18 h PBMC cultures. (B) The mean concentration of IFN-y after
IL-18 stimulation compared with IL-18 in combination with other cytokines in 18 h whole
blood cell cultures. The total number of separate patient derived cultures stimulated with
each cytokine is given in parenthesis. Bars represent the mean cytokine concentration with
the standard error of the mean.
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5.9 A role for IL-18 in bacterial product induced cytokine production in PRD
The foregoing data addressed the experimental role of exogenous IL-18 within the novel
PRD explant culture system. IL-18 was clearly able to induce proinflammatory cytokine
responses within these explant cultures. Of importance, IL-18 substantially increased the
expression of IFN-y. The previous chapter established that this experimental system could
be utilised to investigate the effects of Gram-positive and Gram-negative mitogenic stimuli
upon the induction of the inflammatory cytokine cascade. It was therefore of interest to
determine if endogenously expressed IL-18 was acting as an upstream cytokine regulator,
responsible for promoting the downstream release of inflammatory cytokines resulting
from bacteria-derived mitogenic stimulation of these cultures.
To examine these effects, I therefore cultured PRD explant tissues with either LPS or SEB,
in the presence or absence neutralising anti-IL-18 antibody for 18 h. At 18 h explant
culture, LPS-induced TNF-a (p=0.04) .. IL-8 (p=0.045) and IL-I0 (p=0.045) release were
significantly inhibited by IL-18 neutralisation compared to LPS alone (Figure 5.20A, B).
The neutralisation of IL-18 in combination with LPS addition to PRD explant cultures also
led to decreased secretion of IL-l~, IL-6 and IL-12 and had minimal effect upon IL-17A or
IFN-y secretion. Similarly SEB-induced secretion of IL-l~, TNF-a and IL-lO was
suppressed by IL-18 neutralisation (Figure 5.20C). However, a significant reduction in
IFN-y production was not detectable, commensurate with expected direct activation of T
cells by SEB via TCRV~ interactions.
Taken together, these data suggest that mature (functional) IL-18 is a critical effector
molecule in the PRD response to these stimuli, representing surrogates of the infectious
elements proposed as effectors in PRD.
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Figure 5.20 In vitro effects of IL-18 neutralisation upon mitogen-induced expression
of cytokines within PRD explant cultures. PRD explant tissues were stimulated with
anti-IL-I8 and LPS for 18 h and supernatant collected and analysed by ELISA. (A) The
mean concentration ofIL-I, IL-6, IL-8 and IL-lO after explant tissue stimulation with anti-
IL-18+LPS compared with matched LPS-stimulated or unstimulated control tissues. (B)
The mean concentration of TNF-a and IFN-y after explant tissue stimulation with anti-IL-
I8+LPS compared with matched LPS-stimulated or unstimulated control tissues. (C) The
mean concentration of a panel of cytokines after explant tissue stimulation with anti-IL-
18+SEB compared with matched SEB-stimulated or unstimulated control tissues. The
numbers of PRD explant tissues stimulated with LPS±anti-IL-18 for each individual
cytokine is given in parenthesis. Bars represent the mean cytokine concentration with the
standard error of the mean.
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5.10 Discussion
Human IL-18 is synthesised as a 24 kDa biologically inactive, proIL-18 precursor that is
cleaved by caspase-I to generate the mature and biologically active 18kDa IL-18 molecule
(Gu et al. 1997, Ghayur et al. 1997, Fantuzzi et al. 1999). IL-I8 mRNA and pro-IL-I8
protein are ubiquitously expressed in a variety of cell types (Okamura et al. I995a, Ushio
et al. 1996, Okamura et al. I995b, Udagawa et al. 1997, Sugawara et al. 2001). IL-18 is
predominantly proinflammatory in nature, sharing similar biological properties to IL-I2,
and is associated with numerous pathological processes. The most potent biological
function of IL-18 is its IFN-y inducing activity from T cells, NK cells and NK T cells in
combination with IL-I2 (Micallef et al. 1996, Fehniger et al. 1999, Otani et al. 1999,
Walker and Rotondo 2004). In addition to its important effects upon NK cells, IL-I8 acts
on other immune cells and stromal cell populations participating in inflammatory
responses. IL-I8 exerts its biological effects by binding to the heterodimeric IL-I8 receptor
complex comprising the IL-I8Ra and IL-18RP chains (Torigoe et al. 1997, Debets et al.
2000). In response to infections and foreign antigens, endogenous IL-I8 activity influences
the development of both CD4+ effector Thl and Th2 type immune responses. IL-18BP, a
38 kDa circulating decoy receptor, possesses high-affinity binding to IL-18 and potent
anti-inflammatory properties, thereby regulating inflammatory activity of IL-I8 (Aizawa et
al. 1999, Novick et al. 1999, Kim et al. 2000, Faggioni et al. 200 l, Yatsiv et al. 2002,
Banda et al. 2003). The presence of IL-I8 and! or its contribution towards inflammatory
processes within the PRO lesion has not been described.
Using RT-PCR, IL-18 mRNA expression was detected with human PRO tissues. However,
in non-inflamed pulp tissue samples IL-I8 mRNA was not detected. From
immunohistochemistry experiments, widespread IL-I8 expression was observed
throughout the PRO lesion. This expression was seen predominantly within leukocyte
aggregates, but also in diffuse interstitial tissue areas. Furthermore, double staining
showed that the majority of IL-18 was localised to macrophages whereas CD3+ cells were
consistently IL-I8 negative. Periodontal ligament tissue, exhibited no IL-I8 expression
commensurate with the absence of inflammatory infiltrate. The majority of PRO samples
exhibited IL-I8 as being present in both pro (23 kDa) and mature (18 kDa) forms, whereas
in non-inflamed pulp tissues, only pro-IL-18 was detected. This suggested that IL-18 was
present in resting mucosal tissue but cleaved to mature form only in the context of
inflammation.
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Expression of IL-18R regulates IL-18 bioactivity and IL-18 responsiveness requires the
presence of both IL-I8R chains. It has been demonstrated within SFL cultures that only a
small percentage of these cells express both IL-I8R subunits. Thereby SFL exhibit a lack
of responsiveness to stimulation by exogenous IL-18 (Moller et al. 2002). Experiments
were therefore undertaken to identify expression of both IL-18 receptor subunits within the
PRD lesion. IL-I8Ra and IL-I8RP chains were detected at mRNA level in inflamed PRO
tissues whereas in non-inflamed pulp, IL-I8Ra mRNA but no IL-I8RP was present. These
data were further confirmed by Western blotting, which identified IL-I8Ra protein as
being present within all PRO tissue specimens and half of pulp tissue samples. Current
available antibodies to IL-18RP were not functional in immunochemical assays.
Nevertheless, these data indicated that IL-18 and IL-18Ra mRNA and protein and IL-
18RP mRNA were present in inflamed PRO lesions, providing rationale that IL-I8 may
have functional effects within the novel in vitro explant culture system previously
established.
High levels of spontaneous IL-18 release were observed in the majority of tissue explants
examined. Addition of a range of cytokines or mitogens failed to consistently enhance IL-
18 release suggesting prior maximal induction in vivo. Addition of IL-IO however,
resulted in a 55% reduction in IL-I8 release (p<O.05). Since the majority of this detected
IL-18 was likely to represent pro form, further investigations were undertaken to analyse
the effect of adding exogenous mature IL-I8 to determine if further tissue responses could
be detected. rIL-I8 induced significant increases in the release of IL-I p, IL-6, IL-12, TNF-
a and IFN-y within PRO tissue explant cultures. No effect on IL-4 expression was
observed. The coincident addition of neutralising anti-human IL-I8 antibody abrogated
this effect of IL-I8, confirming specificity. Since IL-I8 conventionally activates T cells in
synergy with IL-I2, I also investigated as to whether synergistic effects on IFN-y release
could be detected. Whereas IL-I8 or IL-12 addition alone induced IFN-y release in PRO
explants, this synthesis was markedly enhanced by addition of IL-I2 and IL-I8 together.
These data suggest that IL-I8 is capable of regulating downstream effector cytokines
within the PRO lesion.
Microbial agents are clearly identified effector stimuli in the initiation of PRD. Although
these agents appeared to have no direct effect upon modulating IL-I8 expression, the
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results from mitogenic stimulation of the explant cultures with neutralising anti-IL-18
antibody clearly suggest that mature (functional) IL-18 was a critical effector molecule in
the up-regulation of endogenous proinflammatory cytokines within the PRD explant
culture system. This further suggests that IL-18 likely plays a critical role in the regulation
of downstream inflammatory mediators within PRD responses to infectious elements.
IL-12, IL-18 and IFN-y are reported to have opposing regulatory functions upon
inflammatory bone destruction. They are responsible for the development of inflammatory
responses within the PRD lesion whilst at the same time having inhibitory effects on
osteoclasts. In vivo experiments have demonstrated that inflammatory bone resorption,
induced by the infection of dental root canals in IL-18-1-, IL-12-1- and IFN-y-I- mice leads
to only a slight reduction in PRD lesion development compared with wild type controls
(Sasaki et al. 2004b). Furthermore, the infusion of rIL-12 into these knockout mice also
exerts no significant effect upon lesion development. Together, these data suggest that, at
least individually, there is considerable functional redundancy of these cytokines in
infection stimulated-bone resorption within the murine pulp exposure model (Sasaki et al.
2004b). The absence of a significant effect on the development of inflammatory PRD
within IL-18-1-, IL-12-1- and IFN-y-I- mice may therefore reflect the balance between a
reduction in proinflammatory signals against a reduction in osteoclast inhibition. However,
it may be postulated that a deficiency in a combination of these cytokines may result in a
significant alteration in PRD lesion development.
Increased IL-18 expression has been observed within tissues derived from patients with
chronic inflammatory diseases for example Crohn's disease and RA thereby suggesting a
possible role in disease pathogenesis (Monteleone et al. 1999, Gracie et al. 1999).
However, early studies did not take into account the role of IL-18BP, which exhibits an
exceptionally high affinity for IL-18. Indeed, IL-18BP was later confirmed to be present
within CD lesions (Kim et al. 2000). Likewise, mRNA expression for IL-18BPa and c
subunits was detected within the PRD lesion. Although the appropriate IL-18BP
neutralising isoforms were detectable in PRD tissues, substantial expression of free IL-18
was observed in PRD explant culture supernatants. This highlights the complexity of the
regulation of IL-18 activity. The significance of the gene expression of IL-18BP and its
role in the inhibition of the proinflammatory effects of IL-18 within the PRO lesion
therefore requires further investigation. Principal biological effects of IL-18 within PRD
inflammatory responses are summarised in Figure 5.21.
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Figure 5.21 Schematic summary of lL-18 orche trated event within PRD.
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6 EFFECTS OF EXOGENOUS CYTOKINES UPON ENDOGENOUS
CYTOKINE EXPRESSION WITHIN HUMAN PRO TISSUE EXPLANTS
6.1 Introduction
Cytokines are key inflammatory mediators involved in orchestrating successful host
responses against pathogenic challenge. They regulate communication between both
immune and stromal cells involved in inflammatory and immune responses (Belardelli and
Ferrantini 2002). Indeed, these mediators modulate the initiation, evolution and cessation
of all immunological processes. They form complex partnerships with one another and
frequently act simultaneously. Cytokines are capable of mutually modulating actions upon
their cellular targets through synergistic enhancement or suppression and by neutralisation
effects. It is established that cytokines playa central mediating role in the pathogenesis of
several chronic inflammatory disorders including rheumatoid arthritis (RA), Crohn's
disease, ulcerative colitis and atherosclerosis. They are responsible for directing chronic
inflammation and are thereby accountable for the concomitant destruction of adjacent
tissue (Andreakos et al. 2004). Depending on the local cytokine milieu, many of these
cytokines are capable of promoting either CD4+ effector Thl or Th2 type immune
responses. The pathway of this response in turn determines whether the host immune status
is directed towards tolerance or immunity (Banchereau and Steinman 1998).
In normal physiological circumstances, inducing stimuli lead to the transient cellular
expression of cytokines. Following this, their gene expression is promptly down-regulated
and they are swiftly degraded. However, in chronic inflammatory disorders, for example
PRD, these cytokines are up-regulated and expressed for extended periods of time.
Dysregulated expression of these cytokines does not occur in a random fashion. Indeed,
they are generally expressed in an ordered hierarchical cascade of events. Several
inflammatory cytokines have been detected within the human PRD lesion. The majority of
studies on human PRD material have identified the presence of cytokines within biopsy
tissue specimens by utilising in-situ hybridisation or immunohistochemistry. In contrast,
only a few studies have examined the concentrations of cytokines released from
unstimulated periradicular cysts and these investigations have analysed only a limited
number of cytokines. To date, no published studies have attempted to characterise
inflammatory events within the human PRD lesion by undertaking functional
investigations upon explant PRD tissue cultures of human origin.
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Experiments within the previous two chapters utilising the novel PRD explant culture
model elucidated that several cytokines are spontaneously released by human PRO tissue
explants. I also established that human PRD explants were responsive to bacterial-derived
mitogens. Furthermore, these moieties were capable of modulating endogenous cytokine
expression within PRO tissue cultures and these effects were quantifiable. Subsequently, I
was able to explore the biology of the novel inflammatory cytokine, interleukin-18, within
this culture system and established the importance of IL-I8 expression in mitogen-driven
inflammatory responses. In addition, I was able to add this proinflammatory mediator to
the PRO tissue cultures and characterise its effects upon endogenous cytokine expression.
The chronically inflamed PRO lesion lS surrounded by dento-alveolar bone that is
constantly remodelling. In addition to physiological homeostasis, this remodelling is
influenced through direct interactions with the adjacent cellular environment of the PRD
tissue. The cytokine milieu established within the lesion is primarily a result of stimulation
from pathogens and their microbial components present within the root canal and cellular
components of the lesion. These cytokines significantly contribute towards protecting the
host from disseminating spread of infectious endodontic pathogens. However, this cytokine
network also plays a central role in the perpetuation of chronic PRO. Additionally, the
release of inflammatory cytokine mediators from cellular constituents of the PRD lesion
likely impact upon neighbouring matrix tissue cells including osteoblasts and osteoclasts.
Thereby, the cytokine network within the PRO lesion likely influences the overall pattern
of surrounding dento-alveolar bone remodelling towards either destruction or repair.
In this chapter, I therefore further investigated the cytokine milieu within the PRO lesion
by utilising the novel PRO explant culture system that I had previously developed. I
analysed the effects of exogenous inflammatory cytokines, which are implicated in
contributing towards perpetuation of the lesion and the concomitant destruction of adjacent
alveolar bone, upon endogenous cytokine expression.
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6.2 In vitro effects of inflammatory mediators upon IL-6 expression within PRD
tissue explant cultures
I had earlier identified that unstimulated PRD explant tissues spontaneously secreted high
levels of IL-18. By using the novel experimental PRD explant culture model, I had also
been able to establish that endogenous expression of critical inflammatory cytokines could
be regulated in vitro by the addition of exogenous IL-18 to tissue cultures. The previous
experiments also demonstrated that unstimulated PRD explant tissue expressed high levels
of spontaneously secreted IL-6. These data suggest that within the PRD lesion, IL-6 might
be an important contributor to the cytokine network. It was therefore of importance to
identify potential upstream regulators of IL-6 expression. Therefore, I first investigated the
effects of the addition of a number of exogenous cytokines to the PRD explant culture
model upon IL-6 expression within short-term cultures.
After 18 h culture, the expression of IL-6 protein within PRD tissue explant supernatants
was moderately increased by the addition of the proinflammatory cytokine IL-12 (p=O.028)
and minimally increased by IL-17A (p=O.020) and IFN-y (p=O.OlS) (Figure 6.1A, B). The
addition of MCSF (p=O.006) to PRD implant cultures also induced a statistically
significant response, resulting in moderately decreased IL-6 supernatant levels. The
addition of IL-IO (p=O.07), IL-lS, IL-22, TNF-a or TGF-p had no observable effect upon
IL-6 secretion at 18 h culture. In addition to the matched, unstimulated explant tissue
controls, cytokine stimulation of PBMC and whole blood cell cultures served as further
controls (Figure 6.2A, B).
I next investigated the effects of these inflammatory mediators over longer-term explant
culture. After 72 h, none of the added cytokines had any effect upon IL-6 cytokine
expression within the PRD explant cultures (Figure 6.3A, B).
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Figure 6.1 In vitro effects of 18 h cytokine stimulation upon IL-6 expression within
PRD explant cultures. PRD explant tissues were stimulated with a panel of key cytokines
for 18 h and supernatant collected and analysed by ELISA. (A) The mean concentration of
IL-6 after cytokine stimulation compared with unstimulated control. (B) The percentage
change in culture supernatant IL-6 concentration between stimulated and unstimulated
control tissues. The total number of PRD explant tissues stimulated with each cytokine is
given in parenthesis. Bars represent the mean IL-6 concentration with the standard error of
the mean.
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Figure 6.2 In vitro effects of 18 h cytokine stimulation upon IL-6 expression within
PBMC and whole blood cell cultures. (A) The mean concentration of IL-6 after cytokine
stimulation compared with unstimulated control in 18 h PBMC cultures. (B) The mean
concentration of IL-6 after cytokine stimulation compared with unstimulated control in 18
h whole blood cell cultures. The total number of separate patient derived cultures
stimulated with each cytokine is given in parenthesis. Bars represent the mean IL-6
concentration with the standard error of the mean.
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Figure 6.3 In vitro effects of 72 h mitogenic stimulation upon IL-6 expression within
PRD explant cultures. PRD explant tissues were stimulated with a panel of key cytokines
for 72 h and supernatant collected and analysed by ELISA. (A) The mean concentration of
IL-6 after cytokine stimulation compared with unstimulated control. (B) The percentage
change in culture supernatant IL-6 concentration between stimulated and unstimulated
control tissues. The total number of PRD explant tissues stimulated with each cytokine is
given in parenthesis. Bars represent the mean IL-6 concentration with the standard error of
the mean.
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6.3 In vitro effects of inflammatory mediators upon IL-8 expression within PRD
tissue explant cultures
The previous experiments established that within the PRD explant system, IL-6 expression
was inducible by key inflammatory cytokine mediators at 18 h culture. Having previously
ascertained that unstimulated PRD explants also produced significant quantities of IL-8,
elucidation of upstream regulators of IL-8 production is therefore of importance.
Therefore, I next investigated whether the same panel of cytokines could modulate IL-8
expression. Initially, I examined their influence upon IL-8 within short-term 18 h PRD
explant cultures.
18 h tissue culture with proinflammatory cytokines IL-12 (p=0.081), IL-17A (p=0.161)
and MCSF (p=0.176) resulted in minor increases in IL-8 expression that were below levels
of significance (Figure 6.4A, B). The addition ofIFN-y (p=O.372), TGF-~ (p=O.147), IL-15
and TNF-u to tissue explants had no observable impact upon IL-8 secretion at 18 h culture.
In addition to matched unstimulated explant tissue controls, cytokine stimulation of PBMC
and whole blood cell cultures served as further controls (Figure 6.5A, B).
Having determined that addition of the selected inflammatory cytokine mediators to human
PRD explants had no marked effect upon IL-8 secretion at 18 h culture, I undertook further
investigations to determine if they were able to modulate IL-8 expression over longer-term
culture. After 72 h culture, the addition ofIL-15 (p=O.031) or IFN-y (p=O.031) resulted in
minimal reductions of IL-8 expression. IL-12 (p=O.053) induced a moderate though non-
significant increase in IL-8 expression. IL-I0, IL-l 7A and TNF -u (p=0.192) had no
observable effect upon IL-8 expression at 72 h culture (Figure 6.6A, B).
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Figure 6.4 In vitro effects of 18 h cytokine stimulation upon IL-8 expression within
PRD explant cultures. PRD explant tissues were stimulated with a panel of key cytokines
for 18 h and supernatant collected and analysed by ELISA. CA)The mean concentration of
IL-8 after cytokine stimulation compared with unstimulated control. CB)The percentage
change in culture supernatant IL-8 concentration between stimulated and unstimulated
control tissues. The total number of PRD explant tissues stimulated with each cytokine is
given in parenthesis. Bars represent the mean IL-8 concentration with the standard error of
the mean.
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Figure 6.5 In vitro effects of 18 h cytokine stimulation upon IL-8 expression within
PBMC and whole blood cell cultures. (A) The mean concentration of IL-8 after cytokine
stimulation compared with unstimulated control in 18 h PBMC cultures. (B) The mean
concentration of IL-8 after cytokine stimulation compared with unstimulated control in 18
h whole blood cell cultures. The total number of separate patient derived cultures
stimulated with each cytokine is given in parenthesis. Bars represent the mean IL-8
concentration with the standard error of the mean.
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Figure 6.6 In vitro effects of 72 h mitogenic stimulation upon IL-8 expression within
PRD explant cultures. PRD explant tissues were stimulated with a panel of key cytokines
for 72 h and supernatant collected and analysed by ELISA. (A) The mean concentration of
IL-8 after cytokine stimulation compared with unstimulated control. (B) The percentage
change in culture supernatant IL-8 concentration between stimulated and unstimulated
control tissues. The total number of PRD explant tissues stimulated with each cytokine is
given in parenthesis. Bars represent the mean IL-8 concentration with the standard error of
the mean.
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6.4 In vitro effects of inflammatory mediators upon IL-IO expression within PRD
tissue explant cultures
The previous experiment demonstrated that exogenous cytokine addition to PRO explant
tissue cultures had minimal modulatory effects upon the expression of endogenous IL-8. I
therefore undertook further investigations to determine if the same panel of exogenous
cytokines had any effect upon the secretion of the predominantly antiinflammatory
cytokine, IL-IO. Initially, I explored the modulation of IL-IO expression by these
mediators in short-term PRO explant culture.
The addition of TNF-a (p=O.OIS) to PRO tissue explants resulted in a moderate and
statistically significant increase in IL-IO secretion at 18 h culture (Figure 6.7AB). IFN-y
and IL-22 (p=O.lS8) also induced minimal increases of IL-I0 expression in 18 h PRO
explant cultures. However, these were below levels of significance. Addition of IL-12, IL-
lS (p=O.12l), IL-17A, MCSF and TGF-~ to explant cultures resulted in only minor
decreases in IL-lO concentrations at 18 h. These were also below levels of statistical
significance. In addition to matched unstimulated explant tissue controls, cytokine
stimulation of 18 h PBMC and whole blood cell cultures served as further controls (Figure
6.8A,B).
I further explored the effects of the addition of these cytokines to long-term explant
cultures. After 72 h explant tissue culture, TNF-a (p=O.05) induced a moderate increase of
IL-lO expression at levels of statistical significance. The addition of IL-IS (p=O.08), IFN-y
(p=O.09) or IL-12 (p=O.0143) to PRO tissue explants induced only minor increases of
secreted IL-lO protein within harvested supernatants at 72 h culture (Figure 6.9A,B).
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Figure 6.7 In vitro effects of 18 h cytokine stimulation upon IL-I0 expression within
PRD explant cultures. PRD explant tissues were stimulated with a panel of key cytokines
for 18 h and supernatant collected and analysed by ELISA. (A) The mean concentration of
IL-IO after cytokine stimulation compared with unstimulated control. (B) The percentage
change in culture supernatant IL-IO concentration between stimulated and unstimulated
control tissues. The total number of PRD explant tissues stimulated with each cytokine is
given in parenthesis. Bars represent the mean IL-IO concentration with the standard error
of the mean.
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Figure 6.8 In vitro effects of 18 h cytokine stimulation upon IL-IO expression within
PBMC and whole blood cell cultures. (A) The mean concentration of IL-I0 after
cytokine stimulation compared with unstimulated control in 18 h PBMC cultures. (B) The
mean concentration of IL-I0 after cytokine stimulation compared with unstimulated
control in 18 h whole blood cell cultures. The total number of separate patient derived
cultures stimulated with each cytokine is given in parenthesis. Bars represent the mean IL-
10 concentration with the standard error of the mean.
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Figure 6.9 In vitro effects of 72 h mitogenic stimulation upon IL-IO expression within
PRD explant cultures. PRD explant tissues were stimulated with a panel of key cytokines
for 72 h and supernatant collected and analysed by ELISA. CA) The mean concentration of
IL-1O after cytokine stimulation compared with unstimulated control. (B) The percentage
change in culture supernatant IL-I0 concentration between stimulated and unstimulated
control tissues. The total number of PRD explant tissues stimulated with each cytokine is
given in parenthesis. Bars represent the mean IL-1O concentration with the standard error
of the mean.
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6.5 In vitro effects of inflammatory mediators upon IL-17 A expression within PRD
tissue explant cultures
I next explored the effects of the same panel of cytokines upon the expression of the
recently discovered and novel cytokine, IL-17A over short-term PRD tissue explant
culture. The addition of IL-15 (p=0.043) to PRD tissue explants markedly increased IL-
17A expression at 18 h culture (Figure 6.1OA, B). Stimulation with exogenous IL-22
(p=0.004), IFN-y (p=O.058) or TNF-a (p=O.OI4) resulted in minor increases of IL-17A
protein expression within 18 h explant culture supernatants. The addition of IL-I0
(p=O.24I ) to explant tissue cultures produced only a moderate decrease in IL-17A
secretion that was below levels of significance. As IL-17A has not been previously
described within the PRD lesion, I undertook further experiments to confirm the presence
and molecular weight of the target molecule within PRD lesions by Western blotting
(Figure 6.11A). Immunohistochemistry experiments were also performed to identify the
cellular expression of IL-17A (Figure 6.11B, C). IL-17A was identified in the majority of
PRD lesions examined by both Western blotting and IHC (n=24/25). From IHC
experiments, IL-17A expression was primarily located to cells exhibiting the morphology
of T lymphocytes. However, fibroblast-like cells were also identified as being positive for
the expression of IL-17A (investigated in chapter 8).
Having determined that IL-17A expression could be modulated by the individual addition
of several exogenous cytokines at 18 h culture, I further examined their effects upon PRD
tissues at 72 h culture. The addition of exogenous IL-15 (p=O.049) to the tissue explant
cultures substantially increased IL-17A expression within culture supernatant at 72 h
(Figure 6.12A,B). Furthermore, TNF-a (p=O.l1) and IFN-y (p=0.048) markedly increased
IL-17A secretion at 72 h explant culture. At 72 h culture, IL-22 and IL-1O induced only
minimal increases in IL-17A secretion, below levels of significance.
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Figure 6.10 In vitro effects of 18 h cytokine stimulation upon IL-17A expression
within PRD explant cultures. PRD explant tissues were stimulated with a panel of key
cytokines for 18 h and supernatant collected and analysed by ELISA. (A) The mean
concentration of IL-17A after cytokine stimulation compared with unstimulated control.
(B) The percentage change in culture supernatant IL-17A concentration between
stimulated and unstimulated control tissues. The total number of PRD explant tissues
stimulated with each cytokine is given in parenthesis. Bars represent the mean IL-17A
concentration with the standard error of the mean.
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Figure 6.11 Confirmation of IL-17A expression in PRD tissue. (A) Western blot of 4
PRD tissue protein lysates confirming the molecular weight of IL-I7 A. (B)
Immunohistochemical detection of IL-I7 A within PRD tissue biopsies, low power
magnification. (C) High power resolution of IL-I7 A within PRD tissues, orange arrows
represent IL-17 A positive cells (T lymphocytes), blue arrows represent IL-I8 positive cells
(macrophages) in close proximity.
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Figure 6.12 In vitro effects of 72 h mitogenic stimulation upon IL-17A expression
within PRD explant cultures. PRD explant tissues were stimulated with a panel of key
cytokines for 72 h and supernatant collected and analysed by ELISA. CA) The mean
concentration of IL-l 7A after cytokine stimulation compared with unstimulated control.
(B) The percentage change in culture supernatant IL-17A concentration between
stimulated and unstimulated control tissues. The total number of PRD explant tissues
stimulated with each cytokine is given in parenthesis. Bars represent the mean IL-I7 A
concentration with the standard error of the mean.
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6.6 In vitro effects of inflammatory mediators upon IFN-y expression within PRD
tissue explant cultures
From the previous experiments, I ascertained that within the novel PRD explant culture
system, proinflammatory cytokine expression could be manipulated and further induced by
the addition of exogenous cytokines. I therefore investigated the effects of these
inflammatory mediators upon the expression of a cytokine that is central to inflammatory
immune responses of infectious aetiology, namely IFN-y. Experiments were initially
undertaken upon short-term tissue explant cultures and the expression of IFN-y was
assayed by ELISA after 18 h.
Concentrations of IFN-y within 18 h PRD tissue explant cultures were substantially
increased by the addition of exogenous IL-12 (p=0.040) or IL-IS (p=0.003) (Figure 6.13A,
B). The addition of IL-17A (p=0.05) to these 18 h tissue cultures also markedly increased
IFN-y expression. The expression of IFN-y was also modestly increased by the addition of
IL-lO (p=O.047) and TNF-a (p=O.085) to explants. Both IL-22 (p=O.270) and TGF-~
(p=0.061) induced only minimal, non-significant increases in IFN-y expression at 18 h
culture. In addition to matched unstimulated explant tissue controls, cytokine stimulation
of 18 h PBMC and whole blood cell cultures served as further controls (Figure 6.14A, B).
Having established that IFN-y production could be manipulated by the addition of
cytokines to PRD explants at 18 h culture, these effects were further explored over periods
of 72 h culture. As observed at 18 h, IL-12 (p=O.024) and IL-15 (p=O.022) substantially
increased IFN-y expression after 72 h tissue culture (Figure 6.15A, B). IL-17A (p=0.040)
also induced a marked increase in the expression of IFN-y compared to unstimulated
controls. However, the greatest modulator ofIFN-y expression was the substantial increase
induced by TNF-a (p=O.037). The addition of IL-tO (p=0.OS7), TGF-~ (p=0.0006, n=4)
and IL-22 to tissue explants moderately increased IFN-y expression after 72 h culture.
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Figure 6.13 In vitro effects of 18 h cytokine stimulation upon IFN-y expression within
PRD explant cultures. PRD explant tissues were stimulated with a panel of key cytokines
for 18 h and supernatant collected and analysed by ELISA. (A) The mean concentration of
IFN-y after cytokine stimulation compared with unstimulated control. (B) The percentage
change in culture supernatant IFN-y concentration between stimulated and unstimulated
control tissues. The total number of PRD explant tissues stimulated with each cytokine is
given in parenthesis. Bars represent the mean IFN-y concentration with the standard error
of the mean.
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Figure 6.14 In vitro effects of 18 h cytokine stimulation upon IFN-y expression within
PBMC and whole blood cell cultures. (A) The mean concentration of IFN-y after
cytokine stimulation compared with unstimulated control in 18 h PBMC cultures. (B) The
mean concentration of IFN-y after cytokine stimulation compared with unstimulated
control in 18 h whole blood cell cultures. The total number of separate patient derived
cultures stimulated with each cytokine is given in parenthesis. Bars represent the mean
IFN-y concentration with the standard error of the mean.
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Figure 6.15 In vitro effects of 72 h cytokine stimulation upon IFN-y expression within
PRD explant cultures. PRD explant tissues were stimulated with a panel of key cytokines
for 72 h and supernatant collected and analysed by ELISA. (A) The mean concentration of
IFN-y after cytokine stimulation compared with unstimulated control. (B) The percentage
change in culture supernatant IFN-y concentration between stimulated and unstimulated
control tissues. The total number of PRD explant tissues stimulated with each cytokine is
given in parenthesis. Bars represent the mean IFN-y concentration with the standard error
of the mean.
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6.7 In vitro effects of inflammatory mediators upon TNF-a expression within PRD
tissue explant cultures
Finally, I investigated the effects of cytokine addition to PRD tissue explants upon
endogenous expression of the proinfiammatory cytokine TNF-a over short-term, 18 h
culture. 18 h stimulation of PRD tissue explants with IFN-y (p=O.027) resulted in a marked
increase in TNF-a expression within culture supernatants (Figure 6.I6A, 8). The addition
of TGF-p (p=O.0026) to PRD tissues resulted in a modest and statistically significant
increase of TNF-a within explant supernatant. Addition of IL-12 (p=O.08), IL-I5
(p=O.0287), IL-17 A (p=O.06) or MCSF (p=O.OO19) only minimally increased expression of
TNF-a at 18 h explant culture. IL-I0 modestly reduced TNF-a expression at 18 h, below
levels of significance. In addition to unstimulated matched explant tissue controls, cytokine
stimulation of 18 h PBMC and whole blood cell cultures further served as controls (Figure
6.17A, B).
These results established that TNF -a expression within the PRD explant culture system
could be modulated by the addition of exogenous inflammatory mediators at 18 h culture. I
therefore also investigated the effects of these cytokines upon TNF -a production over
longer-term culture. After 72 h tissue explant culture, IL-17 A (p=O.044) and TGF-p
(p=O.007) both induced moderate increases in TNF-a expression (Figure 6.18A, B). IFN-y
(p=O.097) stimulation of explant cultures for 72 h induced only a marginal increase in
TNF-a secretion, which was below levels of significance. MCSF, IL-22 and IL-15 had no
observable effects upon TNF-a expression at 72 h culture. IL-IO (p=O.09) induced a minor
reduction ofTNF-a secretion after 72 h of culture.
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Figure 6.16 In vitro effects of 18 h cytokine stimulation upon TNF-a expression within
PRD explant cultures. PRD explant tissues were stimulated with a panel of key cytokines
for 18 h and supernatant collected and analysed by ELISA. (A) The mean concentration of
TNF-a after cytokine stimulation compared with unstimulated control. (B) The percentage
change in culture supernatant TNF -c concentration between stimulated and unstimulated
control tissues. The total number of PRD explant tissues stimulated with each cytokine is
given in parenthesis. Bars represent the mean TNF-a concentration with the standard error
of the mean.
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Figure 6.17 In vitro effects of 18 h cytokine stimulation upon TNF -(1 expression within
PBMC and whole blood cell cultures. (A) The mean concentration of TNF-a after
cytokine stimulation compared with unstimulated control in 18 h PBMe cultures. (B) The
mean concentration of TNF-a after cytokine stimulation compared with unstimulated
control in 18 h whole blood cell cultures. The total number of separate patient derived
cultures stimulated with each cytokine is given in parenthesis. Bars represent the mean
TNF-a concentration with the standard error of the mean.
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Figure 6.18 In vitro effects of 72 h cytokine stimulation upon TNF-a expression within
PRD explant cultures. PRD explant tissues were stimulated with a panel of key cytokines
for 72 h and supernatant collected and analysed by ELISA. CA)The mean concentration of
TNF-a after cytokine stimulation compared with unstimulated control. CB)The percentage
change in culture supernatant TNF-a concentration between stimulated and unstimulated
control tissues. The total number of PRD explant tissues stimulated with each cytokine is
given in parenthesis. Bars represent the mean TNF-a concentration with the standard error
of the mean.
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6.8 Discussion
The cytokine network is central to the perpetuation of inflammatory responses and thereby
chronic persistence of pathological lesions. Recent evidence supports the opinion that the
cytokine network has a central role in initiation and development of the periradicular
lesion. In previous experiments, I established that 18 h and 72 h after surgical retrieval,
PRD tissue explants spontaneously released plenteous quantities of cytokines. The
substantial constitutive release of several key inflammatory cytokines within unstimulated
cultures suggests they are important contributors towards prolonging chronic inflammatory
events within the lesion. The identification of novel upstream cytokines that induce
expression of these secreted inflammatory cytokines is of key importance. I ascertained in
previous experiments that endogenous cytokine expression within PRD explant tissue
cultures could be modulated by addition of bacterial-derived mitogens or cytokine stimuli,
in the form of IL-18.
In this chapter, I further utilised the PRD explant model to investigate potential upstream
inflammatory mediators. I determined their effects upon secretion of endogenously
expressed cytokines that may contribute towards inflammatory events within the PRD
lesion and potentially, the destruction of surrounding alveolar bone. The key important
findings from these experiments are summarised in Table 6.1. The table takes into account
findings that are seen to be statistically significant but may not be of biological importance.
For example, a 15% increase induced by one cytokine stimulant at levels of statistical
significance may be of little biological significance when compared to cytokine
concentrations that have changed by 200% or greater.
IL-lO is a type 2 cytokine primarily produced by macrophages and T cells. Although
possessing pleiotropic effects on immuno-inflammatory reactions, IL-lO is predominantly
anti-inflammatory. Thereby, IL-lO regulates the fine balance between pathology and
protection (Moore et af. 2001). Through its ability to inhibit proinflammatory cytokine
synthesis and reduce surface antigen expression, IL-lO down-regulates inflammatory and
immune responses. Indeed, IL-10 has been described as a macrophage deactivating
cytokine that down-regulates proinflammatory responses such as the release of oxygen
radicals, nitric oxide or TNF-u. It was therefore of interest to find that PRD tissue explants
spontaneously expressed moderate quantities of IL-IO. In agreement with its
acknowledged anti-inflammatory role, IL-10 decreased expression of proinflammatory
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mediators IL-17A and TNF-a within the PRD explant culture model. In contrast, IL-IO had
no effect upon IL-6 or IL-8 and slightly increased expression of IFN-y in long-term
culture. Reductions in IL-17A and TNF-a expression within PRD cultures may reflect a
negative feedback loop, whereby IL-IO limits the inflammatory response to prevent
pathologic damage.
IL-4, another Th2 type cytokine, inhibits bone erosion by interacting directly with bone
osteoclasts and indirectly by inhibiting the production of proinflammatory cytokines. Bone
resorption induced by RANKL is dose dependently inhibited by direct effects of IL-4 upon
both osteoclast precursors and mature osteoclasts (Wei et al. 2002, Mangashetti et al.
2005). Interestingly, IL-4 was not detectable within resting PRD tissue cultures and was
not inducible by other cytokines. This suggests predominance of Th I type responses within
the PRD lesion. It may be postulated that the absence of protective, antiinflammatory
effects afforded by IL-4 may contribute towards lesion expansion. However, in contrast to
IL-IO, PRD lesion size within the murine model is not affected by IL-4 expression,
indicating the heterogeneity amongst Th2 type cytokines (Sasaki et al 2000). Bone
protective responses may therefore be significantly driven by IL-IO-mediated pathways
within the human PRD tissue lesion.
IL-12 is an essential proinflammatory cytokine predominantly produced by phagocytic and
dendritic cells. In contrast to IL-4 and IL-IO, it stimulates innate and CD4+ effector Th 1
type immune responses and is essential for resistance against infection. I had previously
ascertained that IL-12 was spontaneously secreted by unstimulated PRD explant cultures.
The addition of IL-12 to PRD explant cultures resulted in a powerful pro-inflammatory
response, resulting in up-regulated expression of IL-6, IL-8 and IFN-y. Interestingly, after
long term culture IL-12 induced a moderate increase in IL-IO secretion. Similar to TNF-a
and IFN-y, the late increase induced by IL-12 upon IL-IO secretion may form part of a
negative feedback loop to prevent exaggerated destructive proinflammatory responses.
Addition of IL-17A to PRD tissue cultures induced a strong proinflammatory response
with significantly increased levels of TNF-a and IFN-y and increased IL-6 and IL-8
expression. To my knowledge, IL-17A has not previously been reported to induce
increased expression of IFN-y. Previous studies have established a synergistic effect
between IL-17A and IFN-y upon increasing IL-6 and IL-8 expression (Andoh et al. 200 I).
The release of IL-l 7A within the PRD lesion may therefore form a regulatory loop
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whereby IFN-y expression is increased and concomitant production of IL-17A with IFN-y
results in further increased expression of IL-6 and IL-S. The proinflammatory cytokines
IL-15, TNF-a and IFN-y further increased IL-I 7A expression. IL-17A is capable of
stimulating osteoclast differentiation and inducing bone resorption through induction of
RANK on the surface of osteoblasts (Kotake et a/. 200 I). IL-17A expression within the
PRD lesion may therefore be a major contributing factor towards associated periradicular
bone resorption. The potentially damaging effects of these proinflammatory cytokines
upon promoting IL-17A-induced matrix destruction may in part be tempered by
endogenous release of IL-I 0, which modestly decreased IL-17A expression. In contrast,
others have demonstrated that IL-IO has no effect upon IL-17 expression (Chabaud et al.
1999).
NK cells are important innate producers of IFN-y at early stages of host infection (Daniels
et al. 2001, Pien and Biron 2000). Recent data suggest that through cytokine and
chemokine expression, NK cells contribute toward the development of other adaptive
responses. It is well established that the ability of professional APes to mediate many of
their coactivating functions is by the production of soluble mediators such as IL-12. The
ability of NK and NKT cells to rapidly secrete IFN-y, a key molecule in the development
of adaptive immune responses, and chemokines (MIP-I a) that can recruit selective subsets
of leukocytes, suggest that another role of NK cells is to modulate the delicate balance of
immune development in response to viral or microbial challenge. Thereby, innate NK cell
IFN-y production will provide early immune regulation that can alter the outcome and
quality of the adaptive immune response (Ortaldo and Young 2003). It is therefore of great
importance that addition of IL-12, IL-15 and TNF-a to PRD explants induced substantially
increased levels of secreted IFN-v, Furthermore, addition of IL-l 7A to explants
contributed towards increased IFN-y expression. Cellular sources of inducible IFN-y
secretion within PRD tissues remain to be identified, but NK cells are likely to play their
part. The release of IFN-y following the activation of cells with cytokines or bacterial
derived mitogens likely leads to further increased expression of proinflammatory cytokines
including IL-6, IL-17A and TNF-a, thereby perpetuating the inflammatory reaction.
TGF-~I is a multifunctional growth factor released by inflammatory cells in response to
bacterial products and tissue injury (Wahl 1994) and osteoblasts, fibroblasts and
osteoclasts (Bonewald 1999). In addition to its anti-inflammatory properties, TGF-PI
induces prointlammatory effects including recruitment and activation of neutrophils,
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monocytes and T cells (Brandes et at. 1991). Furthermore, TGF-~l triggers production of
bone resorptive cytokines such as IL-L TNF-a, and IL-6 (Brandes et al. 1991, Wahl 1992)
and directly induces mononuclear phagocyte osteoblast precursors to differentiate into
active osteoclast cells in the presence of M-CSF and absence of RANKL (Itonaga et al.
2004). Despite finding that TGF-~l can induce osteoclastogenesis without an absolute
requirement for RANKL it plays a pivotal role in inducing both RANKL gene expression
and protein formation in a dose-dependant manner (Zhang et al. 2003). The role ofTGF-131
within inflammatory bone destruction is rather unclear. Within animal models, TGF-131
down-regulates proinflammatory cytokine production and exerts protective effects in
collagen induced arthritis (Kuruvilla et al. 1991) and suppression of TGF-131by NK cells
promotes antibody-induced joint inflammation (Kim et at. 2005). Conversely, TGF-131
promotes inflammation by enhancing neutrophil infiltration and induces angiogenesis
within joint tissues. Addition of TGF-~l to PRO explant tissues had limited effects upon
modulating endogenous cytokine expression. However, it significantly increased TNF-a
expression at both 18 h and 72 h explant culture and interestingly induced IL-I0 in long-
term culture. The late increase in IL-I0 expression may serve to counter-regulate
potentially destructive proinflammatory effects from increased TNF-a expression induced
by TOF-Pl.
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Table 6.1 Effect of endogenous cytokine stimulation upon endogenous cytokine
expression within PRD explant cultures. Table represents the major biological effects of
a panel of cytokines added to PRD explant cultures. Time point of culture is given in
number of hours at time of analysis (blue represents 18 h, red represents 72 h). Measured
cytokine within explant supernatant by ELISA is displayed in top row. Recombinant
human cytokine added to explant cultures are indicated in left column. i-increased
expression of analysed cytokine. ~- decreased expression of analysed cytokine. Number of
arrows corresponds with the quantity of change in measured cytokine concentration. ?-
represents a query as to the meaningful biological significance of induced change in
cytokine expression in the context of specific quantity of change and its relationship with
changes induced by other cytokine stimulants. A dash represents no observable change in
cytokine concentration compared with control.
Cytokine
measured IL-6 IL-8 IL-I0 IL-17A TNF-a IFN-y
Time r++
18 h 18 h 72h 18 h 72h 18 h 72h 18 h 72h
~Stimulant
18 h 72h 72h
- - - - N/A N/A ~ - ~ , - 1'?... ' .
IL-I0
it - j i? - i? - - - - iii iii
IL-12
- - t? - t? - rt n i? - iii iii
IL-15
i? - - - F N/A N/A i? i it .,..+- i
IL-17A
- - - - j? - i? - - - - -
IL-22
- - - - i? i t i N/A N/A i tit
TNF-a
i - - ~? - i i rr n i N/A N/A
IFN-y
~? - - - - - - - i? - - -
M-CSF
- - - - - i - - i t - -
TGF-p
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Figure 6.19 Schematic representation of the key cytokine inducers within the PRD
cytokine network involved in regulating inflammatory bone resorption.
Figure 6.19 Schematic representation of the key cytokine inducers within the PRD
cytokine network involved in regulating inflammatory bone resorption.
Spontaneous expression of pro inflammatory cytokines IL-12, IL-15, IL-17A and TNF-a is
readily detectable within PRO. These moieties likely induce T and NK cell activation and
thereby contribute towards IF -y secretion. IL-15 and TNF-a promote IL-17 A expression
that likely feedbacks in a regulatory loop to induce increased expression of IFN-y, which in
tum perpetuates the inflammatory response by promoting further increases in secreted IL-
17A. However, continued secretion of IL-12, IF -y and TNF-a stimulates macrophage
release of IL-l 0 which operates in a negative feedback loop to decrease IL-17 A and TNF-a
expression. Thereby adverse destructive inflammatory response may be down-regulated. In
addition to the contribution of immune cells to inflammatory events, IFN-y, 11-12 and IL-
17A promote fibroblast secretion of IL-6 and/or IL-8 which likely contributes towards
matrix destruction.
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CHAPTER 7
OSTEOPROTEGERIN (OPG)
AND
RECEPTOR ACTIVATOR OF NF-KB LIGAND (RANKL)
WITHIN HUMAN
PRD
7 OSTEOPROTEGERIN (OPG) AND RECEPTOR ACTIVATOR OF NF-KB
LIGAND (RANKL) WITHIN HUMAN PRD
7.1 Introduction
Bone remodelling involves the closely regulated and opposing effects of bone deposition
and bone resorption. The key cellular modulators of this dynamic process are bone
synthesising osteoblasts (Ducy et al. 2000) and bone resorbing osteoclasts (Teitelbaum
2000). Osteoclastic bone resorption and osteoblastic bone deposition are intimately related
and closely balanced between one another. Through their effects upon osteoblast and
osteoclast precursors, systemic hormones and local mediators moderate the dynamic
process of bone deposition and resorption. Among the multitude of bone modulating
molecules, receptor activator of nuclear factor-xis ligand (RANKL) is central to the
regulation of osteoclastogenesis. Conversely, osteoprotegerin (OPO) is a naturally
occurring antagonist of RANKL with an inhibitory effect upon bone resorption (Bucay et
. al. 1998, Emery et al. 1998). In order to balance bone density and resorption positively and
negatively, the expression of RANKL and OPO is carefully coordinated. This primarily
occurs through modulating the activation state of RANK on osteoclasts (Simonet et al.
1997, Akatsu et al. 1998, Kong et al. 1999, Boyle et al. 2003).
In addition to the RANKLIRANKJOPO regulatory axis, cytokines are implicated as
important contributors in bone remodelling processes (Manolagas 1995, Jilka 1998). TNF-
a induces osteoclastogenesis through direct stimulation of macro phages (Lam et al. 2000,
Kudo et al. 2002). Furthermore, IL-l and TNF-a are capable of regulating OPO and
RANKL gene expression in osteoblastic cells (Hofbauer et al. 1999). IL-8 also has a direct
stimulatory effect upon osteoclastogenesis and bone destruction ( Bendre et al. 2003).
Thereby, cytokines have the potential to alter the balance from bone remodelling in favour
of bone resorption. Cytokines are therefore central to the pathogenesis of several chronic
inflammatory bone diseases including rheumatoid arthritis (Chu et al. 1991) and
osteomyelitis (Meghji et al. 1998).
Elevated levels of IL-l 7A are detected within synovial fluid from patients with RA
(Kotake et at. 1999, Chabaud et at. 1999). In experimental models, IL-17 A stimulates
osteoclast differentiation and induces bone resorption through inducing RANKL
expression on the surface of osteoblasts. Conversely, OPG inhibits IL-17 A-induced
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osteoclast differentiation (Kotake et al. 2001). Within the collagen induced arthritis (CIA)
model, IL-17 A up-regulates RANKL expression thereby contributing towards disease
progression (Lubberts et al. 2003). Neutralisation of lL-I 7A within this model
significantly reduces the severity of CIA, resulting in markedly suppressed joint damage
(Lubberts et al. 2004). Local release of IL-17 A in chronic inflammatory bone disorders
results in up-regulated expression of RANKL from local stromal cells, thereby contributing
towards osteoclastogenesis (Page and Miossec 2005). Moreover, IL-17-mediated increases
in RANKL expression is potently enhanced by IL-l P or TNF-a.
IL-I7 A, IL-I J3 and TNF-a exhibit predominantly bone resorptive properties. Conversely,
IL-12 inhibits osteoclast formation in co-cultures of mouse adult spleen and osteoblastic
cells treated with M-CSF and RANKL (Horwood et al. 2001). IL-12 also inhibits
osteoclast formation in bone marrow cell cultures (Nagata et al. 2003). Of importance, IL-
12 induces IFN-y production from T and NK cells (Yoshimoto et al. 1998). Subsequently,
IFN-y potently inhibits osteoclast formation by interfering with the RANKL-RANK
signalling pathway (Takayanagi et al. 2000b). IFN-y also prevents osteoclast formation by
directing osteoclast progenitor differentiation towards an alternative cytocidal lineage to
the osteoclast (Fox and Chambers 2000). It can be understood from these studies that the
balance between RANKL and OPG expression is influenced by the overall cytokine
milieu. Therefore, a dominant expression of cytokines that increase RANKL expression
and directly promote bone resorption such as IL-17A, IL-IP and TNF-a will likely drive
inflammatory processes towards localised tissue destruction.
There is limited information on expression of RANKL and OPG within the PRD lesion.
Furthermore, no data is currently available defining modulators of RANKL and OPG
expression within PRO. I therefore undertook investigations to determine if RANKL or
OPG were present within the human PRD lesion. Furthermore, I studied the effects of
mitogen or cytokine addition to PRO explant cultures upon RANKL and OPG expression.
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7.2 Detection ofOPG and RANKL within human PRD tissue
From my previous experiments it was apparent that many cytokines recognised as
mediators of inflammatory bone resorption were detectable within the novel PRD explant
tissue culture model. Furthermore. I established that expression of inflammatory cytokines
could be induced or suppressed by addition of either bacterial-derived microbial products
or inflammatory cytokines to the novel explant culture system. I therefore next investigated
if the principal mediators responsible for directing bone homeostasis. OPG and RANKL,
were detectable within the explant culture model. I initially investigated if secreted
RANKL and OPG could be detected by ELISA as previously described within
unstimulated 18 hand 72 h PRO explant culture supernatant.
RANKL and OPG were spontaneously released by unstimulated PRO explant tissues at 18
hand 72 h culture (Figure 7.1). Using immunohistochemistry staining, OPG was expressed
by a variety of cell types including lymphocytes and stromal cells. Available antibodies for
detection of RANKL were not functional on the FFPE sections. OPG and RANKL
expression was confirmed by Western blotting (Figure 7.2).
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Figure 7.1 Spontaneous release of OPG and RANKL within human PRD explant
tissue cultures. 'Resting' levels of spontaneously released OPG and RANKL within PRD
tissue explant culture supernatants were assessed. Unstimulated PRD explant tissue culture
supernatant was harvested at 18 h (A) and at 72 h (B). RANKL and OPG expression were
analysed by ELISA. Bars represent the mean concentration for each mediator with the
standard error of the mean. The number of unstimulated PRD tissues used in experiments
for the measurement of each individual cytokine is given in parenthesis.
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Figure 7.2 Detection of OPG and RANKL within human PRD tissue. (A) Western
blot of three PRD specimens for OPG protein. Representative of 15 analysed PRD
specimens. (B) Low levels of RANKL detectable in 8/15 PRD specimens by Western
blotting. OPG expression located primarily to (C) fibroblasts and (D) inflammatory cells.
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7.3 In vitro effects of mitogenic addition to PRD explants upon endogenous OPG
and RANKL expression
The previous experiments established that OPG and RANKL were expressed within PRO
lesions and secreted by explant tissues into culture supernatants. I next sought to determine
if moieties responsible for initiation and perpetuation of the PRO lesion, namely microbial-
derived agents were capable of modulating OPG or RANKL expression. Therefore, LPS or
SEB were added to PRD explant tissue cultures at previously described concentrations.
Tissue culture supernatant was harvested at 18 hand 72 h, and OPG and RANKL
concentrations assayed by ELISA as previously described.
After 18 h explant culture, SEB and LPS had no significant effect upon RANKL
supernatant concentrations (Figure 7.3A). However, SEB negatively regulated OPG
secretion, inducing a moderate decrease in OPG expression that was at levels of statistical
significance (p=O.047) at 18 h culture (Figure 7.3B). LPS had no observable effect upon
OPG explant supernatant concentration at 18 h PRO tissue culture.
I next investigated the addition of these moieties to long-term PRO explant cultures and
examined RANKL and OPG expression. SEB induced only a minimal increase in RANKL
concentration after 72 h culture and the addition of LPS resulted in a slight decrease in
RANKL, neither observation being of significance. At 72 h culture, SEB only slightly
down-regulated OPG expression, not at levels of significance (p=O.27). As at 18 h. LPS
had no effect upon OPG secretion at 72 h culture (Figure 7.3C and 0).
From these experiments, I therefore ascertained that these specific Gram-negative and
Gram-positive moieties had no significant biological impact upon OPO and RANKL
expression within the PRO explant model.
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Figure 7.3 In vitro effects of 18 hand 72 h mitogenic stimulation of PRD explants on
RANKL and OPG supernatant levels. PRD explant tissues were stimulated with LPS or
SEB for 18 h and 72 h. Supernatants were collected and analysed by ELISA for RANKL
and OPO. (A) The mean concentration of RANKL after mitogenic stimulation of explants
compared with their corresponding unstimulated controls at 18 h. (B) The mean
concentration of supernatant OPO after mitogenic stimulation of explants compared with
their corresponding unstimulated controls at 18 h. (C) The mean concentration of RANKL
after mitogenic stimulation of explants compared with their corresponding unstimulated
controls at 72 h. (D) The mean concentration of OPG after mitogenic stimulation of
explants compared with their corresponding unstimulated controls at 72 h. The number of
PRD tissues used in experiments for the measurement of each individual cytokine is given
in parenthesis. Bars represent the mean concentration for each cytokine and the standard
error of the mean.
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7.4 In vitro effects of TNF -(I and IFN-y addition to PRD explants upon endogenous
RANKL and OPG expression
Having determined that bacterial-derived stimuli had little effect upon RANKL and OPG, I
next investigated if addition to PRD explant cultures ofTNF-a or IFN-y, two key cytokine
mediators implicated within inflammatory bone diseases, had any modulatory effect upon
RANKL and/or OPG expression. Experiments were initially undertaken with the addition
ofTNF-a or IFN-y to 18 h PRD explant cultures.
The addition of the proinflammatory mediators TNF-a or IFN-y resulted in increased
RANKL supernatant concentrations within tissue explant cultures after 18 h (Figure 7.4A).
The marked increase in RANKL secretion (p=O.OS) arising from IFN-y addition was of
significance. In contrast, OPG expression was slightly down-regulated by TNF-a at 18 h
and IFN-y significantly decreased expression of OPG compared with unstimulated control
PRD cultures (p=O.046) (Figure 7.4B).
Having determined that addition of exogenous TNF -a and IFN-y had observable effects
upon OPG and RANKL secretion at 18 h culture, I further explored the effects of these two
inflammatory cytokines over long-term culture. IFN-y (p=O.OS) significantly reduced OPG
expression within explant tissue cultures at 72 h. Furthermore, IFN-y induced a 156%
increase in RANKL concentration compared with control, although this was just below
levels of statistical significance. At 72 h culture, TNF-a minimally down-regulated culture
supernatant concentrations of OPG although it had no observable effect upon RANKL
expression (Figure 7.SA-C).
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Figure 7.4 In vitro effects of TNF-a and IFN-y manipulation upon RANKL and OPG
in 18 h PRD explant cultures. PRD explant tissues were stimulated with TNF-a or IFN-y
for 18 h and supernatant collected and analysed by ELISA. CA)The mean concentration of
RANKL after 18 h explant tissue stimulation with TNF-a or IFN-y compared with
unstimulated control. CB) The mean concentration of OPO after 18 h explant tissue
stimulation with TNF-a or IFN-y compared with unstimulated control. The total number of
PRD explant tissues stimulated with TNF-a or IFN-y and analysed for each individual
cytokine is given in parenthesis. Bars represent the mean cytokine concentration with the
standard error of the mean.
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Figure 7.5 In vitro effects of TNF-a and IFN-y manipulation upon RANKL and OPG
in 72 h PRO explant cultures. PRD explant tissues were stimulated with TNF-a or IFN-y
for 72 h and supernatant collected and analysed by ELISA. CA)The mean concentration of
RANKL after explant tissue stimulation with TNF-a or IFN-y compared with unstimulated
control. (B) The mean concentration of OPG after 72 h explant tissue stimulation with
TNF-a or IFN-y compared with unstimulated control. (C) Time-line chart representing the
percentage change in culture supernatant cytokine concentrations between stimulated and
unstimulated control tissues. The total number of PRD explant tissue cultures stimulated
with TNF-a or IFN-y for either RANKL or OPG is given in parenthesis. Bars represent the
mean cytokine concentration with the standard error of the mean.
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7.5 In vitro effects of cytokine addition to 18 h PRD explant cultures upon
endogenous RANKL and OPG expression
The previous experiments established that OPG and RANKL expression within the PRD
culture model were modulated by addition ofTNF-a or IFN-y to explant tissues. I therefore
further investigated if other important cytokines related to inflammatory processes within
the PRO lesion were capable of regulating OPG and RANKL expression within 18 h PRD
cultures.
Addition of exogenous IL-IO, IL-I2. IL-15. IL-22 and MCSF to PRD tissue explants
resulted in only minor. but not significantly increased RANKL expression at 18 h culture
(Figure 7.6A-B). However. IL-17 A addition to explant cultures resulted in significantly
increased expression of RANKL (p=O.OI9). TGF-p was the only analysed cytokine that
slightly decreased RANKL secretion at 18 h culture, although this was not of significance.
Having determined that IL-I7 A had a significant effect upon RANKL expression, I further
investigated effects of IL-17 A and the other cytokines upon OPG expression at 18 h
culture. In contrast to the substantial increase in RANKL, IL-17 A significantly decreased
OPG (p=O.032) secretion within culture supernatant at 18 h (Figure 7.6C-D). IL-18, which
had no observable effect upon RANKL production, induced only a minor increase in OPG
(p=O.135) expression, below levels of significance. Interestingly, the addition of IL-12 to
the explants moderately increased OPG (p=O.032) expression after 18 h culture at levels of
statistical significance.
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Figure 7.6 In vitro effects of cytokine manipulation upon RANKL and OPG in 18 h
PRD explant cultures. PR!) explant tissues were stimulated with cytokines for 18 hand
supernatant collected and analysed by ELISA. (A) The mean concentration of RANKL
after 18 h explant tissue stimulation with cytokines compared with unstimulated control.
(B) The percentage change in culture supernatant RANKL concentration between
stimulated and unstimulated paired control tissues. (C) The mean concentration of OPO
after 18 h explant tissue stimulation with cytokines compared with unstimulated control.
(D) The percentage change in culture supernatant OPG concentration between stimulated
and unstimulated paired control tissues. The total number of PRD explant tissues
stimulated by each individual cytokine is given in parenthesis. Bars represent the mean
cytokine concentration with the standard error of the mean.
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7.6 In vitro effects of cytokine addition to 72 h PRD explant cultures upon
endogenous RANKL and OPG expression
The previous series of experiments ascertained that a select number of key inflammatory
cytokines were able to modulate RANKL and OPG expression after 18 h PRD explant
culture. I therefore next investigated whether these effects were exhibited over longer-term
explant culture.
After 72 h culture, the addition ofIL-lO, IL-12 (p=0.194), IL-22 and MCSF (p=O.186) to
PRD tissue explants modestly increased RANKL expression. Furthermore, IL-17 A
induced a 188% increase in the concentration of secreted RANKL. However, these
observations were all below levels of significance. This may be a result of the smaller
number of tissues analysed in long-term cultures. In contrast to these observed increases in
RANKL, IL-18 (p=O.206) induced a slight decrease in RANKL supernatant
concentrations, although this effect was below levels of statistical significance (Figure
7.7A-B).
After 72 h PRD explant culture, OPG supernatant levels were correspondingly reduced by
the addition of exogenous IL-lO (p=O.08), IL-12 (p=0.230), IL-15, IL-17 A, MCSF
(p=O.082), IL-22 and TGF-~. However, these reductions were only moderate and below
levels of significance (Figure 7.7C-D).
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Figure 7.7 In vitro effects of cytokine manipulation upon RANKL and OPG in 72 h
PRD explant cultures. PRD explant tissues were stimulated with cytokines for 72 hand
supernatant collected and analysed by ELISA. (A) The mean concentration of RANKL
after 72 h explant tissue stimulation with cytokines compared with unstimulated control.
(B) The percentage change in culture supernatant RANKL concentration between
stimulated and unstimulated control tissues. (C) The mean concentration of OPG after
explant tissue stimulation with cytokines compared with unstimulated control. (D) The
percentage change in culture supernatant OPG concentration between stimulated and
unstimulated control tissues. The total number of PRD explant tissues stimulated by each
individual cytokine and measured for RANKL and OPG is given in parenthesis. Bars
represent the mean cytokine concentration with the standard error of the mean.
A
150
oCONTROL
RMK.
coocertration
(pgrrl) 100
50·
o
• SlllVlJlANT
IL-10(rF7) IL-12(rF5) IL-17(1F4) IL-18(rF8) IL-22(rF3) tvCSF(rF14) TGF-{3(rF11)
n h cytokine stirr'Uant
270
B
TGFb(n=11) 04
Gytokine MCSF(n=14) 71
stimulant
IL-22(n=3) 127
-441 IL-18 (0=6)
IL-17(0=4) ~ ~1~
IL-12(n=5) 71
IL-10 (ro=7)Ef------ _--_-_-_------------r-----~----- _-_---_-_-----_-----~-_---1142
o-50 50 100
%Olange to 72 h unstim.Jlated control
150 200
c
I
€aXJj
DCONTROL • SllM..JI..PNT
5£XX) ,
(P9'rrI)
4OOl~
1
OPG
concentration
2000 J
IL-10 (n=7) IL-12 (.-.=6) IL-15 (n=3) IL-17 (n=5) IL-18 (n=6) IL-22 (r>----3) fvCSF (n=16) TGF-j3 (n=12)
72 h cytokine stirrulant
D
-181'-------=-'---~
TGFb(n=12) 7
MCSF (n=16) 1
I
1
IL-22 (n=3) 1
I
IL-18(n=6)
IL-17 (n=6) 1
IL-16(n=3)
1
IL-12 (n=6) I
!
IL-10 (0=7) I
-10 0 10
271
-~LI ~~ __ ~
-~LI ~~~~
~7,-------------------------------------------------------~~~~
-~LI ~ __ ~~
~LI ~~~~
-70 -50 -40 -30 -20
% Change to 72 h unstimulated control
7.7 In vitro effects of the addition of RANKL and OPG to 18 h PRD explant
cultures
Foregoing experiments established that endogenous OPO and RANKL expression could be
mediated by addition of exogenous cytokine mediators to the PRO tissue explant model.
Conversely, I next sought to determine if exogenous OPO or RANKL had any regulatory
effect upon endogenous cytokine expression within the PRO explant system. Initially, I
investigated the effects of addition of RANKL and OPO to PRO tissue explants at 18 h
tissue culture. In addition to unstimulated explant tissue controls, addition of RANKL
(Figure 7.9A, B) or OPO (Figure 7.1OA, B) to 18 h PBMC and whole blood cell cultures
served as further controls.
Addition of exogenous RANKL to 18 h PRO explant cultures induced only a modest
increase in IL-8 (p=O.08) secretion. RANKL had no observable effects upon IL-6, IL-17 A,
IL-I8 or TNF-a (p=O.138) expression (Figure 7.8A, B). Interestingly, RANKL
significantly increased the expression of both IFN-y (p=O.0089) and IL-I0 (p=O.046) at 18
h culture. The effect upon IL-I0 was moderate in comparison with the large increase
observed in RANKL-induced expression of IFN-y. Whether increased expression of IFN-y
by RANKL is part of a negative regulatory loop to reduce bone resorption or a positive
feedback loop, inducing further RANKL expression (see chapter 7.4) requires further
investigation.
Having established that RANKL was capable of modulating endogenous cytokine
expression, I next investigated the effects of OPO addition to 18 h PRO explant cultures.
Supernatants were harvested and analysed for expression of a panel of cytokines by
ELISA. The addition of OPO to 18 h explant cultures significantly increased the
supernatant concentration of IL-8 (p=O.021). OPO had no appreciable effect upon IL-17 A
(p=0.489), TNF-a, IFN-y or IL-I8 at 18 h culture (Figure 7.IIA, B). In contrast to
increased IL-1O expression observed after RANKL stimulation at 18 h culture, IL-IO
supernatant concentrations were modestly decreased by OPO (p=O.262), although below
levels of significance.
272
Figure 7.8 In vitro effects of RANKL manipulation upon cytokine expression in 18 h
PRD explant cultures. PRD explant tissues were stimulated with RANKL for 18 h and
supernatant collected and analysed by ELISA. CA)The mean concentration of cytokines
after explant tissue stimulation with RANKL compared with unstimulated control. CB)The
percentage change in culture supernatant cytokine concentration between stimulated and
unstimulated control tissues. The total number of PRD explant tissues stimulated by
RANKL and analysed for each individual cytokine is given in parenthesis. Bars represent
the mean cytokine concentration with the standard error of the mean.
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Figure 7.9 In vitro effects of 18 h RANKL stimulation upon cytokine expression
within PBMC and whole blood cell cultures. CA) The mean concentration of cytokines
after RANKL stimulation compared with unstimulated control in 18 h PBMC cultures. (B)
The mean concentration of cytokines after RANKL stimulation compared with
unstimulated control in 18 h whole blood cell cultures. The total number of separate patient
derived cultures stimulated with each cytokine is given in parenthesis. Bars represent the
mean cytokine concentration with the standard error of the mean.
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Figure 7.10 In vitro effects of 18 h OPG stimulation upon cytokine expression within
PBMC and whole blood cell cultures. CA) The mean concentration of cytokines after
OPG stimulation compared with unstimulated control in 18 h PBMC cultures. (B) The
mean concentration of cytokines after OPG stimulation compared with unstimulated
control in 18 h whole blood cell cultures. The total number of separate patient derived
cultures stimulated with each cytokine is given in parenthesis. Bars represent the mean
cytokine concentration with the standard error of the mean.
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Figure 7.11 In vitro effects of OPG manipulation upon cytokine expression within 18
h PRD explant cultures. PRD explant tissues were stimulated with OPO for 18 hand
supernatant collected and analysed by ELISA. (A) The mean concentration of cytokines
after explant tissue stimulation with OPG compared with unstimulated control. (B) The
percentage change in culture supernatant cytokine concentration between stimulated and
unstimulated control tissues. The total number of PRD explant tissues stimulated by OPG
and analysed for each individual cytokine is given in parenthesis. Bars represent the mean
cytokine concentration with the standard error of the mean.
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7.8 In vitro effects of the addition of RANKL and OPG to 72 h PRD explant
cultures
The previous experiments established that RANKL and OPG were capable of modulating
endogenous cytokine expression at 18 h PRD tissue culture. Therefore, I further
investigated the effects of the addition of exogenous RANKL to the explant model over a
longer period of culture to 72 h. At 72 h explant culture, RANKL induced only a minor
increase in secreted IL-IO (p=O.13S) and IL-I8 (p=O.14), below levels of significance
(Figure 7.I2A, B). However, RANKL significantly increased TNF-a expression (p=O.04)
after 72 h culture. In contrast to results observed at 18 h, addition of RANKL to PRD
explant cultures resulted in a modest but not significant decrease in expression of
endogenous IL-8 and IL-17 A at 72 h. Addition of RANKL to 72 h PRD tissue explant
cultures had no effect upon IL-6 expression.
I next investigated the effects of OPG addition to PRD explant tissues upon endogenous
cytokine expression within 72 h explant cultures. OPG induced only a minimal decrease in
IL-8 secretion and modestly increased the expression of IL-I8 (p=O.lS). These were both
below levels of significance (Figure 7.l3A, B). In contrast to the observed effect upon IL-
10 at 18 h, IL-IO expression was up-regulated by OPG at 72 h culture, although this was
just below levels of statistical significance (p=O.083). Whereas RANKL substantially
increased TNF-a expression at 72 h culture, OPG induced a large decrease in secreted
TNF-a. Indeed, the opposing effects of RANKL and OPG upon TNF-a (p=O.084)
secretion at 72 h almost reached significance.
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Figure 7.12 In vitro effects of RANKL manipulation upon cytokine expression within
72 h PRD explant cultures. PRD explant tissues were stimulated with RANKL for 72 h
and supernatant collected and analysed by ELISA. (A) The mean concentration of
cytokines after explant tissue stimulation with RANKL compared with unstimulated
control. (B) The percentage change in culture supernatant cytokine concentration between
stimulated and unstimulated control tissues. The total number of PRD explant tissues
stimulated by RANKL and analysed for each individual cytokine is given in parenthesis.
Bars represent the mean cytokine concentration with the standard error of the mean.
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Figure 7.13 In vitro effects of OPG manipulation upon cytokine expression within 72
h PRD explant cultures. PRO explant tissues were stimulated with OPG for 72 hand
supernatant collected and analysed by ELISA. CA) The mean concentration of cytokines
after explant tissue stimulation with OPG compared with unstimulated control. CB) The
percentage change in culture supernatant cytokine concentration between stimulated and
unstimulated control tissues. The total number of PRO explant tissues stimulated by OPG
and analysed for each individual cytokine is given in parenthesis. Bars represent the mean
cytokine concentration with the standard error of the mean.
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7.9 Discussion
Physiological bone remodelling is regulated by osteoblastic bone deposition and bone
resorption by osteoclasts (Oucy et al. 2000, Teitelbaum 2000). This equilibrium is
maintained by expression of a multitude of growth factors, cytokines and hormones.
Nevertheless, bone homeostasis is primarily governed through expression of and complex
interactions between RANKL. RANK and OPG. I established that RANKL and OPG were
spontaneously expressed within 'resting' PRO explant tissue cultures. In agreement with
findings from cell culture experiments (Mandelin et al. 2005), concentrations of RANKL
were at least ten times lower than corresponding OPG concentrations within PRO explant
cultures.
IL-17 knockout mice exhibit reduced collagen-induced arthritis thereby suggesting that IL-
17 significantly contributes towards development of CIA (Nakae et al. 2003). Indeed, IL-
17A stimulates osteoclast differentiation and induces bone resorption. IL-l 7A related bone
destruction is mediated through induction of RANK on osteoblast cell membranes whereas
OPG inhibits IL-17 A-induced osteoclast differentiation (Kotake et al. 2001).
Overexpression of IL-17 A within murine CIA joints is associated with increased RANKL
expression (Lubberts et al. 2002). It was therefore of interest that addition of exogenous
IL-17 A to the PRO explant system significantly decreased OPG and increased RANKL
expression. Through these effects, IL-17 A likely plays a central role in the induction of
dentoalveolar bone resorption, which concomitantly occurs with the developing
inflammatory PRO lesion. The significant contribution of IL-17 A towards inflammatory
joint damage is now clearly established (Lubberts et al. 2005). Furthermore, IL-23 is
central to this process by promoting the development of IL-17 A producing cells
(Aggarawal et al. 2003, Murphy et al. 2003). It would therefore be of importance to
undertake further studies to ascertain if IL-23 is expressed within PRO and correlate this
with IL-17 A and RANKL concentrations and clinical symptoms. Nevertheless, IL-l 7A-
induced effects upon inflammatory cytokine and RANKLI OPG expression within PRO
explant cultures strongly implicate IL-17 A as an important mediator of destructive
inflammatory pathways in PRO (Figure 7.14). However, proinflammatory pathologic
effects induced by IL-l 7A may be counter-regulated in a negative feedback loop through
increased lL-l 0 expression induced by RANKL.
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In vitro studies establish that by up-regulating OPG expression, 11,-18 inhibits
osteoclastogenesis (Makiishi-Shimobayashi et al. 2001). Conversely, Dai et al. (2004b)
recently demonstrated that IL-18 induces RANKL production from T cells in RA
synovitis. Moreover, IL-18 has no effect upon OPG expression and therefore, through up-
regulating RANKL expression, IL-18 indirectly stimulates osteoclast formation. Indeed,
IL-18-induced osteoclast formation is as effective as IL-l~ but less potent than TNF-a (Dai
et al. 2004b). Although IL-18 was readily detectable within PRD tissues, the addition of
IL-18 to explant cultures had little effect upon OPG and RANKL expression. It is therefore
unlikely that IL-18 contributes towards destruction of surrounding dentoalveolar bone
through the RANKLIOPG axis. Nevertheless, the direct effects of IL-18 upon local
osteoblast and osteoclast cell populations within dentoalveolar tissues remain to be
elucidated.
IL-4 inhibits bone erosion by interacting directly with osteoclasts and indirectly by
inhibiting production of pro inflammatory cytokines. RANKL-induced bone resorption is
dose dependently inhibited by direct effects of IL-4 upon mature osteoclasts (Mangashetti
et al. 2005) and osteoc1astogenesis is indirectly suppressed by IL-4 down-regulating the
transcription factors NF ATel and c-Fos (Kamel Mohamed et al. 2005). Furthermore, IL-4
suppresses RANKL mRNA and protein expression and promotes OPG secretion by
fibroblast-like synoviocytes (Lee et al. 2004). It was therefore of importance that secreted
IL-4 was not detectable within PRO explant cultures. Neither was IL-4 expression
inducible by addition of cytokines or bacterial moieties to the PRD explant tissue system
(chapter 4.2). Deficient IL-4 expression within the PRO lesion likely impacts upon
homeostasis of the surrounding bone environment, whereby RANKL expression may be
ineffectively down-regulated and the ability to induce OPG expression may be impaired.
Osteoclastogenesis occurs by TNF-a stimulation of macrophages exposed to a stromal
environment expressing permissive levels of RANKL (Lam et al. 2000, Kudo et al. 2002).
IL-l and TNF-a also regulate OPG and RANKL gene expression in osteoblastic cells
(Hofbauer et al. 1999). Interestingly, stimulation of synovial fibroblasts from RA patients
with TNF-a promotes OPG mRNA and protein expression (Kubota et al. 2004). Within
the PRO lesion, TNF-a reduced OPG expression and induced a slight increase of RANKL
although these effects were minimal. These data signify that TNF-a has limited effects
upon RANKL and OPG expression by cellular constituents of the PRO lesion. The
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contribution of TNF-a towards dentoalveolar bone resorption is unlikely mediated by its
influence upon RANKLIOPG expression from cellular components of the tissue lesion.
Through interfering with the RANKL-RANK signalling pathway, IFN-y inhibits osteoclast
formation (Takayanagi et al. 2000b). IFN-y also prevents osteoclast formation by directing
differentiation of osteoclast progenitors towards an alternative cytocidal lineage to the
osteoclast (Fox and Chambers 2000). After T cell activation, IFN-y thereby has a key
responsibility in protecting against calcified tissue destruction. It was therefore surprising
that IFN-y addition to explant cultures significantly increased RANKL and significantly
decreased OPG expression. Furthermore, addition of OPG or RANKL to explant cultures
resulted in substantially increased IFN-y expression. Contrary to its well established bone
protective properties, it may be postulated that through effects upon the RANKLI OPG
ratio, IFN-y has the potential to indirectly contribute to localised periradicular bone
resorption.
Fibroblasts are an important source of RANKL that contributes towards bone erosion in
rheumatoid arthritis and loosening of hip prosthesis (Takayanagi et al. 2000a, Mandelin et
al. 2005). TNF-a, IL-l~, IL-6 and IL-Jl have no apparent effect upon RANKL expression
at mRNA or protein levels in fibroblasts derived from the joint/ tissue interface. In
contrast, TNF-a stimulation of tissue interface fibroblasts leads to increased expression of
OPG (Mandelin et al. 2005). As there is no data describing RANKL and OPG expression
within PRD fibroblasts, I next undertook investigations to determine expression of these
mediators within PRD fibroblast cultures. These experiments are described in chapter 8.
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Figure 7.14 Schematic illustration of effects of inflammatory mediators upon RANKL
expression within the PRD lesion. Bone resorption is carefully balanced between
RANKL expression, which is inducible by IL-17 A and bone protective effects exhibited by
IL-12 and IFN -y. Increased expression of RANKL, induced by IL-17 A, propagates
increased TNF-c expression, which likely contributes towards pathologic bone destruction.
IL-17 A expression, induced by IL-23, leads to increased secretion of a cascade of
proinflarnrnatory cytokines whilst concomitantly decreasing OPG expression. IL-12 and
IFN-y are considered to be bone protective. However, through inducing increased RANKL
expression from cellular components of the PRD lesion, IFN-y may also contribute
towards tissue destructive pathways. Potentially destructive effects of IFN-y may be
counter-regulated by IL-12, inducing increased OPG expression.
jjIL-17A
jjTNF-a
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CHAPTER8
PRD FIBROBLASTS
8 PRD FIBROBLASTS
8.1 Introduction
Fibroblasts constitute a significant cellular component of the tissue microenvironment
disseminated throughout the body. Through the synthesis and release of connective tissue
constituents, fibroblasts are central to remodelling of the extracellular matrix (Everts et al.
1996. Lekic et al. 1997). Furthermore, fibroblasts are capable of responding to a variety of
growth factors. which include cytokines (Haase et al. 1998). In response to these
inflammatory mediators. fibroblasts carefully regulate the balance between ECM synthesis
or tissue degradation (Havemose-Poulsen and Holmstrup 1997). Chronic dysregulation of
this tightly controlled equilibrium leads to pathologic tissue damage such as occurs within
periradicular disease.
A multitude of investigations have been undertaken upon fibroblasts derived from chronic
inflammatory lesions that are associated with concurrent bone degradation. It is established
that fibroblasts have the capacity to instruct reparative and destructive processes occurring
within chronic inflammatory periodontal diseases (Takashiba et al. 2003, Hosokawa et al.
2005) and rheumatoid arthritis (Pap et al. 2005). Fibroblasts derived from chronically
inflamed tissues are known to release effector molecules that act on a variety of cells
including lymphocytes. monocytes and mesenchymal cells. The wide array of
inflammatory mediators produced by fibroblasts includes cytokines, chemokines and
matrix-metalloproteinases (MMPs). Through production and release of these inflammatory
molecules, it is now accepted that fibroblasts directly contribute towards the perpetual
matrix destruction that occurs concomitantly with chronic inflammatory reactions.
Furthermore, it has recently been established that synovial fibroblasts derived from
rheumatoid arthritis joints express mediators central to regulating the delicate balance
between bone resorption and deposition, including OPG (Kubota et al. 2004).
Evidence of the role played by fibroblasts within several chronic intlammatory diseases
reinforces the concept that during development of pathologic diseases. resident
mesenchymal cells may act as effector cells. Infiltrating T lymphocytes and monocytes are
implicated in the initiation and perpetuation of periradicular disease. Through secretion of
chemoattractant mediators. fibroblasts likely perform an important function in recruitment
of leukocytes at an early stage in PRO lesion development. Moreover. cytok ine-stirnulated
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fibroblasts derived from inflamed tissues modulate the inflammatory response by inducing
cytokine expression from recruited immune cells, including IL-17 A from T cells
(Numasaki et al. 2004). Nevertheless, the role of fibroblasts in PRO lesion initiation and/or
progression has received scant attention. Indeed, there is little published research
phenotyping the PRO fibroblast.
The effects of suspected endodontic pathogens upon whole blood cultures obtained from
PRO patients (Matsushita et al. 1999), periodontal ligament cells (Chang et al. 2002b,c)
and pulp-derived fibroblasts (Hosoya and Matsushima 1997, Chang et al. 2002b, Yang et
al. 2003a,b,c) have been investigated. Although these studies have analysed oral tissue-
derived fibroblasts, they are unlikely to be representative of PRO-derived fibroblast
responses as it is recognised that there is significant heterogeneity between and within
fibroblast populations (Reichenbertg et al. 2005). Surprisingly, only one reported study has
analysed effects of cytokines or pathogens upon fibroblasts originating from PRO tissue.
However, fibroblasts analysed were only derived from periradicular bone cysts (Kusumi et
al. 2004). There is clearly a lack of information about spontaneous or inducible release of
cytokines by fibroblasts originating from periradicular disease tissues. I therefore
investigated the potential for PRO-derived fibroblasts to contribute towards the initiation
and perpetuation of the PRO lesion by analysing their expression of key inflammatory
mediators.
In the following senes of fibroblast cell culture experiments, Prevotella intermedia.
Peptostreptococcus micros and Fusobacterium nucleatum were used as live infective
agents. Prevotella intermedia are Gram-negative, short round-ended anaerobic rods,
Peptostreptococcus micros are Gram-positive cocci and Fusobacterium nucleatum are
Gram-negative rods. These microorganisms were selected as they are implicated in
endodontic infections. Moreover, they are frequently isolated from necrotic root canals of
teeth presenting with clinical symptoms and are correlated with the development of
extraradicular infections (Peters et at. 2002, summarised in Table 1.1). Indeed,
Fusobacterium nucleatum is associated with development of the most severe forms of
endodontic symptoms arising from root canal treatment (Chavaz de Paz 2(02). This may
occur due to the ability of F. nucleatum to bind MMP-9, thereby increasing the tissue
invasive potential of this microorganism (Gendron et al. 2004).
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8.2 Spontaneous cytokine production by unstimulated PRD fibroblast cultures
PRO fibroblasts have never been phenotypically analysed or formally characterised. No
data is currently available defining their cytokine repertoire or ability for cytokine
processing and release. Therefore, I initially undertook investigations to determine if
unstimulated, "resting" PRO fibroblast cultures secreted detectable levels of cytokines.
Fibroblast culture supernatants were analysed for a panel of cytokines. These cytokines
were selected on the basis that they are reported to be produced by fibroblast populations
derived from other chronic inflammatory diseased tissues. Levels of other cytokines, such
as those of predominantly T cell or macrophage origin, were additionally measured as
control. Therefore. supernatants from unstimulated PRD fibroblast cultures were assessed
for levels of spontaneously secreted IL-l~, IL-6, IL-8, IL-lO, IL-12, IL-17A, IL-18, TNF-
a, IFN-y, OPG and RANKL by ELISA.
IL-l~, IL-IO, IL-12, IL-18, TNF -a, IFN-y and RANKL were not detected within the
culture supernatant of unstimulated PRO fibroblasts. However, substantial levels of OPG
and IL-6 and moderate levels of IL-8 were detectable within culture supernatants of resting
PRO fibroblasts (Figure 8.lA). Production of such quantities of inflammatory cytokines
indicates that unstimulated PRO fibroblasts were in a high state of cellular activation.
Furthermore, NF-KB p65 was readily detectable in celllysates by Western blotting (Figure
8.1B). Surprisingly, low levels of IL-17 A were also detected from fibroblast cultures, the
significance of which is unknown. As the detection of secreted IL-17 A and OPG were
novel findings, these data were extended to confirm the molecular weight of these
molecules by Western blotting (Figure 8.2A, C). Confirmation of cellular localisation of
OPG and IL-17 A to fibroblasts was also investigated by immunohistochemistry (figure
8.2B,O).
286
Figure 8.1 Spontaneous cytokine release by PRD fibroblast cultures. (A) 'Resting'
levels of spontaneously released cytokines within PRD fibroblast culture supernatants were
assessed. Supernatant from unstimulated PRD explant fibroblast cultures was harvested at
18 h. Culture supernatants were analysed by ELISA for the expression of a panel of
secreted cytokines. Bars represent the mean concentration for each cytokine and the
standard error of the mean. The number of different patient-derived unstimulated fibroblast
populations used in experiments for the measurement of each individual cytokine is given
in parenthesis. (B) High activation status of resting PRD fibroblasts with substantial NF-
lCBp65 expression by Western blot of fibroblast cellular protein lysates. Three blots
representative of 10 differing PRD fibroblast populations.
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Figure 8.2 Confirmation of OPG and IL-17A expression by PRD fibroblasts. (A)
Western blot confirming the molecular weight of OPG within PRD fibroblasts. (B) IHC
identifying OPG localisation to PRD fibroblasts, represented by arrows. (C) Western blot
of PRD fibroblasts for IL-17A. (D) IHC detection of IL-17A localised to fibroblasts,
indicated by arrows (no counterstain). IHC experiments are representative of staining from
20 human PRD tissues, Western blots are representative of 15 PRD tissues.
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8.3 In vitro effects of mitogenic stimulation upon PRD fibroblast cultures
Having established that PRO fibroblasts were capable of spontaneously expressing
inflammatory cytokines, I hypothesised that fibroblasts may contribute towards chronic
inflammatory events within the PRO lesion. Perpetual challenge from the dental root canal
by microorganisms and their by-products leads to chronic inflammatory PRO. From
previous experiments using the novel PRO tissue explant model, I ascertained that PRO
tissue explants were responsive to mitogenic stimulation. As the candidate stimuli of
chronic PRO are microbes, I next investigated the etfect of a pathogen associated
molecular pattern, namely the TLR-4 ligand LPS, upon cytokine responses in PRO-derived
fibroblast cultures. SEB is a bacterial virulence factor that promotes immunological effects
principally through interactions via MHC class II binding. Having been used in the PRO
explant cultures to determine T cell derived effects, it was therefore utilised as a negative
control within fibroblast cultures .
. The addition of LPS to 18 h PRO fibroblast cultures resulted in significant increases in the
expression of both IL-6 (p=O.OOOI) and IL-8 (p=O.008) compared with unstimulated
controls (Figure 8.3A, B). SEB, as a negative control, had no biologically significant effect
upon either IL-6 or IL-8 production from PRO fibroblast cultures. Interestingly, neither
LPS nor SEB had any regulatory effects upon secreted protein expression of either OPG
(Figure 8.3C) or IL-17A (Figure 8.30). Furthermore, IL-IP, IL-IO, IL-12, IL-18, TNF-a,
IFN-y and RANKL. which were not spontaneously secreted by PRO fibroblast cultures,
were not inducible by these mitogenic stimuli.
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Figure 8.3 Effects of bacterial derived moieties upon cytokine expression within 18 h
PRD fibroblast cultures. PRD fibroblasts were stimulated with LPS or SEB for 18 h and
supernatant collected and analysed by ELISA for a panel of cytokines. (A) The mean
concentration of IL-6 after 18 h stimulation of fibroblasts compared with their
corresponding unstimulated controls. (B) The mean concentration of IL-8 after 18 h
stimulation of fibroblasts compared with their corresponding unstimulated controls. (C)
The mean concentration of IL-17 A after 18 h stimulation of fibroblasts compared with
their corresponding unstimulated controls. (D) The mean concentration of OPO after 18 h
stimulation of fibroblasts compared with their corresponding unstimulated controls. The
number of different patient-derived PRD fibroblast populations used in experiments for the
measurement of each individual cytokine is given in parenthesis. Bars represent the mean
concentration for each cytokine and the standard error of the mean.
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8.4 In vitro effects of PRD fibroblast cultures infected by live bacteria upon
cytokine expression
The previous experiments determined that PRD fibroblasts were responsive to stimulation
from the Gram-negative derived microbial agent LPS. 1 therefore hypothesised that PRO-
derived fibroblasts may contribute to the inflammatory status of the PRO lesion by being
directly responsive to microbes suspected as aetiological agents of induction in endodontic
infections. Therefore. 1 next investigated the effects of three key endodontic pathogens
upon cytokine expression within PRD fibroblast cultures. These pathogens were selected
as they are implicated in both initiation of the PRD lesion and exacerbation of clinical
symptoms (see chapter I). PRO fibroblasts were infected with live Fusobacterium
nucleatum, Prevotella intermedia or Peptostreptococcus micros up to 48 h culture. Cell
culture supernatant was subsequently collected at times specified and analysed by ELISA
for a panel of cytokines.
PRD fibroblast cultures infected with Fusobacterium nucleatum secreted significantly
greater levels of IL-6 compared to unstimulated controls at all time points to 48 h culture
(Figure 8.4). Furthermore. fibroblast cultures challenged with F. nucleatum had
significantly raised IL-8 supernatant concentrations at all time points compared to
unstimulated cell cultures. F. nucleatum had no observable effect upon IL-l 7A or OPG
expression within PRO fibroblast cultures at any given time point.
Prevotella intermedia infection of fibroblast cultures resulted in significantly increased IL-
6 expression at 18 h culture and this effect was further observed at 48 h (Figure 8.5). P.
intermedia also induced a significant increase in expression of IL-8 at 4 h culture. IL-8
levels were increased at each subsequent time point compared to non-infected control to 48
h culture. However. these were below levels of statistical significance. Infection of PRD
fihroblast cultures with P. intermedia had no observable effect upon IL-17 A or OPG
secretion at any time points to 48 h.
The addition of live Peptostreptococcus micros to PRO fibroblasts significantly increased
IL-6 expression at 18 h culture (Figure 8.6). In comparison with controls. 11,-6 expression
was increased in fibroblast cultures infected with P. micros at all other time points.
However. these raised concentrations were below levels of significance. P. micros also
induced a significant increase in IL-8 expression at 4 h culture. In comparison to control
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cultures, IL-8 levels were moderately increased at all time points to 48 h, but below levels
of significance. These data suggest that the predominant effect of P. micros upon PRO
fibroblasts was the early up-regulation of IL-6 and IL-8 expression. IL-17 A and OPG
supernatant concentrations were only minimally reduced by P. micros at all time points to
48 h but below levels of significance. Of interest, the increase in IL-6 and IL-8
concentrations induced by P. micros were not as great as those resulting from infection
with the Gram-negative pathogens P. intermedia or F. nucleatum.
I had previously established that within resting PRO fibroblast culture supernatants, TNF-a
was not detectable by ELISA. Surprisingly, F. nucleatum or P. intermedia infection of
fibroblast cultures induced detectable levels of secreted TNF-a within culture supernatants
(Figure 8.7). Although these were modest levels, infection of PRO fibroblast cultures with
F. nucleatum resulted in significant levels ofTNF-a production.
Individual addition of the three endodontic pathogens to PRO fibroblast cultures did not
induce secretion of detectable levels of IL-l p, IL-4, IL-l 0, IL-12, IL-18, IFN-y or RANKL
into culture supernatant at any time points. Further experiments would be necessary to
elucidate if a combination of pathogens has any effects upon these int1ammatory
mediators.
293
Figure 8.4 Effects of Fusobacterium nucleatum infection of PRD fibroblast cultures
upon cytokine expression. Fibroblast cultures were stimulated with F. nucleatum for a
variety of time points as indicated and supernatant collected and analysed by ELISA for
IL-6, IL-8, OPG and IL-17 A. (A) The mean concentration of each cytokine after infection
of fibroblast cultures with F. nucleatum (8) The percentage change in culture supernatant
cytokine concentration between F. nucleatum stimulated and unstimulated paired control
fibroblast cultures. Vertical lines represent the standard error of the mean. Figures are
representative of three separate experiments.
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Figure 8.5 Effects of Prevotella intermedia infection of PRD fibroblast cultures upon
cytokine expression. Fibroblast cultures were stimulated with P. intermedia for a variety
of time points as indicated and supernatant collected and analysed by ELISA for IL-6, IL-
8, OPG and IL-17 A. (A) The mean concentration of each cytokine after infection of
fibroblast cultures with P. intermedia (B) The percentage change in culture supernatant
cytokine concentration between P. intermedia stimulated and unstimulated paired control
fibroblast cultures. Vertical lines represent the standard error of the mean. Figures are
representative of three separate experiments.
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Figure 8.6 Effects of Peptostreptococcus micros infection of PRD fibroblast cultures
upon cytokine expression. Fibroblast cultures were stimulated with P. micros for a variety
of time points as indicated and supernatant collected and analysed by ELISA for IL-6, IL-
8, OPG and IL-17A. (A) The mean concentration of each cytokine after infection of
fibroblast cultures with P. micros. (8) The percentage change in culture supernatant
cytokine concentration between P. micros stimulated and unstimulated paired control
fibroblast cultures. Vertical lines represent the standard error of the mean. Figures are
representative of three separate experiments.
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Figure 8.7 Effects of bacterial infection of PRD fibroblast cultures upon TNF-Q
expression. Fibroblast cultures were stimulated with live endodontic pathogens for 18 h
and supernatant collected and analysed by ELISA for TNF-a. The mean concentration of
TNF-a after stimulation of fibroblast cultures with endodontic pathogens compared with
unstimulated controls. The number of PRD fibroblasts derived from separate patients used
in experiments for the measurement of TNF-(1 is given in parenthesis. Bars represent the
mean concentration for TNF-a and the standard error of the mean. FN- F nucleatum, PI-
P. intermedia.
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8.5 IL-18 biology within PRD fibroblast cultures
From the previous senes of experiments, I ascertained that cytokine expression within
PRO fibroblast cultures could be manipulated by the addition of either live micro-
organisms or microbial-derived agents. Furthermore, investigations undertaken in chapter
5 established that cytokine secretion within the novel PRO tissue explant system could be
regulated by the addition of rhIL-18 to cultures. It was therefore of interest to elucidate if
IL-I8-mediated effects within PRO explant cultures could be attributable, at least in part,
to stimulation of resident fibroblasts within the PRO lesion. Initially I examined PRO-
derived fibroblasts for cellular expression of IL-18, IL-18R and IL-I8BP. Subsequently, I
explored the effects of IL-18 addition to PRO-derived fibroblast cultures upon endogenous
cytokine expression. Recent literature clearly defines fibroblasts as comprising a
heterogeneous cell population. This is applicable to fibroblasts from differing tissue sites
and even to those originating from individual diseased tissue lesions. Therefore, to
investigate the effects of IL-18 upon a representative sample of the potentially diverse
PRO fibroblast population, fibroblasts derived from a large number of patient lesions were
studied.
From Western blotting, IL-18 protein was not detectable in either pro (24 kOa) or mature
form within protein cellular extracts of PRO-derived fibroblasts. Indeed, previous
experiments ascertained that IL-I8 was not secreted by PRO fibroblast cultures. In
contrast, IL-18R was expressed by PRO-derived fibroblasts. IL-18R expression was
detectable within 13/16 fibroblast cultures derived from PRO lesions obtained from sixteen
patients (Figure 8.8A) and was increased upon LPS addition to cultures (Figure 8.8B). This
datum suggested that PRO fibroblasts may be capable of responding to addition of IL-18 to
cultures. Interestingly, IL-18BPa was detectable within cellular extracts of 3 of 4 PRD
fibroblast populations (Figure 8.8C). The contribution of PRD fibroblast-derived IL-18BPa
in regulating IL-I8 concentrations within the PRO lesion requires further investigation.
Having established that the IL-18R was present within the fibroblast cultures, I next
investigated if PRO fibroblasts were responsive to exogenous lL-18. The addition of IL-18
to 18 h PRO fibroblast cultures resulted in significantly increased supernatant levels of IL-
6 (p=O.008) and IL-8 (p=O.002) compared with unstimulated control cultures. Conversely,
IL-I8 had little effect upon IL-I7 A or OPO expression (Figure 8.9A). The responsiveness
of PRO fibroblasts to IL-18 contrasts with studies upon fibroblast populations derived from
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other chronic inflammatory diseased tissues. Several of these investigations have
determined fibroblast cultures to be unresponsive to IL-18. Therefore, I investigated the
specificity of IL-18-mediated effects upon IL-6 and IL-8 expression. A neutralising
antibody to IL-18 was added concomitantly with rh1L-18 to 18 h PRO fibroblast cultures.
Indeed, neutralisation of IL-18 with anti-IL-18 abrogated previously observed fibroblast
responses, confirming specificity of IL-18-induced cytokine expression (Figure 8.9B)
The addition of IL-18 in combination with other cytokines to the PRO explant culture
system synergistically enhanced the expression of several prointlammatory mediators.
Therefore, I also explored if the concomitant addition of IL-18 and other cytokines to PRO
fibroblast cultures exerted synergistic effects upon endogenous cytokine expression. Cell
culture supernatants were harvested at 18 h and cytokine concentrations measured by
ELISA.
IL-18 in combination with TNF-a (p=0.04) and IL-17A (p=0.02) had additive effects upon
IL-6 secretion from 18 h PRO fibroblast cultures compared to stimulation with IL-18 alone
(Figure 8.10A). No additive or synergistic effects upon IL-6 expression were observed
when IL-18 was added to fibroblast cultures with IL-12 or IL-15. IL-18 in combination
with IL-12 (p=0.02), IL-15 (p=O.013), IL-17A (p=0.039) and TNF-a (p=0.04) had a
significant additive effect upon IL-8 expression within 18 h PRO fibroblast cultures
compared with IL-18 stimulation alone (Figure 8.108).
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Figure 8.8 Presence of IL-18R and IL-18BP within PRD fibroblast cultures. Western
blot to determine IL-18R expression by PRD fibroblasts. CA) Bands of 55 kDa were
present in 10114 cultures, protein extracts from two representative fibroblast populations
are shown. (B) LPS addition to PRD fibroblast cultures increased IL-18R expression.
Figure is representative of four repeated experiments upon four differing PRD fibroblast
populations. CC) IL-18BPa detected within PRO fibroblast cellular protein extracts,
representative of two repeated experiments upon four separate PRD fibroblast populations.
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Figure 8.9 In vitro effects of IL-18 addition to PRD fibroblast cultures upon
endogenous cytokine expression. PRD fibroblast cultures were stimulated with
neutralising anti-IL-18 and/or rhIL-18 for 18 h and supernatant collected and analysed for
cytokine expression by ELISA. (A) The mean concentration of fibroblast derived cytokines
after 18 h IL-18 stimulation compared with unstimulated control on a large number of PRD
fibroblasts. (B) Specificity of IL-18-mediated effects upon IL-6 and IL-8 expression within
18 h fibroblast cultures. The total number of fibroblast cultures derived from separate PRD
lesions stimulated with each cytokine is given in parenthesis. Bars represent the mean
cytokine concentration with the standard error of the mean.
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Figure 8.10 In vitro effects of IL-18 in combination with other cytokines upon
endogenous cytokine expression within PRD fibroblast cultures. PRD fibroblast
cultures were stimulated with IL-18 and another cytokine and supernatant collected and
analysed for endogenous cytokine expression by ELISA. (A) The mean concentration of
IL-6 after 18 h stimulation of PRD fibroblast cultures by IL-18 concomitantly with other
cytokines in comparison with IL-18 alone. (B) The mean concentration of IL-8 after 18 h
stimulation of fibroblast cultures by IL-18 concomitantly with other cytokines compared
with matched cultures with IL-18 alone. The total number of different patient PRD
fibroblast cultures stimulated with each cytokine combination is given in parenthesis. Bars
represent the mean cytokine concentration with the standard error of the mean.
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8.6 In vitro effects of exogenous cytokines upon PRD fibroblast IL-6 and IL-8
expression
The previous experiments established that through detectable changes in expression of
secreted cytokines, PRO fibroblast cultures were responsive to infection by endodontic
pathogens and the addition of exogenous IL-18. Cytokine regulatory loops likely inf1uence
the chronicity of disease processes. Having established that IL-18 could modulate cytokine
expression within PRO fibroblast cultures, I further investigated if endogenous cytokine
responses within PRO fibroblast biology could be modulated by the addition of other
exogenous cytokines. Cytokines were added to fibroblast cell cultures and supernatant
collected at several time points up to a period of 72 h.
Stimulation of PRO fibroblasts with both IL-17A (p=O.OOOI) and TNF-a (p=O.OOOI)
resulted in significantly enhanced secretion of IL-6 within culture supernatants at 18 h
(Figure 8.lIA-C). Compared with unstimulated matched control cultures, increased
expression of IL-6 by these two inflammatory cytokines was also observed at 72 h. 18 h
stimulation with IFN-y, IL-IO or IL-15 had no effect upon IL-6 expression. OPG promoted
a minor but non-significant increase in IL-6 production from PRO fibroblast cultures.
IL-8 secretion at 18 h was significantly increased by the addition of IL-17 A (p=O.0080),
TNF-a (p=O.OOOI) and IFN-y (p=O.04) to fibroblast cultures compared with unstimulated
matched controls (Figure 8.12A-C). IL-IO and OPG stimulation of fibroblast cultures for
18 h induced only a minor increase in IL-8 expression that was below levels of
significance. The addition of IL-15 resulted in only a minimal decrease in IL-8 expression,
although this was also below levels of statistical significance.
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Figure 8.11 In vitro effects of cytokine stimulation upon IL-6 production within PRO
fibroblast cultures. PRD fibroblast cultures were stimulated with a panel of cytokines and
supernatant collected and analysed by ELISA for IL-6 at time points indicated. (A) The
mean concentration of IL-6 after 18 h cytokine stimulation compared with unstimulated
control. (B) The percentage change in IL-6 culture supernatant concentration between
stimulated and unstimulated matched control 18 h fibroblast cultures. (C) Effects of
cytokine stimulation upon secretion of endogenous IL-6 in fibroblast cultures over 72 h
culture. The total number of different patient PRD fibroblast cultures stimulated with each
cytokine is given in parenthesis. Timeline chart is representative of three fibroblast
experiments. Bars represent the mean IL-6 concentration with the standard error of the
mean.
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Figure S.12 In vitro effects of cytokine stimulation upon IL-S production within PRD
fibroblast cultures. PRD fibroblast cultures were stimulated with a panel of cytokines and
supernatant collected and analysed by ELISA for IL-8 at time points indicated. (A) The
mean concentration of IL-8 after 18 h cytokine stimulation compared with unstimulated
control. (B) The percentage change in culture supernatant IL-8 concentration between
stimulated and unstimulated matched control 18 h fibroblast cultures. (C) Effects of
cytokine stimulation upon secretion of endogenous IL-8 in fibroblast cultures over 72 h
culture. The total number of different patient PRD fibroblast cultures stimulated with each
cytokine is given in parenthesis. Timeline chart is representative of three fibroblast
experiments. Bars represent the mean IL-8 concentration with the standard error of the
mean.
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8.7 In vitro effects of exogenous cytokines upon PRD fibroblast-derived IL-17A
and OPG secretion
My initial fibroblast experiments established that IL-17 A and OPG were spontaneously
released by PRO fibroblasts at 18 h culture. However, expression of these inflammatory
mediators was not regulated by infection of fibroblast cultures with endodontic pathogens.
Therefore, I finally sought to determine if any key inflammatory cytokines were capable of
modulating the expression of either OPG or IL-17 A within 18 h PRD fibroblast cultures.
The addition of IFN-y (p=O.Ol) and TNF-a (p=O.04) to PRO fibroblasts resulted in
significantly increased concentrations of IL-17 A in supernatants at 18 h culture (Figure
8.13A and B). Conversely, IL-12, IL-15 and IL-18 had no effect upon IL-17 A secretion in
PRD fibroblast cultures. The addition ofIL-lO, IL-12, IL-15, IL-17A, IL-18, IFN-y, TNF-
a, and TGF-p to PRD fibroblasts had no observable effect upon the expression of OPG at
18 h culture (Figure 8.14A and B).
Taken together, these data demonstrate that OPG expression by PRO fibroblasts was not
inducible by addition of microbial agents or individual proinflammatory cytokines to
fibroblast cultures. In contrast, IFN-y and TNF-a were both capable of inducing increased
expression within PRD fibroblast cultures of the proinflammatory cytokine IL-17 A.
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Figure 8.13 In vitro effects of cytokine stimulation upon IL-17 A production within
PRD fibroblast cultures; PRD fibroblast cultures were stimulated with a panel of
cytokines and supernatant collected and analysed by ELISA for IL-17 A at 18 h. CA)The
mean concentration of IL-17 after 18 h cytokine stimulation compared with unstimulated
control. CB)The percentage change in culture supernatant IL-17 A concentration between
stimulated and unstimulated matched control 18 h fibroblast cultures. The total number of
different patient PRD fibroblast cultures stimulated with each cytokine is given in
parenthesis. Bars represent the mean IL-17 A concentration with the standard error of the
mean.
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Figure 8.14 In vitro effects of cytokine stimulation upon OPG production within PRD
fibroblast cultures. PRD fibroblast cultures were stimulated with a panel of cytokines and
supernatant collected and analysed by ELISA for OPG at 18 h. (A) The mean
concentration of OPG after 18 h cytokine stimulation compared with unstimulated control.
(B) The percentage change in culture supernatant OPG concentration between stimulated
and unstimulated matched control 18 h fibroblast cultures. The total number of different
patient PRD fibroblast cultures stimulated with each cytokine is given in parenthesis. Bars
represent the mean OPG concentration with the standard error of the mean.
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8.8 Discussion
8.8.1 Introduction
IL-I and/ or TNF-a expression at sites of infection by monocytes and macrophages
followed by activation of resident tissue cells, including epithelial cells and fibroblasts,
triggers an inflammatory cytokine cascade. In turn, this network amplifies or suppresses
inflammation by inducing further release of cytokines and growth factors. Fibroblasts were
originally recognised as primary targets of proinflammatory cytokines including IL-l and
TNF-a (Butler et al. 1994, Oayer et al. 1977). Upon stimulation by these cytokines,
fibroblasts secrete chemokines such as IL-8 and MCP-I, matrix metalloproteinases and
prostaglandins (Oayer et al. 1986, Larsen et a/. 1989). The release of such inflammatory
mediators implies that fibroblasts are not mere producers of the structural tissue matrix.
Conversely, these data establish the concept of fibroblasts acting as effector cells in disease
processes of an inflammatory nature. Furthermore, fibroblasts are reported to express IL-I,
thereby contributing towards autocrine and paracrine activation of neighbouring cells
(Fuhlbrigge et al. 1988, Sporri et al. 1996, Rezzonico et al. 1998).
Fibroblasts derived from human periradicular cysts express mRNA for IL-I p, IL-6, IL-8,
TNF-a and IFN-y and limited or no gene expression of IL-lO, TGF-~I and GM-CSF
(Kusumi et al. 2004). Furthermore, cyst-derived fibroblasts secrete significantly greater
quantities of IL-6 than gingival and pulp fibroblasts. However, PRO fibroblasts are not
well characterised and their phenotypic attributes have not been elucidated. I first
established that PRO-derived fibroblasts spontaneously secreted IL-6, IL-8, IL-17 A and
OPG in culture. However, IL-I~, IL-IO, IL-I2, IL-I8, TNF-a, IFN-y and RANKL were
not detectable within "resting" culture supernatants. It is of interest that moderate levels of
IL-8 protein was spontaneously secreted by the PRD fibroblasts as IL-8 gene expression is
not detectable within unstimulated pulp-derived fibroblasts (Yang et al. 2003a). This
suggests that PRO fibroblasts cultured in my experiments were in a highly activated state. I
therefore undertook further experiments to determine if microbial-derived agents, live
microbes or cytokines were capable of regulating the expression of secreted inflammatory
mediators within PRO fibroblast cultures.
311
8.8.2 Effects of microbes and microbial products upon PRO fibroblasts
Live periodontal pathogens (Steffen et al. 2000) or their microbial products (Steffen et al.
2000, Imatani et al. 2001) modulate IL-8 expression within gingival fibroblast cultures.
Furthermore, infection of human pulp fibroblast cultures with the endodontic pathogens
Porphyromonas gingivalis, P. intermedia or Porphyromonas endodontalis, increases IL-8
mRNA expression (Yang et al. 2003a). IL-8 gene expression within P. endodontalis
infected pulp fibroblasts gradually increases after 2, 6 and 24 h culture. In contrast,
subsequent to P. intermedia infection, pulp fibroblast gene expression for IL-8 reaches
maximal levels at 2 h and declines to baseline levels between 6 and 24 h. The reason for
differences in achieving maximal IL-8 gene expression by these differing microbial
pathogens are likely related to differences in lipid A and polysaccharide structures (Yang
et al. 2003a).
Despite these observations, no published studies report the effects of endodontic pathogens
or microbial components upon secreted IL-8 expression within human PRO fibroblast
cultures. Similar to studies investigating fibroblast populations originating from other oral
sources, PRO fibroblast cultures were responsive to E. coli-derived LPS and live microbial
pathogens. LPS induced a significant increase in concentrations of secreted IL-8 at 18 h
PRO fibroblast culture. Paralleling gene expression observed within pulp fibroblast
cultures (Yang et al. 2003a), PRO fibroblasts cultured with P. intermedia exhibited
maximal IL-8 protein expression at an early stage of infection. This early inducible effect
upon IL-8 secretion was also observed in fibroblast cultures infected with F. nucleatum
and P. micros. However, only F. nucleatum induced significantly increased levels of
secreted IL-8 to 48 h fibroblast culture.
In addition to IL-8, LPS derived from P. gingivalis, Actinobacillus actinomytemcomitans
and E. coli increase IL-6 secretion from fibroblasts derived from healthy gingival tissue
(Imatani et al. 2001). Furthermore, IL-Ia, TNF-a and Bacteroides spp. up-regulate 11.-6
mRNA expression within human pulp fibroblast cultures (Yang et al. 2003b). Infection of
gingival fibroblast cultures with A. actinomytemcomitans increases IL-6, IL-I P and TNF-a
mRNA although only secreted IL-6 protein is detectable within culture supernatants
(Belibasakis et al. 2005a). The addition of P. intermedia-derived LPS to human dental pulp
fibroblasts increases IL-6 mRNA expression by 1 h and this is sustained to 8 h culture.
Interestingly, this effect is inhibited by antibodies to COl4 and reduced by 50% by the
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addition of IFN-y, IL-IO and/or IL-4 (Tokuda et al. 200 I). Endodontic pathogens derived
from infected root canal and cyst exudates also increase IL-6 expression within periodontal
ligament fibroblast cultures (Ogura et al. 1994). In consideration of these data, it is
surprising that no studies have evaluated the effects of microbial agents or endodontic
pathogens upon secreted IL-6 within PRO-derived fibroblast cultures.
I established that E. coli-derived LPS and live endodontic pathogens were capable of
modulating IL-6 protein expression within cultures of PRO fibroblasts. At 18 h culture, E.
coli-derived LPS induced a significant increase in secreted IL-6 protein within PRO
fibroblast supernatants. Furthermore, PRO fibroblasts infected with F. nucleatum
significantly increased their secretion of IL-6 at all time points to 48 h culture. P.
intermedia induced maximal IL-6 protein expression at 18 h culture and significantly
increased IL-6 concentrations were further detected after 48 h infection. The maximal
effect upon increased IL-6 expression at 18 h was also observed in PRO fibroblast cultures
infected with P. micros.
In whole blood culture experiments, Gram-negative endodontic pathogens induce TNF-a
more strongly than Gram-positive bacteria (Matsushita et al. 1998). Furthermore, Gram-
positive bacterial cell fragments stimulate less cytokine release from human PBMC
cultures than LPS (Safavi and Nichols 2000). Yersinia enterocolitica infection of synovial
fibroblast cultures transiently induces TNF-a mRNA expression at 4 hand 24 h although
this does not translate into secreted TNF-a protein (Meyer-Bahlburg et al. 2004). The
addition of E. coli-derived LPS to PRO fibroblast cultures did not induce TNF-a
expression. Interestingly, infection of PRO fibroblasts by both Gram-negative endodontic
pathogens, P. intermedia and F. nucleatum. resulted in low but detectable levels of
secreted TNF-a. In contrast. P. micros, a Gram-positive microbe. did not induce detectable
levels of TNF-a from the PRO fibroblast cultures. Addition of F nucleatum-derived LPS
to human pulp cell cultures increases production of IL-I P in a dose dependent manner that
is reduced by IL-I ra (Lu et al. 2002). However, I was not able to detect secreted IL-l
protein within resting PRO fibroblast cultures and neither was it inducible by microbial
agents.
In contrast to Streptococcus mutans. the endodontic pathogen P. endodontalis hehaves as a
weak stimulator of inflammatory cytokines, and has little effect upon the production of
IFN-y and TNF-a from mononuclear cells. However, it is also less ahle to induce IL-lO.
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Through its limited stimulatory effects upon host cytokine expression, it is postulated that
P. endodontalis may escape the immune response mounted by leukocytes and thereby
contribute towards bone destruction occurring at PRO sites (Jiang and Schilder 2002).
Infection of fibroblast cultures with Bacteroides spp. results in increased mRNA
expression and/ or secretion of MMPs (Chang et al. 2002a,b), and tissue plasminogen
activator (Yang et al. 2003b). Furthermore, the periodontal pathogens A.
actinomycetemcomitans and P. gingivalis induce MMP-2 secretion from human POLF,
which is counter-regulated by TGF-p (Chang et al. 2002a). These experiments define an
important role for fibroblasts in promoting tissue destructive pathways. Further
investigations are therefore required to elucidate if PRO-derived fibroblasts spontaneously
express MMPs and thereafter, examine the effects of endodontic pathogens upon MMP
expression by PRO fibroblasts.
Infection of PRO fibroblast cultures with endodontic pathogens had no effect upon
expression of secreted OPG, which is also the case with pathogenic challenged SFL
cultures (Zhang et al. 2004). Conversely, the addition of E. coli-derived LPS to POL
fibroblasts stimulates OPG expression through inducing TNF-a and IL-l ~ (Wada et al.
2004). Interestingly, bacterial infection of fibroblasts co-cultured with osteoclast
precursors up-regulates RANKL expression and they become competent in promoting the
maturation of osteoclast precursors into multinucleated TRAP positive bone-resorbing
multinucleated cells (Zhang et al. 2004). Furthermore, A. actinomytemcomitans induces
RANKL gene expression in human gingival fibroblast cultures through a pathway
independent of IL- L IL-6, TNF-a or PGE2 (Belibasakis et al. 2005a). E. coli-derived LPS
also stimulates RANKL expression in POL fibroblasts through the induction of TNF-a and
IL-I P (Wada et al. 2004). Although I did not analyse RANKL mRNA expression, secreted
RANKL was not detected within the supernatant of PRO fibroblast cultures either at rest or
after the addition of microbial agents or infection with live microbes. Furthermore,
RANKL protein was not detected within fibroblast cellular lysates by Western blotting. In
addition to increasing OPG secretion by FLS, IL-4 suppresses RANKL mRNA and protein
expression (Lee et al. 2004b). The lack of detectable IL-4 within PRO explants combined
with the inability of endodontic pathogens to increase OPG expression from PRD
fibroblasts are likely contributing factors promoting inflammatory bone destruction during
development of PRO.
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S.S.3 Effects of cytokines on PRO fibroblasts
Synovial fibroblasts express IL-IS protein and IL-IS mRNA (Moller et al. 200 I) and
release IL-IS in culture (Schuler and Aicher 2004). In contrast, others have been unable to
detect IL-I p, IL-IS and IL-18 protein within FLS cultures, although high levels of IL-6 are
secreted (Hirth et al. 2002). Gingival and dermal fibroblasts express IL-I p mRNA and
ICE, however LPS does not induce IL-IS secretion and induces only low levels of IL-I p
(Tardif et al. 2004). I was unable to detect secreted IL-IS or IL-I p within PRO fibroblast
cultures. In addition, Western blotting revealed a lack of constitutive IL-IS protein
expression and IL-18 was not induced by infection of PRO fibroblast cultures with
endodontic pathogens.
IL-I8 bioactivity is regulated by the expression of IL-18R in various cell types. Fibroblast-
like synoviocytes (FLS) constitutively express IL-ISRa mRNA but do not express IL-
18RP mRNA at rest or upon stimulation with IL-I or IL-I2. Although IL-I p and to a lesser
extent IL-I2 induce increased IL-6 production from FLS cultures, IL-18 exerts no effects
upon IL-6 expression (Kawashima and Miossec 2003, Kawashima et al. 2003). Therefore
it is postulated that in RA, the inflammatory effects of IL-IS likely occur via T cells and
macrophages with no direct action upon FLS (Kawashima and Miossec 2003). In contrast,
Morel et al. (2002) demonstrated that IL-IS modulates inflammatory responses in RA-
derived FLS by up-regulating VCAM expression. I therefore hypothesised that IL-IS
might also participate in PRO fibroblast activation. Initially, I established that PRD
fibroblasts expressed IL-ISR and thereafter, investigated the biological effects of
exogenous IL-I8 upon long-term PRO fibroblast cultures. From these experiments. I
ascertained that cultured PRO fibroblasts were responsive to IL-IS. Expression of IL-6 and
IL-8 was significantly up-regulated by IL-IS addition to cultures. Of importance, addition
of IL-17 A or TNF-a with IL-18 additively increased both IL-6 and IL-8 secretion by PRO
fibroblasts. I had previously detected substantial levels of secreted IL-I7 A. IL-I8 and
TNF-a within the PRO tissue explant culture system. The concomitant release of these
cytokines within the PRO lesion may significantly contribute towards PRD fibroblast
activation, thereby promoting prointlammatory destructive pathways by these cell types.
IL-I7 A induces IL-6 and IL-S expression 111 synovial fibroblasts (Fossiez et al. 1996,
Kehlen et al. 2002) and increases IL-6 secretion from periodontal fibroblasts in a dose
dependent manner (Takahashi et (II. 2005b). I therefore postulated that IL-I 7A might
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contribute towards PRO fibroblast activation. Importantly, IL-17 A increased expression of
both IL-6 and IL-8 in PRO fibroblast cultures. IL-17 A stimulates greater production of lL-
6 and IL-8 than either lFN-y or IL-IS from SLF cultures (Hwang et al. 2004). In agreement
with these data, PRO fibroblasts secreted substantially greater quantities of IL-6 and IL-8
after IL-17 A addition to cultures than IL-15. IL-17 A possesses additive effects with IL-I P
upon the secretion of IL-6 and IL-8 from fibroblast-like synoviocytes (Kehlen et al. 2003).
Further experiments are required to determine if IL-17 A exhibits additive or synergistic
properties when combined with other inflammatory mediators upon endogenous cytokine
expression by PRO fibroblasts.
In addition to the effects of IL-17 A upon PRO fibroblasts, it was surprising to find that IL-
17A was detectable within these cultures. PRO fibroblast-derived IL-17 A was significantly
increased by the addition of the inflammatory cytokines TNF-a and IFN-y to cultures. It is
therefore possible that through IL-l 7A secretion, PRO fibroblasts contribute towards T-
cell activation and lesion expansion. IL-17 A and TNF-a alone have little effect upon SLF-
. derived OPG. However, when these mediators are combined with IL-I, OPG production is
greatly increased, likely reflecting a negative feedback loop to control bone destruction
(Granet et al. 2004). I also ascertained that the individual addition of cytokines to PRO
fibroblast cultures did not modulate expression of secreted OPG. Whether a combination
of cytokines is able to influence OPG expression by PRD fibroblasts requires investigation.
Within pulp cell cultures, IL-la and TNF-a stimulate IL-6mRNA expression (Yang et al.
2003b). The addition of IL-I a to gingival fibroblast cultures decreases TIMP expression
whereas TGF-B leads to increased TIMP expression (Yang et al. 2002). Furthermore, IL-
l P induces greater increases in IL-6 production by PDL fibroblasts than gingival
fibroblasts (Shimizu et al. 1992). However, no studies have evaluated effects of these
int1ammatory mediators upon PRO-derived fibroblasts. I established that addition of TNF-
a to PRO fibroblast cultures significantly increased concentrations of secreted IL-6, IL-8
and IL-17 A. In addition, IFN-y promoted increased expression of IL-8 and IL-17 A within
PRD fibroblast cultures.
Certain fibroblast populations secrete IL-l 0 when challenged with 11,-1P or TNF-a and the
release of low quantities of TNF-a has been observed within fibroblast populations such as
SFLs (Hirth et al. 2002). However, Hirth et al. (2002) suggest that IL-J 0 expression
detected in FLS experiments may be from macrophage contamination in early passage
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cultures. Similarly, TNF-a is predominantly produced by macrophages and its reported
production by fibroblast cultures may be a result of culture contamination with other cell
types. Nevertheless, secreted IL-IO was not evident within the PRO fibroblast cultures and
it was not inducible by infection with live endodontic pathogens or microbial derived
moieties. The absence of IL-I 0 and other monokines suggests that PRO fibroblast cultures
were not contaminated with other cell types. However, stimulation of PRO fibroblasts with
endodontic pathogens elicited TNF-a production, albeit at low concentrations. Although
IL-IOR mRNA is not constitutively expressed by human pulp fibroblasts, stimulation with
P. intermedia-derived LPS induces IL-IOR mRNA expression and is inhibited by
antibodies to COl4 (Tokuda et al. 2003). It is likely that PRD-derived fibroblasts express
IL-J OR as addition of IL-IO to fibroblast cultures induced a moderate increase in IL-8
expression.
8.8.4 Conclusions
Fibroblasts were traditionally recognised as target cells, orchestrating tissue repair In
response to mediators released by monocytes and lymphocytes such as IL-l p or TNF -u.
However, recent evidence establishes that through the release of a variety of growth
factors. including GMCSF and CSF, fibroblasts are capable of regulating the development
and activation of haematopoietic cells and their precursors. Indeed, my experiments clearly
demonstrated that PRO fibroblasts were responsive to a wide panel of inflammatory
cytokines. Furthermore, upon stimulation with these inflammatory mediators, PRO
fibroblasts released effector molecules that are capable of acting on a variety of cells,
including monocytes and macrophages.
Fibroblasts have never been directly implicated in the pathogenesis of PRD. Upon
stimulation with TNF-a. IL-17 A. IL-18, or IFN-y, expression of inflammatory mediators
such as IL-6 and IL-8 were up-regulated by PRO fibroblasts. These findings suggest that
excessive quantities of endogenous TNF-u, IL-17A, IL-18, or IFN-y, which were readily
detectable within PRO explant cultures, may induce further secretion of inflammatory
mediators by PRO fibroblasts. On the basis of these results, the tissue destructive
properties of PRO fibroblasts may be supported by their production of high quantities of
IL-6 and IL-8. Furthermore, secretion of such pro-inflammatory mediators likely supports
continued recruitment of inflammatory cells to the peri radicular tissue. Thereby, PRD
fibroblasts may contribute towards the perpetual chronic inflammatory reaction, ultimately
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leading to destruction of the periradicular tissue matrix. Undoubtedly, numerous cell types
contribute to the pathogenesis of PRO. However, data from my experiments implicate PRO
fibroblasts as central participants within this process.
Bacterial product ligation of TLRs allow SLFs to participate in innate immunity, resulting
in up-regulated ICAM-I, MMP-I, MMP-3, MMP-13 and inflammatory cytokine
expression (Kyburz et al. 2003). I demonstrated that PRO fibroblasts were responsive to all
three endodontic pathogens used in culture experiments. This is likely to be mediated, at
least in part, through TLR expression. Further investigations are necessary to define TLR
expression within this cell population and elucidate downstream inflammatory mediators
activated upon TLR ligation and signalling. Through infection-induced secretion of
substantial quantities of IL-6 and a limited amount of TNF-a, PRO fibroblasts likely
trigger acute phase responses. IL-8 potently attracts neutrophils to inflammatory sites and
IL-8 secretion by PRO fibroblasts was induced by endodontic pathogens. Indeed, within
the PRD lesion, fibroblasts are a major source of this chemokine. Marked release of IL-8
may therefore promote the recruitment of PMNs to the inflamed periradicular area.
Importantly, these data imply that PRO fibroblasts are capable of directly contributing
towards the innate immune response. The contribution of fibroblasts towards inflammatory
processes within PRO is summarised in Figure 8.15.
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Figure 8.15 Diagrammatic summary of PRD fibroblast contribution towards
inflammatory processes within chronic inflammatory PRD. Endodontic pathogens and
endogenous cytokines activate PRD fibroblasts to release proinflammatory cytokines that
recruit and activate inflammatory cells and osteoclasts. Deficiency of an inducible increase
in OPG secretion by PRD fibroblasts tips their contribution within the chronic
inflammatory reaction towards a predominantly pro-inflammatory destructive effect. PRD
fibroblasts release several inflammatory mediators that perpetuate inflammation by
positive feedback regulatory loops, thereby promoting bone destruction.
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CHAPTER 9
GENERAL DISCUSSION
9 GENERAL DISCUSSION
9.1 Introduction
Periradicular disease (PRO) develops as a localised chronic pathological inflammatory
immune reaction in response to continuous microbial stimuli from necrotic, infected dental
root canals. Human periradicular disease is characterised by alveolar bone resorption at the
dental root apex culminating in patient morbidity and occasionally mortality. Host
susceptibility to PRO is determined by complex interactions between bacteria, host factors
and environmental components. In order to successfully attenuate the immune response
and eradicate the disease, understanding the complex pathologic processes that contribute
towards PRO is of importance. Epidemiologic studies undertaken within differing
geographical populations establish that PRO is remarkably prevalent (Saunders et af. 1997,
Loftus et al. 2005, Kabak and Abbott 2005). These employed different criteria in the types
of population groups recruited, differing types of radiographs analysed, differences in
radiographic and/ or clinical examinations and differing protocols for assessing the
presence of PRO. Nevertheless, there is agreement amongst the plethora of studies that
PRO represents a substantial healthcare burden, afflicting between 40-70% of the adult
population (Kirkevang et al. 2001, chapter 1.4).
The majority of patients attending for dental extractions suffer acute dental symptoms,
which are primarily associated with acutely inflamed periradicular lesions (Vier and
Figueiredo 2002). Apical abscesses account for the majority of periradicular lesions
attached to extracted teeth (63.7%) and of the remaining lesions, 24.5% are periradicular
cysts. Importantly, periradicular lesions derived from symptomatic extracted teeth, whether
cystic or not. display comparable signs of acute inflammation (Vier and Figueiredo 2002).
Furthermore. IHe investigations reveal no significant differences in composition of the
inflammatory infiltrate in periradicular cysts and periradicular granulomas (Stem et al.
1981. Torabinejad and Kettering 1985. Gao et al. 1988, Matsuo et a/. 1992. Liapatas et al.
2003). Given these data and small tissue volumes available from each lesion, PRD lesions
used in tissue explant culture experiments from extracted teeth were not subjected to
pathological examination to differentiate between periradicular cysts or granulomas.
PRO poses a primary health care issue of significance in its own right. However. it also
provides an ideal model system in which to explore cytokine interactions in chronic human
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inflammatory responses. I therefore developed a novel explant culture system whereby
PRO tissues were harvested during surgical procedures or after dental extractions and
immediately cultured. Cytokines released at sites of infection have the capacity to modify
normal bone remodelling processes. Thereby, cellular secretion of such inflammatory
mediators contributes towards physiological bone remodelling or pathologic bone
destruction. It was therefore of relevance that spontaneous release of endogenous cytokines
was detected within PRO explant cultures implying that tissues remained immunologically
active for 72 hours. with expression of endogenous factors necessary to sustain such
activity.
Although expression of prototypical proinflammatory cytokines has been described within
PRO tissue, this is the first study to investigate factors that modulate their expression
within human lesions. Furthermore. the endodontic literature is bereft as to the contribution
of novel pleiotropic cytokines in development of inflammatory PRO. I therefore explored
IL-18 biology within the human PRO lesion and further investigated the effects of several
other novel cytokines upon endogenous inf1ammatory mediator expression. Laboratory-
based research using human diseased tissue is frequently difficult due to the many inherent
patient variables, for example smoking status, age, clinical symptoms and genetic
background. A further confounding factor is clinical accessibility in obtaining appropriate
chronically inflamed human tissues in which to study inflammatory events. Furthermore.
there is a significant problem in interpreting data from investigations analysing the
immunopathogenesis of human PRO as relatively low numbers of lesions have been
examined (summarised in Table 9.1). However, experiments within this thesis were
undertaken upon a substantial number of PRO lesions. The large quantity of lesions
analysed strongly support that my experiments are representative of the overall disease
state.
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Table 9.1 Summary of studies investigating cytokine expression within human
chronic inflammatory PRD tissues.
Author Specimen 'I/o Mediator studied Method Control
Meghji
et al. 1989 PRD cysts 5 11.-1 Explant culture/ rhlL-1
cell culture
Artese Granulomas 11.-lfI, TNF-a, CD-J. IIK'- frozen Nil
et al. 1991 10 CD-19. anti Leu M5
Barkhordar PRD IL-I~ EI,ISA-tissue Healthy pulp
et al. 1992 8 homogenatcs
Bando PRD cysts ICAM, ELAM, 11.- Healthy gingival,
et al. 1993 12 l c, IL-ifl. TNF-a. IHC- frozen buccal mucosa
11.-8
Lim Granulomas 22 IL-ifl ELISA-tissue Healthy pulp.
et al. 1994 homogenatcs Inflamed gingiva
Formigli PRO Cysts TRAP, IL-6, PGE2 ELISA. RAI Peripheral serum
et al. 1995 35
Meghji IL-Ia, lL-I~, TNF-a, RT-PCR,
et al. 1996 PRD Cysts 16 11.-6, LPS ELISA Medium only
Honma PRI) Cysts IL-Ia. II.-I~. TNF-a, ill situ
et al. 1998 Gingival 10 IL-6. lL-8, CD3, hybridisation Nil
fibroblasts CD68, 1.26. vimentin
Hren PRD Granulomas ICAM,IL-2R FACS Peripheral blood
et al. 1998 17
Kabashima lL-la.IL-I~. IIA,
et al. 1998, 2004 PRO Granulomas 8/ 11.-6, IFN-y, iNOS, IHC- frozen POL
12 CXeR3
Barkhordar PRD IL-6 ELISA-tissue Inflamed pulp,
et al. 1999 6 homogenates Healthy pulp
Tyler Granulomas IIIC-FFPE
I et (II. 1999 PRD Cysts 17 TGF-~" niF-u ill situ lsotype matched AhI
I hybridisation
TNF-a. TGF-fl, ELISA-tissue Internal
._-
Danin Granulomas
et al. 2000 PRD Cysts 25 homogenatcs
IL-2, 11.-4, IL-6. 11.-
r---- --
Walker Granuloma,
et (I/. 2001 PRJ) Cysts 121 10. IFN-y, (1)20, 111('- IFPI-: lonsil
12 (,D68. CD45RO
Gervasio PRD Cysts 11.-3.11.-6, GM-CSF ELISA-tissue Healthy pulp
et al. 2002 24 homogcnates
Radics Granulomas u-e. (,M-CS!, ELlSi\-tissm: Ilcalthy pulp .--
et (II. 2003 PRD Cysts 42 homogenatcs
De Sa
'-
et (II. 2003 Granulomas 15 IIA, 11.-6. LT-u 111('- 1'1'1'1' Non-immune scrum
~- .__ . .----~~-.--
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9.2 Effects of microbial moieties upon PRD explants
To identify stimuli responsible for inducing cytokine production, I initially evaluated the
capacity for microbial components to promote cytokine expression by developing a novel
in vitro ex vivo PRO tissue explant model. LPS addition to PRO explants resulted in
significantly increased expression of IL-l p and IFN-y and moderately increased levels of
TNF-a and IL-IO. Furthermore, SEB substantially increased culture levels of IL-17A,
TNF-a and IFN-y. Of importance, macrophage and T cell-derived pro-inflammatory
cytokines IL-la. IL-l p, TNF-a and IFN-y are recognised as mediating tissue destruction at
the initiation and subsequent progression of PRO (Tani-Ishii et al. 1995, Kawashima and
Stashenko 1999). Of these, IL-l is significantly up-regulated at the onset of pulpal and
periapical inflammation (Tani-lishii et al. 1995). Within the rodent pulp exposure model,
IL-l a is central to pathogenesis of the periradicular lesion and IL-l p is a key bone
resorptive cytokine in the human PRO lesion. Spontaneous secretion of these cytokines in
unstimulated PRO tissue explants and their significantly increased expression induced by
LPS and/ or SEB reinforces the important contribution of bacteria and their microbial
products to destructive pathways in lesion development.
LPS-induced production of proinflammatory cytokines is likely mediated through ligation
of TLRs. TLR-I, -2, -4 and -6 mRNA expression was readily detectable within human
PRO tissue biopsies (chapter 4.5). Pre-incubation of IFN-y-primed monocytes with LPS
nullities the effect of LPS-induced IL-12 production (Wittmann et al. 1999). Interestingly,
LPS-stimulated PRD explant cultures expressed significantly increased levels of IL-12. It
may be speculated that only low levels of LPS were present within analysed lesions,
thereby implicating a predominantly Gram-positive microbial flora. Indeed, the microbial
flora of teeth with failed root canal treatment (RCT) or persisting root canal infection
consists primarily of anaerobic bacteria with a Gram-positive profile (Pinheiro et al. 2003.
Gomes et al. 2004). Cells other than monocytes could contribute towards the LPS-induced
secretion of IL-12. LPS-activated macrophages in a co-culture system suppress fibroblast
growth. which is reversed by the addition of hydrocortisone. This may provide a
mechanism whereby the removal of pathogens during RCT allows reparative processes to
take place with normal proliferation of fibroblasts (Metzger et al. 1997).
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9.3 A potential role for IL-18 in PRD
IL-18 is produced by activated blood monocytes and tissue macrophages such as Kupffer
cells. An important function of IL-18 is the regulation of growth, differentiation and
modulation of functionally distinct subsets of T helper cells required for Th 1 cell mediated
immune responses (Nakanishi et al. 2001). IL-18 induces production of lFN-y, IL-2 and
GM-CSF and stimulates IL-2R a-chain expression, thereby supporting CD4+ effector Th 1
cell proliferation. The soluble circulating antagonist, IL-18BP is responsible for regulating
IL-18 activity (Aizawa et al. 1999). Although there is no significant homology between IL-
18BP and IL-I8R components, IL-18BP has the immunoglobulin domain homologous to
the third IgG domain of the decoy receptor of IL-I, type II IL-l R. As it lacks a
transmembrane domain, IL-I8BP exists only as a soluble circulating protein and thus
belongs to a novel family of soluble receptor-like proteins including OPG and cytokine
like factor 1 (Novick et al. 1999). IL-18BP neutralises IL-18 effector functions (Novick et
al. 1999) establishing that the IL-I8 system operates through elaboration of its receptors
and binding protein.
Although IL-I8 expression has been widely reported across a range of conditions, little
direct functional analysis has been possible on primary inflamed human tissues. This is
principally due to difficulties in obtaining the appropriate effector lesion. Demonstration
that cytokine blockade is important in therapeutic development is best exemplified by
TNF-a neutralisation in rheumatoid arthritis synovial tissues in vitro in which a
hierarchical role for TNF -a in IL-6 and IL-l ~ production was proposed. This was a critical
step, leading to the development of intliximab and successful clinical product
development. The PRO lesion represents an intriguing inflammatory tissue in this respect.
Unstimulated PRO explant tissues secreted substantial quantities of 11.-18 and both mRNA
and mature protein IL-18 expression were observed within PRO tissues. Within the novel
human PRO explant model, IL-18 significantly increased IFN-y and IL-17 A expression
and moderately increased IL-12, IL-I ~ and TNF-a. Through induction of these potent
prointlammatory mediators, IL-I8 likely contributes towards the plentiful expression of
IL-l ~ and IFN-y observed within human PRO tissues (Barkhordar et ai. 1992, Kabashima
et al. 1998). Furthermore, IL-I8 is likely responsible for, at least in part, the substantial
expression of TNF -a and IL-I ~ present within root canal exudates of teeth associated with
PRO lesions (Safavi and Rossomando 1991, Takeichi et al. 1996).
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The innate cellular immune system is responsible for rapidly initiating cytokine and
cellular responses essential for early microbicidal host defences. IFN-y and TNF-a
expression are central to the development of host inflammatory responses and pre-requisite
to effective host immunity to invading microbial pathogens and clearance of microbial
pathogens. It is therefore of importance that IL-18 induces the expression of both these
cytokines from a variety of cell types (Nakanishi et al. 2001). Critically, addition of
exogenous IL-18 to ex-vivo PRD explant cultures significantly increased expression of
IFN-y and TNF-a. Furthermore, IL-18 in combination with IL-12 synergistically induced
IFN-y expression within PRD tissue cultures, which may occur independently of TCR
engagement (Nakanishi et al. 2001). Of much significance, IL-18 neutralisation
experiments established that IL-18 has an important effector role when bacterial-derived
stimuli were added to chronic PRO explant lesions. Although endogenous IL-18 is
required for the abolition of many pathogens, in Th I dominated responses, it may lead to
tissue destruction.
Increased expression of TNF-a induces MMP-2 and MMP-9 activity from a variety of
human cells, thereby promoting localised matrix destruction (Ueda and Matsushima 200 I).
The contribution of IL-18-up-regulated expression of TNF -a in destructive inflammatory
processes is classically demonstrated in RA. Through inducing increased TNF-a
expression. it is likely that IL-18 indirectly contributes to inflammatory-mediated
destruction of the surrounding periradicular tissue matrix during lesion development.
Within the human PRO lesion, it is conceivable that IL-18 has a role in host protection to
microbes from the infected root canal by enhancing IFN-y expression. Through the
induction of IFN-y. specific T-cell and B cell-mediated responses may be promoted against
pathogenic endodontic bacteria. However, such pathways could equally be associated with
pathological destruction. In addition to TNF-a, these destructive features include increased
expression of IL-l ~ and neutrophil activation (Wyman et al. 2002). IL-l is a potent bone-
resorbing factor that inhibits mediators responsible for promoting bone formation and may
contribute towards radicular cyst expansion (Tanebe et af. 2004). Up-regulated expression
of IL-J J3 and IL-17 A, demonstrated by IL-18 addition to the PRO explant model. may
therefore promote destructive pathways in dento-alveolar bone within the vicinity of the
dental root apex. From immunostaining experiments, the majority of the direct effects of
IL-18 within the PRO lesion would seem to occur via macrophages. The data depicting IL-
18 expression in freshly harvested tissues, in combination with results from ex vivo culture
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experiments provide strong proof of concept that IL-18 is implicated in the host response
within PRO.
It has recently been demonstrated that IL-18 and IL-12 are capable of up-regulating TLR-2
and TLR-4 expression in monocytes through their capacity to increase IFN-y secretion
from T cells (Radstake et al. 2004). Interestingly, IL-18 substantially increased TLR-I
mRNA expression within PRD explant tissue cultures. Whether this is a direct effect of IL-
18 upon TLR-I expression or the actions of IL-18-induced downstream mediators requires
further investigation. My experiments implicate IL-18 as a major contributor towards
. inflammatory processes within the PRO lesion. Nevertheless, mRNA and protein
expression for IL-18BP was readily detectable within PRO tissues (chapter 5.3). The
relevance of this expression in the regulation of endogenous IL-18 within PRO requires
further exploration.
9.4 Unravelling the cytokine network within PRO
The pro-inflammatory and antiapoptotic cytokine, IL-15 has a multifactorial role in chronic
inflammatory disease processes such as RA. Synovial macrophage expression of TNF-a is
stimulated by T cells in an IL-15-dependent manner (McInnes et al. 1997) and IL-15
induces IL-17 production (Ziolkowska et al. 2000, Ferretti et al. 2003). Therefore, IL-15
occupies a central and upstream position within inflammatory cascades contributing to
chronic inflammatory diseases. Individually, IL-15 is unable to stimulate cytokine
production and therefore does not drive antigen-specific T cells to exhaustion. However, in
the presence of IL-12, IL-15 induces IFN-y expression from C04+ and C08+ cells (Liew
2003). Conversely, in IL-4 mediated Th2 conditions, IL-15 induces the production of IL-5
from these T cell subsets (Niedbala et al. 2002). The individual addition of IL-15 to PRO
tissue explant tissues significantly increased expression of T cell derived cytokines IL-I 7A
and IFN-y. Increased expression of these two cytokines may be the result of lL-15
interacting with endogenously expressed IL-12, which was readily detectable within PRO
tissue explants. In addition to increased IL-17 A and IFN-y secretion, IL-15 moderately
decreased IL-IO expression. These data implicate IL-I5 as a potent proinflammatory
mediator contributing towards destructive inflammatory processes within human PRD.
IL-10 is central to orchestrating the balance between pathology and host protection.
Indeed. the phenotype of IL-I 0-1- mice divulges this as the most essential of its many
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functions. A critical responsibility of IL-I 0 in infectious disease is moderating pathological
events arising from host inflammatory responses by suppressing production of
pro inflammatory type I cytokines, including IFN-y, IL-12 and TNF-a and prohibiting T
cell functions by inhibiting accessory C028/B7.1 receptor interaction (Schandene et a/.
1994). Furthermore, IL-IO and IFN-y are known to antagonise one another (De Waal
Malefyt et al. 1991. Fiorentino et al. 1991). As a result, significant attention has focussed
upon the anti-inflammatory properties of IL-l O. Nevertheless, depending on the dose and
route of administration, IL-IO also induces pro-inflammatory effects and can be produced
simultaneously with IFN-y as IL-IO is capable of stimulating IFN-y secretion (Carson et al.
1995, Shibata et al. 1998). As expected, LPS stimulation of PRO explant tissue cultures
significantly increased IL-IO production (Huang et al. 2001, Corinti et al. 2001, Byrne and
Reen 2002). Within human monocyte cultures, gene expression of IL-IO is related to
increased expression ofIL-l~, IL-7, IL-IO, IL-IRap, IL-4R, TNFR, IL-17R, IL-12R and
IL-l RA genes and decreased expression of IL-15, TNF -u, IL-18, IL-24, IL-2Ry, IL-l Ra
(Jung et a/. 2004). Addition of IL-l 0 to PRO explants down-regulated IL-17 A and TNF-a
protein expression. Microbial-induced expression of IL-I 0 likely moderates the developing
inflammatory response within PRO, although inducible IL-IO expression may alone be
insufficient to abrogate destructive inflammatory pathways.
It is logical that IFN-y potentiates inflammatory events when endodontic pathogens that
activate TLRs are present. Conversely, in response to endogenous cytokines TLRs may
also limit inflammation. Thereby, the excessive activity of cytokines such as IL-I, which
can lead to extensive tissue destruction, may be carefully regulated. Furthermore, IFN-y
down-regulates destructive effects of IL-l by inhibiting IL-I R through a Stat I dependent
manner (Hu et al. 2005). Interestingly, IFN-y was significantly inducible within ex vivo
PRO tissues by the addition of IL-18 and IL-12. As both IL-18 and IL-12 were
spontaneously secreted within PRO explant cultures, their concomitant expression likely
contributes towards enhanced levels of IFN-y expression within the lesion. Thereby,
increased levels of IFN-y may propagate inflammatory processes within the developing
lesion. Conversely, through its effects upon osteoblasts and osteoclasts, increased IFN-y
expression may reduce destruction of the surrounding dento-alveolar bone. Whether the
predominating effects of IFN-y are proinflammatory or anti-inf1ammatory within PRD
remains to be clarified.
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By inducing cytokine and chemokine secretion, IL-17 A is a key component in T cell-
triggered inflammation. IL-17 A is central to chronic inflammatory processes including
rheumatoid arthritis (Kotake et al. 1999). inflammatory bowel disease (Fujino et al. 20(3).
psoriasis (Teunissen et al. 1998), atopic dermatitis (Toda et al. 2(03) and periodontal
disease (Takahashi et al. 200Sb). In chronic periodontitis, IL-17 A is significantly increased
in gingival crevicular fluid (GCF) samples and gingival cells (Vernal et al. 2(05). In
contrast, in situ expression of IL-17 A mRNA is higher in gingivitis tissues as opposed to
tissue associated with destructive periodontitis lesions. However, the frequency of IL-17 A
positive samples is higher in periodontitis patients (Oda et al. 2(03). Using Western
blotting. Takahashi et al. (2005) identified IL-17 A protein in 10 of 17 periodontal explant
samples and using ELISA in only five of these tissues. Nevertheless, IL-I 7A
concentrations correlate with the amount of localised periodontal destruction, thereby
implicating a role for IL-17A in disease progression (Johnson et al. 2004).
IL-17 A, a predominantly pro-inflammatory cytokine, was consistently detected within
unstimulated human PRO explant cultures. It was therefore of importance to elucidate
factors contributing towards endogenous IL-I 7A expression within the PRO lesion.
Initially, I examined the effects of microbial moieties upon IL-17 A secretion within PRO
explant cultures. Although PBMC cultures from gingivitis and periodontitis patients
stimulated by Porphyromonas gingiva/is outer membrane protein (OMP) express
comparable levels of IL-17 A mRNA and protein (Oda et al. 2003), E. coli-derived LPS
had little modulatory effect upon IL-17 A expression within the PRO explant model.
Nevertheless. IL-17 A may be involved in early stages of PRO inflammatory responses to
invading pathogens. as it was up-regulated by addition of other bacterial-derived moieties,
for example SEB (chapter 4.4) .
High levels of IL-6 are expressed in RA and correlate with disease activity. IL-6 stimulates
the secretion of immunoglobulin by plasmacytes, activates and promotes proliferation of T
lymphocytes. increases neutrophils and platelets, induces acute phase proteins including
eRP. fibrinogen, haptaglobin and serum amyloid-A, regulates the proliferation and
differentiation of osteoclasts and induces bone resorption (Matsuno et af. 1998). Although
IL-6 and TNF-a are regulated by distinct mechanisms, these two eytokines have
overlapping and synergistic actions (Matsuno et af. 2(02). Of importance. IL-17 A
consistently increased IL-6 expression within PRO tissue explants (chapter 6.2). as has
been observed in cultures of cartilage, synovium and bone tissues (Chabaud et al. 1998.
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Moseley et at. 2003}. IL-17 A-induced secretion of IL-6 may therefore contribute towards
the recruitment of neutrophils to inflamed periradicular sites and high levels of expression
of both IL-17 A and IL-6 likely contributes towards degradation of the surrounding
periradicular tissues. Within my experiments, IL-17 A was added at a concentration of 50
ng/ml as previously described in explant culture experiments (LeGrande et al. 2001).
IL-8 is present within periradicular and inflamed pulp tissue, although barely expressed
within healthy pulps (Shimauchi et al. 2001, Huang et al. 1999). Both IL-4 and IL-IO
suppress neutrophil-derived IL-8, conversely IFN-y increases its expression (Kunkel et at.
1995). The substantial levels of spontaneously released IL-8 within unstimulated PRO
explants likely propagate continued infiltration of immune cells into developing
inflammatory PRO lesions. IL-17 A induces IL-6 and IL-S expression in several cell lines,
including epithelial cells, vascular endothelial cells and fibroblasts (Kawaguchi et al. 2001,
Laan et al. 2001, Jones and Chan 2002) and moderately increased IL-S secretion within
PRO explant cultures. Endogenous IL-8 expression was also increased by addition of
exogenous IL-IS to fibroblast and tissue explant cultures. Up-regulated expression of IL-8,
by the effects of IL-I7 A and IL-18 upon PRD fibroblasts and other cell populations, likely
enhances the recruitment of neutrophils and activated T cells (Laan et al. 1999, Laan et al.
2001), thereby exacerbating localised periradicular tissue pathology.
Several of the biological processes activated by IL-17 A are similar to, though less potent
than IL-l p. Destructive pathways induced by IL-l P and TNF-a within joint compartments
are synergistically or additively augmented by IL-17 A (Moseley et al. 2003). In support of
predominantly pro-inflammatory properties, IL-17 A increased TNF-a and IFN-y
expression within PRO explants (Figure 6.IS and Figure 6.13). IL-17 A-medaited
inflammatory pathways may subsequently be enhanced through positive feedback loops
whereby TNF-a and IFN-y further increase IL-17A secretion (Figure 6.10 and Figure
6.12). IL-IS substantially increased levels of secreted IL-17 A within PRD explants.
Thereby. IL-15 likely amplifies pro-inflammatory responses within PRO from acute
through to chronic stages. Within PRO explants. IL-I0 moderately reduced 11,-171\
expression. Perpetuation of an exaggerated inflammatory reaction, arising from continuous
IL-17 A secretion within the PRD lesion, may therefore be tempered by concomitant IL-1 ()
expression. However. in rheumatoid synovial explant cultures IL-17 A production is
inhibited by IL-4 and IL-13 but not IL-IO (Chabaud et al. 1999). Therefore, the absence of
or low IL-4 expression within PRD tissues may further direct inflammatory pathways
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towards a predominating proinflamrnatory profile. There is evidence that IL-17 acts
upstream of several inflammatory mediators. For example, IL-17 A promotes the release of
human p-defensin 2. which subsequently induces IL-I8 secretion (Niyonsaba et al. 2005).
The many observed effects of IL-I7 A upon PRD explant cultures strongly implicate IL-
17A as an upstream mediator of inflammatory processes within PRO. However, the
position of IL-I7 A in the hierarchical structure of the inflammatory network within PRD
remains to be established.
TNF-a occupies a dominant position in cytokine hierarchy and regulates the synthesis of
several cytokines. In addition to its eHects upon cytokines, TNF-a potently up-regulates E-
selectin, ICAM-I and VCAM-I expression, thereby enhancing leucocyte recruitment
(Mueller 2002). Furthermore, TNF-a is a powerful inducer of MMP-I, MMP-3 and MMP-
13 (Nishikawa et al. 2002). Spontaneous TNF-a expression was readily detected within
PRO explant cultures and substantially increased by exogenous IFN-y and modestly
increased by IL-IS, IL-I7 A and IL-I2 (chapter 6.7). These cytokines were spontaneously
expressed within PRO cultures and likely contribute towards intrinsic and inducible TNF-a
expression. In tum, increased TNF-a secretion likely perpetuates inflammatory processes
by up-regulating IL-17 A and IFN-y expression in a positive feedback loop and contributing
towards destruction of periradicular tissues by inducing MMP production.
9.5 Biology of Th 1 vs Th2 within PRO
The precise contribution of CD4+ effector ThI/Th2 responses to PRO lesion development
is controversial. T cells constitute a significant component of the inflammatory cell
infiltrate within PRO (Kontainen et al. 1986, Stashenko and Yu 1989). A predominance of
Th2 type responses have been reported within human PRO tissues (Walker et al. 2000, De
Sa et al. 2003). The low quantities or frequent absence of detectable T cell-derived
eytokines such as IL-4 within unstimulated tissue explant culture supernatants is therefore
surprising. These data question the capacity of Th2 cells to contribute efficiently towards
inflammatory processes within chronic PRO. Generation of substantial quantities of the
archetypal Thl cytokine IFN-y within stimulated PRO explant cultures, the presence of
high levels ofTNF-a and lack of ability to induce IL-4 strongly support the hypothesis that
inflammatory reactions within PRO are Thl driven (Kabashima et al. 1998, Kabashima et
al. 2004). In addition to patterns of cytokine expression, identification of cell surface
markers including IL-18R and CCRS provide further evidence of predominating Th I
330
immune responses (Xu et al. 1998, Loetscher et al. 1998, Uguccioni et al. 1998) and I
consistently detected IL-18R protein expression within PRO tissues. Furthermore. CCR5
predominates over CCR3 expression within PRO biopsy tissues (Kabashima et al. 2001 b).
Collectively, these data reinforce the conjecture that inflammatory processes within PRO
are promoted by a prevailing C04+ effector Th 1 response. Interestingly, in a background
of IL-12, IL-15 induces a Th 1 type response and in the presence of IL-4, which was barely
detectable within PRO explants, IL-15 induces a Th2 dominated response (Niedbala et al.
2002). Addition of IL-15 to PRO explants significantly increased IFN-y production
(chapter 6.6). Inducible IFN-y production allied with endogenous IL-12 expression and
. absence of IL-4 support the supposition that PRO predominantly comprises a CD4+
effector Th 1 type response.
In vivo elimination of the Th2 cytokine IL-IO in addition to IL-6 results in substantially
increased IL-I a expression within murine PRO tissues, which correlates with increased
periradicular bone resorption (Balto et al. 200 I, Sasaki et al. 2000). Indeed, IL-IO
. knockout mice develop infection-stimulated PRO lesions up to five times the size of those
developing within wild type controls and locally produced IL-Ia is increased IO-fold
(Sasaki et af. 2000). In contrast to IL-IO within the murine model, the Th2 cytokine IL-4
has no influence upon PRO lesion size, indicating the heterogeneity amongst Th2 type
cytokines (Sasaki et al. 2000). Surprisingly, deficiency of IL-12, IL-18 or IFN-y within the
murine model appears to have no effect upon development of infection-induced PRO. In
consideration of these data, Sasaki et al. (2000) suggest that targeting of Th2-derived
cytokines may be a therapeutic option to prevent inflammatory bone loss. Whether
pharmacologic use of Th2 type cytokines, for example IL-IO, would be of any therapeutic
value in the treatment of human PRO lesions remains to be investigated.
9.6 Cellular contribution towards destructive pathways within PRD
Several cellular pathways could contribute to tissue damage arising from PRD. The
stromal cell component of PRO essentially comprises vascular endothelium, epithelial cells
and fibroblasts and accounts for 50% of the total cell population (Morse et al. 1975, Stern
et al. 1981, Yu and Stashenko 1987). The inflammatory cellular infiltrate of the PRD
lesion consists of neutrophils, macrophages, mast cells, lymphocytes, natural killer cells,
plasma cells and eosinophils (Morse et al. 1975, Kontiainen et al. 1986). Release of II~-l [3
or TNF-u by monocytesl macrophages and subsequent activation of resident tissue cells,
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including fibroblasts, endothelial cells and stromal cells, provokes a cascade that amplifies
or suppresses inflammation by inducing further release of cytokines and/or growth factors.
Macrophage and fibroblast derived cytokines were abundantly detected within
unstimulated and stimulated PRD explants, including IL-l, TNF-a, IL-6, IL-18 and the
chemokine IL-8. In addition to activating inflammatory mediator expression within these
cells, several cytokines exhibit chemoattractant properties. IL-l ~ has marked
chemoattractant effects upon C04+ T effector cells (Hunninghake et al. 1987), IL-I a upon
human keratinocytes (Gyulai et al. 1994), IL-18 upon T lymphocytes (Yoshimura et al.
200 I) and IL-18 upon neutrophils and dendritic cells (Leung et al. 2001, Gutzmer et at.
2003). Furthermore, RANKL likely contributes towards increased numbers and persistence
of antigen presenting dendritic cells and subsequent proliferation of T cells (Josien et at.
2000) within PRD. However, regulation of cellular migration and proliferation by
cytokines is complex. The effects are dependent upon cytokine concentrations within the
local cytokine milieu and may be exerted through indirect actions upon cells. Endogenous
release of IL-I, TNF -a, IL-6, IL-8, IL-17 A and IL-18 therefore likely co-ordinates
migration and activation of inflammatory cells into the PRD lesion. Despite significant T
cell infiltrate within the lesions, it was somewhat surprising that concentrations of T cell
derived cytokines, for example IL-4, were low in unstimulated PRO explant cultures. In
contrast, IL-17 A was detected in modest quantities within unstimulated lesions.
Fibroblasts have never been directly implicated in pathogenesis of the PRO lesion.
However, PRO-derived fibroblasts secreted a variety of cytokines that exert pleiotropic
effects on monocytes/ macrophages. Through release of such inflammatory mediators,
fibroblasts significantly contribute towards inflammatory pathways within PRD and
potentially matrix degradation of the surrounding tissues. Importantly, microbial products,
live endodontic pathogens or cytokines (for example IL-I7A, IL-I8, TNF-a or IFN-y)
significantly increased secreted IL-6 and! or IL-8 within PRO fibroblast cultures (chapter
8). Interestingly, IL-17 A and IL-I8 also induced these inflammatory cytokines within PRD
explant cultures. IL-I 7A and IL-I8 likely exaggerate inflammatory pathways within PRD
by inducing and maintaining macrophage and T cell synthesis of TNF-a, IFN-y and IL-
17A. These in tum increase IL-6 and IL-8 secretion from fibroblasts, which enhance the
recruitment of PMNs and other immune cells into the inflamed periradicular site.
Therefore, through the release of such inflammatory mediators, PRJ) fibroblasts contribute
towards perpetuation of inflammatory responses within PRO and thereby lesion chronicity.
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IL-17 A is predominantly produced by T cells. It was therefore surprising to detect 11,-17A
within PRO fibroblast cultures and within fibroblast cell lysates and its expression was
significantly increased by addition of TNF-o or IFN-y to cultures. In addition to
inflammatory effects induced by IL-6 and IL-8 expression, PRO fibroblasts likely
contribute towards T-cell activation and lesion expansion by their production of IL-17 A.
TNF -0 and IL-17 A exert little individual effect upon expression of SLF -derived OPG and
cytokines added individually to PRD fibroblast cultures did not modulate OPG expression.
However. SFL-derived OPG production is greatly increased when TNF -0 or IL-17 A are
combined with IL-I. likely reflecting a negative feedback loop to control bone destruction
(Granet et a/. 2004). The effect of cytokine combinations upon OPG expression by PRO
fibroblasts therefore requires further investigation. Lack of IL-4 protective effects within
PRO combined with an inability of endodontic pathogens to increase OPG expression from
PRO fibroblasts likely contribute towards inflammatory bone destruction concomitantly
occurring with the inflammatory PRO lesion. On the basis of these results, tissue
destructive properties of PRO fibroblasts are supported by production of significant
quantities of IL-6 and IL-8. Moreover, through the expression of inflammatory mediators
(and possibly MMPs) PRD fibroblasts may contribute directly and/ or indirectly to dento-
alveolar bone destruction. MMP expression within PRO fibroblasts and mediators of their
induction remain to be elucidated. Although numerous cell types contribute to the
pathogenesis of PRO. data from my experiments implicate PRO fibroblasts as central
participants in these processes.
Experiments on NK cells establish that IL-12 and IL-15 induce significantly more IL-IO,
MIP-I alpha, MIP-l beta and TNF-o both at protein and transcript levels than IL-18
combined with IL-12. Indeed, IL-12 and IL-18 induce very little IL-IO from NK cells and
optimal release of GM-CSF is obtained by NK cell stimulation with IL-I5 and IL-I8
(Fehniger et a/. 1999). The substantial levels of IFN-y induced by the addition of IL-I8 and
IL-I2 to the PRO explant cultures suggests that NK cells may significantly contribute
towards inflammatory events within the PRO lesion. Furthermore, NKT cells were
consistently detected within PRD sections by IHe (Figure 4.9) and may represent a key
cellular source of IL-18-mediated IFN-y expression. Further studies are necessary to
evaluate the contribution ofNK and NKT cells to inflammatory events within PRO.
CD68+ macrophage-like cells in human PRO lesions are situated in close proximity to
blood vessels, near the epithelium of cysts and in central regions that may be related to
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bacterial ingress (Rodini et al. 2001). My IHC experiments agreed with these observations
and established that they are an important source of IL-18 which was abundantly expressed
within inflamed PRD tissues. Thereby, macrophages are important contributors to
proinflammatory events within PRD. C025 molecules are strongly up-regulated on
activated T cells and can therefore be considered valuable markers of T cell activation.
Immunohistochemical staining revealed C025+ cells within inflamed PRO lesions.
Interestingly, this T cell subset was situated in close contact with IL-18 expressing
macrophages. During chronic infections, suppressive cytokines including IL-IO and TGF~
are produced and moderate immune responses to prevent an exaggerated inflammatory
reaction and harmful pathology. It is likely that some of these int1ammatory suppressors
are produced by C04+C025+ Treg cells (Mittrticker and Kaufmann 2004). Indeed. mice
lacking C04+C025+ cells show enhanced resistance to Candida albicans infection
however, this is associated with severe pathology (Mittrticker and Kaufmann 2004). Whilst
a proportion of C025+ cells observed within the PRD lesion may be Treg cells, there is
currently no data defining Treg cell expression within human PRO. Undoubtedly, the use
of FACS analysis to accurately define the cellular composition of PRO would be of
substantial benefit in establishing the contribution of specific cell subsets to tissue
destructive pathways within PRO.
9.7 Mediators of inflammatory dentoalveolar bone destruction
Healthy adult dentoalveolar bone undergoes continuous dynamic remodelling. The
equilibrium between bone deposition and bone resorption is closely regulated by the
opposing actions of osteoblasts and osteoclasts upon the bone matrix. Osteoclast activity
and bone metabolism is primarily modulated through the relative expression of the key
bone mediators. RANKL and OPG. RANKL-induced bone resorption is inhibited by
secretion of its decoy receptor OPG (Akatsu et al. 1998, Fuller et al. 1998, Lacey et at.
1998, Yasuda et at. 1998b, Lacey et at. 2000, O'Brien et al. 2000). Data from previous
described experiments established the importance of microbial pathogens and microbial
derived products in regulation of inflammatory pathways within PRO (chapter 4.3 and
4.4). Although E. coli-derived LPS had no effect upon OPG or RANKL protein
expression, other microbial-derived moieties likely influence dentoalveolar bone
destruction as SEB reduced the expression of OPG within PRO tissue explant cultures
(chapter 7.3). In addition to the RANKLI OPG regulatory axis, cytokines significantly
contribute towards the coordination of bone metabolism. In the rodent pulp exposure
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model, administration of IL-l receptor agonist (lL-1ra) leads to reduced periradicular
lesion expansion (Stashenko et al. 1994), thereby implicating IL-l a as a key modulator of
periradicular bone destruction (Wang and Stashenko 1993). Of importance, substantial
levels of IL-l ~ and TNF-a expression were present within unstimulated PRO explant
cultures. Through actions upon stromal-osteoblastic cells, IL-l ~ and TNF-a increase local
levels of RANKL expression. However, potentially destructive pathways arising from
concomitant release of IL-l ~ and TNF-a are moderated by a simultaneous increase in Ol'G
production from stromal-osteoblasts (Hofbauer et al. 1999).
T cells are present in the bone microenvironment and their impact upon skeletal turnover is
only now being unravelled. Depending upon local factors, T cells produce mediators of
bone resorption such as RANKL or participate in inhibitory pathways of osteoclast
formation such as that used by IL-18 (Horwood et al. 1998, Horwood et a/. 1999, Kong et
al. 1999). Increased RANKL expression contributes towards bone destruction by
ameliorating Fas-mediated apoptosis of osteoclasts thereby increasing their life span (Wu
et al. 2005). IL-18 is central to T cell development and activation and inducing the
secretion of IFN-y from CD4+ effector Thl cells, NK cells and NKT cells. Although IFN-y
is required for an effective immune response to pathogens, it potently inhibits osteoclast
formation (Fox and Chambers 2000), suppresses osteoclastogenesis by interfering with the
RANKL signalling pathway (Takayanagi et al. 2000) and directs progenitor cell
differentiation towards cell lineages other than that of osteoclasts (Quinn and Gillespie
2005). In view of its described bone protective properties, it was therefore surprising that
IFN-y significantly up-regulated RANKL expression and decreased OPG secretion within
matched PRO explant tissue cultures. Indeed, the opposing effect of IFN-y upon OPG and
RANKL expression was at levels of significance. IFN-y induces cytokine expression from
macrophages and other inflammatory cells that initiate bone destructive pathways thereby
emphasising complexity of the modulatory role for IFN-y in osteoclastic responses.
Through its effects upon cellular constituents within the PRO lesion, IFN-y may therefore
indirectly contribute towards promoting resorption of adjacent periradicular bone.
IL-l. TNF-a, IL-l5 and IL-l7 A enhance osteoclast formation by stimulating production of
RANKL and M-CSF from bone lining cells. However, IL-18, IL-l ~ and TNF-a have no
effect upon RANKL expression within resting T cells (Dai et al. 2004). In contrast,
RANKL expression is increased and sustained for 2 days in PHA-stimulated T cells and
synovial T cells stimulated with these pro-inflammatory cytokines. Within PDL cultures,
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OPG gene expression IS increased by TNF-a and IL-l ~ (Sakata et al. 1999). PRO
fibroblasts spontaneously expressed substantial levels of OPG. Through secretion of high
quantities of OPG, PRO fibroblasts may provide protection against pathologic bone
destruction. Surprisingly, TNF-a and other cytokines had no observable effects upon OPG
expression within PRO fibroblast cultures. The inability of cytokines or bacterial
pathogens and their cell wall components to modulate PRO fibroblast-derived OPG may
result in an inefficiency to counter-regulate increased RANKL expression induced by IL-
17A, TNF -a and IFN-y expression from other cellular components of the PRO lesion.
Further work is therefore required to determine if a combination of microorganisms or
cytokines have modulatory effects upon PRO fibroblast-derived OPG expression.
IL-I7 A markedly increases RANKL within CIA mice joints, thereby inducing joint erosion
(Lubberts et al. 2003) and dose-dependently enhances TNF-a-induced osteoclastic bone
resorption in vitro (van Bezooijen et al. 1999). Following addition of TNF-a to Saos-2
human osteoblastic cell cultures, the RANKLIOPG ratio increases after 2 h and gradually
decreases thereafter (Kim et al. 2002). A similar effect for TNF-a upon the RANKLIOPG
ratio was observed within PRO explant tissues. Indeed, IL-I7 A and TNF -a substantially
increased RANKL expression within PRO explant cultures. Of importance, It-I7 A and
TNF-a also decreased OPG secretion within matched explant tissue cultures. This suggests
that concomitant expression of IL-17 A and TNF-a, both intrinsically expressed by
unstimulated PRO cultures, promotes a powerful pro-osteoclastogenic reaction that likely
contributes towards periradicular bone destruction. A positive regulatory loop is likely
created, whereby increased IFN-y and TNF-a expression induced by up-regulated IL-17 A
promotes further RANKL expression thereby sustaining pathologic damage to adjacent
tissues.
IL-6 promotes osteoclast formation through cellular interactions between osteoblastic cells
and progenitor cells. This is related to IL-6-mediated release of IL- I~ and minimal direct
efIect upon the RANKLIRANKJOPG system (Ishimi et al. 1990, Kurihara et al. 1990,
Rozen et al. 2000). Furthermore, interactions between IL-6 and the PGE2 signalling system
lead to increased osteoclastogenesis (Liu et al. 2005). IL-8 is also a potent stimulator of
bone resorption and has a direct stimulatory effect upon osteoclastogenesis and bone
destruction (Bendre et al. 2003). Therefore, the high quantities of spontaneous and
inducible IL-6 and IL-8 expressed within PRO tissues likely contributes towards
periradicular bone destruction. Increased IL-6 and 11,-8 expression by PRO fibroblasts
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stimulated by endogenously expressed IL-17 A. IL-18 and/ or TNF-a may contribute
significantly towards local matrix degradation.
Taken together. results from the PRO explant culture model and PRO fibroblast cultures
suggest that substantial expression of potent inflammatory cytokines, including IL-6. IL-8.
IL-17 A. IL-18 and TNF-a significantly promotes a strong proinflammatory lesion
phenotype. Through direct interactions upon cells within the bone matrix regulating bone
remodelling and cells capable of secreting RANKL within the PRO lesion, these cytokines
are likely contributors towards destructive pathways within PRO. IL-4 is a potent inhibitor
ofRANKL and osteoclastogenesis (Wei et al. 2002, Mirosavljevic et at. 2003, Mangashetti
et al. 2005). The absence in expression of essential down-regulatory mediators. including
IL-4, within PRO tissues combined with concomitant production of pro-inflammatory
cytokines IL-17 A. IL-I P and TNF -u further reinforces the destructive inflammatory nature
of PRO.
9.8 Clinical implications and future work
Previously. bacteriologic culture tests were used as clinical indicators for the end point of
root canal treatment. However, this is an unreliable procedure and is now infrequently
undertaken other than for research purposes (Trope and Grossman 1985). To determine the
inflammatory status of PRO lesions, it has been suggested that the identification and
measurement of appropriate biological markers may be of clinical relevance. Therefore, a
small number of studies have investigated the potential for sampling of the root canal fluid
in teeth associated with PRO. Concentrations of host inflammatory mediators within the
root canal have then been quantified and correlated with clinical findings.
Root canal concentrations of PGE2 are directly associated with clinical symptoms and
negatively correlate with increasing lesion dimensions (Takayama et al. 1996). TN F-a
(Safavi and Rossomando 1991). immunoglobulins (Kuo et al. 1998). nitrite (Takeichi et al.
1998, Shimauchi et al. 2001), IL-l P (Matsuo et al. 1994. Shimauchi et al. 1996. Takeichi
et al. 1996, Kuo et al. 1998), IL-6 (Takeichi et al. 1998) and IL-8 (Shirnauchi et al. 20(1)
have all been detected within root canals of teeth associated with PRO. IL-I ra levels in
root canal exudates correspond with levels of IL-l p expression and their ratio appears to
correlate with clinical symptoms (Shirnauchi et al. 1998). Root canal concentrations of IL-
8 correlate with symptomatic teeth associated with PRO lesions (Shimauchi et al. 2(01). In
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addition to associations between cytokine concentrations and clinical parameters,
significant reductions in root canal levels of MMP-8 occur during root canal treatment
procedures (Wahlgren et al. 2002). In contrast, root canal concentrations of IL-I ~ or TN F-
a do not correlate with clinical symptoms (Ataoglu et al. 2002) and others have failed to
detect TNF-a within periradicular exudates recovered from necrotic infected canals
(Takeichi et al. 1998).
However, the literature relating to root canal sampling must be interpreted with caution.
The majority of these studies have analysed only small numbers of canals and
reproducibility of findings have not been investigated by follow-up studies. Nevertheless,
root canal sampling may allow development of non- or minimally-invasive techniques
within the clinical environment during routine clinical procedures. The quantification of
inflammatory mediators may elicit information for the clinician of lesion status and
thereby, aid in defining treatment prognosis. However, the current lack of understanding of
inflammatory dynamics and mechanisms of repair and destruction within human PRD is a
major obstacle in developing such host-based biological markers. My experiments
demonstrated that human PRO tissues inherently produce substantial quantities of a
number of proinflammatory cytokines. The majority of observed functional effects were
derived from positive addition of inflammatory mediators to ex vivo explant tissues. Future
work within this ex vivo model requires investigations to additionally investigate the
effects of inhibitors and neutralising antibodies upon inflammatory mediator expression.
Indeed, experiments are planned to examine the effect of TNF-a inhibitors upon
endogenous cytokine expression within the PRO explant model.
Clinical studies are now necessary to attempt to correlate observed inflammatory processes
within the ex vivo human PRO tissue explant model with the presence or absence of
specific clinical signs and/ or symptoms. By developing such studies, an improved
understanding of how inflammatory events within PRO relate to clinical complications
may significantly contribute towards the development of reliable biological markers that
indicate inflammatory disease status. Thereby, root canal exudates could be effectively
sampled and clinicians informed as to whether canals can be successfully obturated and
treatment therefore completed. Importantly, this may aid the clinician in advising the
patient as to the predicted outcome of the treatment procedure (Spangberg 20(0).
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In addition to sampling of root canal exudates, identification of novel inflammatory
mediators and their contribution to proinflammatory pathways may allow the development
of therapeutic devices that could be placed within the root canal or inserted directly into
the PRO lesion. Thereby, destructive inflammatory responses may be impaired and tissue
repair promoted. Cytokines are centrally involved within pathologic processes sustaining
inflammatory PRO. The therapeutic blockade of upstream proinflammatory cytokines
within the lesion may therefore be advantageous. This approach has been successfully
employed in several chronic inflammatory diseases including biologic agents that target
TNF-a in RA and Crohn's disease (Taylor 2003). More recently, a clinical trial has also
established the efficacy of targeting IL-IS in RA patients (Baslund et al. 2005). Although
data from the PRO explant experiments would suggest an upstream pro inflammatory role
for IL-18, inhibition of IL-18 may prove too expensive for therapeutic value. The use of
small molecule approaches including P2X7 receptor inhibition, caspase I inhibition or IL-
l R cascade signalling inhibitors may provide more suitable therapeutic benefits. The
effects of these molecules upon inflammatory processes within PRO require investigation
within the PRO explant model system.
9.9 Conclusion
The successful identification of therapeutic targets that attenuate destructive
immunoinflammatory pathways within PRD is greatly sought after. To achieve this, a
functional understanding of complex interactions between differing cell populations,
between these cells and tissue matrix and between cells of the PRD lesion and cells within
the matrix of the surrounding dentoalveolar bone is prerequisite. The cytokine milieu is
central in orchestrating these interactions yet to date is poorly defined within human PRD,
the majority of data being derived from observational studies. Results of experiments
undertaken within this thesis support the working hypothesis that the development of a
novel PRO explant culture model would enable detailed investigations of the cytokine
network within PRO. Indeed, the spontaneous release of endogenous cytokincs was readily
detected within explant cultures, confirming significant inflammatory activity within
chronic PRO. Importantly, the PRO model facilitated analysis of functional cellular/ tissue
responses to exogenous stimuli and established the contribution of bacterial moieties to
prointlammatory destructive pathways.
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Taken together, results from my experiments strongly implicate IL-18 as a key modulating
moiety driving inflammatory processes within human PRO. Indeed, addition of 11.-18 to
PRO tissue explants up-regulated expression of proinflammatory cytokines including IL-
Ip. IL-6. TNF-a, IFN-y and IL-17 A and moderately reduced IL-IO secretion. Of
importance, experiments utilising the novel PRO explant model provide strong proof of
concept that IL-18 regulates host responses to pathogenic microorganisms within PRO.
Cell culture experiments defined periradicular fibroblasts as a target of IL-18-mediated
processes within PRD inflammatory responses. Through increased production of IL-6 and
IL-8, PRO fibroblasts likely contribute towards destructive inflammatory events arising
from up-regulated expression of IL-I8 within the lesion. Indeed, the effects of exogenous
IL-I8 upon endogenous cytokine expression clearly suggest that IL-I8 promotes
proinflammatory pathways within the lesion. Nevertheless, IL-I8-mediated effects may not
necessarily be detrimental to the surrounding periradicular tissues. Through induction of
GM-CSF, IL-I8 inhibits osteoclast maturation (Udagawa et al. 1997, Horwood et al. 1998)
and induces PG expression (Makiishi-Shimobayashi et al. 2001). Therefore, IL-I8 secreted
by cellular components of PRO tissues may have the capacity to impede local resorption of
dentoalveolar bone. The precise contribution of IL-18 towards destructive or compensatory
pathways within the periradicular tissues requires further exploration.
Having established that the PRO lesion serves as a useful in vitro ex vivo experimental
model, future work is necessary to establish associations between underlying immunologic
observations within PRO lesions to clinical parameters. Thereby, identification of novel
proinflammatory molecules and pathways that significantly contribute towards destructive
inflammatory events may be elucidated. Potentially, this may facilitate the development of
appropriate pharmacologic agents that attenuate destructive inflammatory responses
leading to lesion chronicity and the identification of inflammatory mediators that may
provide diagnostic information from root canal sampling.
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Conclusions from experiments undertaken within this thesis may be summarised against
the original aims of the study as follows:
I. Human PRD provided an effective in vitro ex vivo novel explant culture model in
which to investigate functional dynamics of likely inflammatory mediators
contributing to the initiation and perpetuation of PRO.
2. Substantial IL-18 expression was observed within PRO tissue and IL-18 biology
significantly contributes towards proinflammatory pathways within the PRO lesion.
3. Inflammatory mediators directly related to bone regulatory pathways, including
cytokines, RANKL and OPG were readily detectable within the human PRD lesion.
Furthermore, several factors were identified that modulate expression of these
inflammatory moieties.
4. PRO fibroblasts were successfully cultured in vitro. Through the release of
inflammatory mediators including IL-6, IL-8, IL-17 A, TNF-a and OPG, PRO
fibroblasts are important regulators of inflammatory processes within human PRD.
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Figure 9.1 Schematic illustration summarising inflammatory processes within
chronic inflammatory PRD.
PAMPs originating from contents of infected dental root canals enter the periradicular
tissues and bind to PRRs, including Toll-like receptors-l , -2, -4 and -6, activating cells of
innate immunity and resident stromal cells. Upon activation, inflammatory mediators
including cytokines are released leading to an inflammatory cascade which is enhanced by
cell-cell contact. Following activation of innate immunity, acquired immune responses are
instigated. Secreted cytokines act in autocrine or paracrine manners and in positive or
negative regulatory feedback loops. Substantial expression of proinflammatory cytokines
within the lesion, including IL-l~, IL-6, IL-8, IL-17 A, IL-12, IL-18, TNF-a and IFN-1,
promotes a powerful inflammatory reaction that results in further cell activation. Continued
release of these proinflammatory mediators perpetuates inflammatory events within the
PRD lesion. High levels of spontaneous and inducible IF -y, TNF-a and IL-12 expression
implicate a predominating CD4+ effector Th 1 pathway. Deficient antiinflammatory Th2
type cytokine expression within PRD, for example the absence of IL-4, likely contributes
towards dysregulated inflammatory pathways which promote tissue destruction. Release of
MMPs, RANKL, TNF -a, lL-l~, IL-6, IL-8 and IL-17 A by PRD fibroblasts and other
cellular constituents of the PRD lesion results in the activation of cells within the bone
matrix, including osteoclasts, and bone destruction. IF -1 and IL-18 are essential in
successful host responses to endodontic pathogens and may be protective against local
matrix degradation by preventing osteoclastogenesis. Conversely, through inducin g an
increase in the RANKLI Ol'G ratio and promoting pro inflammatory cytokine expression
(including TNF-a, IL-lP, IL-6, IL-8 and IL-17A) IF -1 and IL-18 respectively contribute
towards destructive pathways in surrounding dento-alveolar bone.
Figure 9.1 Schematic illustration summarising inflammatory processes within
chronic inflammatory PRD.
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Abstract
Murray CA. Saunders WP. Root canal treatment and
general health: a review of the literature. International
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Review The focal infection theory was prominent in
the medical literature during the early 190()s and
curtailed the progress of endodontics. This theory
proposed that microorganisms, or their toxins, arising
from a focus of circumscribed infection within a tissue
could disseminate systemically, resulting in the
initiation or exacerbauon of systemic illness or the
damage of a distant tissue site. For example. during the
focal infection era rheumatoid arthritis IRA) was
identified as having a close relationship with dental
health. The theory was eventually discredited because
there was only anecdotal evidence to support its claims
and few scientifically controlled studies.
There has been a renewed interest in the influence
that foci of infection within the oral tissues may
have on general health. Some current research
suggests a possible relationship between dental health
and cardiovascular disease and published case reports
have cited dental sources as causes for several systemic
illnesses. Improved laboratory procedures employing
sophisticated molecular biological techniques and
enhanced culturing techniques have allowed
researchers to confirm that bacteria recovered from the
peripheral blood during root canal treatment
originated in the root canal. It has been suggested that
the bacteraemia. or the associated bacterial endotoxins.
subsequent to root canal treatment. may cause
potential systemic complications. Further research is
required. however. using current sampling and
laboratory methods from SCientifically controlled
population groups to determine if a Significant relation-
ship between general health and periradicular infection
exists.
Keywords: arthritis. bacteraemia, focal infection.
health. root canal treatment.
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Introduction
Bacteria were first demonstrated scientifically in the
diseased dental pulp by Miller 11H94). The medical
profession took notable interest in the importance of
the infected dental pulp and oral tissues when William
Hunter 1190()) theorized that microorganisms present
in the oral cavity could disseminate throughout the
body. resulting in systemic disease. Following further
studies (Dads 1912. Billings 1914. Rosenow 1914). a
number of research articles appeared in the literature
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investigating the effect that diseased tissue sites.
including oral tissues. had upon systemic illness.
Researchers presented the idea that the dissemination
of microorganisms. or their associated toxins.
throughout the body from a focus of circumscribed
infection at a particular tissue site could initiate or
exacerbate systemic disease or damage a distant tissue
(Daland 1916. Giltner 191 h. Hunter 1921. Thompson
1925). This concept became known as the Focal
Infection Theory.
The focal infection theory
During the period Ilj 10 to the Ilj40s. the medical and
dental literature contained several references
International Endodontic Journal. 33, 1 18,2000 •
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concerning focal infections of dental origin (Mayo
1914. Rosenow 1917. Mayo 1922. Bedell 1925. Peck
1925. Price 1926. Rosenow 1927). Billings (1912)
and his coworkers' efforts were instrumental in gaining
the medical profession's broad acceptance that a
localized. low grade chronic infection could produce
disease elsewhere in the body. Billings declared 'when
the focal infection. wheresoever it may be located.
seems to be related to the systemic disease. radical
measures should be instituted to remove if. Mayo
(1914) concluded that 'root abscesses and pus pockets
connecting with them are often the source of acute
and chronic rheumatism'. Rosenow (1917) reinforced
the concept of a focus of infection from which microor-
ganisms could enter the bloodstream causing systemic
illness. proclaiming 'these results call for a public
health propaganda so that the people may be fully
informed of the dangers to their continued health that
arise (rom infected teeth'.
Concomitant with the focal infection theory there
arose the hypothesis of elective localization (Rosenow
1919). This theory suggested that bacteria located
within a certain focus of infection could cause systemic
infections by localizing within a specific distant target
organ or tissue. Rosenow insisted that enclosed lesions
that could only drain into the circulation. such as a
necrotic pulp, were the most dangerous foci of infection.
Goadby (1911) demonstrated that cultivated micro-
organisms from oral infections were capable of
inducing rheumatoid arthritis (RA) in the knee joints
of rabbits. Other published articles claimed a clearly
defined link between infective rheumatoid arthritis and
foci of infection. with oral sepsis cited as a main contri-
buting origin (Billings 1913. Hartzell & Henrici 1916).
Research revealed that the primary infective agent in
rheumatoid sufferers was apparently the Streptococcus
organism which was prevalent in the oral tissues
(Shandalow 1928, Cecil et al. 1929).
The subject of focal infection was debated and re-
commendations proposed that were based on limited
scientific research. few controlled studies and anecdotal
evidence. These early papers promoted the ritual of
wholesale dental extractions and tonsillectomies as the
complete cure for many systemic ailments. The theory
of focal infection was taught vigorously. citing infected
teeth or their surrounding structures as being
responsible for a wide range of diseases (Holman
1928). Rhoads & Dick (1932) regarded all pulpless
teeth as probable foci of infection and determined that
the extraction of teeth in several individuals improved
their various medical conditions. Rhein et a/. (1926)
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suggested that the extraction of healthy teeth was
justifiable in the prevention of focal infection. In
America, the reaction against root canal treatment
was so strong that the teaching of clinical endodontic
techniques was stopped altogether in most institutions
in favour of dental extractions (Grossman 1971). Con-
sequently the progress in root canal treatment. still
very much in its infancy, was severely curtailed for
over 40 years.
Few scientists had published any doubts concerning
the focal infection theory during its early development
(Howe 1919, Miller 1926). However. by the 19305
researchers began to question the evidence supporting
the focal infection theory (Valentine & Van Meter 1930,
Bernhardt & Hench 1931). despite review articles
upholding its claims (Holman 1925). Cecil & Archer
(1927) recorded that from 200 rheumatoid cases. 62%
of those who had undergone dental extractions were
either cured or had improved. They concluded that
success in treatment was dependent upon a relentless
search for foci of infection and advocated prompt
removal of such foci early in the course of the disease.
The tonsils and teeth were determined as the most
common foci of infection. Ten years later Cecil &
Angevine (1938) questioned the validity of these results
and denounced the link between RA and oral disease
because, from the original study, there was only a small
percentage of RA patients whose condition could have
resulted from a focal infection. Their second study de-
monstrated that chronic focal infection played a com-
paratively small role in patients with RA and thus
disputed the role of focal infection in systemic disease.
Despite the indication 1T0mearlier papers of a relation-
ship between Streptococcus sp. and rheumatoid arthritis,
it proved difficult to reproduce these results with further
research (Nye & Waxelbaum 1930, Dawson et al.
1932).
Reimann & Havens (1940) suggested that Hunter's
views expressed 30 years previously had been misinter-
preted. They stated that Hunter had laid the blame of
systemic disease on 'ill fitting dentures and crowns and
not on apical abscesses about pulpless teeth'. In
reviewing the literature and from experiments they
had performed. Reimann & Havens concluded that 'the
removal of local infections in the hope of influencing
remote or general symptoms and disease must still be
regarded as an experimental procedure not devoid of
hazard.' Whilst others (Slocumb et II/. 194 L. Ensign
1945) continued to support the concept of focal
infection, particularly in relation to specific clinical
entities including heart disease, chronic infectious
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arthritis and glomerulonephritis. they accepted that a
mort' logical and scient ilk approach to focal infection
should be adopted. In a critical appraisal reviewing the
relationship between focal infection and rheumatoid
disease. Frevberg (194h) postulated that removal of
foci of infection should only be part of a broad
spectrum of treatment and that in chronic cases
removal of these foci would be of little benefit. t\ focus
of infection was deemed important in RA patients
though it was proposed that it should only be
corrected as a prophylactic measure at an early stage
in the disease process rather than as a therapeutic in-
tervcntion.
Researchers who continued to declare their
allegiance to the local infection theory (Shuster 1"41)
acknowledged that not every focus of infection was
responsible for a focal infection and that anaemia,
emotional strain, exposure, malnutrition. endocrine
imbalance. fatigue. senility. trauma. age and infectious
disease all had a role to play in lowering the patient's
resistance to disease (Arnett & Ennis I" 3 31. Those
sceptical of the focal infection theory IEaslick I", I.
Mitchell & Helman 19:; 3) claimed that most of the
research up until 19:;0 exhibited no foci of infection
that could be located in the afflicted individual and
that there was often no dramatic improvement in the
patient's medical condition after the removal of the
!(lCUS. Mitchell & Helman (1953) also noted that many
persons in perfect health had as many septic foci as
patients suffering from diseases such as arthritis. The
early focal infection studies were crude, with no
control cohorts and unreliable bacteriological culture
techniques had been used which affected the findings.
These criticisms of the focal infection theory led to its
gradual demise, although case reports of focal infection
from an oral source were occasionully published during
the 19~Os IKnapp 19~2).
Subsequently. the emphasis in research on the focal
infection theory graduated toward investigating
potential systemic effects as a consequence of
bacteraemia following oral and medical procedures.
Studies within dentistry started to analyse closely the
only apparent identifiable form of a focal infection and
elective localization from dental origin, that of infective
cndocardtns (Jones & Newsom 19311. The link
between focal infection and an oral origin for tnfcctivc
cndocarditis arose after acute episodes of infcction.
whereas no chronic infection from a dental origin
could dearly be ldentlfled as initiating or aggravating
xystenuc illness.
The rise of the focal infection theory during the early
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decades of the 20th century owed as much to social
and economic factors as to scientific validity (Dussault
& Sheiham 19S2). In Britain, the increasing popularity
of Hunter's local infection theory offered a convincing
argument for the lowly regarded dental profession to
gain better public credibility and to help support a law
amendment for the compulsory registration of dental
practitioncrs. Support of the fucal inlectlon theory
helped to achieve this aim when in 1921 a Dental Act
was passed acknowledging the professional status of
dentists in Britain.
Concurrent with fulfilling the professional objectives
of dentists in Britain, there was also a favourable
political and social environment to promote the focal
infection theory at the beginning of the century.
There were great concerns over the poor physical
condition of entrants into the British Armed Forces
and the appalling health of large sections of the
community. These concerns led to the creation of a
Ministry of Health in 1919. The focal mlecnon theory
emerged at a time where there was great political
interest in the physical health of the population in
Britain, thus helping to fuel its popularity. Criticism of
the theory was stronger in the United States, where
dentistry was already well established as an
autonomous profession, yet it was nnly after the
passing of the Dental Act in 1921 that British dentists
began to question Hunter's views, By the I"40s there
was sufficient scientific data available to discredit the
focal infection theory, and although the Dental Board
of the United Kingdom maintained its support for the
theory, it had served the profession's objectives and
lost its popularity.
In recent years, however, the issue of focal
infection has once again resurfaced with the
publication of sclentiflc review papers (Hughes 19"4.
Newman 199h). A popular book (Meinig 1"Sh) has
questioned whether the dental profession has chosen
to ignore a very significant and much researched
concept in relation to the population's general
health. This has particularly called into question the
role of root canal treatment and its importance in
the long-term effect on an individual's health (Inter-
national Academy of Oral Medicine and TOXicology
I""H, IITfl':llwww.rheumatic.org/tecth.htm. 11'1"1'1':1/
www.netset.com/-docws/pagel Lhtml, IITI'I':/lwww
zip.com.au/-rgammal/root_therapit's.htll1). However.
the possible link between general health and root
ranal treatment has been strongly disputed by
dellial governing bodies IBritish Dental Association
1"%).
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General bacteraemia, infective endocarditis and
prosthetic joints
The earliest published studies analysing the species of
microorganisms in a bacteraemia. originating from a
focus of infection. used rudimentary laboratory
equipment and techniques that could only cultivate a
limited number of microorganisms (Richards 14l21.
However. these studies were useful in confirming that
bacteraemia was possible from foci of infections within
a variety of tissue sites. including the oral cavity.
Whilst bactcraemlas related to oral procedures were
only beginning to be explored. the medical profession
had already recorded bacteruemtas following various
medical procedures (Lake 1419. Harrington & Wright
1930. Elliot 1939a. Rhoads er ill. 14 'i SI. Several
papers followed. investigating different aspects of the
postoperative bacteraemia consequent to dental
extractions (Burket & Burn 1937. Faillo 19o12.
McEntegart & Porterfield 19o19. Schirger t'l til. 19hOI.
Murray & Moosnick ( 1941 ) proved that a bacteraemia
could even occur without dental operator intervention
by the chewing of paraffin wax in diseased mouths.
Although it was apparent that a bacteraemia occurred
after dental extractions. it was suggested that apical
infections were 'effectively walled olT by the associated
inflammatory reaction' and thus did not contribute
toward a bacteraemia (Elliot 1939b). Burket & Burn
( 19371 claimed that a reduced bacteraemia occurred
following the administration of local anaesthetic.
compared with extractions performed under general
anaesthesia. although this claim was contradicted by
Robinson et Ill. ( 19 SO).
The focal infection theory motivated many
researchers to investigate the role of dental extraction
and its relationship to endocarditis and other cardiac
diseases including valvular defects. congenital defects
and rheumatic heart disease (Abrahamson 1931.
(Hell & Elliot 193 'i. Feldman & Trace I') 3H. Hopkins
1939. Palmer & Kempf 19l9. Geiger 1942). These
studies paved the way for research into the relationship
between bacteraemia and endodontic procedures (Ross
& Rogers 1943. Beechen i't Ill. 1956. Bender er Ill.
19hO). Kennedy et ill. (19Si) showed that bacteraemia
could occur in monkeys after the introduction of Strep-
rococcus Illlt'lllOl!lliCl4S into the root canal. Other oral
manipulations were also demonstrated to produce a
bacteraemia. including chewing (Cobc 14')4).
periodontal scaling (Bandt et al. 19h41. tooth brushing
(Rise et al. 19h9. Sconyers ct til. 1971). oral
prophylaxis (Del.eo et ul. 1974). dental flossing
• International Endodontic Journal. 33, , 18,2000
(Ramadan rt al. 197::;1 and the removal of osteosynth-
esis plates (Otten i't til. 19H7). Not only was the
bacteraemia following dental extractions implicated
with bacterial endocarditis but noninvasive procedures
including scaling and root canal therapy were noted as
possible causes of potentially fatal bacteraemia
(Etsenbud 19h21.
However. these studies had their limitations.
especially in relation to the sensitivity of blood culture
techniques. Thus large variations in the frequency of
bacteraemia following dental extractions were
recorded. ranging from 34 to 100%. depending 011 the
different techniques employed at the time of extraction
(Lazansky t't til. 1949. Coffin & Thompson 14'ihl and
the laboratory methods sanctioned by the authors
(Hockett er al. 1477). It was also evident that the soil'
use of aerobic culturing techniques was an inadequate
environment for the growth of all microorganisms
originating within the oral cavity and that in order to
detect a broader range of microorganisms. better
anaerobic techniques would have to be employed
(Rogosa et ill. 19hO. Bender et al. 19h I. Khairat 19hh.
Goldberg 19hK).
The improved laboratory skills and materials enabled
a more accurate analysis of the quantitative and
qualitative aspects of bacteraemlas during the 19,)lIs.
Refinements of anaerobic culturing techniques
combined with the increasing availability of antibiotics
allowed researchers to determine the elTect of antibac-
terial prophylaxis on bacterial endocarditis consequent
to bacteraemia from an oral origin (Bender &
Pressman 1945. Peterson 19S I. Cates & Christie
19')1. Merrill et al. 19'i 1. Bender et al. 19'iS. Render
er al. 19h3. Baltch er al. 19H2. Oakley 19S?). As a
consequence of studies analysing antimicrohial agents
in the prevention of endocarditis (Everett &
Hirschmann 1977. Von Reyn et Ill. 14Hl. Oakley &
Somerville 19S II guidelines were developed for the
prophylactic use of ant imicrohial agents for medically
'high risk' patients during various dental procedures
(Guntheroth 19Sol. Kaye 19Hb. Pallasch I 4S4 I.
However. there wert' no clear published guidelines
relating specifically to nonsurgical root canal treatment
(Bender & Montgomery 19Sh). although articles in the
literature have discussed this issue with varving
opinions (McCowan 14S2. Bender et al. 14S4. Lavelle
199h)'
In addition to antibiotic prophylaxis of bacterial en-
docarditis. other methods of reducing bacteracmias
from an oral origin were sought. The usc of a
presurgery mouthwash was demonstrated ttl cause a
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significunt reduction ill bacteraemia from oral sourn's
IRise I't til. l'lh'l. Scopp & Orvieto 1'1;11. \\'ank I't al.
\ 1'17h 1 Were unable to show a reduction ill
bacteraemia with improved oral hygiene. However,
Sconyers rt al. 11'1731 . Madsen ( 197 -l) and Silver I't al.
11'17;) confirmed that greater bacteraemia occurred
with higher levels of gingival intlammation although
plaque le\'el, did not appear to be directly correlated.
Therefore. 'high risk' dental patients. including cardiac
patients and elderly patients with native valve infective
endocarditis. require meticulous oral hygiene regimes
(Diener et til. 1'1M. Silver et al. 1'177. Friedlander &
Marshall 1'1'1-l). Despite these recornrncndanons. cases
of infective endocarditis and subsequent deaths as a
result of dental treatment or oral neglect are still
reported in the literature (Younessi 1'1 oj. 1995).
The greatest peak in delectable bacteraemia alter
extractions has been noted to occur within 30 s of the
procedure IRoberts I't al. 1'192). Whilst this
bacteraemia may cause no harm in the healthy host.
bacteraemia in the susceptible host such as immune-
compromised patients. the elderly. RA patients and
those with damaged heart valves. may potentially
cause serious systemic problems. Okabe rt /11. 11'19 S)
discussed the faclors affecting bacteraemia after dental
extractions and indicated a close relationship between
increasing age. presence of gingival inflammation. the
number of tcerh extracted and the length of time taken
for extractions. with bacteraemia.
Another concern of bacteraemia from an oral origin
has been the role of oral bacteria in the infection of
prosthct«: joints. in particular late inlection of lotal hip
replacements ITIIR). A number of retrospective
anecdotal case reports have speculated that microor-
ganisms derived from an oral origin were responsible
li,r late infection of prosthetic joints IRubin PI III. 1'l76.
jal'llbsen & Murray I'lS(), Mulligan 1'ISO. Lindqvist &
Slat is I '1K'i. Strazzeri & Anzcl 1'ISh. Sullivan 1'1 til.
1'I'l(). Waldman ,'I til. 1'l'l7). However. none of these
studies have been Hble to confirm a positive origin from
the oral cavity by the use of ribotyping. This has raised
much debatt' as to whether individuals with prosthetic
joints. undergoing dental treatment. shuuld receive
antihiotic prophylaxis (Littie 19113. Tsevat cl til. I'lS'I).
LaPorle ct til. (I '199). in re\'iewing almost 30()() THR
patients. conduded that dental procedures were
implicated in h% of late infections in their patient
sample. However. there arc no controlled prospective
studit's that have determined if root canal treatment
procedures increase the probability of infection in these
patients.
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Root canal flora
After Miller (11l'l4) showed the presence of microor-
ganisrns within the root canal. multiple studies charac-
terized the different species of microorganisms within
the root canal (Henrici & Hartzell I'll 'I. Haden 1'12 5.
Thoma 1'l2S, Winkler & van Alllef<lIlgcn 1459.
Sciaky & Sultzcnu 1% 1. Engstrom I%4). An
experiment by Kakehashi et III. (1965) revealed the sig-
nificance of microorganisms in the root canal. They de-
monstrated that exposed pulps in gnotobiotic rats did
not develop periradlcular lesions. However, pulp
exposures in ordinary rats led to pulpal necrosis Ihat
was determined to be caused by oral microorganisms
invading the pulp tissue.
Not only were microorganisms capable of infecting
root canals from the oral environment. but Robinson &
Holing 11'141 j demonstrated that systemic bacteria
were able to enter inflamed dental pulps. this process
being termed anachoresis, MacDonald I't til. (19 S;)
identified the presence of bacteria in Ihe canals of
nonvital, intact. traumatized teeth and suggested that
bacteria were capable of entering the root canal system
of these nonvital teeth through the individual's general
circulation or via the lymphatics and blood vessels
from the periodontium.
Consequently. root canal treatment procedures were
developed to attempt to eradicate these microorgan-
isms biomechanically (Crossman 1'14 'i. Ingle & Zeldow
19511. Cvek I't <II. 1'17h, Bystrom & Sundqvist I'ISI) or
with intracanal antimicrobial agents (Auerbach 1'1:; 3.
Matsumiya & Kitamura 1'1hO, Shovelton & Sidaway
1'160. Melville & Slack 1Yh I. Shih et ai. 1'170). Several
researchers indicated that better anaerobic culture
techniques were needed to cultivat« all the microor-
ganisms present within the root canal tHrown &
Rudolph 1'1S7, Engstrom & Frnstell l'lh I. Crawford &
Shankle 1%1. Melville & Hirch I '!h7), Subsequently.
speCific canal medicaments could be used to eliminate
these microorganisms prior to obturation of the root
canal.
The benefit of determining the microflora or the
root canal was questioned aftef studies revealed no
difference in success rates ill teet h Ihat showed a
positive culture at preobturatioll with those that wtTe
negative (Seltzer I't al. 1'1h J. Bender 1'1 aJ. l'lh4.
Eggink 141-:2), Morse (1'171) thought that there were
so many inherent shortcomings with the sampling
and culturing techniques that culturing or the root
canal contents was of little value tilr clinical purposes.
This was especially true IClrteeth with no radiographic
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periradicular radiolucencies where it was considered
by Stobberingh & Eggink (14H 2) that the possibility of
a positive microbiological result was so low that root
canal sampling was of no benefit. Sims (19 7 ~)
suggested that sterility was unattainable in the root
canal and that disinfection of t he root canal need only
be surgically safe. However. Pitt Ford (1982) demon-
strated that a high incidence of persisting periradicu-
lar inflammation occurred from canals that had not
had all the microorganisms removed by the
combination of both mechanical instrumentation and
intracanal medicaments. Bystrom ct al. (1 '18 7) proved
that a careful aseptic technique was capable of
eliminating bacteria from root canals with consequent
healing of periradicular lesions.
Developments in microbial laboratory techniques
continued during the early 1'l70s. with a greater
research emphasis being placed on the culturing of
anaerobic organisms that may inhabit the root canal.
Enhanced methods to grow these groups of bacteria
were developed (Aranki & Freter 1972. Fulghum et al.
1973. Crawford elal. 1974. Matusow 1979). Even the
process of sampling the root canal contents was
improved by using an anaerobic sampling technique
(Berg & Nord 1973). although the use of media supple-
mented with blood. rather than exposure of the micro-
organisms to oxygen during sampling. was deemed to
be more important (Carlsson et al. 1977). The use of
rubber dam provided an aseptic technique under
which to perform the root canal treatment and micro-
bioiogical sampling.
Several studies were undertaken that evaluated the
quality and location of microorganisms within the root
canals of teeth in relation to varying dental signs and
symptoms (Taklan 1974. Wittgow & Sabiston 197~.
Rowe & Binnie 1977. Griffee et a[. 19S0. Yoshida et at.
19S7. Hashioka et al. 1992. Gomes et al. 1'190). It
became possible for the first time to culture and identify
the presence of anaerobic microorganisms to the species
level (Kantz & Henry 19741. Many articles established
that the use of certain culture media and an anaerobic
environment were more effective in producing successful
cultures from root canal samples (Zielke et a[. 1970,
Kendell et a[. ) 970. Goodman 1977. Zielke et al. 1979.
Griffee et al. 19S 1). A predominance of anaerobic micro-
organisms was shown to be present (Bcrgenholtz 1974).
Consequently. it is now known that the ecology of the
root canal flora is very diverse. containing complex
bacterial interrelationships (Sundqvist et ill. 1'179.
Baumgartner & Falkler 1991. Sundqvist 1'l'l1a. 1942b.
Baumgartner & Watkins 19'14. Sundqvist 1'194).
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Endodontic bacteraemia
With the understanding that a bacteraemia could
occur during root canal procedures (Ross & Rogers
1943) further research was conducted to measure the
bacteraemia after root canal treatment (Bender et al.
1900. Klotz et al. 1'ln5). These studies illustrated that
it was far more probable that a bacteraemia would
occur if root canal instrumentation was performed
beyond the apex of the root than when maintained
within the confines of the root canal system. The post-
operative bacteraemia following endodontic procedures
was shown to last no longer than [() min (Bender
er al. 1900). the microorganisms within the circulation
being cleared by phagocytes initially and then by the
reticuloendothelial system.
It was not until 147n that a study measuring
bacteraemia subsequent to surgical and nonsurgical
root canal treatment. applying an aseptic technique
and improved anaerobic culture mediums. was
published (Baumgartner et ,,[. 1'I7h). The authors
were able to confirm from their 30 patient sample that
a bacteraemia was not produced if root canal instru-
mentation remained within the root canal. In a follow-
up study, Baumgartner et al. (1977) demonstrated that
nonsurgical root canal treatment resulted in a much
lower bacteraemia incidence (3.3%: as a result of over-
instrumentation). than surgical flap rellection (83.3%).
periradicular curettage (33.3%) or tooth extraction
1100%). No further studies that analysed root canal
treatment-induced bacteraemia were conducted or
published for nearly 2 () years.
By the 1480s improved transport media (Carlsson &
Sundqvist 1980) enhanced consistently superior results
of bacterial growth [rom the culturing of root canals.
The use of good aseptic techniques and careful
culturing methods in both anaerobic and aerobic envir-
onments were sullicient to determine that a relatively
large and varied population of bacteria. in terms of
species and bacterial concentration. were present in
infected root canals (Zavistoski et al. 19801. The root
canal hosts more than 100 different bacterial species
(Tronstad 1992).
Whilst culturing oral anaerobic bacterial samples
was an ellicient method of identifying bacteria from
root canals. it was confirmed that the use of DNA
probes was a far more reliable and precise method for
the tdenttflcatton of microorganisms recovered from the
root system (Loesche et al. 1992). YMCA III has been
proved to be an effective transport medium for oral mi-
croorganisms allowing a high and consistent lv reliable
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recovery rille of anaerobic organisms. probably as a
result of its low redox potential (Dahlen ,'1 u]. 14411.
Recent studies analysing root canal treatment
fostered bacteraemia have used these improved
anaerobic techniques and more sophisticated
diagnostic tools. Debelian ,'1 al. (14411 published
further evidence that a bacteraemia occurred if root
canal instrumentation was carried beyond the apex.
and the most likelv bacteria involved were anaerobic
types. Subsequent studies by the same authors demon-
strated that the root canals contained a diverse group
of microorganisms wit h I 12 strains being isolated and
the number of species contained within an individual
canal varying from one to II. Flisobllclrrilll1l 11IIcll'atlll1l.
the most common isolate within the root canal was
located from S 1% of root canals studied. They also
showed that a bacteraemia could occur even if instru-
mentation WaS maintained within the root canal and
that the most common organisms present within the
associated bacteraemia were anaerobes (Ikbelian et al.
144 ~I. Using SOS-PAGE electrophoresis they
established that the organisms in an endodontic-
related bacteraemia were identical to those arising
from within the root canal (Debelian cl al. 144h).
These results were repeated with ribotvping using a
D:'-J:\ hybridization method iDebelian 1'1 al. 1947) and
then using both phenotype and genetic methods
(Debeliun 1'1 al. 1995I. Bacteraemias occurred in 31 to
~4'::, of the root canal treatments. however, this study
was based on a small sample group and intenttonul in-
strumentation through the apex resulted in the higher
recordings of bacteraemia. Nonetheless. this study
showed far greater bacteraerruas resulting from root
canal treatment procedures than ligures produced in
the past. because of more sensitive culturing and iden-
tilkation techniques applied.
Oral disease and general health
Over the past 2; years there has been an increased
interest in the significance of oral disease and its rela-
tionship with systemic disorders. Many researchers
have studied the significance of systemic disease on
oral health though there has been limited scientific
work undertaken to study the effect of oral disease on
general health. There has been an increase in the
number of case reports published in the medical
literature citing dental infection as an associated factor
in several systemic illnesses including: uveitis (seta &
Sharav 147;. Murphy ..I al. 14741. intracranial
abscesses t l lollln ..t al. 19h7. Ilenig ,·t al. I<)7S.
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Ingham rt. al. I97S. Churton & Creer 14XO. Aldous
<'I al. 19S 7. Marks I'l al. 14SS. Saal ..t al. 14SS I.
childhood hemiplegia (Hamlyn 1<)7S I. cerebral
infarction (Syrjanen 1'1 al. 1'is'll. bucteriospermla and
subfertllity (Bieniek & Riedel 14931. necrotizing fasciitis
(Callia & Johnson 1<)111.Steel 14117. Stoykewych et ill.
1492). mediastinitis (Hendler & Quinn I47X.
Zachariades et ill. I9HH. Musgrove & Malden 141141.
fatal endocarditis (Kralovic et al. 194 'i) and toxic
shock syndrome (Egbert et al. 19117. Navazesh et al.
1994). Septicaemia has been reported to occur as a
possible complication of root canal treatment (Lee
14114).
The probability of a systemic disorder occurring from
oral foci of infection has been suggested to be particu-
larly prevalent in susceptible individuals with a
lowered immune response. These individuals include
cirrhotic patients (Borowsky "I al. 14741. patients
taking regular steroids (Latronica & Shukes 1973). the
elderly (Navazesh & Mulligan J Y9 5) and RA patients
(Ainscow & Denham 19114. Stoll c! al. 1496). Such
articles have aroused a renewed interest in the focal
infection theory. However. despite the availability of
more accurate culturing and microbiological identilica-
tion techniques and improved sclentlflc methodology.
most of these recent case reports provide only
anecdotal evidence of a possible oral source for the
bacteria. The bacterial species recovered from the
infected tissue in these patients have been assumed to
be derived from the oral cavity but they have not had
their origin reliably confirmed by rtbotyptug methods.
Consequently. there is only speculation that a dental
focus may have been the origin of the microorganisms
and the possible cause of the systemic illness.
There is continued interest in attempting to
determine if oral disease and associated oral microor-
ganisms are aetiological factors in systemic disorders.
Advanced research techniques over t he past I () years
have taken into account the many deficiencies in
older. traditional studies and thus not only has the
primary factor in a disease process been analysed. out
also the interrelationship of other risk factors (Stamler
19791. This has resulted in the dental profession scruti-
nizing more closely the correlation between dental
disease and systemic disorders. In particular. the
association between periodontal or dental disease and
cardiovascular disease has been investigated (Ceneo
.. t al. 1997. Loesche 1497. Beck & Offenbncher 144X).
A relationship has been suggested between dental
health and acute myocardial infarction (Mattila 1'1 al.
14119. Mattila I'll) 31. vascular disease and oral
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infections (Svrjanen 1990). coronary heart disease and
dental health (DeStefano 1'1al. 1993. Mattila 1'1al.
1993. Mattila 1'1al. 1995. [oshipura 1'1al. 199h).
missing teeth and ischaemic heart disease (Paunio
1'1 al. 19931. periodontal disease and cardiovascular
disease (Beck (·Ial. 199h. Beck I'lal. 19951 and acute
cerebrovascular ischaemia and dental disease (Grau
elal. 1997. Loesche 1'1 al. 1995I. Seymour & Steele
1199S) have suggested that. even taking into account
the multitude of risk factors associated with coronary
heart disease (The Pooling Project Research Group
1975)' there is strong evidence that dental health is an
important factor in the development of cardiovascular
disease. Other researchers have suggested that a rela-
tionship may exist between periodontal disease and
spontaneous abortions and premature births (Boyd
et al. 1994) and periodontal disease and preterm low
birthweight (Offenbacher 1'1 til. 199hl.
In addition. pyrexia or fever of unknown origin
IPUO) has been described as a possible symptom of oral
infection in the medical literature for many years IAlt
& Barker 1930 I. This is dell ned as episodes of fever of
31>.3 degrees centigrade or more over a three-week
period with an unclear cause upon examination after
I week of hospitalization (Petersdorf & Beeson 1961 I.
This definition has changed little over the years. Oral
sepsis has been implicated in several case reports
(Berry & Silver 19 ih. Levinson & Barondcss 1979.
Hedstrom el al. 19S0. Siminoski 19931. although the
evidence of an oral cause has been anecdotal.
However. some authors have indicated an oral cause
for PUO to be as high as 1.Jc%(:'I:aschitz & Yeshurun
19K5). This has led to debate about the potential role
of oral disease in these cases (Huebner & llrout 19Sh.
Samra 1'1 al. 19Sh. Cordon <'I Ill. 19S5I. The
involvement of pyrogens within the root canal
t Shinoda et al. 19S7) or from periodontal disease (Katz
1'1 til. 1992) have been postulated as the most probable
initiating causes in certain cases of POll. These
published case reports have once again raised the
possibility of a link between various oral disease
processes and general systemic illness 1\' an \' elzen
cl al. 19S4. Meurrnan 19971.
Oral disease. endodontics and rheumatoid arthritis
Rheumatoid disease. a chronic systemic illness. is a
common autoimmune disease of unknown aetiology
that affects approximately 1 3";, of the population
(Freese 191>5). Despite the many indications of a
possible relationship between R:\ and dcntal disease
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proclaimed during the focal infection theory era. few
articles have been published analysing this relationship
using current research techniques. Cecil & Angevine
(193S) provided evidence to discredit the focal
infection theory and demonstrated that there was no
apparent link between oral disease and RA. Nordh
(19hS) showed no correlation between chronic oral in-
lIammatory conditions and the presence of rheumatoid
arthritis serum factors. whilst other researchers
concluded that infections of the ear. nose or throat
played no role in the aetiology of rheumatoid arthritis
(Davidson 1'1 al. 1949). These findings may have led to
a reduction in the quantity and quality of research in-
vestigating any further potential links between RA and
oral disease. Despite the demise of the locnl infection
theory. there are still occasional publications linking
dental foci of infection with RA (Morer 1977. Shimizu
et al. 1977).
Scientific interest in the link between RA and oral
disease was again raised when it was demonstrated
thilt children suffering from rheumatoid arthritis and
rheumatic fever had significantly more carious teeth
than control cohorts. suggesting a possible correlation
bel ween the incidence of caries and rheumatoid
arthritis (Drecka-Kuzun 1971). This had also been
recorded by Matlashenko (19hS 1 who showed that
44.7% of a group of RA patients had complicated
forms of caries.
Malmstrom (197~1. Malmstrom & Calonius (19iS).
Malmstrom & Jokinen 119751 and Malmstrom &
'<atvig (19'151 analysed the signiflcanre of periradicu-
lar lesions within RA sufferers, The link between
rheumatoid patients and the occurrence of periradicu-
lar lesions was found to be tenuous but some
important findings were made. No relationship was
shown between the histological features or number of
perirudicular lesions present and the incidence of
rheumatoid arthritis (Malmstrom & Calonius 19751. A
weak link was detected between the presence of
rheumatoid factor in periradicular lesions and the
rheumatoid patient group. Rheumatoid factor occurred
in h% of the RA group (Malmstrom & Jokinen 1971),
although no rheumatoid factor could be found in the
gingival tissues. The 1110St convincing association
observed was the immunological and histological
reaction occurring in a periradicular lesion which was
similar to the intlammatory reaction occurring in
rheumatoid arthritis (Malmstrom & Natvig 1975). 'l'he
authors also observed a positive correlation lor the
presence of IgC rheumatoid factor in the periapical
tissues of rheumatoid sulfen-rx. Ikspite the tlndillgs
(1"' 2000 Blackwell Science Ltd
from this series of articles. there have been no other
papers published investigating the relationship of peri-
aradlcular periodontitis and rheumatoid arthritis.
Articles descrihing general oral disease patterns in
RA patients. with conflicting results, do however. exist.
Several authors have noted an increased number of
missing teeth in rheumatoid patients compared to an
unaffected population sample (Malmstrom & Calonius
1'0175. Tolo & [orkjend 1'01'010.Kasser rt al. 19'017). Blair
& Chalmers (I Y7hl had also recorded a greater
number of missing teeth in RA patients and suggested
the signilkantly earlier age of becoming totally
edentulous in the RA sample could have been a result
of extractions performed under the influence of the
focal infection theory. These fmdings were in contrast
to those of other research groups. who found no
significant difference in tooth loss for rheumatoid
arthritis patients compared with an age and sex
matched systemically healthy population (Yavuzytlmaz
et al. 1992. Arneberg et al. 1992). An epidemiological
study of 10 523 individuals in the United States also
reported no correlation between self-reported arthritis
and tooth loss (Eklund & Burt 19941.
Several studies have investigated the periodontal
condition of rheumatoid patients against population
controls. Helminen-Pakkala (19721 observed that male
RA patients had similar periodontal status to their
controls. yet female RA patients had improved
periodontal health compared to their controls. Sjostrom
et al. (I YIlY) obtained similar results observing that RA
patients had better periodontal condition than the
control population group. Yavuzyilmaz <'1 al. (I '0192)
also showed that RA patients were not a risk group for
advanced periodontal disease. However. Kasser et al.
(19'017) obtained contrasting results and concluded that
patients with longstanding active RA had a substan-
tially increased frequency of periodontal disease
compared with controls.
There have also been articles analysing the impact
of RA on the well-being of affected patients and its
potentially crippling nature in the orofacial region
(Trimble 1'1 til. 19113. Larhelm 1'1 til. 191l 3. Chalmers &
Blair 1'01'012.Kallenberg et al. I '01'017).In a review article
by Donaldson (I '01'01') I it was noted that temporoman-
dibular joint (TMII involvement in RA patients varied
from between =i() and S S%. Some research is now
being directed at investigating the roll' that oral micro-
organisms may have in initiating septic arthritis
Ijackson et al. IY'J'J). howl' ver, further research is
required to ascertain whether OTHI mn-roorganisms
play an actiological role in RA.
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Current research
Considerable research has attempted to analyse the re-
lationship of periodontal disease to general systemic
disease (Van Dyke 1'1 al. I YSh). In contrast. the role of
periradicular disease and root canal therapy in rciation
to systemic healt h has received less consideration. The
emphasis in current research is toward investigating
the relationship between periodontal disease and
coronary heart disease. although the association
between periodontal disease and RA is also being
studied (Gargiulo et al. I YS1. Yusof et al. I '0195. The &
Ebersole 199h). There is evidence that antigen injected
into the gingivae of mice is capable of inducing inflam-
mation in the knee joint (Lens & Beersten I YSS). It
has been postulated that antigenic stimulation from
inflamed gingival tissue in humans may potentially
have the same effect, In two classic studies. administra-
tion of antigen through the root canal of primates and
rabbits caused both a local and systemic immunologi-
cal response (Hames & Langeland 190h. Okada 1'1 al.
19h 7). Further animal studies have also shown that
antigenic stimulation within the root canal elicits a
strong immune response. stimulating the production of
circulating antibodies (Steffen 1'1 al. 197h. Dahlen I't al.
19112). It may therefore be possible for chronic latent
periradicular lesions to stimulate arthritic inflammation
in a similar manner to that displayed from the gingival
tissues.
The development of advanced laboratory techniques
to identify microorganisms has resulted in a greater
interest in oral microbiology (Loesche 1'1 al. 1992). In
particular. the development of the polymerase chain
reaction (Pf'R) (Birtle» 19'013) has fostered the identifi-
cation of many previously unculturable and unidentifi-
able oral microorganisms that may play a role in
systemic disease (Riggio et al. I YYh). [Ising these
highly sensitive microbiological procedures. Debelian
I't al. (1997. 1991l) have confirmed that microorgan-
isms present in bacteraemia resulting from root canal
procedures originated from the root canal. These
modern laboratory methods may allow researchers to
identify the origin of microorganisms. claimed by
authors to be from a dental source. that have been
implicated in the aetiology of septic arthritis and other
systemic disease (Patrick & Lewis 1'0192. Marshall l't al.
1'0193. Payne & Wolfe 19'014). They will also help to
determine if chronic dental infection has any influence
upon chronic RA.
Despite all the research suggesting a link between
RA and peri radicular disease. no contemporary
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sampling and analysing techniques hill'e been used 10
study the species of microorganisms present either in
the root canal or in the bacteraemia resulting from
root canal therapy in systemically ill RA patients
compared with a healthy population sample. Some
authors have stated that there is no relationship
between chronic pcnradicuiar disease and rheumatoid
arthritis ISugita 1994) although controlled scientific
evidence to support this claim is lacking. :'I1t'wman
1199h). in reviewing the theory of focal infection. has
suggested a possible link between systemic disease and
RA with oral disease.
Conclusion
Further research is required to determine whether
patients who are systemically ill with RA or PliO and
TIIR patients have a greater incidence of periradicular
disease and whether root canal treatment and any
subsequent bacteraemia may have adverse effects on
these population groups compared to matched healthy
cohorts. There have been no publications to suggest
that root canal treatment has any adverse systemic
effects since Rogers (197h) and Ehrmann (1977)
dismissed any relationship between endodontics and
focal infection in review articles. With an enhanced
awareness amongst the population toward their
general health and an increasing concern that
disturbance of the periradicular tissues may potentially
cause systemic upset. it is necessary to ascertain
whether root canal therapy is indeed exacerbating or
causing ill health. There is currently an international
body of dental practitioners who refuse to perform root
canal treatment. reCiting the research performl·d 10
SO years ago to justify this stance. However. thert' is
neither reccnt scientific evidenc(' nor studies to support
this view. Further scientific research is required to
establish the relationship between pulpally induced or
trcatment-f()sll'red pcriradicular disease and systemic
health.
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